1	The	DT	O	the	det	3	SENT_1	[p1l474t188r583b249],
2	NEW	NNP	O	NEW	nn	3	SENT_1	[p1l644t175r955b251],
3	ENGLAND	NNP	LOCATION	ENGLAND	_	0	SENT_1	[p1l1008t174r1680b251],

1	JOURNAL	NN	O	journal	_	0	SENT_2	[p1l312t299r949b402],
2	of	IN	O	of	_	0	SENT_2	[p1l1014t313r1084b392],
3	MEDICINE	NNP	O	MEDICINE	prep_of	1	SENT_2	[p1l1125t299r1840b376],

1	ESTABLISHED	VBN	O	establish	_	0	SENT_3	[p1l318t481r520b499],
2	IN	IN	O	in	_	0	SENT_3	[p1l532t481r567b499],
3	1812	CD	DATE	1812	prep_in	1	SENT_3	[p1l580t481r647b499],

1	OCTOBER	NN	DATE	october	_	0	SENT_4	[p1l925t475r1118b499],
2	28	CD	DATE	28	num	1	SENT_4	[p1l1131t474r1188b506],
3	,	,	DATE	,	_	0	SENT_4	[p1l1131t474r1188b506],
4	2010	CD	DATE	2010	appos	1	SENT_4	[p1l1206t474r1298b499],

1	VOL	NNP	O	VOL	_	0	SENT_5	[p1l1577t481r1642b499],
2	.	.	O	.	_	0	SENT_5	[p1l1577t481r1642b499],

1	363	CD	NUMBER	363	_	0	SENT_6	[p1l1654t480r1703b500],
2	NO.	NNP	O	NO.	dep	1	SENT_6	[p1l1742t481r1795b499],
3	18	CD	NUMBER	18	num	2	SENT_6	[p1l1809t481r1840b499],

1	Anaplastic	JJ	O	anaplastic	amod	4	SENT_7	[p1l153t593r471b663],
2	Lymphoma	NN	O	lymphoma	nn	4	SENT_7	[p1l499t593r841b663],
3	Kinase	NN	O	kinase	nn	4	SENT_7	[p1l868t594r1071b650],
4	Inhibition	NN	O	inhibition	_	0	SENT_7	[p1l1099t593r1404b648],
5	in	IN	O	in	_	0	SENT_7	[p1l1432t594r1490b647],
6	N	NN	O	n	prep_in	4	SENT_7	[p1l1517t598r1570b649],
7	on	IN	O	on	prep	4	SENT_7	[p1l1573t593r2003b648],
8	.	.	O	.	_	0	SENT_7	[p1l1573t593r2003b648],

1	—	NN	O	—	_	0	SENT_8	[p1l1573t593r2003b648],
2	.	.	O	.	_	0	SENT_8	[p1l1573t593r2003b648],

1	Small	JJ	O	small	_	0	SENT_9	[p1l1573t593r2003b648],
2	.	.	O	.	_	0	SENT_9	[p1l1573t593r2003b648],

1	—	NN	O	—	_	0	SENT_10	[p1l1573t593r2003b648],
2	.	.	O	.	_	0	SENT_10	[p1l1573t593r2003b648],

1	Cell	NN	O	cell	_	0	SENT_11	[p1l1573t593r2003b648],

1	Lung	NN	O	lung	nn	2	SENT_12	[p1l883t681r1039b746],
2	Cancer	NN	O	cancer	_	0	SENT_12	[p1l1065t680r1276b731],

1	Eunice	NNP	PERSON	Eunice	nn	18	SENT_13	[p1l326t785r435b813],
2	L.	NNP	PERSON	L.	nn	18	SENT_13	[p1l450t785r475b813],
3	Kwak	NNP	PERSON	Kwak	nn	18	SENT_13	[p1l492t782r585b819],
4	,	,	O	,	_	0	SENT_13	[p1l492t782r585b819],
5	M.D.	NNP	O	M.D.	appos	18	SENT_13	[p1l602t785r690b819],
6	,	,	O	,	_	0	SENT_13	[p1l602t785r690b819],
7	Ph.D.	NNP	O	Ph.D.	appos	18	SENT_13	[p1l708t782r805b819],
8	,	,	O	,	_	0	SENT_13	[p1l708t782r805b819],
9	Yung-Jue	NNP	O	Yung-Jue	appos	18	SENT_13	[p1l819t785r969b823],
10	Bang	NNP	O	Bang	nn	18	SENT_13	[p1l985t785r1076b823],
11	,	,	O	,	_	0	SENT_13	[p1l985t785r1076b823],
12	M.D.	NNP	O	M.D.	appos	18	SENT_13	[p1l1093t785r1182b819],
13	,	,	O	,	_	0	SENT_13	[p1l1093t785r1182b819],
14	Ph.D.	NNP	O	Ph.D.	appos	18	SENT_13	[p1l1199t782r1296b819],
15	,	,	O	,	_	0	SENT_13	[p1l1199t782r1296b819],
16	D.	NNP	PERSON	D.	appos	18	SENT_13	[p1l1314t785r1345b813],
17	Ross	NNP	PERSON	Ross	nn	18	SENT_13	[p1l1362t785r1438b813],
18	Camidge	NNP	PERSON	Camidge	_	0	SENT_13	[p1l1452t782r1611b823],
19	,	,	O	,	_	0	SENT_13	[p1l1452t782r1611b823],
20	M.D.	NNP	O	M.D.	nn	22	SENT_13	[p1l1628t785r1717b819],
21	,	,	O	,	_	0	SENT_13	[p1l1628t785r1717b819],
22	Ph.D.	NNP	O	Ph.D.	appos	18	SENT_13	[p1l1734t782r1832b819],
23	,	,	O	,	_	0	SENT_13	[p1l1734t782r1832b819],

1	Alice	NNP	PERSON	Alice	nn	20	SENT_14	[p1l271t832r352b863],
2	T.	NNP	PERSON	T.	nn	20	SENT_14	[p1l364t835r391b863],
3	Shaw	NNP	PERSON	Shaw	nn	20	SENT_14	[p1l406t832r502b869],
4	,	,	O	,	_	0	SENT_14	[p1l406t832r502b869],
5	M.D.	NNP	O	M.D.	appos	20	SENT_14	[p1l519t835r607b869],
6	,	,	O	,	_	0	SENT_14	[p1l519t835r607b869],
7	Ph.D.	NNP	O	Ph.D.	appos	20	SENT_14	[p1l625t832r722b869],
8	,	,	O	,	_	0	SENT_14	[p1l625t832r722b869],
9	Benjamin	NNP	PERSON	Benjamin	appos	20	SENT_14	[p1l740t835r896b873],
10	Solomon	NNP	PERSON	Solomon	nn	20	SENT_14	[p1l912t832r1074b869],
11	,	,	O	,	_	0	SENT_14	[p1l912t832r1074b869],
12	M.B.	NNP	LOCATION	M.B.	appos	20	SENT_14	[p1l1091t835r1176b869],
13	,	,	O	,	_	0	SENT_14	[p1l1091t835r1176b869],
14	B.S.	NNP	O	B.S.	appos	20	SENT_14	[p1l1193t834r1265b869],
15	,	,	O	,	_	0	SENT_14	[p1l1193t834r1265b869],
16	Ph.D.	NNP	O	Ph.D.	appos	20	SENT_14	[p1l1282t832r1379b869],
17	,	,	O	,	_	0	SENT_14	[p1l1282t832r1379b869],
18	Robert	NNP	PERSON	Robert	appos	20	SENT_14	[p1l1397t832r1509b863],
19	G.	NNP	PERSON	G.	nn	20	SENT_14	[p1l1521t834r1557b863],
20	Maki	NNP	PERSON	Maki	_	0	SENT_14	[p1l1574t832r1662b869],
21	,	,	O	,	_	0	SENT_14	[p1l1574t832r1662b869],
22	M.D.	NNP	O	M.D.	nn	24	SENT_14	[p1l1679t835r1768b869],
23	,	,	O	,	_	0	SENT_14	[p1l1679t835r1768b869],
24	Ph.D.	NNP	O	Ph.D.	appos	20	SENT_14	[p1l1785t832r1882b869],
25	,	,	O	,	_	0	SENT_14	[p1l1785t832r1882b869],

1	Sai-Hong	NNP	LOCATION	Sai-Hong	nn	3	SENT_15	[p1l149t884r308b923],
2	I.	NNP	LOCATION	I.	nn	3	SENT_15	[p1l323t885r339b913],
3	Ou	NNP	LOCATION	Ou	_	0	SENT_15	[p1l353t884r413b919],
4	,	,	O	,	_	0	SENT_15	[p1l353t884r413b919],
5	M.D.	NNP	O	M.D.	nn	10	SENT_15	[p1l430t885r519b919],
6	,	,	O	,	_	0	SENT_15	[p1l430t885r519b919],
7	Ph.D.	NNP	O	Ph.D.	appos	10	SENT_15	[p1l536t882r634b919],
8	,	,	O	,	_	0	SENT_15	[p1l536t882r634b919],
9	Bruce	NNP	PERSON	Bruce	appos	10	SENT_15	[p1l651t885r776b922],
10	]	NNP	O	]	appos	3	SENT_15	[p1l651t885r776b922],
11	.	.	O	.	_	0	SENT_15	[p1l651t885r776b922],

1	Dezube	NNP	PERSON	Dezube	nn	15	SENT_16	[p1l793t882r929b919],
2	,	,	O	,	_	0	SENT_16	[p1l793t882r929b919],
3	M.D.	NNP	O	M.D.	appos	15	SENT_16	[p1l947t885r1035b919],
4	,	,	O	,	_	0	SENT_16	[p1l947t885r1035b919],
5	Pasi	NNP	PERSON	Pasi	appos	15	SENT_16	[p1l1053t885r1116b913],
6	A.	NNP	PERSON	A.	nn	15	SENT_16	[p1l1130t884r1280b922],
7	Janne	NNP	PERSON	Janne	nn	15	SENT_16	[p1l1130t884r1280b922],
8	,	,	O	,	_	0	SENT_16	[p1l1130t884r1280b922],
9	M.D.	NNP	O	M.D.	appos	15	SENT_16	[p1l1297t885r1385b919],
10	,	,	O	,	_	0	SENT_16	[p1l1297t885r1385b919],
11	Ph.D.	NNP	O	Ph.D.	appos	15	SENT_16	[p1l1403t882r1500b919],
12	,	,	O	,	_	0	SENT_16	[p1l1403t882r1500b919],
13	Daniel	NNP	PERSON	Daniel	appos	15	SENT_16	[p1l1517t882r1622b913],
14	B.	NNP	PERSON	B.	nn	15	SENT_16	[p1l1639t885r1667b913],
15	Costa	NNP	PERSON	Costa	_	0	SENT_16	[p1l1682t884r1786b919],
16	,	,	O	,	_	0	SENT_16	[p1l1682t884r1786b919],
17	M.D.	NNP	O	M.D.	nn	19	SENT_16	[p1l1803t885r1892b919],
18	,	,	O	,	_	0	SENT_16	[p1l1803t885r1892b919],
19	Ph.D.	NNP	O	Ph.D.	appos	15	SENT_16	[p1l1909t882r2007b919],
20	,	,	O	,	_	0	SENT_16	[p1l1909t882r2007b919],

1	Marileila	NNP	PERSON	Marileila	nn	2	SENT_17	[p1l267t932r410b963],
2	Varella-Garcia	NNP	PERSON	Varella-Garcia	_	0	SENT_17	[p1l423t932r670b969],
3	,	,	O	,	_	0	SENT_17	[p1l423t932r670b969],
4	Ph.D.	NNP	O	Ph.D.	appos	2	SENT_17	[p1l687t932r784b969],
5	,	,	O	,	_	0	SENT_17	[p1l687t932r784b969],
6	Woo-Ho	NNP	O	Woo-Ho	nn	7	SENT_17	[p1l798t935r943b963],
7	Kim	NNP	PERSON	Kim	appos	2	SENT_17	[p1l959t935r1031b969],
8	,	,	O	,	_	0	SENT_17	[p1l959t935r1031b969],
9	M.D.	NNP	O	M.D.	appos	2	SENT_17	[p1l1048t935r1137b969],
10	,	,	O	,	_	0	SENT_17	[p1l1048t935r1137b969],
11	Thomas	NNP	PERSON	Thomas	nn	12	SENT_17	[p1l1150t932r1320b972],
12	]	NNP	O	]	appos	2	SENT_17	[p1l1150t932r1320b972],
13	.	.	O	.	_	0	SENT_17	[p1l1150t932r1320b972],

1	Lynch	NNP	PERSON	Lynch	nn	6	SENT_18	[p1l1337t932r1441b973],
2	,	,	O	,	_	0	SENT_18	[p1l1337t932r1441b973],
3	M.D.	NNP	O	M.D.	appos	6	SENT_18	[p1l1458t935r1547b969],
4	,	,	O	,	_	0	SENT_18	[p1l1458t935r1547b969],
5	Panos	NNP	PERSON	Panos	appos	6	SENT_18	[p1l1564t935r1663b963],
6	Fidias	NNP	PERSON	Fidias	_	0	SENT_18	[p1l1680t932r1785b969],
7	,	,	O	,	_	0	SENT_18	[p1l1680t932r1785b969],
8	M.D.	NNP	O	M.D.	dep	6	SENT_18	[p1l1802t935r1891b969],
9	,	,	O	,	_	0	SENT_18	[p1l1802t935r1891b969],

1	Hannah	NNP	PERSON	Hannah	nn	2	SENT_19	[p1l168t981r299b1012],
2	Stubbs	NNP	PERSON	Stubbs	dep	39	SENT_19	[p1l314t981r439b1018],
3	,	,	O	,	_	0	SENT_19	[p1l314t981r439b1018],
4	M.S.	NNP	LOCATION	M.S.	appos	2	SENT_19	[p1l456t981r660b1022],
5	,	,	O	,	_	0	SENT_19	[p1l456t981r660b1022],
6	Jel	NNP	PERSON	Jel	nn	10	SENT_19	[p1l456t981r660b1022],
7	’	NNP	O	’	nn	10	SENT_19	[p1l456t981r660b1022],
8	frey	NN	O	frey	nn	10	SENT_19	[p1l456t981r660b1022],
9	A.	NN	PERSON	a.	nn	10	SENT_19	[p1l671t983r704b1012],
10	Engelman	NNP	PERSON	Engelman	appos	2	SENT_19	[p1l722t981r897b1022],
11	,	,	O	,	_	0	SENT_19	[p1l722t981r897b1022],
12	M.D.	NNP	O	M.D.	appos	2	SENT_19	[p1l914t984r1003b1018],
13	,	,	O	,	_	0	SENT_19	[p1l914t984r1003b1018],
14	Ph.D.	NNP	O	Ph.D.	appos	2	SENT_19	[p1l1020t981r1118b1018],
15	,	,	O	,	_	0	SENT_19	[p1l1020t981r1118b1018],
16	Lecia	NNP	PERSON	Lecia	nn	18	SENT_19	[p1l1135t984r1218b1012],
17	V.	NNP	PERSON	V.	nn	18	SENT_19	[p1l1230t984r1259b1013],
18	Sequist	NNP	PERSON	Sequist	appos	2	SENT_19	[p1l1274t984r1408b1022],
19	,	,	O	,	_	0	SENT_19	[p1l1274t984r1408b1022],
20	M.D.	NNP	O	M.D.	appos	2	SENT_19	[p1l1425t984r1514b1018],
21	,	,	O	,	_	0	SENT_19	[p1l1425t984r1514b1018],
22	M.P.H.	NNP	O	M.P.H.	appos	2	SENT_19	[p1l1531t984r1653b1018],
23	,	,	O	,	_	0	SENT_19	[p1l1531t984r1653b1018],
24	WeiWei	NNP	O	WeiWei	nn	25	SENT_19	[p1l1666t984r1793b1012],
25	Tan	NNP	O	Tan	appos	2	SENT_19	[p1l1806t984r1875b1018],
26	,	,	O	,	_	0	SENT_19	[p1l1806t984r1875b1018],
27	Ph.D.	NNP	O	Ph.D.	appos	2	SENT_19	[p1l1892t981r1990b1018],
28	,	,	O	,	_	0	SENT_19	[p1l1892t981r1990b1018],
29	Leena	NNP	PERSON	Leena	nn	30	SENT_19	[p1l157t1034r254b1062],
30	Gandhi	NNP	PERSON	Gandhi	appos	2	SENT_19	[p1l267t1031r399b1068],
31	,	,	O	,	_	0	SENT_19	[p1l267t1031r399b1068],
32	M.D.	NNP	O	M.D.	appos	2	SENT_19	[p1l416t1034r505b1068],
33	,	,	O	,	_	0	SENT_19	[p1l416t1034r505b1068],
34	Ph.D.	NNP	O	Ph.D.	appos	2	SENT_19	[p1l522t1031r620b1068],
35	,	,	O	,	_	0	SENT_19	[p1l522t1031r620b1068],
36	Mari	NNP	PERSON	Mari	nn	37	SENT_19	[p1l637t1034r710b1062],
37	Mino-l	NNP	PERSON	Mino-l	appos	2	SENT_19	[p1l727t1031r1008b1068],
38	(	NN	O	(	nn	39	SENT_19	[p1l727t1031r1008b1068],
39	enudson	NN	O	enudson	_	0	SENT_19	[p1l727t1031r1008b1068],
40	,	,	O	,	_	0	SENT_19	[p1l727t1031r1008b1068],
41	M.D.	NNP	O	M.D.	appos	39	SENT_19	[p1l1026t1034r1114b1068],
42	,	,	O	,	_	0	SENT_19	[p1l1026t1034r1114b1068],
43	Greg	NNP	PERSON	Greg	nn	45	SENT_19	[p1l1129t1033r1211b1072],
44	C.	NNP	PERSON	C.	nn	45	SENT_19	[p1l1223t1033r1255b1062],
45	Wei	NNP	PERSON	Wei	appos	39	SENT_19	[p1l1268t1034r1340b1068],
46	,	,	O	,	_	0	SENT_19	[p1l1268t1034r1340b1068],
47	Ph.D.	NNP	O	Ph.D.	appos	39	SENT_19	[p1l1357t1031r1454b1068],
48	,	,	O	,	_	0	SENT_19	[p1l1357t1031r1454b1068],
49	S.	NNP	PERSON	S.	nn	51	SENT_19	[p1l1470t1033r1497b1062],
50	Martin	NNP	PERSON	Martin	nn	51	SENT_19	[p1l1514t1034r1624b1062],
51	Shreeve	NNP	PERSON	Shreeve	appos	39	SENT_19	[p1l1639t1031r1780b1068],
52	,	,	O	,	_	0	SENT_19	[p1l1639t1031r1780b1068],
53	M.D.	NNP	O	M.D.	appos	39	SENT_19	[p1l1797t1034r1886b1068],
54	,	,	O	,	_	0	SENT_19	[p1l1797t1034r1886b1068],
55	Ph.D.	NNP	O	Ph.D.	appos	39	SENT_19	[p1l1903t1031r2001b1068],
56	,	,	O	,	_	0	SENT_19	[p1l1903t1031r2001b1068],
57	Mark	NNP	PERSON	Mark	appos	39	SENT_19	[p1l178t1080r293b1120],
58	]	CD	NUMBER	]	num	57	SENT_19	[p1l178t1080r293b1120],
59	.	.	O	.	_	0	SENT_19	[p1l178t1080r293b1120],

1	Ratain	NNP	O	Ratain	_	0	SENT_20	[p1l310t1083r422b1117],
2	,	,	O	,	_	0	SENT_20	[p1l310t1083r422b1117],
3	M.D.	NNP	O	M.D.	dep	1	SENT_20	[p1l439t1080r649b1121],
4	,	,	O	,	_	0	SENT_20	[p1l439t1080r649b1121],
5	Jeffrey	NNP	PERSON	Jeffrey	nn	6	SENT_20	[p1l439t1080r649b1121],
6	Settleman	NNP	PERSON	Settleman	appos	3	SENT_20	[p1l661t1080r843b1117],
7	,	,	O	,	_	0	SENT_20	[p1l661t1080r843b1117],
8	Ph.D.	NNP	O	Ph.D.	appos	3	SENT_20	[p1l861t1080r1074b1120],
9	,	,	O	,	_	0	SENT_20	[p1l861t1080r1074b1120],
10	James	NNP	PERSON	James	nn	12	SENT_20	[p1l861t1080r1074b1120],
11	G.	NNP	PERSON	G.	nn	12	SENT_20	[p1l1088t1083r1123b1111],
12	Christensen	NNP	PERSON	Christensen	appos	3	SENT_20	[p1l1138t1080r1350b1117],
13	,	,	O	,	_	0	SENT_20	[p1l1138t1080r1350b1117],
14	Ph.D.	NNP	O	Ph.D.	appos	3	SENT_20	[p1l1367t1080r1465b1117],
15	,	,	O	,	_	0	SENT_20	[p1l1367t1080r1465b1117],
16	Daniel	NNP	PERSON	Daniel	nn	18	SENT_20	[p1l1482t1080r1586b1111],
17	A.	NNP	PERSON	A.	nn	18	SENT_20	[p1l1600t1082r1633b1111],
18	Haber	NNP	PERSON	Haber	appos	3	SENT_20	[p1l1650t1080r1759b1117],
19	,	,	O	,	_	0	SENT_20	[p1l1650t1080r1759b1117],
20	M.D.	NNP	O	M.D.	appos	3	SENT_20	[p1l1776t1083r1865b1117],
21	,	,	O	,	_	0	SENT_20	[p1l1776t1083r1865b1117],
22	Ph.D.	NNP	O	Ph.D.	appos	3	SENT_20	[p1l1882t1080r1980b1117],
23	,	,	O	,	_	0	SENT_20	[p1l1882t1080r1980b1117],

1	Keith	NNP	PERSON	Keith	nn	15	SENT_21	[p1l228t1129r309b1160],
2	Wilner	NNP	PERSON	Wilner	nn	15	SENT_21	[p1l322t1129r440b1166],
3	,	,	O	,	_	0	SENT_21	[p1l322t1129r440b1166],
4	Ph.D.	NNP	O	Ph.D.	appos	15	SENT_21	[p1l457t1129r555b1166],
5	,	,	O	,	_	0	SENT_21	[p1l457t1129r555b1166],
6	Ravi	NNP	PERSON	Ravi	appos	15	SENT_21	[p1l572t1132r637b1160],
7	Salgia	NNP	PERSON	Salgia	nn	15	SENT_21	[p1l652t1129r760b1170],
8	,	,	O	,	_	0	SENT_21	[p1l652t1129r760b1170],
9	M.D.	NNP	O	M.D.	appos	15	SENT_21	[p1l777t1132r866b1166],
10	,	,	O	,	_	0	SENT_21	[p1l777t1132r866b1166],
11	Ph.D.	NNP	O	Ph.D.	appos	15	SENT_21	[p1l883t1129r981b1166],
12	,	,	O	,	_	0	SENT_21	[p1l883t1129r981b1166],
13	Geoffrey	NNP	PERSON	Geoffrey	appos	15	SENT_21	[p1l995t1129r1141b1170],
14	I.	NNP	PERSON	I.	nn	15	SENT_21	[p1l1155t1132r1171b1160],
15	Shapiro	NNP	PERSON	Shapiro	_	0	SENT_21	[p1l1186t1129r1323b1170],
16	,	,	O	,	_	0	SENT_21	[p1l1186t1129r1323b1170],
17	M.D.	NNP	O	M.D.	nn	27	SENT_21	[p1l1340t1132r1428b1166],
18	,	,	O	,	_	0	SENT_21	[p1l1340t1132r1428b1166],
19	Ph.D.	NNP	O	Ph.D.	appos	27	SENT_21	[p1l1446t1129r1664b1170],
20	,	,	O	,	_	0	SENT_21	[p1l1446t1129r1664b1170],
21	Jefl	NNP	O	Jefl	appos	27	SENT_21	[p1l1446t1129r1664b1170],
22	’re	FW	O	’re	nn	27	SENT_21	[p1l1446t1129r1664b1170],
23	y	NNP	O	y	nn	27	SENT_21	[p1l1446t1129r1664b1170],
24	W.	NNP	PERSON	W.	nn	27	SENT_21	[p1l1675t1132r1716b1160],
25	Clark	NNP	PERSON	Clark	nn	27	SENT_21	[p1l1731t1129r1824b1166],
26	,	,	O	,	_	0	SENT_21	[p1l1731t1129r1824b1166],
27	M.D.	NNP	O	M.D.	appos	15	SENT_21	[p1l1841t1132r1930b1166],
28	,	,	O	,	_	0	SENT_21	[p1l1841t1132r1930b1166],

1	and	CC	O	and	dep	6	SENT_22	[p1l810t1178r869b1209],
2	A.	NN	PERSON	a.	nn	6	SENT_22	[p1l883t1178r1005b1218],
3	john	NN	PERSON	john	nn	6	SENT_22	[p1l883t1178r1005b1218],
4	Iafrate	NNP	PERSON	Iafrate	nn	6	SENT_22	[p1l1022t1178r1136b1215],
5	,	,	O	,	_	0	SENT_22	[p1l1022t1178r1136b1215],
6	M.D.	NNP	O	M.D.	_	0	SENT_22	[p1l1153t1181r1241b1215],
7	,	,	O	,	_	0	SENT_22	[p1l1153t1181r1241b1215],
8	Ph.D.	NNP	O	Ph.D.	appos	6	SENT_22	[p1l1259t1178r1346b1209],
9	.	.	O	.	_	0	SENT_22	[p1l1259t1178r1346b1209],

1	ABSTRACT	NN	O	abstract	_	0	SENT_23	[p1l967t1298r1190b1321],

1	BAC	NN	O	bac	nn	7	SENT_24	[p1l94t1403r149b1422],
2	KG	NN	O	kg	nn	7	SENT_24	[p1l154t1403r191b1422],
3	R	NN	O	r	nn	7	SENT_24	[p1l197t1403r211b1422],
4	o	NN	O	o	nn	7	SENT_24	[p1l216t1403r237b1422],
5	u	NN	O	u	nn	7	SENT_24	[p1l242t1403r259b1422],
6	N	NN	O	n	nn	7	SENT_24	[p1l266t1403r283b1422],
7	D	NN	O	d	nsubj	22	SENT_24	[p1l291t1403r309b1422],
8	Oncogenic	JJ	MISC	oncogenic	amod	10	SENT_24	[p1l92t1445r264b1484],
9	fusion	NN	O	fusion	nn	10	SENT_24	[p1l274t1444r375b1476],
10	genes	NNS	O	gene	dep	7	SENT_24	[p1l386t1455r476b1484],
11	consisting	VBG	O	consist	partmod	7	SENT_24	[p1l488t1445r654b1484],
12	of	IN	O	of	_	0	SENT_24	[p1l664t1444r702b1475],
13	EML4	NN	O	eml4	prep_of	11	SENT_24	[p1l705t1447r793b1475],
14	and	CC	O	and	_	0	SENT_24	[p1l803t1444r863b1475],
15	anaplastic	JJ	O	anaplastic	amod	20	SENT_24	[p1l873t1444r1035b1484],
16	lymphoma	NN	O	lymphoma	nn	20	SENT_24	[p1l1045t1444r1218b1484],
17	kinase	NN	O	kinase	nn	20	SENT_24	[p1l1228t1444r1332b1476],
18	(	NN	O	(	nn	20	SENT_24	[p1l1345t1447r1429b1480],
19	ALK	NN	O	alk	nn	20	SENT_24	[p1l1345t1447r1429b1480],
20	)	NN	O	)	prep_of	11	SENT_24	[p1l1345t1447r1429b1480],
21	are	VBP	O	be	cop	22	SENT_24	[p1l1442t1455r1490b1475],
22	present	JJ	DATE	present	_	0	SENT_24	[p1l91t1501r215b1534],
23	in	IN	O	in	_	0	SENT_24	[p1l225t1495r258b1525],
24	a	DT	O	a	det	25	SENT_24	[p1l270t1505r287b1526],
25	subgroup	NN	O	subgroup	prep_in	22	SENT_24	[p1l299t1495r456b1534],
26	of	IN	O	of	_	0	SENT_24	[p1l469t1495r508b1526],
27	non	JJ	O	non	amod	33	SENT_24	[p1l513t1495r762b1526],
28	—	JJ	O	—	amod	33	SENT_24	[p1l513t1495r762b1526],
29	small	JJ	O	small	amod	33	SENT_24	[p1l513t1495r762b1526],
30	—	NN	O	—	nn	33	SENT_24	[p1l513t1495r762b1526],
31	cell	NN	O	cell	nn	33	SENT_24	[p1l513t1495r762b1526],
32	lung	NN	O	lung	nn	33	SENT_24	[p1l774t1495r849b1534],
33	cancers	NNS	O	cancer	prep_of	25	SENT_24	[p1l860t1505r994b1532],
34	,	,	O	,	_	0	SENT_24	[p1l860t1505r994b1532],
35	representing	VBG	O	represent	partmod	33	SENT_24	[p1l1008t1495r1220b1534],
36	2	CD	NUMBER	2	dobj	35	SENT_24	[p1l1231t1497r1249b1525],
37	to	TO	O	to	_	0	SENT_24	[p1l1262t1501r1294b1526],
38	7	CD	NUMBER	7	number	39	SENT_24	[p1l1307t1497r1358b1526],
39	°	CD	NUMBER	°	prep_to	35	SENT_24	[p1l1307t1497r1358b1526],
40	/	:	O	/	punct	41	SENT_24	[p1l1307t1497r1358b1526],
41	o	NN	O	o	dep	22	SENT_24	[p1l1307t1497r1358b1526],
42	of	IN	O	of	_	0	SENT_24	[p1l1371t1495r1410b1526],
43	such	JJ	O	such	amod	44	SENT_24	[p1l1415t1495r1490b1526],
44	tumors	NNS	O	tumor	prep_of	41	SENT_24	[p1l92t1552r219b1576],
45	.	.	O	.	_	0	SENT_24	[p1l92t1552r219b1576],

1	We	PRP	O	we	nsubj	2	SENT_25	[p1l231t1548r283b1576],
2	explored	VBD	O	explore	_	0	SENT_25	[p1l295t1545r435b1584],
3	the	DT	O	the	det	5	SENT_25	[p1l447t1545r498b1576],
4	therapeutic	JJ	O	therapeutic	amod	5	SENT_25	[p1l510t1545r694b1584],
5	efﬁcacy	NN	O	efﬁcacy	dobj	2	SENT_25	[p1l706t1545r834b1584],
6	of	IN	O	of	_	0	SENT_25	[p1l845t1545r883b1576],
7	inhibiting	VBG	O	inhibit	prepc_of	5	SENT_25	[p1l888t1545r1052b1585],
8	ALK	NNP	O	ALK	dobj	7	SENT_25	[p1l1062t1548r1135b1577],
9	in	IN	O	in	_	0	SENT_25	[p1l1146t1546r1178b1575],
10	such	JJ	O	such	amod	11	SENT_25	[p1l1191t1545r1265b1576],
11	tumors	NNS	O	tumor	prep_in	7	SENT_25	[p1l1277t1552r1394b1576],
12	in	IN	O	in	_	0	SENT_25	[p1l1407t1546r1439b1575],
13	an	DT	O	a	det	18	SENT_25	[p1l1451t1555r1490b1576],
14	early	JJ	O	early	amod	18	SENT_25	[p1l92t1595r272b1634],
15	—	NN	O	—	nn	18	SENT_25	[p1l92t1595r272b1634],
16	phase	NN	O	phase	nn	18	SENT_25	[p1l92t1595r272b1634],
17	clinical	JJ	O	clinical	amod	18	SENT_25	[p1l283t1595r399b1626],
18	trial	NN	O	trial	prep_in	11	SENT_25	[p1l410t1595r476b1626],
19	of	IN	O	of	_	0	SENT_25	[p1l487t1595r526b1626],
20	crizotinib	NN	O	crizotinib	nn	22	SENT_25	[p1l530t1595r685b1626],
21	(	CD	NUMBER	(	num	22	SENT_25	[p1l699t1598r934b1632],
22	PF	NN	O	pf	prep_of	18	SENT_25	[p1l699t1598r934b1632],
23	—	CD	NUMBER	—	num	22	SENT_25	[p1l699t1598r934b1632],
24	02341066	CD	NUMBER	02341066	num	25	SENT_25	[p1l699t1598r934b1632],
25	)	NN	O	)	tmod	7	SENT_25	[p1l699t1598r934b1632],
26	,	,	O	,	_	0	SENT_25	[p1l699t1598r934b1632],
27	an	DT	O	a	det	33	SENT_25	[p1l947t1605r986b1626],
28	orally	RB	O	orally	advmod	29	SENT_25	[p1l998t1595r1088b1634],
29	available	JJ	O	available	amod	33	SENT_25	[p1l1097t1595r1235b1626],
30	small	JJ	O	small	amod	33	SENT_25	[p1l1247t1595r1490b1626],
31	—	NN	O	—	nn	33	SENT_25	[p1l1247t1595r1490b1626],
32	molecule	NN	O	molecule	nn	33	SENT_25	[p1l1247t1595r1490b1626],
33	inhibitor	NN	O	inhibitor	appos	25	SENT_25	[p1l92t1645r237b1676],
34	of	IN	O	of	_	0	SENT_25	[p1l248t1645r287b1676],
35	the	DT	O	the	det	38	SENT_25	[p1l292t1645r343b1675],
36	ALK	NNP	O	ALK	nn	38	SENT_25	[p1l354t1648r428b1676],
37	tyrosine	NN	O	tyrosine	nn	38	SENT_25	[p1l439t1645r570b1684],
38	kinase	NN	O	kinase	prep_of	33	SENT_25	[p1l583t1645r697b1676],
39	.	.	O	.	_	0	SENT_25	[p1l583t1645r697b1676],

1	M	NN	O	m	nn	4	SENT_26	[p1l95t1731r115b1749],
2	ETH	NN	O	eth	nn	4	SENT_26	[p1l123t1731r178b1749],
3	o	NN	O	o	nn	4	SENT_26	[p1l184t1730r205b1750],
4	DS	NN	O	d	npadvmod	29	SENT_26	[p1l211t1730r247b1750],
5	After	IN	O	after	_	0	SENT_26	[p1l91t1773r174b1804],
6	screening	VBG	O	screen	prepc_after	29	SENT_26	[p1l186t1774r341b1813],
7	tumor	NN	O	tumor	nn	8	SENT_26	[p1l352t1780r453b1804],
8	samples	NNS	O	sample	dobj	6	SENT_26	[p1l465t1774r593b1813],
9	from	IN	O	from	_	0	SENT_26	[p1l607t1773r686b1804],
10	approximately	RB	O	approximately	quantmod	11	SENT_26	[p1l698t1774r927b1813],
11	1500	CD	NUMBER	1500	num	12	SENT_26	[p1l939t1776r1016b1804],
12	patients	NNS	O	patient	prep_from	6	SENT_26	[p1l1028t1774r1154b1813],
13	with	IN	O	with	_	0	SENT_26	[p1l1166t1774r1239b1804],
14	non	JJ	O	non	amod	20	SENT_26	[p1l1252t1774r1490b1804],
15	—	JJ	O	—	amod	20	SENT_26	[p1l1252t1774r1490b1804],
16	small	JJ	O	small	amod	20	SENT_26	[p1l1252t1774r1490b1804],
17	—	NN	O	—	nn	20	SENT_26	[p1l1252t1774r1490b1804],
18	cell	NN	O	cell	nn	20	SENT_26	[p1l1252t1774r1490b1804],
19	lung	NN	O	lung	nn	20	SENT_26	[p1l92t1823r164b1862],
20	cancer	NN	O	cancer	prep_with	6	SENT_26	[p1l175t1833r284b1854],
21	for	IN	O	for	_	0	SENT_26	[p1l296t1823r344b1854],
22	the	DT	O	the	det	23	SENT_26	[p1l356t1823r407b1854],
23	presence	NN	O	presence	prep_for	20	SENT_26	[p1l420t1833r565b1862],
24	of	IN	O	of	_	0	SENT_26	[p1l579t1823r618b1854],
25	ALK	NN	O	alk	nn	26	SENT_26	[p1l621t1825r689b1854],
26	rearrangements	NNS	O	rearrangement	prep_of	23	SENT_26	[p1l698t1830r972b1862],
27	,	,	O	,	_	0	SENT_26	[p1l698t1830r972b1862],
28	we	PRP	O	we	nsubj	29	SENT_26	[p1l985t1833r1031b1854],
29	identified	VBD	O	identify	_	0	SENT_26	[p1l1044t1823r1206b1854],
30	82	CD	NUMBER	82	num	31	SENT_26	[p1l1219t1825r1257b1854],
31	patients	NNS	O	patient	dobj	29	SENT_26	[p1l1270t1824r1402b1862],
32	with	IN	O	with	_	0	SENT_26	[p1l1414t1823r1490b1854],
33	advanced	JJ	O	advanced	amod	37	SENT_26	[p1l92t1873r242b1904],
34	ALK	NNP	O	ALK	dep	36	SENT_26	[p1l252t1874r452b1912],
35	—	CD	NUMBER	—	num	34	SENT_26	[p1l252t1874r452b1912],
36	positive	JJ	O	positive	amod	37	SENT_26	[p1l252t1874r452b1912],
37	disease	NN	O	disease	prep_with	29	SENT_26	[p1l465t1873r583b1904],
38	who	WP	O	who	nsubj	40	SENT_26	[p1l594t1873r664b1904],
39	were	VBD	O	be	cop	40	SENT_26	[p1l675t1883r752b1904],
40	eligible	JJ	O	eligible	rcmod	37	SENT_26	[p1l765t1873r883b1913],
41	for	IN	O	for	_	0	SENT_26	[p1l895t1873r942b1904],
42	the	DT	O	the	det	44	SENT_26	[p1l954t1873r1005b1904],
43	clinical	JJ	O	clinical	amod	44	SENT_26	[p1l1017t1873r1136b1904],
44	trial	NN	O	trial	prep_for	40	SENT_26	[p1l1149t1873r1224b1904],
45	.	.	O	.	_	0	SENT_26	[p1l1149t1873r1224b1904],

1	Most	JJS	O	most	nsubj	6	SENT_27	[p1l1238t1876r1322b1904],
2	of	IN	O	of	_	0	SENT_27	[p1l1332t1873r1371b1904],
3	the	DT	O	the	det	4	SENT_27	[p1l1376t1873r1427b1904],
4	patients	NNS	O	patient	prep_of	1	SENT_27	[p1l1439t1883r1490b1912, p1l92t1924r182b1954],
5	had	VBD	O	have	aux	6	SENT_27	[p1l193t1923r254b1954],
6	received	VBN	O	receive	_	0	SENT_27	[p1l265t1923r399b1954],
7	previous	JJ	O	previous	amod	8	SENT_27	[p1l410t1924r551b1963],
8	treatment	NN	O	treatment	dobj	6	SENT_27	[p1l563t1930r735b1954],
9	.	.	O	.	_	0	SENT_27	[p1l563t1930r735b1954],

1	These	DT	O	these	det	2	SENT_28	[p1l747t1923r845b1954],
2	patients	NNS	O	patient	nsubjpass	4	SENT_28	[p1l856t1924r988b1963],
3	were	VBD	O	be	auxpass	4	SENT_28	[p1l999t1934r1077b1954],
4	enrolled	VBN	O	enrol	dep	17	SENT_28	[p1l1089t1923r1225b1954],
5	in	IN	O	in	_	0	SENT_28	[p1l1236t1924r1268b1954],
6	an	DT	O	a	det	9	SENT_28	[p1l1279t1933r1319b1954],
7	expanded	VBN	O	expand	amod	9	SENT_28	[p1l1331t1923r1490b1963],
8	cohort	NN	O	cohort	nn	9	SENT_28	[p1l92t1973r199b2004],
9	study	NN	O	study	prep_in	4	SENT_28	[p1l209t1973r297b2012],
10	instituted	VBN	O	institute	partmod	9	SENT_28	[p1l306t1973r464b2004],
11	after	IN	O	after	_	0	SENT_28	[p1l475t1973r552b2004],
12	phase	NN	O	phase	nn	15	SENT_28	[p1l562t1973r657b2012],
13	1	CD	NUMBER	1	num	15	SENT_28	[p1l669t1975r687b2003],
14	dose	NN	O	dose	nn	15	SENT_28	[p1l699t1973r773b2004],
15	escalation	NN	O	escalation	prep_after	10	SENT_28	[p1l785t1973r950b2004],
16	had	VBD	O	have	aux	17	SENT_28	[p1l961t1973r1021b2004],
17	established	VBN	O	establish	_	0	SENT_28	[p1l1033t1973r1216b2004],
18	a	DT	O	a	det	21	SENT_28	[p1l1227t1983r1244b2004],
19	recommended	VBN	O	recommend	amod	21	SENT_28	[p1l1255t1973r1490b2004],
20	crizotinib	NN	O	crizotinib	nn	21	SENT_28	[p1l92t2023r255b2053],
21	dose	NN	O	dose	dobj	17	SENT_28	[p1l271t2023r347b2053],
22	of	IN	O	of	_	0	SENT_28	[p1l362t2022r401b2053],
23	250	CD	NUMBER	250	num	24	SENT_28	[p1l409t2025r468b2053],
24	mg	NN	O	mg	prep_of	21	SENT_28	[p1l484t2033r538b2062],
25	twice	RB	O	twice	advmod	26	SENT_28	[p1l552t2023r640b2053],
26	daily	RB	SET	daily	nsubj	17	SENT_28	[p1l656t2023r737b2062],
27	in	IN	O	in	_	0	SENT_28	[p1l750t2023r783b2053],
28	28-day	JJ	DURATION	28-day	amod	29	SENT_28	[p1l798t2023r909b2062],
29	cycles	NNS	O	cycle	prep_in	26	SENT_28	[p1l923t2023r1028b2062],
30	.	.	O	.	_	0	SENT_28	[p1l923t2023r1028b2062],

1	Patients	NNS	O	patient	nsubjpass	3	SENT_29	[p1l1045t2023r1177b2053],
2	were	VBD	O	be	auxpass	3	SENT_29	[p1l1191t2033r1270b2053],
3	assessed	VBN	O	assess	_	0	SENT_29	[p1l1285t2023r1428b2053],
4	for	IN	O	for	_	0	SENT_29	[p1l1443t2022r1491b2053],
5	adverse	JJ	O	adverse	amod	6	SENT_29	[p1l92t2073r214b2103],
6	events	NNS	O	event	prep_for	3	SENT_29	[p1l228t2079r330b2103],
7	and	CC	O	and	_	0	SENT_29	[p1l344t2073r405b2103],
8	response	NN	O	response	prep_for	3	SENT_29	[p1l418t2083r566b2112],
9	to	TO	O	to	_	0	SENT_29	[p1l579t2079r611b2103],
10	therapy	NN	O	therapy	prep_to	3	SENT_29	[p1l625t2073r755b2112],
11	.	.	O	.	_	0	SENT_29	[p1l625t2073r755b2112],

1	RESULTS	NNS	O	result	nn	2	SENT_30	[p1l94t2159r221b2179],
2	Patients	NNS	O	patient	nsubj	6	SENT_30	[p1l92t2203r223b2233],
3	with	IN	O	with	_	0	SENT_30	[p1l236t2202r311b2234],
4	ALK	NN	O	alk	nn	5	SENT_30	[p1l322t2205r390b2233],
5	rearrangements	NNS	O	rearrangement	prep_with	2	SENT_30	[p1l400t2209r664b2242],
6	tended	VBD	O	tend	_	0	SENT_30	[p1l678t2202r790b2233],
7	to	TO	O	to	aux	9	SENT_30	[p1l804t2209r835b2233],
8	be	VB	O	be	cop	9	SENT_30	[p1l850t2202r887b2233],
9	younger	JJR	O	younger	xcomp	6	SENT_30	[p1l899t2212r1034b2242],
10	than	IN	O	than	_	0	SENT_30	[p1l1047t2202r1123b2233],
11	those	DT	O	those	prep_than	9	SENT_30	[p1l1136t2202r1226b2233],
12	without	IN	O	without	_	0	SENT_30	[p1l1238t2202r1370b2234],
13	the	DT	O	the	det	14	SENT_30	[p1l1381t2202r1433b2233],
14	rearrangements	NNS	O	rearrangement	prep_without	11	SENT_30	[p1l1446t2213r1490b2233, p1l92t2259r328b2292],
15	,	,	O	,	_	0	SENT_30	[p1l1446t2213r1490b2233, p1l92t2259r328b2292],
16	and	CC	O	and	_	0	SENT_30	[p1l341t2253r403b2283],
17	most	JJS	O	most	nsubj	29	SENT_30	[p1l414t2259r498b2283],
18	of	IN	O	of	_	0	SENT_30	[p1l507t2252r546b2283],
19	the	DT	O	the	det	20	SENT_30	[p1l550t2253r602b2283],
20	patients	NNS	O	patient	prep_of	17	SENT_30	[p1l612t2253r745b2292],
21	had	VBD	O	have	conj_and	6	SENT_30	[p1l757t2253r817b2283],
22	little	JJ	O	little	dobj	21	SENT_30	[p1l828t2253r905b2283],
23	or	CC	O	or	_	0	SENT_30	[p1l916t2263r951b2283],
24	no	DT	O	no	det	25	SENT_30	[p1l960t2263r1001b2283],
25	exposure	NN	O	exposure	conj_or	22	SENT_30	[p1l1013t2263r1163b2292],
26	to	TO	O	to	_	0	SENT_30	[p1l1174t2259r1206b2283],
27	tobacco	NN	O	tobacco	prep_to	21	SENT_30	[p1l1218t2253r1346b2283],
28	and	CC	O	and	_	0	SENT_30	[p1l1357t2253r1419b2283],
29	had	VBD	O	have	conj_and	6	SENT_30	[p1l1429t2253r1490b2283],
30	adenocarcinomas	NNS	O	adenocarcinoma	dobj	29	SENT_30	[p1l92t2302r388b2333],
31	.	.	O	.	_	0	SENT_30	[p1l92t2302r388b2333],

1	At	IN	O	at	_	0	SENT_31	[p1l401t2305r440b2333],
2	a	DT	O	a	det	5	SENT_31	[p1l450t2312r468b2333],
3	mean	NN	O	mean	nn	5	SENT_31	[p1l479t2312r571b2333],
4	treatment	NN	O	treatment	nn	5	SENT_31	[p1l583t2309r744b2333],
5	duration	NN	O	duration	prep_at	16	SENT_31	[p1l755t2302r894b2333],
6	of	IN	O	of	_	0	SENT_31	[p1l907t2302r946b2333],
7	6.4	CD	DURATION	6.4	num	8	SENT_31	[p1l951t2305r999b2333],
8	months	NNS	NUMBER	month	prep_of	5	SENT_31	[p1l1012t2302r1146b2339],
9	,	,	O	,	_	0	SENT_31	[p1l1012t2302r1146b2339],
10	the	DT	O	the	det	13	SENT_31	[p1l1161t2302r1212b2333],
11	overall	JJ	O	overall	amod	13	SENT_31	[p1l1225t2302r1333b2333],
12	response	NN	O	response	nn	13	SENT_31	[p1l1345t2312r1490b2341],
13	rate	NN	O	rate	nsubj	16	SENT_31	[p1l92t2358r153b2382],
14	was	VBD	O	be	cop	16	SENT_31	[p1l161t2361r224b2382],
15	57	CD	PERCENT	57	num	16	SENT_31	[p1l235t2353r306b2382],
16	%	NN	PERCENT	%	_	0	SENT_31	[p1l235t2353r306b2382],
17	(	CD	NUMBER	(	number	18	SENT_31	[p1l317t2354r363b2387],
18	47	CD	NUMBER	47	num	16	SENT_31	[p1l317t2354r363b2387],
19	of	IN	O	of	_	0	SENT_31	[p1l374t2351r412b2382],
20	82	CD	NUMBER	82	num	21	SENT_31	[p1l415t2354r453b2382],
21	patients	NNS	O	patient	prep_of	16	SENT_31	[p1l463t2352r602b2390],
22	,	,	O	,	_	0	SENT_31	[p1l463t2352r602b2390],
23	with	IN	O	with	_	0	SENT_31	[p1l612t2351r687b2382],
24	46	CD	NUMBER	46	prep_with	16	SENT_31	[p1l696t2354r735b2382],
25	conﬁrmed	VBN	O	conﬁrmed	partmod	24	SENT_31	[p1l746t2351r918b2382],
26	partial	JJ	O	partial	amod	27	SENT_31	[p1l928t2351r1037b2390],
27	responses	NNS	O	response	nsubj	30	SENT_31	[p1l1046t2361r1208b2390],
28	and	CC	O	and	_	0	SENT_31	[p1l1218t2351r1278b2382],
29	1	CD	NUMBER	1	nsubj	30	SENT_31	[p1l1290t2354r1307b2381],
30	confirmed	VBD	O	confirm	ccomp	25	SENT_31	[p1l1317t2351r1490b2382],
31	complete	JJ	O	complete	amod	33	SENT_31	[p1l92t2400r240b2439],
32	response	NN	O	response	nn	33	SENT_31	[p1l252t2403r416b2439],
33	)	NN	O	)	dobj	30	SENT_31	[p1l252t2403r416b2439],
34	;	:	O	;	_	0	SENT_31	[p1l252t2403r416b2439],
35	27	CD	NUMBER	27	num	36	SENT_31	[p1l430t2403r468b2431],
36	patients	NNS	O	patient	nsubj	41	SENT_31	[p1l480t2401r610b2439],
37	(	CD	PERCENT	(	number	38	SENT_31	[p1l625t2402r714b2436],
38	33	CD	PERCENT	33	num	39	SENT_31	[p1l625t2402r714b2436],
39	%	NN	PERCENT	%	dep	36	SENT_31	[p1l625t2402r714b2436],
40	)	CD	NUMBER	)	dep	36	SENT_31	[p1l625t2402r714b2436],
41	had	VBD	O	have	parataxis	16	SENT_31	[p1l728t2400r788b2431],
42	stable	JJ	O	stable	amod	43	SENT_31	[p1l801t2400r895b2431],
43	disease	NN	O	disease	dobj	41	SENT_31	[p1l908t2400r1034b2431],
44	.	.	O	.	_	0	SENT_31	[p1l908t2400r1034b2431],

1	A	DT	O	a	det	2	SENT_32	[p1l1047t2403r1073b2430],
2	total	NN	O	total	_	0	SENT_32	[p1l1085t2400r1159b2431],
3	of	IN	O	of	_	0	SENT_32	[p1l1172t2400r1210b2431],
4	63	CD	NUMBER	63	prep_of	2	SENT_32	[p1l1216t2403r1252b2431],
5	of	IN	O	of	_	0	SENT_32	[p1l1266t2400r1305b2431],
6	82	CD	NUMBER	82	num	7	SENT_32	[p1l1310t2403r1348b2431],
7	patients	NNS	O	patient	prep_of	4	SENT_32	[p1l1360t2401r1489b2439],
8	(	IN	O	(	_	0	SENT_32	[p1l94t2451r186b2485],
9	77	CD	PERCENT	77	num	10	SENT_32	[p1l94t2451r186b2485],
10	%	NN	PERCENT	%	prep_(	36	SENT_32	[p1l94t2451r186b2485],
11	)	CD	NUMBER	)	nsubj	13	SENT_32	[p1l94t2451r186b2485],
12	were	VBD	O	be	aux	13	SENT_32	[p1l201t2460r278b2481],
13	continuing	VBG	O	continue	rcmod	10	SENT_32	[p1l293t2450r473b2489],
14	to	TO	O	to	aux	15	SENT_32	[p1l486t2456r518b2480],
15	receive	VB	O	receive	xcomp	13	SENT_32	[p1l533t2450r642b2481],
16	crizotinib	NN	O	crizotinib	dobj	15	SENT_32	[p1l657t2449r817b2480],
17	at	IN	O	at	_	0	SENT_32	[p1l832t2456r862b2480],
18	the	DT	O	the	det	19	SENT_32	[p1l875t2449r926b2480],
19	time	NN	O	time	prep_at	15	SENT_32	[p1l941t2450r1014b2480],
20	of	IN	O	of	_	0	SENT_32	[p1l1029t2449r1068b2480],
21	data	NNS	O	datum	nn	22	SENT_32	[p1l1075t2449r1145b2480],
22	cutoff	NN	O	cutoff	prep_of	19	SENT_32	[p1l1160t2449r1264b2487],
23	,	,	O	,	_	0	SENT_32	[p1l1160t2449r1264b2487],
24	and	CC	O	and	_	0	SENT_32	[p1l1281t2449r1341b2480],
25	the	DT	O	the	det	27	SENT_32	[p1l1356t2449r1407b2480],
26	estimated	VBN	O	estimate	amod	27	SENT_32	[p1l1422t2450r1490b2480, p1l92t2499r194b2530],
27	probability	NN	O	probability	prep_(	36	SENT_32	[p1l205t2499r384b2539],
28	of	IN	O	of	_	0	SENT_32	[p1l394t2499r432b2530],
29	6-month	JJ	DURATION	6-month	amod	30	SENT_32	[p1l437t2499r578b2530],
30	progression	NN	O	progression	prep_of	27	SENT_32	[p1l589t2499r858b2539],
31	—	CD	NUMBER	—	num	33	SENT_32	[p1l589t2499r858b2539],
32	free	JJ	O	free	amod	33	SENT_32	[p1l589t2499r858b2539],
33	survival	NN	O	survival	nsubj	36	SENT_32	[p1l870t2499r996b2531],
34	was	VBD	O	be	cop	36	SENT_32	[p1l1005t2510r1067b2531],
35	72	CD	NUMBER	72	number	36	SENT_32	[p1l1080t2502r1160b2537],
36	°	CD	NUMBER	°	rcmod	7	SENT_32	[p1l1080t2502r1160b2537],
37	/	:	O	/	punct	2	SENT_32	[p1l1080t2502r1160b2537],
38	o	NN	O	o	nsubj	46	SENT_32	[p1l1080t2502r1160b2537],
39	,	,	O	,	_	0	SENT_32	[p1l1080t2502r1160b2537],
40	with	IN	O	with	_	0	SENT_32	[p1l1171t2499r1246b2530],
41	no	DT	O	no	det	42	SENT_32	[p1l1257t2509r1298b2530],
42	median	NN	O	median	prep_with	38	SENT_32	[p1l1310t2499r1433b2530],
43	for	IN	O	for	_	0	SENT_32	[p1l1444t2499r1491b2530],
44	the	DT	O	the	det	45	SENT_32	[p1l92t2549r142b2580],
45	study	NN	O	study	prep_for	42	SENT_32	[p1l153t2549r240b2589],
46	reached	VBD	O	reach	dep	2	SENT_32	[p1l248t2549r381b2580],
47	.	.	O	.	_	0	SENT_32	[p1l248t2549r381b2580],

1	The	DT	O	the	det	2	SENT_33	[p1l392t2549r453b2580],
2	drug	NN	O	drug	nsubj	3	SENT_33	[p1l463t2549r540b2589],
3	resulted	VBD	O	result	_	0	SENT_33	[p1l549t2549r677b2581],
4	in	IN	O	in	_	0	SENT_33	[p1l687t2550r718b2580],
5	grade	NN	O	grade	prep_in	3	SENT_33	[p1l728t2549r818b2589],
6	1	CD	NUMBER	1	num	5	SENT_33	[p1l829t2552r847b2580],
7	or	CC	O	or	_	0	SENT_33	[p1l857t2559r891b2580],
8	2	CD	NUMBER	2	number	9	SENT_33	[p1l900t2552r918b2580],
9	(	CD	NUMBER	(	num	11	SENT_33	[p1l930t2549r1025b2585],
10	mild	JJ	O	mild	amod	11	SENT_33	[p1l930t2549r1025b2585],
11	)	NN	O	)	prep_in	3	SENT_33	[p1l930t2549r1025b2585],
12	gastrointestinal	JJ	O	gastrointestinal	amod	14	SENT_33	[p1l1036t2549r1291b2589],
13	side	JJ	O	side	amod	14	SENT_33	[p1l1301t2549r1363b2580],
14	effects	NNS	O	effect	dep	11	SENT_33	[p1l1374t2549r1488b2580],
15	.	.	O	.	_	0	SENT_33	[p1l1374t2549r1488b2580],

1	CONCLUSIONS	NNS	O	conclusion	nsubj	13	SENT_34	[p1l92t2636r319b2655],
2	The	DT	O	the	det	3	SENT_34	[p1l91t2677r153b2708],
3	inhibition	NN	O	inhibition	dep	1	SENT_34	[p1l168t2677r334b2708],
4	of	IN	O	of	_	0	SENT_34	[p1l350t2677r388b2708],
5	ALK	NNP	O	ALK	prep_of	1	SENT_34	[p1l395t2680r469b2709],
6	in	IN	O	in	_	0	SENT_34	[p1l483t2678r515b2708],
7	lung	NN	O	lung	nn	8	SENT_34	[p1l530t2678r605b2717],
8	tumors	NNS	O	tumor	prep_in	5	SENT_34	[p1l619t2684r738b2709],
9	with	IN	O	with	_	0	SENT_34	[p1l752t2677r828b2709],
10	the	DT	O	the	det	12	SENT_34	[p1l843t2677r895b2708],
11	ALK	NNP	O	ALK	nn	12	SENT_34	[p1l907t2680r975b2708],
12	rearrangement	NN	O	rearrangement	prep_with	8	SENT_34	[p1l987t2684r1236b2717],
13	resulted	VBD	O	result	_	0	SENT_34	[p1l1249t2677r1382b2709],
14	in	IN	O	in	_	0	SENT_34	[p1l1397t2678r1429b2708],
15	tumor	NN	O	tumor	nn	16	SENT_34	[p1l1445t2684r1490b2709, p1l92t2737r160b2758],
16	shrinkage	NN	O	shrinkage	prep_in	13	SENT_34	[p1l177t2727r343b2767],
17	or	CC	O	or	_	0	SENT_34	[p1l360t2737r395b2758],
18	stable	JJ	O	stable	amod	19	SENT_34	[p1l411t2727r507b2758],
19	disease	NN	O	disease	prep_in	13	SENT_34	[p1l525t2727r645b2758],
20	in	IN	O	in	_	0	SENT_34	[p1l663t2728r695b2758],
21	most	JJS	O	most	amod	22	SENT_34	[p1l712t2734r796b2758],
22	patients	NNS	O	patient	prep_in	13	SENT_34	[p1l811t2728r953b2767],
23	.	.	O	.	_	0	SENT_34	[p1l811t2728r953b2767],

1	(	NN	O	(	nsubj	2	SENT_35	[p1l974t2727r1110b2763],
2	Funded	VBN	O	fund	_	0	SENT_35	[p1l974t2727r1110b2763],
3	by	IN	O	by	_	0	SENT_35	[p1l1127t2727r1165b2767],
4	Pfizer	NNP	ORGANIZATION	Pfizer	prep_by	2	SENT_35	[p1l1180t2727r1281b2758],
5	and	CC	O	and	_	0	SENT_35	[p1l1296t2727r1358b2758],
6	others	NNS	O	other	prep_by	2	SENT_35	[p1l1375t2727r1489b2765],
7	;	:	O	;	_	0	SENT_35	[p1l1375t2727r1489b2765],
8	ClinicalTrials	NNS	O	clinicaltrial	dep	4	SENT_35	[p1l92t2777r387b2816],
9	.	.	O	.	_	0	SENT_35	[p1l92t2777r387b2816],

1	gov	NN	O	gov	nn	2	SENT_36	[p1l92t2777r387b2816],
2	number	NN	O	number	_	0	SENT_36	[p1l399t2777r537b2814],
3	,	,	O	,	_	0	SENT_36	[p1l399t2777r537b2814],
4	NCT00585195	NN	O	nct00585195	appos	2	SENT_36	[p1l552t2779r808b2812],
5	.	.	O	.	_	0	SENT_36	[p1l552t2779r808b2812],
6	)	SYM	O	)	dep	2	SENT_36	[p1l552t2779r808b2812],

1	NENGLJ	NNP	O	NENGLJ	_	0	SENT_37	[p1l594t2880r701b2902],
2	Mr	NNP	O	Mr	dep	1	SENT_37	[p1l715t2874r854b2902],
3	-	:	O	-	_	0	SENT_37	[p1l715t2874r854b2902],
4	:	:	O	:	_	0	SENT_37	[p1l715t2874r854b2902],
5	D363	NN	O	d363	dep	1	SENT_37	[p1l715t2874r854b2902],
6	;	:	O	;	_	0	SENT_37	[p1l715t2874r854b2902],
7	18	CD	NUMBER	18	dep	5	SENT_37	[p1l715t2874r854b2902],
8	NEJM.ORG	NN	O	nejm.org	rcmod	7	SENT_37	[p1l889t2880r1013b2902],
9	ocToBI	NN	O	octobus	dep	8	SENT_37	[p1l1048t2874r1278b2900],
10	-	:	O	-	_	0	SENT_37	[p1l1048t2874r1278b2900],
11	:	:	O	:	_	0	SENT_37	[p1l1048t2874r1278b2900],
12	R28	NN	O	r28	prep	5	SENT_37	[p1l1048t2874r1278b2900],
13	,2	CD	NUMBER	,2	dep	12	SENT_37	[p1l1048t2874r1278b2900],
14	o1o	NN	O	o1o	dep	1	SENT_37	[p1l1048t2874r1278b2900],

1	The	DT	O	the	det	4	SENT_38	[p1l750t2937r801b2961],
2	New	NNP	O	New	nn	4	SENT_38	[p1l810t2938r872b2961],
3	England	NNP	O	England	nn	4	SENT_38	[p1l882t2937r992b2968],
4	Journal	NNP	O	Journal	_	0	SENT_38	[p1l1001t2937r1099b2961],
5	of	IN	O	of	_	0	SENT_38	[p1l1108t2937r1137b2961],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_38	[p1l1144t2937r1269b2961],

1	From	IN	O	from	dep	25	SENT_39	[p1l1532t1452r1595b1474],
2	the	DT	O	the	det	9	SENT_39	[p1l1608t1450r1648b1474],
3	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	9	SENT_39	[p1l1663t1450r1854b1474],
4	General	NNP	ORGANIZATION	General	nn	9	SENT_39	[p1l1867t1450r1965b1474],
5	Hospital	NNP	ORGANIZATION	Hospital	nn	9	SENT_39	[p1l1981t1452r2065b1481, p1l1529t1488r1559b1512],
6	Cancer	NNP	ORGANIZATION	Cancer	nn	9	SENT_39	[p1l1579t1490r1668b1512],
7	Center	NNP	ORGANIZATION	Center	nn	9	SENT_39	[p1l1685t1490r1770b1512],
8	(	CD	NUMBER	(	num	9	SENT_39	[p1l1790t1490r1878b1519],
9	E.L.K.	NNP	O	E.L.K.	pobj	1	SENT_39	[p1l1790t1490r1878b1519],
10	,	,	O	,	_	0	SENT_39	[p1l1790t1490r1878b1519],
11	A.T.S.	NNP	O	A.T.S.	nn	23	SENT_39	[p1l1897t1489r1976b1516],
12	,	,	O	,	_	0	SENT_39	[p1l1897t1489r1976b1516],
13	T.J.L.	NNP	O	T.J.L.	appos	23	SENT_39	[p1l1995t1490r2064b1518],
14	,	,	O	,	_	0	SENT_39	[p1l1995t1490r2064b1518],
15	P.F.	NNP	LOCATION	P.F.	appos	23	SENT_39	[p1l1532t1528r1578b1553],
16	,	,	O	,	_	0	SENT_39	[p1l1532t1528r1578b1553],
17	H.S.	NNP	LOCATION	H.S.	appos	23	SENT_39	[p1l1604t1527r1663b1553],
18	,	,	O	,	_	0	SENT_39	[p1l1604t1527r1663b1553],
19	j.A.E.	NNP	O	j.A.E.	appos	23	SENT_39	[p1l1682t1527r1761b1556],
20	,	,	O	,	_	0	SENT_39	[p1l1682t1527r1761b1556],
21	L.V.S.	NNP	LOCATION	L.V.S.	appos	23	SENT_39	[p1l1786t1527r1861b1554],
22	,	,	O	,	_	0	SENT_39	[p1l1786t1527r1861b1554],
23	M.M.-K.	NNP	O	M.M.-K.	appos	9	SENT_39	[p1l1886t1528r1994b1553],
24	,	,	O	,	_	0	SENT_39	[p1l1886t1528r1994b1553],
25	1.5	CD	NUMBER	1.5	_	0	SENT_39	[p1l2013t1527r2064b1556],
26	.	.	O	.	_	0	SENT_39	[p1l2013t1527r2064b1556],

1	,	,	O	,	_	0	SENT_40	[p1l2013t1527r2064b1556],
2	D.A.H.	NNP	O	D.A.H.	nn	7	SENT_40	[p1l1532t1565r1715b1594],
3	,	,	O	,	_	0	SENT_40	[p1l1532t1565r1715b1594],
4	J.W.C.	NNP	O	J.W.C.	appos	7	SENT_40	[p1l1532t1565r1715b1594],
5	,	,	O	,	_	0	SENT_40	[p1l1532t1565r1715b1594],
6	A.J.	NNP	PERSON	A.J.	appos	7	SENT_40	[p1l1725t1565r1802b1594],
7	|	NNP	O	|	nsubj	9	SENT_40	[p1l1725t1565r1802b1594],
8	.	.	O	.	_	0	SENT_40	[p1l1725t1565r1802b1594],
9	)	NN	O	)	_	0	SENT_40	[p1l1725t1565r1802b1594],

1	,	,	O	,	_	0	SENT_41	[p1l1725t1565r1802b1594],
2	Beth	NNP	ORGANIZATION	Beth	dep	8	SENT_41	[p1l1815t1563r1870b1587],
3	Israel	NNP	ORGANIZATION	Israel	nn	8	SENT_41	[p1l1882t1563r1948b1587],
4	Deaconess	NNP	ORGANIZATION	Deaconess	nn	8	SENT_41	[p1l1961t1565r2065b1587, p1l1530t1609r1569b1624],
5	Medical	NNP	ORGANIZATION	Medical	nn	8	SENT_41	[p1l1587t1601r1685b1624],
6	Center	NNP	ORGANIZATION	Center	nn	8	SENT_41	[p1l1702t1603r1786b1624],
7	(	CD	NUMBER	(	num	8	SENT_41	[p1l1803t1603r1889b1632],
8	B.j.D.	NNP	O	B.j.D.	_	0	SENT_41	[p1l1803t1603r1889b1632],
9	,	,	O	,	_	0	SENT_41	[p1l1803t1603r1889b1632],
10	D.B.C.	NNP	O	D.B.C.	conj_and	8	SENT_41	[p1l1908t1603r2002b1632],
11	)	CD	NUMBER	)	num	10	SENT_41	[p1l1908t1603r2002b1632],
12	,	,	O	,	_	0	SENT_41	[p1l1908t1603r2002b1632],
13	and	CC	O	and	_	0	SENT_41	[p1l2019t1601r2064b1624],
14	Dana	NNP	PERSON	Dana	conj_and	8	SENT_41	[p1l1532t1638r1695b1661],
15	.	.	O	.	_	0	SENT_41	[p1l1532t1638r1695b1661],

1	—	NN	O	—	_	0	SENT_42	[p1l1532t1638r1695b1661],
2	.	.	O	.	_	0	SENT_42	[p1l1532t1638r1695b1661],

1	Farber	NNP	ORGANIZATION	Farber	nn	5	SENT_43	[p1l1532t1638r1695b1661],
2	Cancer	NNP	ORGANIZATION	Cancer	nn	5	SENT_43	[p1l1704t1640r1792b1661],
3	Institute	NNP	ORGANIZATION	Institute	nn	5	SENT_43	[p1l1803t1640r1905b1661],
4	(	NNP	O	(	nn	5	SENT_43	[p1l1917t1639r1996b1669],
5	P.A.j.	NNP	O	P.A.j.	_	0	SENT_43	[p1l1917t1639r1996b1669],
6	,	,	O	,	_	0	SENT_43	[p1l1917t1639r1996b1669],
7	L.G.	NNP	LOCATION	L.G.	appos	5	SENT_43	[p1l2009t1640r2064b1666],
8	,	,	O	,	_	0	SENT_43	[p1l2009t1640r2064b1666],
9	G.	NNP	O	G.	nn	10	SENT_43	[p1l1530t1677r1608b1706],
10	|	NNP	O	|	appos	7	SENT_43	[p1l1530t1677r1608b1706],
11	.	.	O	.	_	0	SENT_43	[p1l1530t1677r1608b1706],

1	S.	NNP	O	S.	_	0	SENT_44	[p1l1530t1677r1608b1706],
2	)	CD	NUMBER	)	number	3	SENT_44	[p1l1530t1677r1608b1706],
3	—	CD	NUMBER	—	dep	1	SENT_44	[p1l1625t1690r1657b1692],
4	all	DT	O	all	dep	3	SENT_44	[p1l1672t1675r1698b1699],
5	in	IN	O	in	_	0	SENT_44	[p1l1717t1677r1737b1699],
6	Boston	NNP	LOCATION	Boston	prep_in	3	SENT_44	[p1l1756t1677r1852b1703],
7	;	:	O	;	_	0	SENT_44	[p1l1756t1677r1852b1703],
8	Seoul	NNP	ORGANIZATION	Seoul	nn	11	SENT_44	[p1l1869t1675r1938b1699],
9	National	NNP	ORGANIZATION	National	nn	11	SENT_44	[p1l1958t1675r2064b1699],
10	University	NNP	ORGANIZATION	University	nn	11	SENT_44	[p1l1531t1714r1662b1743],
11	College	NNP	ORGANIZATION	College	dep	3	SENT_44	[p1l1680t1712r1776b1743],
12	of	IN	ORGANIZATION	of	_	0	SENT_44	[p1l1795t1712r1823b1736],
13	Medicine	NNP	ORGANIZATION	Medicine	nn	19	SENT_44	[p1l1839t1712r1965b1740],
14	,	,	O	,	_	0	SENT_44	[p1l1839t1712r1965b1740],
15	Seoul	NNP	LOCATION	Seoul	appos	19	SENT_44	[p1l1985t1712r2064b1740],
16	,	,	O	,	_	0	SENT_44	[p1l1985t1712r2064b1740],
17	Korea	NNP	LOCATION	Korea	appos	19	SENT_44	[p1l1532t1752r1603b1773],
18	(	CD	NUMBER	(	num	19	SENT_44	[p1l1618t1752r1708b1781],
19	Y.-j.B.	NNP	O	Y.-j.B.	prep_of	11	SENT_44	[p1l1618t1752r1708b1781],
20	,	,	O	,	_	0	SENT_44	[p1l1618t1752r1708b1781],
21	W.-H.K.	NNP	O	W.-H.K.	appos	19	SENT_44	[p1l1721t1752r1836b1781],
22	)	CD	NUMBER	)	num	21	SENT_44	[p1l1721t1752r1836b1781],
23	;	:	O	;	_	0	SENT_44	[p1l1721t1752r1836b1781],
24	the	DT	O	the	det	25	SENT_44	[p1l1849t1750r1889b1773],
25	University	NNP	ORGANIZATION	University	dep	3	SENT_44	[p1l1903t1752r2030b1781],
26	of	IN	ORGANIZATION	of	_	0	SENT_44	[p1l2042t1749r2070b1773],
27	Colorado	NNP	ORGANIZATION	Colorado	nn	33	SENT_44	[p1l1530t1787r1647b1811],
28	Cancer	NNP	ORGANIZATION	Cancer	nn	33	SENT_44	[p1l1661t1789r1749b1811],
29	Center	NNP	ORGANIZATION	Center	nn	33	SENT_44	[p1l1762t1789r1851b1815],
30	,	,	O	,	_	0	SENT_44	[p1l1762t1789r1851b1815],
31	Aurora	NNP	LOCATION	Aurora	appos	33	SENT_44	[p1l1865t1789r1951b1811],
32	(	CD	NUMBER	(	num	33	SENT_44	[p1l1968t1789r2064b1818],
33	D.R.C.	NNP	O	D.R.C.	prep_of	25	SENT_44	[p1l1968t1789r2064b1818],
34	,	,	O	,	_	0	SENT_44	[p1l1968t1789r2064b1818],
35	M.V.-G	NNP	O	M.V.-G	nn	37	SENT_44	[p1l1532t1826r1641b1855],
36	.	.	O	.	_	0	SENT_44	[p1l1532t1826r1641b1855],
37	)	NN	O	)	appos	33	SENT_44	[p1l1532t1826r1641b1855],

1	;	:	O	;	_	0	SENT_45	[p1l1532t1826r1641b1855],
2	Peter	NNP	PERSON	Peter	nn	3	SENT_45	[p1l1652t1826r1716b1848],
3	MacCal	NNP	PERSON	MacCal	_	0	SENT_45	[p1l1725t1824r1868b1848],
4	|	CD	NUMBER	|	num	7	SENT_45	[p1l1725t1824r1868b1848],
5	um	NN	O	um	nn	7	SENT_45	[p1l1725t1824r1868b1848],
6	Cancer	NN	O	cancer	nn	7	SENT_45	[p1l1878t1826r1967b1848],
7	Centre	NNP	O	Centre	dep	3	SENT_45	[p1l1974t1826r2064b1852],
8	,	,	O	,	_	0	SENT_45	[p1l1974t1826r2064b1852],
9	Melbourne	NNP	LOCATION	Melbourne	nn	13	SENT_45	[p1l1532t1862r1680b1890],
10	,	,	O	,	_	0	SENT_45	[p1l1532t1862r1680b1890],
11	Australia	NNP	LOCATION	Australia	appos	13	SENT_45	[p1l1701t1862r1817b1886],
12	(	CD	NUMBER	(	num	13	SENT_45	[p1l1841t1864r1917b1893],
13	B.S.	NNP	O	B.S.	appos	3	SENT_45	[p1l1841t1864r1917b1893],
14	)	CD	NUMBER	)	dep	13	SENT_45	[p1l1841t1864r1917b1893],
15	;	:	O	;	_	0	SENT_45	[p1l1841t1864r1917b1893],
16	Memorial	NNP	O	Memorial	nn	19	SENT_45	[p1l1941t1862r2064b1886],
17	Sloan-Kettering	NNP	O	Sloan-Kettering	nn	19	SENT_45	[p1l1530t1900r1731b1931],
18	Cancer	NNP	O	Cancer	nn	19	SENT_45	[p1l1742t1901r1830b1923],
19	Center	NNP	O	Center	dep	3	SENT_45	[p1l1841t1901r1929b1928],
20	,	,	O	,	_	0	SENT_45	[p1l1841t1901r1929b1928],
21	New	NNP	LOCATION	New	nn	22	SENT_45	[p1l1944t1902r2000b1923],
22	York	NNP	LOCATION	York	appos	19	SENT_45	[p1l2009t1900r2066b1923],
23	(	NN	O	(	nn	25	SENT_45	[p1l1532t1939r1644b1968],
24	R.G.M.	NN	O	r.g.m.	nn	25	SENT_45	[p1l1532t1939r1644b1968],
25	)	NN	O	)	dep	22	SENT_45	[p1l1532t1939r1644b1968],
26	;	:	O	;	_	0	SENT_45	[p1l1532t1939r1644b1968],
27	the	DT	O	the	det	31	SENT_45	[p1l1651t1937r1691b1961],
28	University	NNP	O	University	nn	31	SENT_45	[p1l1699t1939r1824b1968],
29	ofCa	NN	O	ofca	nn	31	SENT_45	[p1l1830t1937r1987b1965],
30	|	NN	O	|	nn	31	SENT_45	[p1l1830t1937r1987b1965],
31	ifornia	NN	O	ifornium	dep	3	SENT_45	[p1l1830t1937r1987b1965],
32	,	,	O	,	_	0	SENT_45	[p1l1830t1937r1987b1965],
33	Irvine	NNP	LOCATION	Irvine	nn	35	SENT_45	[p1l1997t1939r2065b1961],
34	(	CD	NUMBER	(	num	35	SENT_45	[p1l1533t1976r1661b2005],
35	S.-H	NN	O	s.-h	appos	31	SENT_45	[p1l1533t1976r1661b2005],
36	.	.	O	.	_	0	SENT_45	[p1l1533t1976r1661b2005],

1	|	NN	O	|	_	0	SENT_46	[p1l1533t1976r1661b2005],
2	.	.	O	.	_	0	SENT_46	[p1l1533t1976r1661b2005],

1	O.	NNP	O	O.	nn	2	SENT_47	[p1l1533t1976r1661b2005],
2	)	NNP	O	)	_	0	SENT_47	[p1l1533t1976r1661b2005],
3	;	:	O	;	_	0	SENT_47	[p1l1533t1976r1661b2005],
4	Pfizer	NNP	ORGANIZATION	Pfizer	nn	5	SENT_47	[p1l1672t1974r1742b1998],
5	Pharmaceuticals	NNP	ORGANIZATION	Pharmaceuticals	dep	2	SENT_47	[p1l1752t1974r1960b2002],
6	,	,	O	,	_	0	SENT_47	[p1l1752t1974r1960b2002],
7	Lajolla	NNP	LOCATION	Lajolla	appos	5	SENT_47	[p1l1972t1974r2064b2005],
8	,	,	O	,	_	0	SENT_47	[p1l1972t1974r2064b2005],
9	CA	NNP	LOCATION	CA	nn	11	SENT_47	[p1l1530t2013r1567b2035],
10	(	NNP	O	(	nn	11	SENT_47	[p1l1587t2013r1655b2042],
11	W.T.	NNP	PERSON	W.T.	appos	7	SENT_47	[p1l1587t2013r1655b2042],
12	,	,	O	,	_	0	SENT_47	[p1l1587t2013r1655b2042],
13	G.C.W.	NNP	O	G.C.W.	nn	20	SENT_47	[p1l1674t2013r1768b2039],
14	,	,	O	,	_	0	SENT_47	[p1l1674t2013r1768b2039],
15	S.M.S.	NNP	O	S.M.S.	appos	20	SENT_47	[p1l1787t2013r1876b2039],
16	,	,	O	,	_	0	SENT_47	[p1l1787t2013r1876b2039],
17	J.G.C.	NNP	O	J.G.C.	appos	20	SENT_47	[p1l1891t2013r1973b2042],
18	,	,	O	,	_	0	SENT_47	[p1l1891t2013r1973b2042],
19	K.W.	NNP	LOCATION	K.W.	appos	20	SENT_47	[p1l1994t2013r2064b2042],
20	)	NNP	O	)	appos	5	SENT_47	[p1l1994t2013r2064b2042],
21	;	:	O	;	_	0	SENT_47	[p1l1994t2013r2064b2042],
22	and	CC	O	and	_	0	SENT_47	[p1l1530t2049r1575b2072],
23	the	DT	O	the	det	24	SENT_47	[p1l1592t2049r1633b2072],
24	University	NNP	ORGANIZATION	University	conj_and	5	SENT_47	[p1l1651t2051r1779b2080],
25	of	IN	ORGANIZATION	of	_	0	SENT_47	[p1l1795t2048r1823b2072],
26	Chicago	NNP	ORGANIZATION	Chicago	nn	30	SENT_47	[p1l1835t2049r1944b2080],
27	,	,	O	,	_	0	SENT_47	[p1l1835t2049r1944b2080],
28	Chicago	NNP	LOCATION	Chicago	appos	30	SENT_47	[p1l1963t2049r2065b2080],
29	(	CD	NUMBER	(	num	30	SENT_47	[p1l1533t2088r1625b2117],
30	M.j.R.	NNP	O	M.j.R.	prep_of	24	SENT_47	[p1l1533t2088r1625b2117],
31	,	,	O	,	_	0	SENT_47	[p1l1533t2088r1625b2117],
32	R.S.	NNP	PERSON	R.S.	nn	33	SENT_47	[p1l1638t2088r1702b2117],
33	)	NNP	O	)	appos	30	SENT_47	[p1l1638t2088r1702b2117],
34	.	.	O	.	_	0	SENT_47	[p1l1638t2088r1702b2117],

1	Address	NN	O	address	nsubj	2	SENT_48	[p1l1712t2086r1815b2110],
2	reprint	VB	O	reprint	_	0	SENT_48	[p1l1827t2089r1912b2117],
3	requests	NNS	O	request	dobj	2	SENT_48	[p1l1923t2091r2031b2117],
4	to	TO	O	to	_	0	SENT_48	[p1l2040t2091r2065b2110],
5	Dr.	NNP	O	Dr.	nn	6	SENT_48	[p1l1532t2126r1566b2148],
6	Kwak	NNP	PERSON	Kwak	prep_to	2	SENT_48	[p1l1585t2124r1648b2148],
7	at	IN	O	at	_	0	SENT_48	[p1l1664t2128r1686b2148],
8	the	DT	O	the	det	13	SENT_48	[p1l1700t2124r1741b2148],
9	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	13	SENT_48	[p1l1758t2124r1949b2148],
10	General	NNP	ORGANIZATION	General	nn	13	SENT_48	[p1l1966t2124r2064b2148],
11	Hospital	NNP	ORGANIZATION	Hospital	nn	13	SENT_48	[p1l1532t2162r1638b2193],
12	Cancer	NNP	ORGANIZATION	Cancer	nn	13	SENT_48	[p1l1651t2164r1740b2186],
13	Center	NNP	ORGANIZATION	Center	prep_at	6	SENT_48	[p1l1750t2164r1839b2190],
14	,	,	O	,	_	0	SENT_48	[p1l1750t2164r1839b2190],
15	55	CD	NUMBER	55	dep	2	SENT_48	[p1l1852t2164r1879b2186],
16	Fruit	NNP	O	Fruit	nn	17	SENT_48	[p1l1894t2164r1951b2186],
17	St.	NNP	O	St.	dep	15	SENT_48	[p1l1962t2164r2000b2190],
18	,	,	O	,	_	0	SENT_48	[p1l1962t2164r2000b2190],
19	Professional	NNP	ORGANIZATION	Professional	nn	21	SENT_48	[p1l2015t2164r2065b2186, p1l1529t2199r1641b2223],
20	Office	NNP	ORGANIZATION	Office	nn	21	SENT_48	[p1l1657t2199r1735b2223],
21	Bldg.	NNP	ORGANIZATION	Bldg.	appos	17	SENT_48	[p1l1751t2199r1820b2231],
22	,	,	O	,	_	0	SENT_48	[p1l1751t2199r1820b2231],
23	Rm	NNP	O	Rm	appos	17	SENT_48	[p1l1837t2201r1885b2223],
24	.	.	O	.	_	0	SENT_48	[p1l1837t2201r1885b2223],

1	238	CD	NUMBER	238	_	0	SENT_49	[p1l1900t2201r1951b2228],
2	,	,	O	,	_	0	SENT_49	[p1l1900t2201r1951b2228],
3	Boston	NNP	LOCATION	Boston	nn	5	SENT_49	[p1l1969t2201r2064b2227],
4	,	,	O	,	_	0	SENT_49	[p1l1969t2201r2064b2227],
5	MA	NNP	O	MA	appos	1	SENT_49	[p1l1532t2239r1575b2261],
6	02114	CD	DATE	02114	num	5	SENT_49	[p1l1582t2239r1663b2265],
7	,	,	O	,	_	0	SENT_49	[p1l1582t2239r1663b2265],
8	or	CC	O	or	_	0	SENT_49	[p1l1672t2246r1699b2261],
9	at	IN	O	at	advmod	5	SENT_49	[p1l1707t2242r1729b2261],
10	ekwak@partners.org	NN	O	ekwak@partners.org	appos	1	SENT_49	[p1l1737t2237r2013b2268],
11	.	.	O	.	_	0	SENT_49	[p1l1737t2237r2013b2268],

1	N	NN	MISC	n	nn	3	SENT_50	[p1l1532t2314r1549b2335],
2	Englj	NNP	MISC	Englj	nn	3	SENT_50	[p1l1563t2312r1631b2343],
3	Med	NNP	O	Med	_	0	SENT_50	[p1l1645t2312r1699b2335],
4	2010	CD	DATE	2010	num	3	SENT_50	[p1l1710t2313r1956b2340],
5	;	:	O	;	_	0	SENT_50	[p1l1710t2313r1956b2340],
6	363:1693	CD	NUMBER	363:1693	number	7	SENT_50	[p1l1710t2313r1956b2340],
7	-703	CD	NUMBER	-703	dep	3	SENT_50	[p1l1710t2313r1956b2340],
8	.	.	O	.	_	0	SENT_50	[p1l1710t2313r1956b2340],

1	Copyright	NN	O	copyright	_	0	SENT_51	[p1l1530t2353r1624b2378],
2	©	CD	NUMBER	©	num	6	SENT_51	[p1l1633t2355r1654b2376],
3	2010	CD	DATE	2010	num	6	SENT_51	[p1l1664t2354r1714b2372],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_51	[p1l1722t2353r1862b2372],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_51	[p1l1871t2353r1948b2372],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_51	[p1l1956t2354r2028b2378],
7	.	.	O	.	_	0	SENT_51	[p1l1956t2354r2028b2378],

1	The	DT	O	the	det	4	SENT_52	[p1l673t3125r718b3146],
2	NEW	NNP	O	NEW	nn	4	SENT_52	[p1l737t3127r822b3146],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_52	[p1l841t3127r1029b3146],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_52	[p1l1048t3127r1227b3153],
5	of	IN	O	of	_	0	SENT_52	[p1l1247t3125r1275b3152],
6	MEDICINE	NNP	O	MEDICINE	prep_of	4	SENT_52	[p1l1287t3127r1486b3146],

1	PECIFIC	NNP	O	PECIFIC	nn	3	SENT_53	[p1l265t3369r612b3426],
2	GENETIC	NNP	O	GENETIC	nn	3	SENT_53	[p1l669t3369r1073b3426],
3	LESIONS	NNS	O	lesion	_	0	SENT_53	[p1l1133t3369r1507b3426],
4	THAT	WDT	O	that	nsubj	5	SENT_53	[p1l1561t3369r1808b3425],
5	DRIVE	VBP	O	drive	rcmod	3	SENT_53	[p1l1863t3369r2147b3426],

1	the	DT	O	the	det	2	SENT_54	[p1l263t3477r394b3556],
2	proliferation	NN	O	proliferation	nsubj	6	SENT_54	[p1l424t3476r958b3578],
3	of	IN	O	of	_	0	SENT_54	[p1l989t3476r1089b3556],
4	cancer	NN	O	cancer	nn	5	SENT_54	[p1l1101t3503r1378b3556],
5	cells	NNS	O	cell	prep_of	2	SENT_54	[p1l1406t3477r1591b3556],
6	render	VBP	O	render	_	0	SENT_54	[p1l1623t3477r1897b3556],
7	some	DT	O	some	det	8	SENT_54	[p1l1926t3503r2148b3556],
8	cancers	NNS	O	cancer	nsubj	13	SENT_54	[p1l263t3633r585b3686],
9	sensitive	JJ	O	sensitive	dep	13	SENT_54	[p1l638t3608r1004b3686],
10	to	TO	O	to	_	0	SENT_54	[p1l1053t3623r1135b3686],
11	therapeutic	JJ	O	therapeutic	amod	12	SENT_54	[p1l1186t3607r1674b3708],
12	inhibitors	NNS	O	inhibitor	prep_to	9	SENT_54	[p1l1722t3607r2145b3686],
13	targeting	VBG	O	target	xcomp	6	SENT_54	[p2l12t22r414b122],
14	the	DT	O	the	det	16	SENT_54	[p2l448t21r582b100],
15	mutated	VBN	O	mutate	amod	16	SENT_54	[p2l620t21r976b100],
16	pathway	NN	O	pathway	dobj	13	SENT_54	[p2l1012t21r1388b122],
17	.	.	O	.	_	0	SENT_54	[p2l1012t21r1388b122],

1	For	IN	O	for	_	0	SENT_55	[p2l1430t29r1573b100],
2	example	NN	O	example	prep_for	15	SENT_55	[p2l1608t21r1989b122],
3	,	,	O	,	_	0	SENT_55	[p2l1608t21r1989b122],
4	inhibitors	NNS	O	inhibitor	nsubj	15	SENT_55	[p2l2031t22r2147b99, p2l12t149r346b228],
5	of	IN	O	of	_	0	SENT_55	[p2l387t149r488b228],
6	the	DT	O	the	det	10	SENT_55	[p2l507t149r641b228],
7	epidermal	JJ	O	epidermal	amod	10	SENT_55	[p2l680t149r1115b250],
8	growth	NN	O	growth	nn	10	SENT_55	[p2l1152t149r1468b250],
9	factor	NN	O	factor	nn	10	SENT_55	[p2l1506t149r1758b228],
10	receptor	NN	O	receptor	prep_of	4	SENT_55	[p2l1793t166r2151b250],
11	(	CD	NUMBER	(	num	12	SENT_55	[p2l17t283r326b369],
12	EGFR	NN	ORGANIZATION	egfr	dep	10	SENT_55	[p2l17t283r326b369],
13	)	CD	NUMBER	)	dep	12	SENT_55	[p2l17t283r326b369],
14	have	VBP	O	have	aux	15	SENT_55	[p2l370t277r561b356],
15	produced	VBN	O	produce	_	0	SENT_55	[p2l598t277r1003b378],
16	consistent	JJ	O	consistent	amod	17	SENT_55	[p2l1042t278r1483b356],
17	responses	NNS	O	response	dobj	15	SENT_55	[p2l1517t303r1943b378],
18	in	IN	O	in	_	0	SENT_55	[p2l1983t278r2066b355],
19	a	DT	O	a	det	20	SENT_55	[p2l2105t304r2149b356],
20	subgroup	NN	O	subgroup	prep_in	15	SENT_55	[p2l14t405r419b506],
21	of	IN	O	of	_	0	SENT_55	[p2l476t405r576b484],
22	patients	NNS	O	patient	prep_of	20	SENT_55	[p2l611t406r955b506],
23	with	IN	O	with	_	0	SENT_55	[p2l1007t405r1203b485],
24	non	JJ	O	non	amod	30	SENT_55	[p2l1257t405r1904b484],
25	—	JJ	O	—	amod	30	SENT_55	[p2l1257t405r1904b484],
26	small	JJ	O	small	amod	30	SENT_55	[p2l1257t405r1904b484],
27	—	NN	O	—	nn	30	SENT_55	[p2l1257t405r1904b484],
28	cell	NN	O	cell	nn	30	SENT_55	[p2l1257t405r1904b484],
29	lung	NN	O	lung	nn	30	SENT_55	[p2l1957t405r2152b506],
30	cancer	NN	O	cancer	prep_with	15	SENT_55	[p2l13t559r296b612],
31	with	IN	O	with	_	0	SENT_55	[p2l342t533r539b612],
32	activating	VBG	O	activate	prepc_with	15	SENT_55	[p2l593t534r1017b634],
33	EGFR	NN	ORGANIZATION	egfr	nn	35	SENT_55	[p2l1066t540r1280b613],
34	mutations	NNS	O	mutation	nn	35	SENT_55	[p2l1328t534r1887b612],
35	.1	NN	NUMBER	.1	dobj	32	SENT_55	[p2l1328t534r1887b612],
36	'	''	O	'	_	0	SENT_55	[p2l1328t534r1887b612],
37	3	CD	NUMBER	3	num	39	SENT_55	[p2l1328t534r1887b612],
38	Such	JJ	O	such	amod	39	SENT_55	[p2l1945t533r2148b612],
39	findings	NNS	O	finding	nsubj	40	SENT_55	[p2l12t661r379b762],
40	suggest	VBP	O	suggest	rcmod	35	SENT_55	[p2l417t678r747b762],
41	that	IN	O	that	complm	47	SENT_55	[p2l778t661r951b740],
42	patients	NNS	O	patient	nsubjpass	47	SENT_55	[p2l981t662r1347b762],
43	’	CD	NUMBER	’	num	44	SENT_55	[p2l981t662r1347b762],
44	outcomes	NNS	O	outcome	dep	42	SENT_55	[p2l1388t678r1801b740],
45	may	MD	O	may	aux	47	SENT_55	[p2l1840t687r2019b762],
46	be	VB	O	be	auxpass	47	SENT_55	[p2l2051t661r2148b740],
47	optimized	VBN	O	optimize	ccomp	40	SENT_55	[p2l13t789r457b890],
48	by	IN	O	by	_	0	SENT_55	[p2l487t789r585b890],
49	testing	NN	O	testing	nn	50	SENT_55	[p2l611t790r910b890],
50	tumors	NNS	O	tumor	agent	47	SENT_55	[p2l938t806r1247b868],
51	for	IN	O	for	_	0	SENT_55	[p2l1279t789r1403b868],
52	specific	JJ	O	specific	amod	54	SENT_55	[p2l1431t789r1763b890],
53	mutated	VBN	O	mutate	amod	54	SENT_55	[p2l1792t789r2148b868],
54	pathways	NNS	O	pathway	prep_for	35	SENT_55	[p2l11t917r412b1018],
55	and	CC	O	and	_	0	SENT_55	[p2l463t917r621b996],
56	directing	VBG	O	direct	prepc_with	15	SENT_55	[p2l671t917r1065b1018],
57	therapies	NNS	O	therapy	dobj	56	SENT_55	[p2l1111t917r1503b1018],
58	against	IN	O	against	_	0	SENT_55	[p2l1553t918r1870b1018],
59	those	DT	O	those	det	61	SENT_55	[p2l1915t917r2148b996],
60	mutant	JJ	O	mutant	amod	61	SENT_55	[p2l12t1062r328b1124],
61	pathways	NNS	O	pathway	prep_against	57	SENT_55	[p2l356t1045r782b1146],
62	.	.	O	.	_	0	SENT_55	[p2l356t1045r782b1146],

1	Activating	VBG	O	activate	dep	16	SENT_56	[p2l138t1174r583b1274],
2	mutations	NNS	O	mutation	dobj	1	SENT_56	[p2l621t1174r1058b1252],
3	or	CC	O	or	_	0	SENT_56	[p2l1103t1199r1191b1252],
4	translocations	NNS	O	translocation	dobj	1	SENT_56	[p2l1230t1173r1847b1252],
5	of	IN	O	of	_	0	SENT_56	[p2l1891t1173r1991b1252],
6	the	DT	O	the	det	11	SENT_56	[p2l2014t1173r2148b1252],
7	anaplastic	JJ	O	anaplastic	amod	11	SENT_56	[p2l11t1301r431b1402],
8	lymphoma	NN	O	lymphoma	nn	11	SENT_56	[p2l463t1301r911b1402],
9	kinase	NN	O	kinase	nn	11	SENT_56	[p2l942t1301r1212b1381],
10	gene	NN	O	gene	nn	11	SENT_56	[p2l1246t1327r1439b1402],
11	(	NN	O	(	prep_of	2	SENT_56	[p2l1478t1307r1694b1393],
12	ALK	NN	O	alk	nsubjpass	16	SENT_56	[p2l1478t1307r1694b1393],
13	)	CD	NUMBER	)	num	12	SENT_56	[p2l1478t1307r1694b1393],
14	have	VBP	O	have	aux	16	SENT_56	[p2l1733t1301r1917b1380],
15	been	VBN	O	be	auxpass	16	SENT_56	[p2l1952t1301r2148b1380],
16	identiﬁed	VBN	O	identiﬁed	_	0	SENT_56	[p2l11t1429r412b1508],
17	in	IN	O	in	_	0	SENT_56	[p2l441t1430r523b1507],
18	several	JJ	O	several	amod	19	SENT_56	[p2l555t1429r834b1508],
19	types	NNS	O	type	prep_in	16	SENT_56	[p2l865t1446r1081b1530],
20	of	IN	O	of	_	0	SENT_56	[p2l1114t1429r1212b1508],
21	cancer	NN	O	cancer	prep_of	19	SENT_56	[p2l1225t1455r1512b1525],
22	,	,	O	,	_	0	SENT_56	[p2l1225t1455r1512b1525],
23	including	VBG	O	include	_	0	SENT_56	[p2l1547t1429r1943b1530],
24	anaplastic	JJ	O	anaplastic	amod	27	SENT_56	[p2l1970t1455r2147b1508, p2l11t1557r281b1658],
25	large	JJ	O	large	amod	27	SENT_56	[p2l333t1557r737b1658],
26	—	NN	O	—	nn	27	SENT_56	[p2l333t1557r737b1658],
27	cell	NN	O	cell	prep_including	19	SENT_56	[p2l333t1557r737b1658],
28	lymphoma	NN	O	lymphoma	nn	30	SENT_56	[p2l791t1557r1319b1658],
29	,4	CD	NUMBER	,4	num	30	SENT_56	[p2l791t1557r1319b1658],
30	neuroblastoma	NN	O	neuroblastoma	dep	27	SENT_56	[p2l1374t1557r2148b1653],
31	,5	CD	NUMBER	,5	num	32	SENT_56	[p2l1374t1557r2148b1653],
32	>	JJR	O	>	dep	27	SENT_56	[p2l1374t1557r2148b1653],
33	6	CD	NUMBER	6	num	37	SENT_56	[p2l1374t1557r2148b1653],
34	inflammatory	JJ	O	inflammatory	amod	37	SENT_56	[p2l11t1685r625b1786],
35	myofibroblastic	JJ	O	myofibroblastic	amod	37	SENT_56	[p2l656t1685r1339b1786],
36	tumor	NN	O	tumor	nn	37	SENT_56	[p2l1374t1692r1700b1781],
37	,7	NN	O	,7	dep	43	SENT_56	[p2l1374t1692r1700b1781],
38	and	CC	O	and	_	0	SENT_56	[p2l1736t1685r1895b1764],
39	nonsmall	JJ	O	nonsmall	amod	42	SENT_56	[p2l1931t1711r2151b1764, p2l14t1813r435b1892],
40	—	NN	O	—	nn	42	SENT_56	[p2l1931t1711r2151b1764, p2l14t1813r435b1892],
41	cell	NN	O	cell	nn	42	SENT_56	[p2l1931t1711r2151b1764, p2l14t1813r435b1892],
42	lung	NN	O	lung	conj_and	43	SENT_56	[p2l484t1813r679b1914],
43	cancer	NN	O	cancer	dep	32	SENT_56	[p2l727t1819r1070b1892],
44	.8	CD	NUMBER	.8	num	43	SENT_56	[p2l727t1819r1070b1892],
45	In	IN	O	in	_	0	SENT_56	[p2l1121t1821r1210b1891],
46	non	JJ	O	non	amod	52	SENT_56	[p2l1261t1813r1908b1892],
47	—	JJ	O	—	amod	52	SENT_56	[p2l1261t1813r1908b1892],
48	small	JJ	O	small	amod	52	SENT_56	[p2l1261t1813r1908b1892],
49	—	NN	O	—	nn	52	SENT_56	[p2l1261t1813r1908b1892],
50	cell	NN	O	cell	nn	52	SENT_56	[p2l1261t1813r1908b1892],
51	lung	NN	O	lung	nn	52	SENT_56	[p2l1957t1813r2152b1914],
52	cancer	NN	O	cancer	prep_in	43	SENT_56	[p2l13t1967r307b2037],
53	,	,	O	,	_	0	SENT_56	[p2l13t1967r307b2037],
54	EML4	NN	O	eml4	appos	27	SENT_56	[p2l349t1947r777b2020],
55	.	.	O	.	_	0	SENT_56	[p2l349t1947r777b2020],

1	—	NN	O	—	_	0	SENT_57	[p2l349t1947r777b2020],
2	.	.	O	.	_	0	SENT_57	[p2l349t1947r777b2020],

1	ALK	NNP	O	ALK	nsubj	6	SENT_58	[p2l349t1947r777b2020],
2	is	VBZ	O	be	cop	6	SENT_58	[p2l807t1942r872b2020],
3	an	DT	O	a	det	6	SENT_58	[p2l911t1967r1013b2020],
4	aberrant	JJ	O	aberrant	amod	6	SENT_58	[p2l1051t1941r1412b2020],
5	fusion	NN	O	fusion	nn	6	SENT_58	[p2l1444t1941r1710b2020],
6	gene	NN	O	gene	_	0	SENT_58	[p2l1748t1967r1944b2042],
7	that	WDT	O	that	nsubj	8	SENT_58	[p2l1983t1941r2153b2020],
8	encodes	VBZ	O	encode	rcmod	6	SENT_58	[p2l13t2069r350b2148],
9	a	DT	O	a	det	12	SENT_58	[p2l385t2096r430b2148],
10	cytoplasmic	JJ	O	cytoplasmic	amod	12	SENT_58	[p2l463t2069r969b2170],
11	chimeric	JJ	O	chimeric	amod	12	SENT_58	[p2l1003t2069r1372b2148],
12	protein	NN	O	protein	dobj	8	SENT_58	[p2l1403t2070r1710b2170],
13	with	IN	O	with	_	0	SENT_58	[p2l1739t2069r1931b2148],
14	constitutive	JJ	O	constitutive	amod	16	SENT_58	[p2l1966t2095r2147b2148, p2l14t2198r357b2276],
15	kinase	NN	O	kinase	nn	16	SENT_58	[p2l403t2197r684b2277],
16	activity	NN	O	activity	prep_with	8	SENT_58	[p2l730t2198r1055b2298],
17	.	.	O	.	_	0	SENT_58	[p2l730t2198r1055b2298],

1	Multiple	JJ	O	multiple	amod	3	SENT_59	[p2l1104t2197r1465b2298],
2	distinct	JJ	O	distinct	amod	3	SENT_59	[p2l1512t2197r1843b2276],
3	EML4ALK	NN	O	eml4alk	nsubj	26	SENT_59	[p2l1883t2204r2146b2276, p2l6t2331r179b2403],
4	chimeric	JJ	O	chimeric	amod	5	SENT_59	[p2l204t2325r573b2404],
5	variants	NNS	O	variant	nsubjpass	8	SENT_59	[p2l602t2326r939b2404],
6	have	VBP	O	have	aux	8	SENT_59	[p2l974t2325r1162b2404],
7	been	VBN	O	be	auxpass	8	SENT_59	[p2l1196t2325r1395b2404],
8	identiﬁed	VBN	O	identiﬁed	rcmod	3	SENT_59	[p2l1427t2325r1860b2421],
9	,	,	O	,	_	0	SENT_59	[p2l1427t2325r1860b2421],
10	repre	NN	O	repre	nn	11	SENT_59	[p2l1897t2351r2147b2426],
11	—	NN	O	—	dobj	8	SENT_59	[p2l1897t2351r2147b2426],
12	senting	VBG	O	sent	partmod	11	SENT_59	[p2l14t2454r328b2554],
13	breakpoints	NNS	O	breakpoint	dobj	12	SENT_59	[p2l366t2453r884b2554],
14	within	IN	O	within	_	0	SENT_59	[p2l923t2453r1210b2533],
15	various	JJ	O	various	amod	17	SENT_59	[p2l1247t2454r1559b2532],
16	EML4	NN	O	eml4	nn	17	SENT_59	[p2l1600t2460r1834b2532],
17	exons	NNS	O	exon	prep_within	12	SENT_59	[p2l1874t2479r2142b2549],
18	,	,	O	,	_	0	SENT_59	[p2l1874t2479r2142b2549],
19	all	DT	O	all	dep	20	SENT_59	[p2l11t2581r117b2660],
20	of	IN	O	of	nsubj	23	SENT_59	[p2l157t2581r258b2660],
21	which	WDT	O	which	pobj	20	SENT_59	[p2l275t2581r539b2661],
22	are	VBP	O	be	aux	23	SENT_59	[p2l578t2608r708b2660],
23	transforming	VBG	O	transform	rcmod	17	SENT_59	[p2l749t2581r1333b2682],
24	in	IN	O	in	_	0	SENT_59	[p2l1369t2582r1452b2659],
25	vitro9	NN	O	vitro9	prep_in	23	SENT_59	[p2l1488t2582r1822b2660],
26	=	JJ	O	=	_	0	SENT_59	[p2l1488t2582r1822b2660],
27	1	CD	NUMBER	1	num	28	SENT_59	[p2l1488t2582r1822b2660],
28	°	CD	NUMBER	°	iobj	26	SENT_59	[p2l1488t2582r1822b2660],
29	(	CD	NUMBER	(	num	30	SENT_59	[p2l1868t2582r2052b2682],
30	Fig	NN	O	fig	dobj	26	SENT_59	[p2l1868t2582r2052b2682],
31	.	.	O	.	_	0	SENT_59	[p2l1868t2582r2052b2682],

1	1	CD	NUMBER	1	_	0	SENT_60	[p2l2103t2587r2147b2659],
2	in	IN	O	in	_	0	SENT_60	[p2l11t2710r96b2787],
3	the	DT	O	the	det	5	SENT_60	[p2l148t2709r281b2788],
4	Supplementary	NNP	O	Supplementary	nn	5	SENT_60	[p2l337t2709r987b2810],
5	Appendix	NNP	O	Appendix	prep_in	1	SENT_60	[p2l1031t2709r1473b2810],
6	,	,	O	,	_	0	SENT_60	[p2l1031t2709r1473b2810],
7	available	JJ	O	available	amod	5	SENT_60	[p2l1530t2709r1904b2788],
8	with	IN	O	with	_	0	SENT_60	[p2l1952t2709r2148b2789],
9	the	DT	O	the	det	11	SENT_60	[p2l12t2837r146b2916],
10	full	JJ	O	full	amod	11	SENT_60	[p2l191t2837r341b2916],
11	text	NN	O	text	prep_with	7	SENT_60	[p2l386t2854r547b2916],
12	of	IN	O	of	_	0	SENT_60	[p2l588t2837r689b2916],
13	this	DT	O	this	det	14	SENT_60	[p2l716t2837r876b2916],
14	article	NN	O	article	prep_of	11	SENT_60	[p2l922t2837r1191b2916],
15	at	IN	O	at	_	0	SENT_60	[p2l1236t2854r1316b2916],
16	NEJM.org	NN	O	nejm.org	nn	17	SENT_60	[p2l1353t2844r1833b2938],
17	)	NN	O	)	prep_at	1	SENT_60	[p2l1353t2844r1833b2938],
18	.	.	O	.	_	0	SENT_60	[p2l1353t2844r1833b2938],

1	EML4ALK	CD	NUMBER	eml4alk	nsubj	24	SENT_61	[p2l1883t2844r2147b2916, p2l6t2971r181b3043],
2	is	VBZ	O	be	cop	3	SENT_61	[p2l219t2966r285b3044],
3	uncommon	JJ	O	uncommon	_	0	SENT_61	[p2l334t2991r856b3061],
4	,	,	O	,	_	0	SENT_61	[p2l334t2991r856b3061],
5	occurring	VBG	O	occur	xcomp	3	SENT_61	[p2l910t2966r1334b3066],
6	in	IN	O	in	_	0	SENT_61	[p2l1377t2966r1461b3043],
7	2	CD	NUMBER	2	number	9	SENT_61	[p2l1508t2971r1555b3043],
8	to	TO	O	to	dep	9	SENT_61	[p2l1604t2982r1686b3044],
9	7	CD	PERCENT	7	num	10	SENT_61	[p2l1735t2970r1869b3044],
10	%	NN	PERCENT	%	prep_in	5	SENT_61	[p2l1735t2970r1869b3044],
11	of	IN	O	of	_	0	SENT_61	[p2l1915t2965r2016b3044],
12	all	DT	O	all	det	19	SENT_61	[p2l2044t2965r2149b3044],
13	non	JJ	O	non	amod	19	SENT_61	[p2l12t3093r659b3172],
14	—	CD	NUMBER	—	tmod	13	SENT_61	[p2l12t3093r659b3172],
15	small	JJ	O	small	amod	19	SENT_61	[p2l12t3093r659b3172],
16	—	JJ	O	—	amod	19	SENT_61	[p2l12t3093r659b3172],
17	cell	NN	O	cell	nn	19	SENT_61	[p2l12t3093r659b3172],
18	lung	NN	O	lung	nn	19	SENT_61	[p2l697t3093r891b3194],
19	cancers	NNS	O	cancer	prep_of	10	SENT_61	[p2l929t3119r1276b3189],
20	,	,	O	,	_	0	SENT_61	[p2l929t3119r1276b3189],
21	and	CC	O	and	_	0	SENT_61	[p2l1321t3093r1479b3172],
22	is	VBZ	O	be	cop	24	SENT_61	[p2l1518t3094r1585b3172],
23	more	RBR	O	more	advmod	24	SENT_61	[p2l1626t3119r1847b3172],
24	prevalent	JJ	O	prevalent	conj_and	3	SENT_61	[p2l1885t3119r2147b3194, p2l11t3221r175b3300],
25	in	IN	O	in	_	0	SENT_61	[p2l212t3222r296b3299],
26	patients	NNS	O	patient	prep_in	24	SENT_61	[p2l338t3222r681b3322],
27	who	WP	O	who	nsubj	30	SENT_61	[p2l723t3221r907b3300],
28	have	VBP	O	have	aux	30	SENT_61	[p2l952t3221r1143b3300],
29	never	RB	O	never	neg	30	SENT_61	[p2l1187t3247r1417b3300],
30	smoked	VBN	O	smoke	rcmod	26	SENT_61	[p2l1460t3221r1794b3301],
31	or	CC	O	or	_	0	SENT_61	[p2l1838t3247r1927b3300],
32	who	WP	O	who	nsubj	33	SENT_61	[p2l1963t3221r2147b3301],
33	have	VBP	O	have	conj_or	30	SENT_61	[p2l12t3349r203b3428],
34	a	DT	O	a	det	35	SENT_61	[p2l247t3376r292b3428],
35	history	NN	O	history	dobj	33	SENT_61	[p2l336t3349r641b3450],
36	of	IN	O	of	_	0	SENT_61	[p2l682t3349r783b3428],
37	light	JJ	O	light	amod	38	SENT_61	[p2l808t3349r1011b3450],
38	smoking	NN	O	smoking	prep_of	35	SENT_61	[p2l1052t3349r1431b3450],
39	and	CC	O	and	_	0	SENT_61	[p2l1472t3349r1631b3428],
40	in	IN	O	in	_	0	SENT_61	[p2l1675t3350r1759b3427],
41	patients	NNS	O	patient	prep_in	24	SENT_61	[p2l1802t3350r2145b3450],
42	with	IN	O	with	_	0	SENT_61	[p2l7t3477r204b3557],
43	adenocarcinomas	NNS	O	adenocarcinoma	prep_with	41	SENT_61	[p2l247t3477r1269b3556],
44	.8	CD	NUMBER	.8	num	45	SENT_61	[p2l247t3477r1269b3556],
45	v1	NN	O	v1	dep	53	SENT_61	[p2l247t3477r1269b3556],
46	°	CD	NUMBER	°	num	47	SENT_61	[p2l247t3477r1269b3556],
47	‘	CD	NUMBER	‘	dep	45	SENT_61	[p2l247t3477r1269b3556],
48	14	CD	NUMBER	14	dep	53	SENT_61	[p2l247t3477r1269b3556],
49	Other	JJ	O	other	amod	53	SENT_61	[p2l1311t3477r1579b3573],
50	,	,	O	,	_	0	SENT_61	[p2l1311t3477r1579b3573],
51	rarer	JJR	O	rarer	amod	53	SENT_61	[p2l1627t3503r1837b3556],
52	fusion	NN	O	fusion	nn	53	SENT_61	[p2l1877t3477r2148b3557],
53	partners	NNS	O	partner	dep	66	SENT_61	[p2l11t3623r375b3707],
54	for	IN	O	for	_	0	SENT_61	[p2l419t3606r543b3685],
55	ALK	NNP	O	ALK	prep_for	53	SENT_61	[p2l576t3612r751b3684],
56	(	CD	NUMBER	(	num	55	SENT_61	[p2l790t3613r985b3707],
57	e.g.	FW	O	e.g.	nsubjpass	66	SENT_61	[p2l790t3613r985b3707],
58	,	,	O	,	_	0	SENT_61	[p2l790t3613r985b3707],
59	KIFSB	NN	ORGANIZATION	kifsb	nsubjpass	66	SENT_61	[p2l1031t3613r1267b3685],
60	and	CC	O	and	_	0	SENT_61	[p2l1309t3606r1468b3685],
61	TFG	NN	O	tfg	nsubjpass	66	SENT_61	[p2l1509t3612r1694b3698],
62	)	CD	NUMBER	)	num	61	SENT_61	[p2l1509t3612r1694b3698],
63	have	VBP	O	have	aux	66	SENT_61	[p2l1741t3606r1932b3685],
64	also	RB	O	also	advmod	66	SENT_61	[p2l1974t3606r2147b3685],
65	been	VBN	O	be	auxpass	66	SENT_61	[p3l13t20r215b99],
66	reported	VBN	O	report	ccomp	24	SENT_61	[p3l259t20r628b121],
67	in	IN	O	in	_	0	SENT_61	[p3l670t21r754b98],
68	non	JJ	O	non	amod	74	SENT_61	[p3l798t20r1444b99],
69	—	JJ	O	—	amod	74	SENT_61	[p3l798t20r1444b99],
70	small	JJ	O	small	amod	74	SENT_61	[p3l798t20r1444b99],
71	—	NN	O	—	nn	74	SENT_61	[p3l798t20r1444b99],
72	cell	NN	O	cell	nn	74	SENT_61	[p3l798t20r1444b99],
73	lung	NN	O	lung	nn	74	SENT_61	[p3l1487t20r1682b121],
74	cancers	NNS	O	cancer	prep_in	66	SENT_61	[p3l1723t25r2145b99],
75	.	.	O	.	_	0	SENT_61	[p3l1723t25r2145b99],

1	“	NN	O	“	ccomp	7	SENT_62	[p3l1723t25r2145b99],
2	Thus	RB	O	thus	advmod	1	SENT_62	[p3l8t148r237b244],
3	,	,	O	,	_	0	SENT_62	[p3l8t148r237b244],
4	ALK	NN	O	alk	nn	5	SENT_62	[p3l269t154r441b226],
5	rearrangements	NNS	O	rearrangement	nsubj	7	SENT_62	[p3l465t165r1122b249],
6	may	MD	O	may	aux	7	SENT_62	[p3l1158t174r1334b249],
7	define	VB	O	define	_	0	SENT_62	[p3l1363t148r1624b227],
8	a	DT	O	a	det	10	SENT_62	[p3l1657t175r1701b227],
9	molecular	JJ	O	molecular	amod	10	SENT_62	[p3l1732t148r2151b227],
10	subgroup	NN	O	subgroup	dobj	7	SENT_62	[p3l14t276r419b377],
11	of	IN	O	of	_	0	SENT_62	[p3l465t276r566b355],
12	these	DT	O	these	det	13	SENT_62	[p3l592t276r816b355],
13	tumors	NNS	O	tumor	prep_of	10	SENT_62	[p3l861t293r1171b355],
14	that	WDT	O	that	nsubj	16	SENT_62	[p3l1217t276r1391b355],
15	is	VBZ	O	be	cop	16	SENT_62	[p3l1429t277r1495b355],
16	susceptible	JJ	O	susceptible	rcmod	13	SENT_62	[p3l1543t276r2021b377],
17	to	TO	O	to	_	0	SENT_62	[p3l2065t293r2147b355],
18	targeted	JJ	O	targeted	amod	20	SENT_62	[p3l12t404r370b505],
19	kinase	NN	O	kinase	nn	20	SENT_62	[p3l409t404r690b484],
20	inhibition	NN	O	inhibition	prep_to	16	SENT_62	[p3l729t404r1184b483],
21	.	.	O	.	_	0	SENT_62	[p3l729t404r1184b483],

1	In	IN	O	in	_	0	SENT_63	[p3l141t540r230b610],
2	preclinical	JJ	O	preclinical	amod	3	SENT_63	[p3l271t532r729b633],
3	analyses	NNS	O	analysis	prep_in	21	SENT_63	[p3l769t532r1131b633],
4	of	IN	O	of	_	0	SENT_63	[p3l1176t532r1276b611],
5	more	JJR	O	more	mwe	6	SENT_63	[p3l1300t558r1520b611],
6	than	IN	O	than	quantmod	7	SENT_63	[p3l1563t532r1760b611],
7	600	CD	NUMBER	600	num	9	SENT_63	[p3l1802t538r1958b611],
8	cell	NN	O	cell	nn	9	SENT_63	[p3l2002t532r2148b611],
9	lines	NNS	O	line	prep_of	3	SENT_63	[p3l11t660r214b739],
10	derived	VBN	O	derive	partmod	9	SENT_63	[p3l255t660r566b739],
11	from	IN	O	from	_	0	SENT_63	[p3l604t660r816b739],
12	human	JJ	O	human	amod	13	SENT_63	[p3l855t660r1160b739],
13	cancers	NNS	O	cancer	prep_from	10	SENT_63	[p3l1200t686r1547b756],
14	,	,	O	,	_	0	SENT_63	[p3l1200t686r1547b756],
15	an	DT	O	a	det	19	SENT_63	[p3l1591t686r1695b739],
16	investigational	JJ	O	investigational	amod	19	SENT_63	[p3l1732t661r2147b761, p3l12t788r258b867],
17	selective	JJ	O	selective	amod	19	SENT_63	[p3l295t788r645b867],
18	ALK	NN	O	alk	nn	19	SENT_63	[p3l676t796r867b869],
19	inhibitor	NN	O	inhibitor	nsubj	21	SENT_63	[p3l898t788r1273b867],
20	specifically	RB	O	specifically	advmod	21	SENT_63	[p3l1307t788r1786b889],
21	reduced	VBD	O	reduce	_	0	SENT_63	[p3l1817t788r2149b867],
22	the	DT	O	the	det	23	SENT_63	[p3l12t916r146b995],
23	proliferation	NN	O	proliferation	dobj	21	SENT_63	[p3l185t916r732b1017],
24	of	IN	O	of	_	0	SENT_63	[p3l772t916r873b995],
25	cells	NNS	O	cell	prep_of	23	SENT_63	[p3l895t916r1082b995],
26	carrying	VBG	O	carry	partmod	25	SENT_63	[p3l1125t917r1491b1017],
27	genetic	JJ	O	genetic	amod	28	SENT_63	[p3l1527t917r1838b1017],
28	alterations	NNS	O	alteration	dobj	26	SENT_63	[p3l1876t916r2147b995, p3l12t1045r220b1123],
29	in	IN	O	in	_	0	SENT_63	[p3l266t1045r349b1122],
30	ALK	NNP	O	ALK	prep_in	26	SENT_63	[p3l385t1050r573b1140],
31	,	,	O	,	_	0	SENT_63	[p3l385t1050r573b1140],
32	supporting	VBG	O	support	partmod	21	SENT_63	[p3l624t1045r1093b1145],
33	the	DT	O	the	det	34	SENT_63	[p3l1133t1044r1264b1123],
34	role	NN	O	role	dobj	32	SENT_63	[p3l1308t1044r1465b1123],
35	of	IN	O	of	_	0	SENT_63	[p3l1509t1044r1609b1123],
36	ALK	NNP	O	ALK	prep_of	34	SENT_63	[p3l1630t1052r1821b1125],
37	in	IN	O	in	_	0	SENT_63	[p3l1860t1045r1943b1122],
38	malignant	JJ	O	malignant	amod	39	SENT_63	[p3l1986t1070r2147b1123, p3l11t1172r319b1273],
39	proliferation	NN	O	proliferation	prep_in	32	SENT_63	[p3l346t1172r893b1273],
40	and	CC	O	and	_	0	SENT_63	[p3l926t1172r1085b1251],
41	as	IN	O	as	_	0	SENT_63	[p3l1119t1199r1205b1251],
42	a	DT	O	a	det	45	SENT_63	[p3l1241t1199r1286b1251],
43	valid	JJ	O	valid	amod	45	SENT_63	[p3l1314t1172r1521b1251],
44	drug	NN	O	drug	nn	45	SENT_63	[p3l1556t1172r1761b1273],
45	target	NN	O	target	prep_as	32	SENT_63	[p3l1793t1176r2148b1273],
46	.	.	O	.	_	0	SENT_63	[p3l1793t1176r2148b1273],

1	“	NN	O	“	nn	2	SENT_64	[p3l1793t1176r2148b1273],
2	Crizotinib	NN	O	crizotinib	_	0	SENT_64	[p3l12t1300r454b1379],
3	(	CD	NUMBER	(	num	4	SENT_64	[p3l501t1306r1107b1396],
4	PF	NN	O	pf	dep	2	SENT_64	[p3l501t1306r1107b1396],
5	.	.	O	.	_	0	SENT_64	[p3l501t1306r1107b1396],

1	—	NN	O	—	_	0	SENT_65	[p3l501t1306r1107b1396],
2	.	.	O	.	_	0	SENT_65	[p3l501t1306r1107b1396],

1	O2341066	NN	O	o2341066	nsubj	34	SENT_66	[p3l501t1306r1107b1396],
2	,	,	O	,	_	0	SENT_66	[p3l501t1306r1107b1396],
3	Pfizer	NNP	ORGANIZATION	Pfizer	nn	4	SENT_66	[p3l1152t1300r1436b1392],
4	)	NNP	O	)	nsubj	10	SENT_66	[p3l1152t1300r1436b1392],
5	is	VBZ	O	be	cop	10	SENT_66	[p3l1482t1301r1547b1379],
6	an	DT	O	a	det	10	SENT_66	[p3l1590t1326r1694b1379],
7	oral	JJ	O	oral	amod	10	SENT_66	[p3l1735t1300r1901b1379],
8	ATPcompetitive	JJ	O	atpcompetitive	amod	10	SENT_66	[p3l1938t1306r2147b1378, p3l13t1430r493b1530],
9	selective	JJ	O	selective	amod	10	SENT_66	[p3l524t1429r866b1509],
10	inhibitor	NN	O	inhibitor	parataxis	34	SENT_66	[p3l895t1429r1262b1508],
11	of	IN	O	of	_	0	SENT_66	[p3l1289t1429r1387b1508],
12	the	DT	O	the	det	13	SENT_66	[p3l1399t1429r1528b1508],
13	ALK	NNP	O	ALK	prep_of	10	SENT_66	[p3l1554t1437r1742b1510],
14	and	CC	O	and	_	0	SENT_66	[p3l1767t1429r1922b1508],
15	MET	NN	O	met	nn	17	SENT_66	[p3l1948t1435r2152b1508],
16	tyrosine	NN	O	tyrosine	nn	17	SENT_66	[p3l12t1558r353b1658],
17	kinases	NNS	O	kinase	prep_of	10	SENT_66	[p3l385t1557r702b1637],
18	that	WDT	O	that	nsubj	19	SENT_66	[p3l737t1557r907b1636],
19	inhibits	VBZ	O	inhibit	rcmod	10	SENT_66	[p3l934t1557r1258b1636],
20	tyrosine	NN	O	tyrosine	dobj	19	SENT_66	[p3l1292t1558r1633b1658],
21	phosphory	JJ	O	phosphory	amod	23	SENT_66	[p3l1664t1557r2147b1658],
22	—	NN	O	—	nn	23	SENT_66	[p3l1664t1557r2147b1658],
23	lation	NN	O	lation	tmod	19	SENT_66	[p3l11t1685r254b1765],
24	of	IN	O	of	_	0	SENT_66	[p3l294t1685r395b1765],
25	activated	VBN	O	activate	amod	26	SENT_66	[p3l416t1685r797b1765],
26	ALK	NN	O	alk	prep_of	23	SENT_66	[p3l833t1693r1025b1767],
27	at	IN	O	at	_	0	SENT_66	[p3l1061t1702r1141b1764],
28	nanomolar	JJ	O	nanomolar	amod	29	SENT_66	[p3l1176t1685r1654b1765],
29	concentrations	NNS	O	concentration	prep_at	26	SENT_66	[p3l1692t1702r2147b1765, p3l12t1815r423b1893],
30	.16	CD	NUMBER	.16	number	31	SENT_66	[p3l1692t1702r2147b1765, p3l12t1815r423b1893],
31	»	CD	NUMBER	»	num	29	SENT_66	[p3l1692t1702r2147b1765, p3l12t1815r423b1893],
32	17	CD	NUMBER	17	dep	23	SENT_66	[p3l1692t1702r2147b1765, p3l12t1815r423b1893],
33	We	PRP	O	we	nsubj	34	SENT_66	[p3l481t1822r614b1893],
34	conducted	VBD	O	conduct	_	0	SENT_66	[p3l676t1814r1120b1893],
35	an	DT	O	a	det	38	SENT_66	[p3l1181t1840r1284b1893],
36	open	JJ	O	open	amod	38	SENT_66	[p3l1345t1814r1818b1915],
37	—	NN	O	—	nn	38	SENT_66	[p3l1345t1814r1818b1915],
38	label	NN	O	label	dobj	34	SENT_66	[p3l1345t1814r1818b1915],
39	,	,	O	,	_	0	SENT_66	[p3l1345t1814r1818b1915],
40	multicenter	NN	O	multicenter	dobj	34	SENT_66	[p3l1885t1814r2147b1893, p3l13t1959r296b2038],
41	,	,	O	,	_	0	SENT_66	[p3l1885t1814r2147b1893, p3l13t1959r296b2038],
42	two	CD	NUMBER	two	number	43	SENT_66	[p3l360t1959r737b2043],
43	—	CD	NUMBER	—	num	47	SENT_66	[p3l360t1959r737b2043],
44	part	NN	O	part	nn	47	SENT_66	[p3l360t1959r737b2043],
45	phase	NN	O	phase	nn	47	SENT_66	[p3l789t1942r1038b2043],
46	1	CD	NUMBER	1	num	47	SENT_66	[p3l1100t1948r1145b2020],
47	trial	NN	O	trial	conj_and	38	SENT_66	[p3l1204t1942r1383b2021],
48	of	IN	O	of	_	0	SENT_66	[p3l1441t1942r1542b2021],
49	crizotinib	NN	O	crizotinib	prep_of	47	SENT_66	[p3l1582t1942r2005b2021],
50	to	TO	O	to	aux	51	SENT_66	[p3l2065t1959r2147b2021],
51	evaluate	VB	O	evaluate	infmod	47	SENT_66	[p3l13t2070r361b2149],
52	the	DT	O	the	det	56	SENT_66	[p3l397t2070r530b2149],
53	adverse	JJ	O	adverse	amod	56	SENT_66	[p3l565t2070r1149b2149],
54	—	NN	O	—	nn	56	SENT_66	[p3l565t2070r1149b2149],
55	event	NN	O	event	nn	56	SENT_66	[p3l565t2070r1149b2149],
56	proﬁle	NN	O	proﬁle	dobj	51	SENT_66	[p3l1178t2070r1468b2171],
57	and	CC	O	and	_	0	SENT_66	[p3l1502t2070r1661b2149],
58	efficacy	NN	O	efficacy	dobj	34	SENT_66	[p3l1696t2070r2035b2171],
59	in	IN	O	in	_	0	SENT_66	[p3l2065t2071r2148b2148],
60	an	DT	O	a	det	62	SENT_66	[p3l11t2224r114b2277],
61	expanded	VBN	O	expand	amod	62	SENT_66	[p3l149t2198r555b2299],
62	cohort	NN	O	cohort	prep_in	58	SENT_66	[p3l590t2198r868b2277],
63	of	IN	O	of	_	0	SENT_66	[p3l899t2198r998b2277],
64	patients	NNS	O	patient	prep_of	62	SENT_66	[p3l1012t2199r1348b2299],
65	with	IN	O	with	_	0	SENT_66	[p3l1380t2198r1573b2278],
66	lung	NN	O	lung	nn	67	SENT_66	[p3l1607t2198r1799b2299],
67	cancers	NNS	O	cancer	prep_with	64	SENT_66	[p3l1830t2224r2146b2277],
68	carrying	VBG	O	carry	partmod	67	SENT_66	[p3l13t2328r379b2428],
69	ALK	NN	O	alk	nn	70	SENT_66	[p3l408t2333r584b2405],
70	rearrangements	NNS	O	rearrangement	dobj	68	SENT_66	[p3l616t2343r1326b2428],
71	.	.	O	.	_	0	SENT_66	[p3l616t2343r1326b2428],

1	METHODS	NNS	O	method	_	0	SENT_67	[p3l802t2575r1344b2634],

1	STUDY	NN	O	study	nn	2	SENT_68	[p3l12t2821r268b2871],
2	DESIGN	NN	O	design	nsubj	4	SENT_68	[p3l305t2821r600b2871],
3	We	PRP	O	we	nsubj	4	SENT_68	[p3l8t2929r141b3000],
4	administered	VBD	O	administer	_	0	SENT_68	[p3l175t2922r745b3000],
5	oral	JJ	O	oral	amod	6	SENT_68	[p3l780t2922r946b3000],
6	crizotinib	NN	O	crizotinib	dobj	4	SENT_68	[p3l980t2922r1401b3000],
7	on	IN	O	on	_	0	SENT_68	[p3l1437t2947r1543b3000],
8	a	DT	O	a	det	11	SENT_68	[p3l1577t2948r1621b3000],
9	continuous	JJ	O	continuous	amod	11	SENT_68	[p3l1655t2923r2132b3001],
10	daily	JJ	SET	daily	amod	11	SENT_68	[p3l13t3050r220b3149],
11	schedule	NN	O	schedule	prep_on	4	SENT_68	[p3l271t3050r642b3129],
12	in	IN	O	in	_	0	SENT_68	[p3l695t3051r778b3126],
13	patients	NNS	O	patient	prep_in	11	SENT_68	[p3l830t3051r1171b3149],
14	with	IN	O	with	_	0	SENT_68	[p3l1222t3050r1417b3129],
15	advanced	JJ	O	advanced	amod	16	SENT_68	[p3l1470t3050r1866b3128],
16	nonsmall	JJ	O	nonsmall	amod	20	SENT_68	[p3l1919t3075r2139b3127, p3l14t3178r432b3256],
17	—	NN	O	—	nn	20	SENT_68	[p3l1919t3075r2139b3127, p3l14t3178r432b3256],
18	cell	NN	O	cell	nn	20	SENT_68	[p3l1919t3075r2139b3127, p3l14t3178r432b3256],
19	lung	NN	O	lung	nn	20	SENT_68	[p3l468t3178r661b3279],
20	cancer	NN	O	cancer	prep_with	4	SENT_68	[p3l695t3204r994b3256],
21	.	.	O	.	_	0	SENT_68	[p3l695t3204r994b3256],

1	One	CD	NUMBER	one	num	2	SENT_69	[p3l1037t3183r1208b3256],
2	cycle	NN	O	cycle	nsubjpass	4	SENT_69	[p3l1246t3178r1449b3278],
3	was	VBD	O	be	auxpass	4	SENT_69	[p3l1482t3204r1644b3257],
4	defined	VBN	O	define	_	0	SENT_69	[p3l1684t3177r2011b3256],
5	as	IN	O	as	_	0	SENT_69	[p3l2047t3204r2132b3256],
6	28	CD	DURATION	28	num	7	SENT_69	[p3l12t3311r110b3384],
7	days	NNS	NUMBER	day	prep_as	4	SENT_69	[p3l140t3306r345b3406],
8	.	.	O	.	_	0	SENT_69	[p3l140t3306r345b3406],

1	The	DT	O	the	det	3	SENT_70	[p3l375t3306r533b3384],
2	first	JJ	ORDINAL	first	amod	3	SENT_70	[p3l561t3305r740b3384],
3	part	NN	O	part	nsubj	7	SENT_70	[p3l762t3322r938b3406],
4	of	IN	O	of	_	0	SENT_70	[p3l961t3305r1059b3384],
5	the	DT	O	the	det	6	SENT_70	[p3l1069t3306r1199b3384],
6	trial	NN	O	trial	prep_of	3	SENT_70	[p3l1228t3306r1401b3384],
7	enrolled	VBD	O	enrol	dep	30	SENT_70	[p3l1429t3306r1772b3384],
8	patients	NNS	O	patient	dobj	7	SENT_70	[p3l1798t3307r2132b3406],
9	with	IN	O	with	_	0	SENT_70	[p3l7t3434r203b3513],
10	any	DT	O	any	det	12	SENT_70	[p3l235t3460r385b3534],
11	solid	JJ	O	solid	amod	12	SENT_70	[p3l415t3434r619b3512],
12	tumor	NN	O	tumor	nn	22	SENT_70	[p3l652t3450r920b3513],
13	refractory	JJ	O	refractory	amod	22	SENT_70	[p3l949t3433r1374b3534],
14	to	TO	O	to	_	0	SENT_70	[p3l1403t3451r1484b3512],
15	standard	JJ	O	standard	amod	16	SENT_70	[p3l1519t3434r1899b3512],
16	therapy	NN	O	therapy	prep_to	13	SENT_70	[p3l1931t3434r2134b3512, p3l11t3587r157b3661],
17	in	IN	O	in	_	0	SENT_70	[p3l185t3563r268b3638],
18	a	DT	O	a	det	20	SENT_70	[p3l301t3588r345b3639],
19	dose	NN	O	dose	nn	20	SENT_70	[p3l378t3562r1048b3639],
20	—	NN	O	—	prep_in	16	SENT_70	[p3l378t3562r1048b3639],
21	escalation	NN	O	escalation	nn	22	SENT_70	[p3l378t3562r1048b3639],
22	study	NN	O	study	prep_with	7	SENT_70	[p3l1083t3562r1312b3661],
23	to	TO	O	to	aux	24	SENT_70	[p3l1341t3578r1423b3639],
24	determine	VB	O	determine	xcomp	7	SENT_70	[p3l1458t3562r1896b3639],
25	toxic	JJ	O	toxic	amod	26	SENT_70	[p3l1930t3563r2136b3639],
26	effects	NNS	O	effect	dobj	24	SENT_70	[p3l13t3689r294b3768],
27	and	CC	O	and	_	0	SENT_70	[p3l326t3690r484b3768],
28	the	DT	O	the	det	29	SENT_70	[p3l515t3690r647b3768],
29	maximum	NN	O	maximum	dobj	24	SENT_70	[p3l678t3691r1124b3769],
30	tolerated	VBD	O	tolerate	_	0	SENT_70	[p3l1155t3690r1531b3768],
31	dose	NN	O	dose	nn	32	SENT_70	[p3l1563t3690r1757b3768],
32	(	NN	O	(	dobj	30	SENT_70	[p3l1792t3691r1966b3786],
33	i.e.	FW	O	i.e.	nsubj	30	SENT_70	[p3l1792t3691r1966b3786],
34	,	,	O	,	_	0	SENT_70	[p3l1792t3691r1966b3786],
35	the	DT	O	the	det	37	SENT_70	[p3l2002t3690r2135b3768],
36	highest	JJS	O	highest	amod	37	SENT_70	[p4l12t23r333b124],
37	dose	NN	O	dose	appos	33	SENT_70	[p4l370t23r564b101],
38	that	WDT	O	that	nsubj	41	SENT_70	[p4l606t23r778b101],
39	would	MD	O	would	aux	41	SENT_70	[p4l811t23r1076b102],
40	not	RB	O	not	neg	41	SENT_70	[p4l1118t39r1260b101],
41	cause	VB	O	cause	rcmod	37	SENT_70	[p4l1297t49r1530b102],
42	unacceptable	JJ	O	unacceptable	acomp	41	SENT_70	[p4l1572t23r2135b123],
43	side	JJ	O	side	amod	44	SENT_70	[p4l14t151r178b229],
44	effects	NNS	O	effect	nsubj	45	SENT_70	[p4l216t150r549b242],
45	)	VBP	O	)	ccomp	42	SENT_70	[p4l216t150r549b242],
46	.	.	O	.	_	0	SENT_70	[p4l216t150r549b242],

1	Details	NNS	O	detail	nsubjpass	13	SENT_71	[p4l591t151r893b229],
2	of	IN	O	of	_	0	SENT_71	[p4l934t150r1033b229],
3	dose	NN	O	dose	nn	4	SENT_71	[p4l1053t151r1247b229],
4	escalation	NN	O	escalation	prep_of	1	SENT_71	[p4l1286t151r1743b247],
5	,	,	O	,	_	0	SENT_71	[p4l1286t151r1743b247],
6	toxic	JJ	O	toxic	amod	7	SENT_71	[p4l1786t152r1992b229],
7	effects	NNS	O	effect	prep_of	1	SENT_71	[p4l2030t150r2134b229, p4l12t278r234b375],
8	,	,	O	,	_	0	SENT_71	[p4l2030t150r2134b229, p4l12t278r234b375],
9	and	CC	O	and	_	0	SENT_71	[p4l280t279r437b357],
10	pharmacokinetics	NNS	O	pharmacokinetic	prep_of	1	SENT_71	[p4l477t279r1253b379],
11	have	VBP	O	have	aux	13	SENT_71	[p4l1296t279r1485b358],
12	been	VBN	O	be	auxpass	13	SENT_71	[p4l1527t279r1728b357],
13	reported	VBN	O	report	_	0	SENT_71	[p4l1768t279r2135b379],
14	previously	RB	DATE	previously	advmod	13	SENT_71	[p4l11t407r540b506],
15	.	.	O	.	_	0	SENT_71	[p4l11t407r540b506],

1	”	NN	O	”	nsubjpass	5	SENT_72	[p4l11t407r540b506],
2	The	DT	O	the	det	3	SENT_72	[p4l583t407r744b484],
3	study	NN	O	study	dep	1	SENT_72	[p4l790t407r1020b506],
4	was	VBD	O	be	auxpass	5	SENT_72	[p4l1055t433r1218b486],
5	conducted	VBN	O	conduct	_	0	SENT_72	[p4l1265t407r1706b486],
6	in	IN	O	in	_	0	SENT_72	[p4l1750t407r1833b483],
7	accordance	NN	O	accordance	prep_in	5	SENT_72	[p4l1877t432r2134b484, p4l13t535r263b612],
8	with	IN	O	with	_	0	SENT_72	[p4l314t535r509b614],
9	the	DT	O	the	det	10	SENT_72	[p4l566t535r698b612],
10	protocol	NN	O	protocol	prep_with	5	SENT_72	[p4l753t535r1136b634],
11	,	,	O	,	_	0	SENT_72	[p4l753t535r1136b634],
12	which	WDT	O	which	nsubj	14	SENT_72	[p4l1194t535r1456b614],
13	is	VBZ	O	be	cop	14	SENT_72	[p4l1511t536r1576b612],
14	available	JJ	O	available	rcmod	10	SENT_72	[p4l1634t535r2006b613],
15	at	IN	O	at	_	0	SENT_72	[p4l2061t551r2140b612],
16	NEJM.org	NN	O	nejm.org	prep_at	14	SENT_72	[p4l10t670r454b764],
17	.	.	O	.	_	0	SENT_72	[p4l10t670r454b764],

1	On	IN	O	on	_	0	SENT_73	[p4l495t668r621b741],
2	the	DT	O	the	det	3	SENT_73	[p4l657t663r789b741],
3	basis	NN	O	basis	prep_on	31	SENT_73	[p4l826t663r1037b741],
4	of	IN	O	of	_	0	SENT_73	[p4l1075t662r1175b741],
5	evidence	NN	O	evidence	prep_of	3	SENT_73	[p4l1193t663r1558b742],
6	of	IN	O	of	_	0	SENT_73	[p4l1595t662r1695b741],
7	activity	NN	O	activity	prep_of	5	SENT_73	[p4l1711t664r2021b763],
8	in	IN	O	in	_	0	SENT_73	[p4l2052t664r2135b740],
9	two	CD	NUMBER	two	num	10	SENT_73	[p4l12t807r168b870],
10	patients	NNS	O	patient	prep_in	7	SENT_73	[p4l196t792r530b891],
11	with	IN	O	with	_	0	SENT_73	[p4l556t791r748b870],
12	non	JJ	O	non	amod	18	SENT_73	[p4l776t791r1405b869],
13	—	JJ	O	—	amod	18	SENT_73	[p4l776t791r1405b869],
14	small	JJ	O	small	amod	18	SENT_73	[p4l776t791r1405b869],
15	—	NN	O	—	nn	18	SENT_73	[p4l776t791r1405b869],
16	cell	NN	O	cell	nn	18	SENT_73	[p4l776t791r1405b869],
17	lung	NN	O	lung	nn	18	SENT_73	[p4l1431t791r1621b892],
18	cancer	NN	O	cancer	prep_with	10	SENT_73	[p4l1647t817r1922b869],
19	with	IN	O	with	_	0	SENT_73	[p4l1942t791r2135b870],
20	ALK	NN	O	alk	nn	21	SENT_73	[p4l6t924r180b997],
21	rearrangement	NN	O	rearrangement	prep_with	18	SENT_73	[p4l210t935r852b1020],
22	who	WP	O	who	nsubjpass	24	SENT_73	[p4l881t919r1064b998],
23	were	VBD	O	be	auxpass	24	SENT_73	[p4l1100t945r1301b998],
24	treated	VBN	O	treat	rcmod	3	SENT_73	[p4l1340t919r1638b997],
25	during	IN	O	during	_	0	SENT_73	[p4l1678t919r1966b1020],
26	the	DT	O	the	det	28	SENT_73	[p4l2002t919r2135b997],
27	dose-escalation	JJ	O	dose-escalation	amod	28	SENT_73	[p4l13t1047r682b1124],
28	period	NN	O	period	prep_during	24	SENT_73	[p4l715t1047r1015b1146],
29	,	,	O	,	_	0	SENT_73	[p4l715t1047r1015b1146],
30	we	PRP	O	we	nsubj	31	SENT_73	[p4l1050t1073r1167b1126],
31	enrolled	VBD	O	enrol	_	0	SENT_73	[p4l1202t1047r1553b1124],
32	an	DT	O	a	det	34	SENT_73	[p4l1586t1072r1689b1124],
33	expanded	VBN	O	expand	amod	34	SENT_73	[p4l1723t1047r2135b1146],
34	cohort	NN	O	cohort	dobj	31	SENT_73	[p4l13t1175r295b1253],
35	of	IN	O	of	_	0	SENT_73	[p4l332t1174r432b1253],
36	patients	NNS	O	patient	prep_of	34	SENT_73	[p4l455t1176r796b1275],
37	who	WP	O	who	nsubj	38	SENT_73	[p4l837t1175r1019b1254],
38	had	VBD	O	have	rcmod	34	SENT_73	[p4l1063t1175r1220b1253],
39	non	JJ	O	non	amod	45	SENT_73	[p4l1261t1175r1904b1253],
40	—	JJ	O	—	amod	41	SENT_73	[p4l1261t1175r1904b1253],
41	small	JJ	O	small	amod	45	SENT_73	[p4l1261t1175r1904b1253],
42	—	NN	O	—	nn	45	SENT_73	[p4l1261t1175r1904b1253],
43	cell	NN	O	cell	nn	45	SENT_73	[p4l1261t1175r1904b1253],
44	lung	NN	O	lung	nn	45	SENT_73	[p4l1945t1175r2139b1276],
45	cancer	NN	O	cancer	dobj	38	SENT_73	[p4l13t1329r294b1381],
46	with	IN	O	with	prep	45	SENT_73	[p4l349t1303r544b1382],
47	prospectively	RB	O	prospectively	pcomp	46	SENT_73	[p4l607t1303r1172b1403],
48	identified	VBN	O	identify	partmod	45	SENT_73	[p4l1230t1302r1647b1381],
49	ALK	NN	O	alk	nn	50	SENT_73	[p4l1704t1308r1879b1381],
50	rearrangement	NN	O	rearrangement	dobj	48	SENT_73	[p4l1934t1329r2134b1381, p4l12t1447r499b1532],
51	.	.	O	.	_	0	SENT_73	[p4l1934t1329r2134b1381, p4l12t1447r499b1532],

1	The	DT	O	the	det	2	SENT_74	[p4l137t1559r298b1637],
2	protocol	NN	O	protocol	nsubjpass	4	SENT_74	[p4l345t1559r707b1659],
3	was	VBD	O	be	auxpass	4	SENT_74	[p4l750t1585r912b1638],
4	approved	VBN	O	approve	_	0	SENT_74	[p4l962t1559r1352b1659],
5	by	IN	O	by	_	0	SENT_74	[p4l1400t1559r1498b1659],
6	the	DT	O	the	det	9	SENT_74	[p4l1542t1559r1674b1637],
7	investigational	JJ	O	investigational	amod	9	SENT_74	[p4l1722t1560r2134b1660, p4l12t1687r262b1764],
8	review	NN	O	review	nn	9	SENT_74	[p4l300t1688r580b1766],
9	board	NN	O	board	agent	4	SENT_74	[p4l616t1687r864b1764],
10	at	IN	O	at	_	0	SENT_74	[p4l901t1703r980b1764],
11	each	DT	O	each	det	13	SENT_74	[p4l1015t1687r1206b1764],
12	study	NN	O	study	nn	13	SENT_74	[p4l1247t1687r1476b1786],
13	center	NN	O	center	prep_at	9	SENT_74	[p4l1511t1703r1792b1782],
14	,	,	O	,	_	0	SENT_74	[p4l1511t1703r1792b1782],
15	and	CC	O	and	_	0	SENT_74	[p4l1835t1687r1993b1764],
16	all	DT	O	all	det	17	SENT_74	[p4l2030t1687r2135b1764],
17	patients	NNS	O	patient	nsubj	18	SENT_74	[p4l11t1816r352b1915],
18	provided	VBD	O	provide	conj_and	4	SENT_74	[p4l389t1815r763b1915],
19	written	VBN	O	write	amod	21	SENT_74	[p4l794t1816r1108b1894],
20	informed	VBN	O	inform	amod	21	SENT_74	[p4l1143t1814r1545b1893],
21	consent	NN	O	consent	dobj	18	SENT_74	[p4l1581t1831r1936b1893],
22	.	.	O	.	_	0	SENT_74	[p4l1581t1831r1936b1893],

1	The	DT	O	the	det	2	SENT_75	[p4l1974t1815r2135b1893],
2	study	NN	O	study	nsubjpass	4	SENT_75	[p4l14t1943r243b2043],
3	was	VBD	O	be	auxpass	4	SENT_75	[p4l278t1969r441b2022],
4	designed	VBN	O	design	_	0	SENT_75	[p4l488t1943r871b2044],
5	jointly	RB	O	jointly	advmod	4	SENT_75	[p4l901t1943r1185b2043],
6	by	IN	O	by	_	0	SENT_75	[p4l1226t1943r1323b2043],
7	representatives	NNS	O	representative	agent	4	SENT_75	[p4l1363t1944r2007b2043],
8	of	IN	O	of	_	0	SENT_75	[p4l2054t1942r2154b2021],
9	Pfizer	NNP	ORGANIZATION	Pfizer	prep_of	7	SENT_75	[p4l11t2070r270b2149],
10	and	CC	O	and	_	0	SENT_75	[p4l304t2071r462b2149],
11	the	DT	O	the	det	12	SENT_75	[p4l499t2071r632b2149],
12	investigators	NNS	O	investigator	prep_of	7	SENT_75	[p4l669t2072r1241b2172],
13	.	.	O	.	_	0	SENT_75	[p4l669t2072r1241b2172],

1	Data	NNS	O	datum	nsubjpass	3	SENT_76	[p4l1283t2078r1484b2149],
2	were	VBD	O	be	auxpass	3	SENT_76	[p4l1515t2097r1717b2150],
3	collected	VBN	O	collect	_	0	SENT_76	[p4l1755t2071r2135b2149],
4	from	IN	O	from	_	0	SENT_76	[p4l12t2198r223b2277],
5	the	DT	O	the	det	7	SENT_76	[p4l267t2199r400b2277],
6	academic	JJ	O	academic	amod	7	SENT_76	[p4l443t2199r843b2277],
7	sites	NNS	O	site	prep_from	3	SENT_76	[p4l888t2200r1073b2277],
8	and	CC	O	and	_	0	SENT_76	[p4l1119t2199r1277b2277],
9	analyzed	VBN	O	analyze	conj_and	3	SENT_76	[p4l1320t2199r1699b2299],
10	by	IN	O	by	_	0	SENT_76	[p4l1744t2199r1841b2299],
11	representatives	NNS	O	representative	prep_by	9	SENT_76	[p4l1880t2225r2134b2299, p4l14t2328r432b2406],
12	of	IN	O	of	_	0	SENT_76	[p4l466t2326r566b2405],
13	Pfizer	NNP	ORGANIZATION	Pfizer	prep_of	11	SENT_76	[p4l579t2326r856b2405],
14	.	.	O	.	_	0	SENT_76	[p4l579t2326r856b2405],

1	The	DT	O	the	det	3	SENT_77	[p4l890t2327r1051b2405],
2	primary	JJ	O	primary	amod	3	SENT_77	[p4l1082t2328r1432b2427],
3	data	NNS	O	datum	nsubjpass	5	SENT_77	[p4l1460t2327r1643b2405],
4	were	VBD	O	be	auxpass	5	SENT_77	[p4l1669t2353r1871b2406],
5	made	VBN	O	make	_	0	SENT_77	[p4l1903t2327r2135b2405],
6	available	JJ	O	available	acomp	5	SENT_77	[p4l11t2455r383b2534],
7	to	TO	O	to	_	0	SENT_77	[p4l423t2472r504b2533],
8	the	DT	O	the	det	9	SENT_77	[p4l546t2455r678b2533],
9	investigators	NNS	O	investigator	prep_to	6	SENT_77	[p4l718t2456r1290b2556],
10	,	,	O	,	_	0	SENT_77	[p4l718t2456r1290b2556],
11	who	WP	O	who	nsubj	12	SENT_77	[p4l1331t2455r1514b2534],
12	vouch	VBP	O	vouch	rcmod	9	SENT_77	[p4l1550t2455r1803b2534],
13	for	IN	O	for	_	0	SENT_77	[p4l1842t2454r1966b2533],
14	the	DT	O	the	det	15	SENT_77	[p4l2002t2455r2135b2533],
15	results	NNS	O	result	prep_for	12	SENT_77	[p4l12t2583r295b2662],
16	after	IN	O	after	_	0	SENT_77	[p4l353t2582r556b2661],
17	independent	JJ	O	independent	amod	18	SENT_77	[p4l608t2583r1147b2683],
18	review	NN	O	review	prep_after	12	SENT_77	[p4l1199t2584r1478b2662],
19	and	CC	O	and	_	0	SENT_77	[p4l1531t2583r1689b2661],
20	analyses	NNS	O	analysis	prep_after	12	SENT_77	[p4l1745t2583r2129b2683],
21	.	.	O	.	_	0	SENT_77	[p4l1745t2583r2129b2683],

1	The	DT	O	the	det	3	SENT_78	[p4l8t2711r169b2789],
2	first	JJ	ORDINAL	first	amod	3	SENT_78	[p4l208t2710r392b2789],
3	draft	NN	O	draft	nsubjpass	8	SENT_78	[p4l427t2710r640b2789],
4	of	IN	O	of	_	0	SENT_78	[p4l675t2710r775b2789],
5	the	DT	O	the	det	6	SENT_78	[p4l795t2711r928b2789],
6	manuscript	NN	O	manuscript	prep_of	3	SENT_78	[p4l967t2712r1460b2811],
7	was	VBD	O	be	auxpass	8	SENT_78	[p4l1489t2737r1652b2790],
8	written	VBN	O	write	_	0	SENT_78	[p4l1688t2712r2003b2790],
9	by	IN	O	by	_	0	SENT_78	[p4l2042t2711r2139b2811],
10	the	DT	O	the	det	12	SENT_78	[p4l12t2839r145b2917],
11	corresponding	JJ	O	corresponding	amod	12	SENT_78	[p4l187t2839r818b2940],
12	author	NN	O	author	agent	8	SENT_78	[p4l855t2839r1155b2935],
13	,	,	O	,	_	0	SENT_78	[p4l855t2839r1155b2935],
14	with	IN	O	with	_	0	SENT_78	[p4l1197t2839r1392b2918],
15	review	NN	O	review	prep_with	8	SENT_78	[p4l1433t2840r1713b2918],
16	and	CC	O	and	_	0	SENT_78	[p4l1749t2839r1907b2917],
17	revision	NN	O	revision	conj_and	15	SENT_78	[p4l1947t2840r2134b2918, p4l14t2968r189b3044],
18	by	IN	O	by	_	0	SENT_78	[p4l229t2967r326b3066],
19	the	DT	O	the	det	21	SENT_78	[p4l362t2967r495b3044],
20	other	JJ	O	other	amod	21	SENT_78	[p4l535t2967r762b3044],
21	coauthors	NNS	O	coauthor	agent	8	SENT_78	[p4l799t2967r1246b3045],
22	.	.	O	.	_	0	SENT_78	[p4l799t2967r1246b3045],

1	PATIENTS	NNS	O	patient	_	0	SENT_79	[p4l18t3241r384b3291],
2	We	PRP	O	we	nsubj	3	SENT_79	[p4l8t3348r141b3419],
3	evaluated	VBD	O	evaluate	rcmod	1	SENT_79	[p4l202t3341r603b3420],
4	82	CD	NUMBER	82	num	5	SENT_79	[p4l663t3346r761b3419],
5	patients	NNS	O	patient	dobj	3	SENT_79	[p4l819t3341r1161b3441],
6	with	IN	O	with	_	0	SENT_79	[p4l1217t3341r1412b3420],
7	ALK-rearranged	JJ	O	alk-rearranged	amod	10	SENT_79	[p4l1465t3341r2135b3442],
8	advanced	JJ	O	advanced	amod	10	SENT_79	[p4l11t3469r397b3548],
9	non	JJ	O	non	amod	10	SENT_79	[p4l424t3469r1047b3547],
10	—	NN	O	—	prep_with	3	SENT_79	[p4l424t3469r1047b3547],
11	small	JJ	O	small	amod	15	SENT_79	[p4l424t3469r1047b3547],
12	—	NN	O	—	nn	15	SENT_79	[p4l424t3469r1047b3547],
13	cell	NN	O	cell	nn	15	SENT_79	[p4l424t3469r1047b3547],
14	lung	NN	O	lung	nn	15	SENT_79	[p4l1072t3469r1261b3570],
15	cancer	NN	O	cancer	dep	1	SENT_79	[p4l1286t3494r1558b3547],
16	who	WP	O	who	nsubjpass	18	SENT_79	[p4l1578t3469r1758b3548],
17	were	VBD	O	be	auxpass	18	SENT_79	[p4l1782t3495r1979b3548],
18	enrolled	VBN	O	enrol	rcmod	15	SENT_79	[p4l2007t3494r2134b3547, p4l12t3597r251b3675],
19	through	IN	O	through	_	0	SENT_79	[p4l286t3597r634b3698],
20	February	NNP	DATE	February	prep_through	18	SENT_79	[p4l669t3597r1054b3697],
21	10	CD	DATE	10	num	20	SENT_79	[p4l1089t3602r1204b3692],
22	,	,	DATE	,	_	0	SENT_79	[p4l1089t3602r1204b3692],
23	2010	CD	DATE	2010	num	20	SENT_79	[p4l1246t3602r1468b3675],
24	.	.	O	.	_	0	SENT_79	[p4l1246t3602r1468b3675],

1	These	DT	O	these	det	2	SENT_80	[p4l1505t3597r1757b3675],
2	patients	NNS	O	patient	nsubj	33	SENT_80	[p4l1791t3598r2133b3697],
3	underwent	VBD	O	undergo	_	0	SENT_80	[p5l12t20r464b98],
4	a	DT	O	a	det	7	SENT_80	[p5l484t46r529b97],
5	baseline	NN	O	baseline	nn	7	SENT_80	[p5l554t20r895b97],
6	tumor	NN	O	tumor	nn	7	SENT_80	[p5l921t36r1183b98],
7	assessment	NN	O	assessment	dobj	3	SENT_80	[p5l1205t36r1701b115],
8	,	,	O	,	_	0	SENT_80	[p5l1205t36r1701b115],
9	received	VBD	O	receive	conj_or	3	SENT_80	[p5l1732t20r2068b98],
10	a	DT	O	a	det	11	SENT_80	[p5l2092t46r2136b97],
11	dose	NN	O	dose	dobj	9	SENT_80	[p5l13t147r206b225],
12	of	IN	O	of	_	0	SENT_80	[p5l242t146r342b225],
13	crizotinib	NN	O	crizotinib	prep_of	11	SENT_80	[p5l358t147r779b225],
14	on	IN	O	on	_	0	SENT_80	[p5l815t172r921b225],
15	the	DT	DURATION	the	det	17	SENT_80	[p5l955t147r1089b225],
16	first	JJ	DURATION	first	amod	17	SENT_80	[p5l1123t146r1307b225],
17	day	NN	DURATION	day	prep_on	9	SENT_80	[p5l1337t147r1483b247],
18	of	IN	O	of	_	0	SENT_80	[p5l1514t146r1614b225],
19	cycle	NN	O	cycle	prep_of	17	SENT_80	[p5l1630t147r1833b247],
20	1	CD	NUMBER	1	num	19	SENT_80	[p5l1870t152r1937b243],
21	,	,	O	,	_	0	SENT_80	[p5l1870t152r1937b243],
22	and	CC	O	and	_	0	SENT_80	[p5l1977t147r2135b225],
23	underwent	VBD	O	undergo	conj_and	9	SENT_80	[p5l12t275r460b354],
24	at	IN	O	at	quantmod	26	SENT_80	[p5l486t291r562b352],
25	least	JJS	O	least	mwe	24	SENT_80	[p5l589t275r779b352],
26	one	CD	NUMBER	one	nsubj	27	SENT_80	[p5l807t300r954b352],
27	post	NN	O	post	ccomp	23	SENT_80	[p5l985t275r1527b374],
28	—	RB	O	—	advmod	27	SENT_80	[p5l985t275r1527b374],
29	baseline	JJ	O	baseline	amod	31	SENT_80	[p5l985t275r1527b374],
30	tumor	NN	O	tumor	nn	31	SENT_80	[p5l1560t291r1819b354],
31	assessment	NN	O	assessment	dobj	9	SENT_80	[p5l1848t301r2134b352, p5l12t420r228b481],
32	or	CC	O	or	_	0	SENT_80	[p5l269t428r358b481],
33	discontinued	VBN	O	discontinue	conj_or	3	SENT_80	[p5l402t403r961b482],
34	the	DT	O	the	det	35	SENT_80	[p5l1008t403r1140b481],
35	study	NN	O	study	dobj	33	SENT_80	[p5l1189t403r1419b503],
36	before	IN	O	before	_	0	SENT_80	[p5l1461t402r1730b481],
37	the	DT	O	the	det	42	SENT_80	[p5l1777t403r1909b481],
38	first	JJ	ORDINAL	first	amod	42	SENT_80	[p5l1956t402r2140b481],
39	protocol	NN	O	protocol	nn	42	SENT_80	[p5l11t531r755b630],
40	—	CD	NUMBER	—	num	42	SENT_80	[p5l11t531r755b630],
41	planned	VBN	O	plan	amod	42	SENT_80	[p5l11t531r755b630],
42	tumor	NN	O	tumor	prep_before	33	SENT_80	[p5l794t547r1062b609],
43	assessment	NN	O	assessment	dep	42	SENT_80	[p5l1097t547r1609b608],
44	.	.	O	.	_	0	SENT_80	[p5l1097t547r1609b608],

1	We	PRP	O	we	nsubj	2	SENT_81	[p5l1649t537r1783b608],
2	present	VBP	DATE	present	_	0	SENT_81	[p5l1821t547r2140b630],
3	safety	NN	O	safety	nn	6	SENT_81	[p5l14t658r261b759],
4	and	CC	O	and	_	0	SENT_81	[p5l286t659r441b737],
5	response	NN	O	response	conj_and	3	SENT_81	[p5l470t684r844b759],
6	data	NNS	O	datum	dobj	2	SENT_81	[p5l874t659r1054b737],
7	that	WDT	O	that	nsubj	9	SENT_81	[p5l1083t659r1251b737],
8	were	VBD	O	be	cop	9	SENT_81	[p5l1271t685r1470b738],
9	available	JJ	O	available	rcmod	6	SENT_81	[p5l1500t659r1863b738],
10	in	IN	O	in	_	0	SENT_81	[p5l1892t660r1974b736],
11	the	DT	O	the	det	12	SENT_81	[p5l2004t659r2135b737],
12	database	NN	O	database	prep_in	9	SENT_81	[p5l13t787r378b865],
13	as	IN	O	as	_	0	SENT_81	[p5l406t813r490b865],
14	of	IN	O	of	prepc_as_of	9	SENT_81	[p5l522t786r620b865],
15	April	NNP	DATE	April	pobj	9	SENT_81	[p5l626t787r837b887],
16	7	CD	DATE	7	num	15	SENT_81	[p5l866t794r923b883],
17	,	,	DATE	,	_	0	SENT_81	[p5l866t794r923b883],
18	2010	CD	DATE	2010	num	15	SENT_81	[p5l958t792r1174b865],
19	.	.	O	.	_	0	SENT_81	[p5l958t792r1174b865],

1	Key	NN	O	key	nn	3	SENT_82	[p5l1207t794r1361b887],
2	eligibility	NN	O	eligibility	nn	3	SENT_82	[p5l1386t787r1780b888],
3	requirements	NNS	O	requirement	nsubj	4	SENT_82	[p5l1804t788r2134b887, p5l12t931r272b993],
4	included	VBD	O	include	_	0	SENT_82	[p5l309t915r676b994],
5	ALK	NN	O	alk	nn	6	SENT_82	[p5l704t920r878b993],
6	positivity	NN	O	positivity	dobj	4	SENT_82	[p5l903t916r1303b1015],
7	on	IN	O	on	_	0	SENT_82	[p5l1334t941r1440b993],
8	fluorescence	NN	O	fluorescence	prep_on	4	SENT_82	[p5l1475t914r2017b994],
9	in	FW	O	in	nn	10	SENT_82	[p5l2052t916r2135b992],
10	situ	FW	O	situ	advmod	14	SENT_82	[p5l14t1044r164b1121],
11	hybridization	NN	O	hybridization	nn	14	SENT_82	[p5l198t1043r760b1142],
12	(	CD	NUMBER	(	num	14	SENT_82	[p5l799t1048r1086b1138],
13	FISH	NN	O	fish	nn	14	SENT_82	[p5l799t1048r1086b1138],
14	)	NN	O	)	rcmod	8	SENT_82	[p5l799t1048r1086b1138],
15	,	,	O	,	_	0	SENT_82	[p5l799t1048r1086b1138],
16	measurable	JJ	O	measurable	amod	17	SENT_82	[p5l1126t1043r1607b1122],
17	disease	NN	O	disease	rcmod	8	SENT_82	[p5l1643t1043r1967b1137],
18	,	,	O	,	_	0	SENT_82	[p5l1643t1043r1967b1137],
19	adequate	JJ	O	adequate	amod	21	SENT_82	[p5l2007t1043r2133b1120, p5l13t1188r281b1271],
20	bone	NN	O	bone	nn	21	SENT_82	[p5l309t1171r510b1249],
21	marrow	NN	O	marrow	rcmod	8	SENT_82	[p5l538t1197r871b1250],
22	and	CC	O	and	_	0	SENT_82	[p5l894t1171r1047b1249],
23	organ	NN	O	organ	nn	24	SENT_82	[p5l1075t1197r1316b1272],
24	function	NN	O	function	conj_and	14	SENT_82	[p5l1344t1170r1716b1267],
25	,	,	O	,	_	0	SENT_82	[p5l1344t1170r1716b1267],
26	and	CC	O	and	_	0	SENT_82	[p5l1749t1171r1902b1249],
27	resolution	NN	O	resolution	conj_and	8	SENT_82	[p5l1929t1197r2133b1249, p5l11t1299r255b1378],
28	of	IN	O	of	_	0	SENT_82	[p5l281t1298r379b1377],
29	all	DT	O	all	det	32	SENT_82	[p5l386t1299r487b1377],
30	previous	JJ	O	previous	amod	32	SENT_82	[p5l511t1300r863b1399],
31	treatment	NN	O	treatment	nn	32	SENT_82	[p5l891t1299r1610b1377],
32	—	NN	O	—	prep_of	27	SENT_82	[p5l891t1299r1610b1377],
33	related	JJ	O	related	amod	35	SENT_82	[p5l891t1299r1610b1377],
34	toxic	JJ	O	toxic	amod	35	SENT_82	[p5l1635t1300r1834b1377],
35	effects	NNS	O	effect	dep	27	SENT_82	[p5l1860t1298r2132b1377],
36	to	TO	O	to	_	0	SENT_82	[p5l12t1443r94b1505],
37	grade	NN	O	grade	prep_to	4	SENT_82	[p5l133t1427r372b1528],
38	1	CD	NUMBER	1	num	37	SENT_82	[p5l414t1432r458b1504],
39	or	CC	O	or	_	0	SENT_82	[p5l498t1452r587b1505],
40	less	JJR	O	less	num	37	SENT_82	[p5l621t1427r801b1505],
41	.	.	O	.	_	0	SENT_82	[p5l621t1427r801b1505],

1	Also	RB	O	also	advmod	2	SENT_83	[p5l842t1427r1033b1505],
2	required	VBN	O	require	_	0	SENT_83	[p5l1074t1427r1436b1527],
3	was	VBD	O	be	auxpass	2	SENT_83	[p5l1469t1453r1632b1506],
4	an	DT	O	a	det	5	SENT_83	[p5l1671t1452r1775b1505],
5	Eastern	NNP	MISC	Eastern	nsubjpass	2	SENT_83	[p5l1812t1434r2134b1505],

1	1694	CD	DATE	1694	num	3	SENT_84	[p5l149t1603r225b1627],
2	NENGLJ	NNP	O	NENGLJ	nn	3	SENT_84	[p5l938t1614r1044b1636],
3	MED	NN	O	med	_	0	SENT_84	[p5l1059t1614r1110b1629],
4	363	CD	NUMBER	363	dep	3	SENT_84	[p5l1121t1608r1197b1636],
5	;	:	O	;	_	0	SENT_84	[p5l1121t1608r1197b1636],
6	18	CD	NUMBER	18	num	8	SENT_84	[p5l1121t1608r1197b1636],
7	NEJM.ORG	NN	O	nejm.org	nn	8	SENT_84	[p5l1232t1614r1356b1636],
8	OCTOBER28	NN	O	october28	dep	4	SENT_84	[p5l1392t1608r1549b1634],
9	,	,	O	,	_	0	SENT_84	[p5l1392t1608r1549b1634],
10	2010	CD	DATE	2010	appos	8	SENT_84	[p5l1560t1614r1621b1630],

1	The	DT	O	the	det	4	SENT_85	[p5l935t1647r986b1671],
2	New	NNP	O	New	nn	4	SENT_85	[p5l995t1648r1057b1671],
3	England	NNP	O	England	nn	4	SENT_85	[p5l1066t1647r1177b1678],
4	Joumal	NNP	O	Joumal	_	0	SENT_85	[p5l1186t1647r1283b1671],
5	of	IN	O	of	_	0	SENT_85	[p5l1293t1647r1322b1671],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_85	[p5l1329t1647r1454b1671],

1	ALK	NNP	O	ALK	nn	2	SENT_86	[p5l627t1835r691b1855],
2	INHIBITION	NNP	O	INHIBITION	_	0	SENT_86	[p5l704t1835r908b1854],
3	IN	IN	O	in	_	0	SENT_86	[p5l923t1835r961b1854],
4	NON	NNP	O	NON	prep_in	2	SENT_86	[p5l977t1835r1279b1854],
5	.	.	O	.	_	0	SENT_86	[p5l977t1835r1279b1854],

1	—	NN	O	—	_	0	SENT_87	[p5l977t1835r1279b1854],
2	.	.	O	.	_	0	SENT_87	[p5l977t1835r1279b1854],

1	SMALL-CELL	NN	O	small-cell	nn	2	SENT_88	[p5l977t1835r1279b1854],
2	LUNG	NN	O	lung	_	0	SENT_88	[p5l1293t1835r1385b1854],
3	CANCER	NNP	O	CANCER	dep	2	SENT_88	[p5l1399t1835r1533b1854],

1	Cooperative	NNP	ORGANIZATION	Cooperative	nn	5	SENT_89	[p5l13t2052r527b2151],
2	Oncology	NNP	ORGANIZATION	Oncology	nn	5	SENT_89	[p5l583t2051r1000b2152],
3	Group	NNP	ORGANIZATION	Group	nn	5	SENT_89	[p5l1052t2057r1322b2151],
4	performance	NN	O	performance	nn	5	SENT_89	[p5l1379t2050r1937b2151],
5	status19	NN	O	status19	_	0	SENT_89	[p5l1995t2068r2145b2129, p5l14t2183r213b2258],
6	between	IN	O	between	_	0	SENT_89	[p5l247t2178r606b2258],
7	o	NN	O	o	prep_between	5	SENT_89	[p5l640t2184r687b2257],
8	(	CD	NUMBER	(	num	7	SENT_89	[p5l725t2177r948b2278],
9	fully	RB	O	fully	advmod	10	SENT_89	[p5l725t2177r948b2278],
10	active	JJ	O	active	amod	5	SENT_89	[p5l975t2179r1217b2257],
11	and	CC	O	and	_	0	SENT_89	[p5l1249t2178r1409b2257],
12	able	JJ	O	able	conj_and	10	SENT_89	[p5l1440t2178r1612b2257],
13	to	TO	O	to	aux	14	SENT_89	[p5l1645t2195r1727b2257],
14	carry	VB	O	carry	xcomp	12	SENT_89	[p5l1762t2204r1984b2278],
15	out	RP	O	out	prt	14	SENT_89	[p5l2013t2195r2153b2257],
16	all	DT	O	all	det	18	SENT_89	[p5l13t2306r118b2384],
17	predisease	NN	O	predisease	nn	18	SENT_89	[p5l169t2306r623b2406],
18	performance	NN	O	performance	dobj	14	SENT_89	[p5l675t2305r1232b2406],
19	without	IN	O	without	_	0	SENT_89	[p5l1280t2306r1621b2386],
20	restriction	NN	O	restriction	nn	21	SENT_89	[p5l1668t2307r2142b2397],
21	)	NN	O	)	prep_without	10	SENT_89	[p5l1668t2307r2142b2397],
22	and	CC	O	and	_	0	SENT_89	[p5l13t2434r172b2513],
23	2	CD	NUMBER	2	number	24	SENT_89	[p5l201t2440r249b2512],
24	(	CD	NUMBER	(	conj_and	21	SENT_89	[p5l285t2434r811b2534],
25	ambulatory	JJ	O	ambulatory	amod	24	SENT_89	[p5l285t2434r811b2534],
26	and	CC	O	and	_	0	SENT_89	[p5l836t2434r995b2513],
27	capable	JJ	O	capable	conj_and	25	SENT_89	[p5l1026t2434r1347b2534],
28	of	IN	O	of	_	0	SENT_89	[p5l1379t2433r1479b2513],
29	all	DT	O	all	det	31	SENT_89	[p5l1490t2434r1594b2512],
30	self	NN	O	self	nn	31	SENT_89	[p5l1626t2433r1792b2512],
31	care	NN	O	care	prep_of	24	SENT_89	[p5l1805t2460r1981b2512],
32	but	CC	O	but	_	0	SENT_89	[p5l2012t2434r2152b2514],
33	unable	JJ	O	unable	amod	39	SENT_89	[p5l13t2563r301b2642],
34	to	TO	O	to	aux	35	SENT_89	[p5l349t2580r431b2642],
35	carry	VB	O	carry	xcomp	33	SENT_89	[p5l481t2589r703b2663],
36	out	RP	O	out	prt	35	SENT_89	[p5l746t2580r886b2642],
37	any	DT	O	any	det	38	SENT_89	[p5l928t2589r1078b2663],
38	work	NN	O	work	dobj	35	SENT_89	[p5l1117t2563r1339b2643],
39	activities	NNS	O	activity	conj_and	21	SENT_89	[p5l1381t2564r1785b2659],
40	;	:	O	;	_	0	SENT_89	[p5l1381t2564r1785b2659],
41	up	RB	O	up	advmod	47	SENT_89	[p5l1836t2589r1940b2663],
42	and	CC	O	and	_	0	SENT_89	[p5l1988t2563r2147b2642],
43	about	RB	O	about	conj_and	41	SENT_89	[p5l13t2692r259b2771],
44	more	JJR	O	more	mwe	45	SENT_89	[p5l302t2718r523b2771],
45	than	IN	O	than	quantmod	46	SENT_89	[p5l573t2692r770b2770],
46	50	CD	PERCENT	50	num	47	SENT_89	[p5l821t2698r1008b2771],
47	%	NN	PERCENT	%	dep	39	SENT_89	[p5l821t2698r1008b2771],
48	of	IN	O	of	_	0	SENT_89	[p5l1057t2691r1157b2771],
49	waking	VBG	O	wake	prepc_of	5	SENT_89	[p5l1184t2692r1508b2793],
50	hours	NNS	DURATION	hour	dobj	49	SENT_89	[p5l1554t2692r1850b2783],
51	)	RB	O	)	advmod	49	SENT_89	[p5l1554t2692r1850b2783],
52	.	.	O	.	_	0	SENT_89	[p5l1554t2692r1850b2783],

1	There	EX	O	there	expl	2	SENT_90	[p5l1901t2692r2147b2770],
2	was	VBD	O	be	_	0	SENT_90	[p5l9t2845r170b2899],
3	no	DT	O	no	det	4	SENT_90	[p5l204t2845r308b2898],
4	limit	NN	O	limit	nsubj	2	SENT_90	[p5l340t2819r545b2897],
5	on	IN	O	on	_	0	SENT_90	[p5l572t2845r678b2898],
6	the	DT	O	the	det	7	SENT_90	[p5l709t2819r841b2897],
7	number	NN	O	number	prep_on	4	SENT_90	[p5l872t2819r1205b2899],
8	of	IN	O	of	_	0	SENT_90	[p5l1235t2818r1334b2898],
9	previous	JJ	O	previous	amod	11	SENT_90	[p5l1345t2820r1701b2919],
10	treatment	NN	O	treatment	nn	11	SENT_90	[p5l1735t2836r2152b2897],
11	regimens	NNS	O	regimen	prep_of	7	SENT_90	[p5l13t2949r414b3049],
12	for	IN	O	for	_	0	SENT_90	[p5l450t2947r575b3027],
13	any	DT	O	any	det	14	SENT_90	[p5l606t2974r757b3048],
14	patient	NN	O	patient	prep_for	11	SENT_90	[p5l786t2949r1110b3048],
15	.	.	O	.	_	0	SENT_90	[p5l786t2949r1110b3048],

1	MOLECULAR	JJ	O	molecular	amod	2	SENT_91	[p5l21t3224r502b3275],
2	SCREENING	NN	O	screening	nn	6	SENT_91	[p5l536t3224r995b3275],
3	AND	CC	O	and	_	0	SENT_91	[p5l1030t3225r1200b3274],
4	ANALYSES	NNS	O	analysis	nn	6	SENT_91	[p5l1233t3224r1627b3275],
5	Unstained	JJ	O	unstained	amod	6	SENT_91	[p5l13t3323r456b3402],
6	slides	NNS	O	slide	nsubj	10	SENT_91	[p5l504t3323r742b3402],
7	from	IN	O	from	_	0	SENT_91	[p5l790t3322r1002b3402],
8	formalin	NN	O	formalin	prep_from	6	SENT_91	[p5l1047t3322r1705b3419],
9	—	CD	NUMBER	—	num	8	SENT_91	[p5l1047t3322r1705b3419],
10	fixed	VBN	O	fix	partmod	19	SENT_91	[p5l1047t3322r1705b3419],
11	,	,	O	,	_	0	SENT_91	[p5l1047t3322r1705b3419],
12	paraffinembedded	JJ	O	paraffinembedded	amod	17	SENT_91	[p5l1755t3322r2145b3423, p5l15t3452r460b3531],
13	(	NN	O	(	nn	17	SENT_91	[p5l507t3458r775b3543],
14	FFPE	NN	O	ffpe	nn	17	SENT_91	[p5l507t3458r775b3543],
15	)	CD	NUMBER	)	num	17	SENT_91	[p5l507t3458r775b3543],
16	tumor	NN	O	tumor	nn	17	SENT_91	[p5l824t3469r1092b3531],
17	samples	NNS	O	sample	nsubjpass	19	SENT_91	[p5l1134t3452r1480b3552],
18	were	VBD	O	be	auxpass	19	SENT_91	[p5l1520t3478r1724b3531],
19	analyzed	VBN	O	analyze	_	0	SENT_91	[p5l1766t3452r2147b3552],
20	prospectively	RB	O	prospectively	advmod	19	SENT_91	[p5l12t3580r568b3680],
21	by	IN	O	by	_	0	SENT_91	[p5l596t3580r692b3680],
22	means	NNS	O	means	_	0	SENT_91	[p5l719t3606r995b3658],
23	of	IN	O	of	_	0	SENT_91	[p5l1030t3579r1129b3659],
24	FISH	NN	O	fish	prep_by_means_of	19	SENT_91	[p5l1140t3586r1347b3659],
25	with	IN	O	with	_	0	SENT_91	[p5l1375t3580r1568b3660],
26	the	DT	O	the	det	27	SENT_91	[p5l1599t3580r1731b3658],
27	use	NN	O	use	prep_with	19	SENT_91	[p5l1762t3606r1902b3660],
28	of	IN	O	of	_	0	SENT_91	[p5l1934t3579r2033b3659],
29	an	DT	O	a	det	31	SENT_91	[p5l2045t3606r2148b3658],
30	ALK	NN	O	alk	nn	31	SENT_91	[p5l7t3715r182b3787],
31	break	NN	O	break	prep_of	27	SENT_91	[p5l204t3709r701b3809],
32	—	JJ	O	—	amod	31	SENT_91	[p5l204t3709r701b3809],
33	apart	RB	O	apart	advmod	32	SENT_91	[p5l204t3709r701b3809],
34	(	CD	NUMBER	(	tmod	32	SENT_91	[p5l730t3716r845b3800],
35	or	CC	O	or	_	0	SENT_91	[p5l730t3716r845b3800],
36	split	JJ	O	split	amod	41	SENT_91	[p5l873t3709r1376b3810],
37	—	NN	O	—	nn	41	SENT_91	[p5l873t3709r1376b3810],
38	signal	NN	O	signal	nn	41	SENT_91	[p5l873t3709r1376b3810],
39	)	NN	O	)	nn	41	SENT_91	[p5l873t3709r1376b3810],
40	probe	NN	O	probe	nn	41	SENT_91	[p5l1410t3709r1759b3809],
41	.2	NN	NUMBER	.2	prep_with	19	SENT_91	[p5l1410t3709r1759b3809],
42	°	CD	NUMBER	°	num	43	SENT_91	[p5l1410t3709r1759b3809],
43	Samples	NNS	O	sample	nsubjpass	45	SENT_91	[p5l1791t3709r2145b3809],
44	were	VBD	O	be	auxpass	45	SENT_91	[p6l9t47r209b101],
45	deemed	VBN	O	deem	rcmod	41	SENT_91	[p6l236t21r565b100],
46	to	TO	O	to	aux	49	SENT_91	[p6l592t38r672b100],
47	be	VB	O	be	cop	49	SENT_91	[p6l701t21r797b100],
48	FISH	NN	O	fish	nn	49	SENT_91	[p6l822t22r1387b121],
49	—	NN	O	—	xcomp	45	SENT_91	[p6l822t22r1387b121],
50	positive	JJ	O	positive	dep	61	SENT_91	[p6l822t22r1387b121],
51	if	IN	O	if	mark	61	SENT_91	[p6l1413t20r1489b99],
52	more	JJR	O	more	mwe	53	SENT_91	[p6l1498t47r1715b100],
53	than	IN	O	than	quantmod	54	SENT_91	[p6l1742t21r1937b99],
54	15	CD	PERCENT	15	num	55	SENT_91	[p6l1967t26r2148b100],
55	%	NN	PERCENT	%	nsubj	61	SENT_91	[p6l1967t26r2148b100],
56	of	IN	O	of	_	0	SENT_91	[p6l15t148r114b228],
57	scored	VBN	O	score	amod	59	SENT_91	[p6l125t149r399b228],
58	tumor	NN	O	tumor	nn	59	SENT_91	[p6l427t166r692b229],
59	cells	NNS	O	cell	prep_of	55	SENT_91	[p6l719t149r902b227],
60	had	VBD	O	have	aux	61	SENT_91	[p6l933t149r1088b228],
61	split	VBN	O	split	dep	49	SENT_91	[p6l1118t150r1300b249],
62	ALK	NNP	O	ALK	nn	64	SENT_91	[p6l1317t156r1490b227],
63	5	CD	NUMBER	5	num	64	SENT_91	[p6l1512t147r1585b228],
64	’	NN	O	’	dobj	61	SENT_91	[p6l1512t147r1585b228],
65	and	CC	O	and	_	0	SENT_91	[p6l1615t149r1771b228],
66	3	CD	NUMBER	3	num	69	SENT_91	[p6l1801t147r1876b228],
67	’	NN	O	’	nn	69	SENT_91	[p6l1801t147r1876b228],
68	probe	NN	O	probe	nn	69	SENT_91	[p6l1904t150r2147b249],
69	signals	NNS	O	signal	conj_and	64	SENT_91	[p6l15t278r316b380],
70	or	CC	O	or	_	0	SENT_91	[p6l362t304r452b358],
71	had	VBD	O	have	aux	72	SENT_91	[p6l492t278r649b358],
72	isolated	VBN	O	isolate	conj_or	61	SENT_91	[p6l692t278r1028b358],
73	3	CD	NUMBER	3	num	75	SENT_91	[p6l1073t276r1148b358],
74	’	NN	O	’	nn	75	SENT_91	[p6l1073t276r1148b358],
75	signals	NNS	O	signal	dobj	72	SENT_91	[p6l1195t278r1520b380],
76	.	.	O	.	_	0	SENT_91	[p6l1195t278r1520b380],

1	Reverse	JJ	O	reverse	amod	9	SENT_92	[p6l1568t285r2145b362],
2	—	NN	O	—	nn	9	SENT_92	[p6l1568t285r2145b362],
3	tran	NN	O	tran	nn	9	SENT_92	[p6l1568t285r2145b362],
4	—	NN	O	—	nn	9	SENT_92	[p6l1568t285r2145b362],
5	scriptase	NN	O	scriptase	nn	9	SENT_92	[p6l15t407r1576b507],
6	—	CD	NUMBER	—	num	9	SENT_92	[p6l15t407r1576b507],
7	polymerase	NN	O	polymerase	nn	9	SENT_92	[p6l15t407r1576b507],
8	—	NN	O	—	nn	9	SENT_92	[p6l15t407r1576b507],
9	chain	NN	O	chain	_	0	SENT_92	[p6l15t407r1576b507],
10	—	CD	NUMBER	—	num	11	SENT_92	[p6l15t407r1576b507],
11	reaction	NN	O	reaction	dep	9	SENT_92	[p6l15t407r1576b507],
12	(	CD	NUMBER	(	num	13	SENT_92	[p6l1611t413r1994b498],
13	RT	NN	O	rt	dep	11	SENT_92	[p6l1611t413r1994b498],
14	.	.	O	.	_	0	SENT_92	[p6l1611t413r1994b498],

1	—	NN	O	—	_	0	SENT_93	[p6l1611t413r1994b498],
2	.	.	O	.	_	0	SENT_93	[p6l1611t413r1994b498],

1	PCR	NN	O	pcr	nn	3	SENT_94	[p6l1611t413r1994b498],
2	)	NN	O	)	nn	3	SENT_94	[p6l1611t413r1994b498],
3	assays	NNS	O	assay	_	0	SENT_94	[p6l2027t433r2145b485, p6l15t561r184b635],
4	for	IN	O	for	_	0	SENT_94	[p6l218t534r342b614],
5	speciﬁc	NN	O	speciﬁc	nn	6	SENT_94	[p6l375t534r706b635],
6	EML4	NN	O	eml4	prep_for	3	SENT_94	[p6l737t541r1174b615],
7	.	.	O	.	_	0	SENT_94	[p6l737t541r1174b615],

1	—	NN	O	—	_	0	SENT_95	[p6l737t541r1174b615],
2	.	.	O	.	_	0	SENT_95	[p6l737t541r1174b615],

1	ALK	NN	O	alk	nn	2	SENT_96	[p6l737t541r1174b615],
2	fusions	NNS	O	fusion	nsubj	19	SENT_96	[p6l1200t534r1513b615],
3	and	CC	O	and	_	0	SENT_96	[p6l1548t535r1707b614],
4	immunohistochemical	JJ	O	immunohistochemical	amod	5	SENT_96	[p6l1740t536r2145b615, p6l13t663r623b742],
5	analyses	NNS	O	analysis	nsubj	19	SENT_96	[p6l691t663r1052b763],
6	for	IN	O	for	mark	10	SENT_96	[p6l1123t662r1248b742],
7	ALK	NN	O	alk	nn	8	SENT_96	[p6l1310t671r1502b744],
8	protein	NN	O	protein	nsubjpass	10	SENT_96	[p6l1567t664r1879b763],
9	were	VBD	O	be	auxpass	10	SENT_96	[p6l1944t689r2147b743],
10	performed	VBN	O	perform	dep	5	SENT_96	[p6l12t791r471b892],
11	retrospectively	RB	O	retrospectively	advmod	10	SENT_96	[p6l504t792r1136b892],
12	on	IN	O	on	_	0	SENT_96	[p6l1165t818r1272b871],
13	a	DT	O	a	det	14	SENT_96	[p6l1305t818r1349b870],
14	subgroup	NN	O	subgroup	prep_on	10	SENT_96	[p6l1382t792r1787b893],
15	of	IN	O	of	_	0	SENT_96	[p6l1823t791r1923b871],
16	FFPE	NN	O	ffpe	nn	18	SENT_96	[p6l1936t799r2145b870],
17	tumor	NN	O	tumor	nn	18	SENT_96	[p6l14t936r283b999],
18	samples	NNS	O	sample	prep_of	14	SENT_96	[p6l327t919r674b1019],
19	(	VBP	O	(	ccomp	23	SENT_96	[p6l726t918r876b1010],
20	for	IN	O	for	_	0	SENT_96	[p6l726t918r876b1010],
21	details	NNS	O	detail	prep_for	19	SENT_96	[p6l920t919r1228b1015],
22	,	,	O	,	_	0	SENT_96	[p6l920t919r1228b1015],
23	see	VBP	O	see	_	0	SENT_96	[p6l1281t945r1412b997],
24	the	DT	O	the	det	27	SENT_96	[p6l1458t919r1592b997],
25	Supplementary	NNP	O	Supplementary	nn	27	SENT_96	[p6l1639t919r2145b1019, p6l14t1064r185b1147],
26	Appendix	NNP	O	Appendix	nn	27	SENT_96	[p6l208t1047r676b1147],
27	)	NN	O	)	nsubj	23	SENT_96	[p6l208t1047r676b1147],
28	.	.	O	.	_	0	SENT_96	[p6l208t1047r676b1147],

1	A	DT	O	a	det	2	SENT_97	[p6l710t1055r776b1125],
2	total	NN	O	total	nsubj	8	SENT_97	[p6l804t1047r1003b1126],
3	of	IN	O	of	_	0	SENT_97	[p6l1034t1046r1134b1126],
4	70	CD	NUMBER	70	prep_of	2	SENT_97	[p6l1148t1053r1244b1126],
5	of	IN	O	of	_	0	SENT_97	[p6l1278t1046r1378b1126],
6	82	CD	NUMBER	82	num	7	SENT_97	[p6l1392t1053r1489b1126],
7	samples	NNS	O	sample	prep_of	4	SENT_97	[p6l1523t1047r1869b1147],
8	(	VBP	O	(	_	0	SENT_97	[p6l1908t1053r2142b1138],
9	85	CD	PERCENT	85	num	10	SENT_97	[p6l1908t1053r2142b1138],
10	%	NN	PERCENT	%	nsubj	27	SENT_97	[p6l1908t1053r2142b1138],
11	)	CD	NUMBER	)	nsubjpass	13	SENT_97	[p6l1908t1053r2142b1138],
12	were	VBD	O	be	auxpass	13	SENT_97	[p6l9t1201r212b1255],
13	confirmed	VBN	O	confirm	rcmod	10	SENT_97	[p6l254t1174r710b1254],
14	to	TO	O	to	aux	17	SENT_97	[p6l751t1192r833b1254],
15	be	VB	O	be	cop	17	SENT_97	[p6l876t1175r973b1254],
16	FISH	NN	O	fish	nn	17	SENT_97	[p6l1013t1176r1590b1275],
17	—	NN	O	—	xcomp	13	SENT_97	[p6l1013t1176r1590b1275],
18	positive	JJ	O	positive	amod	17	SENT_97	[p6l1013t1176r1590b1275],
19	by	IN	O	by	_	0	SENT_97	[p6l1633t1175r1730b1275],
20	a	DT	O	a	det	22	SENT_97	[p6l1765t1201r1810b1253],
21	central	JJ	O	central	amod	22	SENT_97	[p6l1851t1175r2148b1253],
22	laboratory	NN	O	laboratory	prep_by	18	SENT_97	[p6l12t1304r461b1404],
23	under	IN	O	under	_	0	SENT_97	[p6l492t1304r744b1383],
24	standards	NNS	O	standard	prep_under	22	SENT_97	[p6l777t1304r1200b1383],
25	and	CC	O	and	_	0	SENT_97	[p6l1236t1304r1395b1383],
26	conditions	NNS	O	condition	prep_under	22	SENT_97	[p6l1431t1304r1885b1383],
27	certiﬁed	VBD	O	certiﬁed	ccomp	8	SENT_97	[p6l1923t1305r2145b1382, p6l13t1432r177b1512],
28	according	VBG	O	accord	_	0	SENT_97	[p6l205t1433r625b1534],
29	to	TO	O	to	prepc_according_to	27	SENT_97	[p6l651t1450r732b1512],
30	the	DT	O	the	det	34	SENT_97	[p6l763t1433r893b1512],
31	Clinical	JJ	O	clinical	amod	34	SENT_97	[p6l922t1433r1249b1512],
32	Laboratory	NN	O	laboratory	nn	34	SENT_97	[p6l1276t1433r1742b1533],
33	Improvement	NN	O	improvement	nn	34	SENT_97	[p6l1764t1441r2145b1533, p6l13t1579r233b1640],
34	Amendments	NNS	O	amendment	pobj	27	SENT_97	[p6l257t1562r863b1641],
35	.	.	O	.	_	0	SENT_97	[p6l257t1562r863b1641],

1	TREATMENT	NN	O	treatment	nsubj	3	SENT_98	[p6l11t1836r483b1884],
2	We	PRP	O	we	nsubj	3	SENT_98	[p6l10t1943r143b2013],
3	escalated	VBD	O	escalate	_	0	SENT_98	[p6l179t1935r576b2014],
4	the	DT	O	the	det	5	SENT_98	[p6l611t1935r744b2014],
5	doses	NNS	O	dose	dobj	3	SENT_98	[p6l780t1935r1017b2014],
6	of	IN	O	of	_	0	SENT_98	[p6l1055t1934r1155b2014],
7	crizotinib	NN	O	crizotinib	prep_of	5	SENT_98	[p6l1172t1935r1594b2014],
8	from	IN	O	from	_	0	SENT_98	[p6l1630t1934r1842b2014],
9	50	CD	NUMBER	50	num	10	SENT_98	[p6l1878t1941r1976b2014],
10	mg	NN	O	mg	prep_from	3	SENT_98	[p6l2011t1961r2150b2036],
11	once	RB	DATE	once	advmod	12	SENT_98	[p6l15t2089r212b2142],
12	daily	JJ	SET	daily	advmod	3	SENT_98	[p6l258t2063r467b2163],
13	to	TO	O	to	_	0	SENT_98	[p6l508t2080r589b2142],
14	300	CD	NUMBER	300	num	15	SENT_98	[p6l637t2069r791b2142],
15	mg	NN	O	mg	prep_to	12	SENT_98	[p6l837t2089r976b2164],
16	twice	RB	O	twice	advmod	17	SENT_98	[p6l1018t2064r1247b2142],
17	daily	RB	SET	daily	advmod	12	SENT_98	[p6l1292t2063r1514b2163],
18	,	,	O	,	_	0	SENT_98	[p6l1292t2063r1514b2163],
19	using	VBG	O	use	partmod	3	SENT_98	[p6l1564t2064r1803b2164],
20	a	DT	O	a	det	25	SENT_98	[p6l1844t2089r1889b2141],
21	standard	JJ	O	standard	amod	25	SENT_98	[p6l1934t2080r2145b2141, p6l15t2191r213b2270],
22	dose	NN	O	dose	nn	25	SENT_98	[p6l261t2191r950b2270],
23	—	NN	O	—	nn	25	SENT_98	[p6l261t2191r950b2270],
24	escalation	NN	O	escalation	nn	25	SENT_98	[p6l261t2191r950b2270],
25	design	NN	O	design	dobj	19	SENT_98	[p6l998t2191r1309b2292],
26	.	.	O	.	_	0	SENT_98	[p6l998t2191r1309b2292],

1	Doses	NNS	O	dose	nsubj	9	SENT_99	[p6l1361t2198r1623b2270],
2	of	IN	O	of	_	0	SENT_99	[p6l1673t2190r1775b2270],
3	200	CD	NUMBER	200	num	4	SENT_99	[p6l1804t2197r1961b2270],
4	mg	NN	O	mg	prep_of	1	SENT_99	[p6l2009t2217r2150b2292],
5	or	CC	O	or	_	0	SENT_99	[p6l15t2345r104b2398],
6	more	JJR	O	more	conj_or	4	SENT_99	[p6l150t2345r370b2398],
7	twice	RB	O	twice	advmod	8	SENT_99	[p6l418t2320r646b2399],
8	daily	JJ	SET	daily	advmod	9	SENT_99	[p6l693t2319r902b2419],
9	resulted	VBD	O	result	_	0	SENT_99	[p6l944t2319r1288b2398],
10	in	IN	O	in	_	0	SENT_99	[p6l1334t2320r1418b2397],
11	a	DT	O	a	det	15	SENT_99	[p6l1463t2345r1508b2397],
12	mean	JJ	O	mean	amod	15	SENT_99	[p6l1553t2345r1791b2397],
13	plasma	NN	O	plasma	nn	15	SENT_99	[p6l1836t2319r2148b2419],
14	trough	NN	O	trough	nn	15	SENT_99	[p6l14t2448r304b2549],
15	concentration	NN	O	concentration	prep_in	9	SENT_99	[p6l354t2449r953b2527],
16	of	IN	O	of	_	0	SENT_99	[p6l1003t2447r1103b2527],
17	more	JJR	O	more	mwe	18	SENT_99	[p6l1134t2474r1354b2527],
18	than	IN	O	than	quantmod	19	SENT_99	[p6l1405t2448r1602b2526],
19	120	CD	NUMBER	120	num	20	SENT_99	[p6l1655t2454r1806b2527],
20	ng	NN	O	ng	prep_of	15	SENT_99	[p6l1856t2474r1965b2549],
21	per	IN	O	per	_	0	SENT_99	[p6l2010t2474r2151b2548],
22	milliliter	NN	O	milliliter	prep_per	20	SENT_99	[p6l13t2575r405b2671],
23	,	,	O	,	_	0	SENT_99	[p6l13t2575r405b2671],
24	the	DT	O	the	det	28	SENT_99	[p6l443t2575r574b2653],
25	preclinically	RB	O	preclinically	advmod	26	SENT_99	[p6l603t2575r1126b2675],
26	predicted	VBN	O	predict	amod	28	SENT_99	[p6l1151t2575r1548b2675],
27	effective	JJ	O	effective	amod	28	SENT_99	[p6l1579t2574r1930b2655],
28	concentration	NN	O	concentration	appos	15	SENT_99	[p6l1961t2601r2145b2654, p6l15t2705r478b2783],
29	.	.	O	.	_	0	SENT_99	[p6l1961t2601r2145b2654, p6l15t2705r478b2783],

1	During	IN	O	during	_	0	SENT_100	[p6l532t2705r843b2805],
2	dose	NN	O	dose	nn	3	SENT_100	[p6l889t2704r1084b2783],
3	escalation	NN	O	escalation	prep_during	20	SENT_100	[p6l1134t2704r1593b2800],
4	,	,	O	,	_	0	SENT_100	[p6l1134t2704r1593b2800],
5	one	CD	NUMBER	one	num	6	SENT_100	[p6l1649t2730r1801b2783],
6	patient	NN	O	patient	appos	3	SENT_100	[p6l1848t2705r2152b2804],
7	with	IN	O	with	_	0	SENT_100	[p6l9t2832r208b2911],
8	non	JJ	O	non	amod	14	SENT_100	[p6l263t2832r923b2911],
9	—	JJ	O	—	amod	14	SENT_100	[p6l263t2832r923b2911],
10	small	JJ	O	small	amod	14	SENT_100	[p6l263t2832r923b2911],
11	—	NN	O	—	nn	14	SENT_100	[p6l263t2832r923b2911],
12	cell	NN	O	cell	nn	14	SENT_100	[p6l263t2832r923b2911],
13	lung	NN	O	lung	nn	14	SENT_100	[p6l976t2832r1173b2933],
14	cancer	NN	O	cancer	prep_with	6	SENT_100	[p6l1225t2858r1513b2911],
15	with	IN	O	with	_	0	SENT_100	[p6l1559t2832r1759b2911],
16	ALK	NN	O	alk	nn	17	SENT_100	[p6l1807t2838r1985b2910],
17	re	NN	O	re	prep_with	14	SENT_100	[p6l2030t2858r2145b2910],
18	—	CD	NUMBER	—	num	19	SENT_100	[p6l2030t2858r2145b2910],
19	arrangement	NN	O	arrangement	nsubj	20	SENT_100	[p6l13t2977r560b3061],
20	entered	VBD	O	enter	_	0	SENT_100	[p6l590t2960r901b3039],
21	the	DT	O	the	det	22	SENT_100	[p6l937t2960r1067b3038],
22	cohort	NN	O	cohort	dobj	20	SENT_100	[p6l1104t2960r1380b3039],
23	receiving	VBG	O	receive	partmod	22	SENT_100	[p6l1410t2961r1792b3061],
24	300	CD	NUMBER	300	num	25	SENT_100	[p6l1825t2966r1977b3039],
25	mg	NN	O	mg	npadvmod	26	SENT_100	[p6l2013t2986r2151b3061],
26	twice	RB	O	twice	advmod	23	SENT_100	[p6l14t3089r242b3167],
27	daily	RB	SET	daily	advmod	23	SENT_100	[p6l291t3088r513b3188],
28	,	,	O	,	_	0	SENT_100	[p6l291t3088r513b3188],
29	and	CC	O	and	_	0	SENT_100	[p6l567t3088r725b3167],
30	one	CD	NUMBER	one	nsubj	31	SENT_100	[p6l774t3114r925b3167],
31	entered	VBD	O	enter	conj_and	20	SENT_100	[p6l975t3088r1293b3167],
32	a	DT	O	a	det	34	SENT_100	[p6l1340t3114r1385b3166],
33	de	FW	O	de	nn	34	SENT_100	[p6l1432t3088r1967b3167],
34	—	FW	O	—	dobj	31	SENT_100	[p6l1432t3088r1967b3167],
35	escalated	VBD	O	escalate	rcmod	34	SENT_100	[p6l1432t3088r1967b3167],
36	cohort	NN	O	cohort	dobj	35	SENT_100	[p6l2016t3114r2145b3167, p6l13t3217r197b3296],
37	receiving	VBG	O	receive	xcomp	35	SENT_100	[p6l228t3218r620b3318],
38	2OO	NN	O	2oo	nn	39	SENT_100	[p6l653t3223r807b3296],
39	mg	NN	O	mg	dobj	37	SENT_100	[p6l845t3243r984b3318],
40	twice	RB	O	twice	advmod	37	SENT_100	[p6l1017t3218r1245b3296],
41	daily	RB	SET	daily	advmod	37	SENT_100	[p6l1282t3217r1504b3317],
42	.	.	O	.	_	0	SENT_100	[p6l1282t3217r1504b3317],

1	Dose	NN	O	dose	nn	2	SENT_101	[p6l1544t3217r2151b3318],
2	—	NN	O	—	nsubj	13	SENT_101	[p6l1544t3217r2151b3318],
3	limiting	VBG	O	limit	partmod	2	SENT_101	[p6l1544t3217r2151b3318],
4	fatigue	NN	O	fatigue	dobj	3	SENT_101	[p6l13t3344r306b3446],
5	in	IN	O	in	_	0	SENT_101	[p6l338t3346r421b3423],
6	the	DT	O	the	det	7	SENT_101	[p6l453t3345r584b3423],
7	cohort	NN	O	cohort	prep_in	3	SENT_101	[p6l618t3345r895b3424],
8	receiving	VBG	O	receive	partmod	7	SENT_101	[p6l923t3346r1306b3446],
9	300	CD	NUMBER	300	num	10	SENT_101	[p6l1336t3351r1489b3424],
10	mg	NN	O	mg	dobj	8	SENT_101	[p6l1522t3371r1660b3446],
11	twice	RB	O	twice	advmod	8	SENT_101	[p6l1690t3346r1913b3424],
12	daily	RB	SET	daily	advmod	13	SENT_101	[p6l1947t3345r2152b3445],
13	led	VBD	O	lead	_	0	SENT_101	[p6l12t3473r138b3552],
14	to	TO	O	to	_	0	SENT_101	[p6l175t3490r257b3552],
15	the	DT	O	the	det	16	SENT_101	[p6l296t3473r429b3552],
16	establishment	NN	O	establishment	prep_to	13	SENT_101	[p6l466t3473r1078b3552],
17	of	IN	O	of	_	0	SENT_101	[p6l1110t3472r1211b3552],
18	a	DT	O	a	det	19	SENT_101	[p6l1228t3499r1273b3551],
19	regimen	NN	O	regimen	prep_of	16	SENT_101	[p6l1308t3474r1666b3574],
20	of	IN	O	of	_	0	SENT_101	[p6l1703t3472r1803b3552],
21	250	CD	NUMBER	250	num	22	SENT_101	[p6l1821t3479r1974b3552],
22	mg	NN	O	mg	prep_of	19	SENT_101	[p6l2011t3499r2150b3574],
23	twice	RB	O	twice	advmod	24	SENT_101	[p6l14t3602r242b3681],
24	daily	RB	SET	daily	advmod	13	SENT_101	[p6l282t3601r491b3701],
25	as	IN	O	as	mark	28	SENT_101	[p6l523t3627r609b3679],
26	the	DT	O	the	det	27	SENT_101	[p6l650t3601r784b3679],
27	maximum	NN	O	maximum	nsubj	28	SENT_101	[p6l822t3602r1270b3680],
28	tolerated	VBD	O	tolerate	advcl	13	SENT_101	[p6l1309t3601r1688b3680],
29	dose	NN	O	dose	dobj	28	SENT_101	[p6l1726t3601r1945b3680],
30	.	.	O	.	_	0	SENT_101	[p6l1726t3601r1945b3680],

1	The	DT	O	the	det	3	SENT_102	[p6l1985t3601r2147b3679],
2	expanded	VBN	O	expand	amod	3	SENT_102	[p7l15t21r427b121],
3	cohort	NN	O	cohort	nsubj	12	SENT_102	[p7l481t21r764b100],
4	with	IN	O	with	_	0	SENT_102	[p7l808t21r1004b101],
5	FISH	NN	O	fish	npadvmod	7	SENT_102	[p7l1056t22r1633b121],
6	—	CD	NUMBER	—	num	5	SENT_102	[p7l1056t22r1633b121],
7	positive	JJ	O	positive	amod	8	SENT_102	[p7l1056t22r1633b121],
8	results	NNS	O	result	prep_with	3	SENT_102	[p7l1686t21r1971b101],
9	for	IN	O	for	_	0	SENT_102	[p7l2026t20r2150b100],
10	ALK	NNP	O	ALK	nn	11	SENT_102	[p7l7t156r182b228],
11	rearrangement	NN	O	rearrangement	prep_for	8	SENT_102	[p7l214t167r859b251],
12	received	VBD	O	receive	_	0	SENT_102	[p7l894t150r1241b229],
13	250	CD	NUMBER	250	num	14	SENT_102	[p7l1281t156r1433b229],
14	mg	NN	O	mg	npadvmod	15	SENT_102	[p7l1474t176r1614b251],
15	twice	RB	O	twice	advmod	12	SENT_102	[p7l1651t151r1878b229],
16	daily	RB	SET	daily	advmod	12	SENT_102	[p7l1919t150r2141b250],
17	.	.	O	.	_	0	SENT_102	[p7l1919t150r2141b250],

1	Patients	NNS	O	patient	nsubj	2	SENT_103	[p7l12t279r353b357],
2	continued	VBD	O	continue	_	0	SENT_103	[p7l400t278r831b357],
3	to	TO	O	to	aux	4	SENT_103	[p7l875t295r956b357],
4	receive	VB	O	receive	xcomp	2	SENT_103	[p7l1001t279r1292b357],
5	therapy	NN	O	therapy	dobj	4	SENT_103	[p7l1336t278r1659b378],
6	as	RB	O	as	advmod	7	SENT_103	[p7l1698t304r1784b356],
7	long	RB	O	long	advmod	4	SENT_103	[p7l1827t278r2020b379],
8	as	IN	O	as	mark	12	SENT_103	[p7l2059t304r2145b356],
9	they	PRP	O	they	nsubj	12	SENT_103	[p7l14t406r198b506],
10	did	VBD	O	do	aux	12	SENT_103	[p7l235t406r370b485],
11	not	RB	O	not	neg	12	SENT_103	[p7l410t423r554b485],
12	have	VB	O	have	ccomp	7	SENT_103	[p7l589t406r780b485],
13	progressive	JJ	O	progressive	amod	14	SENT_103	[p7l820t407r1311b507],
14	disease	NN	O	disease	dobj	12	SENT_103	[p7l1353t406r1664b485],
15	or	CC	O	or	_	0	SENT_103	[p7l1706t432r1795b485],
16	intolerable	JJ	O	intolerable	amod	18	SENT_103	[p7l1832t406r2145b485, p7l13t534r185b613],
17	side	JJ	O	side	amod	18	SENT_103	[p7l221t534r386b613],
18	effects	NNS	O	effect	conj_or	14	SENT_103	[p7l422t533r729b613],
19	.	.	O	.	_	0	SENT_103	[p7l422t533r729b613],

1	STU	NNP	O	STU	nn	4	SENT_104	[p7l14t808r157b859],
2	DY	NNP	O	DY	nn	4	SENT_104	[p7l175t809r271b858],
3	ASSESSMENTS	NNP	O	ASSESSMENTS	nn	4	SENT_104	[p7l301t808r870b859],
4	Patients	NNPS	O	Patients	nsubjpass	6	SENT_104	[p7l12t907r353b985],
5	were	VBD	O	be	auxpass	6	SENT_104	[p7l401t932r604b986],
6	evaluated	VBN	O	evaluate	_	0	SENT_104	[p7l655t906r1059b986],
7	for	IN	O	for	_	0	SENT_104	[p7l1109t905r1233b985],
8	safety	NN	O	safety	prep_for	6	SENT_104	[p7l1281t905r1535b1006],
9	at	IN	O	at	advmod	8	SENT_104	[p7l1580t923r1659b984],
10	least	JJS	O	least	pobj	9	SENT_104	[p7l1703t906r1903b984],
11	once	RB	DATE	once	advmod	6	SENT_104	[p7l1949t932r2147b985],
12	every	DT	SET	every	det	14	SENT_104	[p7l15t1059r237b1133],
13	2	CD	SET	2	num	14	SENT_104	[p7l266t1039r313b1111],
14	weeks	NNS	NUMBER	week	tmod	6	SENT_104	[p7l344t1033r606b1113],
15	for	IN	O	for	prep	6	SENT_104	[p7l642t1032r766b1112],
16	the	DT	O	the	det	19	SENT_104	[p7l798t1033r931b1111],
17	first	JJ	ORDINAL	first	amod	19	SENT_104	[p7l965t1032r1150b1111],
18	two	CD	NUMBER	two	num	19	SENT_104	[p7l1179t1050r1337b1113],
19	cycles	NNS	O	cycle	pobj	15	SENT_104	[p7l1373t1033r1620b1133],
20	and	CC	O	and	_	0	SENT_104	[p7l1655t1033r1814b1112],
21	then	RB	O	then	prep	6	SENT_104	[p7l1848t1033r2039b1111],
22	at	IN	O	at	quantmod	25	SENT_104	[p7l2073t1050r2152b1111],
23	least	JJS	O	least	mwe	22	SENT_104	[p7l9t1162r210b1241],
24	every	DT	SET	every	quantmod	25	SENT_104	[p7l238t1188r461b1263],
25	4	CD	SET	4	num	26	SENT_104	[p7l488t1169r538b1242],
26	weeks	NNS	NUMBER	week	npadvmod	27	SENT_104	[p7l566t1162r829b1242],
27	thereafter	RB	O	thereafter	dep	21	SENT_104	[p7l865t1161r1313b1242],
28	.	.	O	.	_	0	SENT_104	[p7l865t1161r1313b1242],

1	Radiologic	JJ	MISC	radiologic	amod	2	SENT_105	[p7l1349t1162r1816b1264],
2	assessments	NNS	O	assessment	nsubjpass	4	SENT_105	[p7l1847t1189r2148b1241, p7l10t1308r272b1370],
3	were	VBD	O	be	auxpass	4	SENT_105	[p7l310t1317r513b1371],
4	performed	VBN	O	perform	_	0	SENT_105	[p7l551t1290r1011b1392],
5	at	IN	O	at	dep	4	SENT_105	[p7l1050t1308r1130b1370],
6	baseline	NN	O	baseline	pobj	5	SENT_105	[p7l1164t1291r1519b1371],
7	and	CC	O	and	_	0	SENT_105	[p7l1558t1291r1717b1371],
8	generally	RB	O	generally	dep	4	SENT_105	[p7l1756t1291r2154b1393],
9	after	IN	O	after	mark	25	SENT_105	[p7l10t1418r213b1497],
10	every	DT	O	every	det	12	SENT_105	[p7l253t1445r476b1519],
11	two	CD	NUMBER	two	num	12	SENT_105	[p7l514t1436r672b1499],
12	cycles	NNS	O	cycle	nsubj	25	SENT_105	[p7l717t1419r963b1519],
13	of	IN	O	of	_	0	SENT_105	[p7l1008t1418r1109b1498],
14	treatment	NN	O	treatment	prep_of	12	SENT_105	[p7l1133t1436r1560b1497],
15	with	IN	O	with	_	0	SENT_105	[p7l1592t1419r1789b1499],
16	the	DT	O	the	det	17	SENT_105	[p7l1832t1419r1966b1497],
17	use	NN	O	use	prep_with	14	SENT_105	[p7l2008t1445r2149b1499],
18	of	IN	O	of	_	0	SENT_105	[p7l11t1546r111b1626],
19	Response	NN	O	response	nn	21	SENT_105	[p7l131t1554r545b1647],
20	Evaluation	NN	O	evaluation	nn	21	SENT_105	[p7l583t1547r1038b1627],
21	Criteria	NNS	O	criterion	prep_of	17	SENT_105	[p7l1078t1548r1403b1626],
22	in	IN	O	in	_	0	SENT_105	[p7l1440t1548r1525b1625],
23	Solid	JJ	MISC	solid	amod	24	SENT_105	[p7l1566t1547r1780b1626],
24	Tumors	NNS	MISC	tumor	prep_in	21	SENT_105	[p7l1816t1554r2147b1627],
25	(	VBP	O	(	conj_and	5	SENT_105	[p7l15t1681r433b1771],
26	RECIST	NN	O	recist	nsubj	35	SENT_105	[p7l15t1681r433b1771],
27	)	CD	NUMBER	)	num	26	SENT_105	[p7l15t1681r433b1771],
28	,	,	O	,	_	0	SENT_105	[p7l15t1681r433b1771],
29	version	NN	O	version	nn	31	SENT_105	[p7l466t1676r776b1755],
30	1.0	CD	NUMBER	1.0	num	31	SENT_105	[p7l811t1681r935b1754],
31	(	NN	O	(	appos	26	SENT_105	[p7l972t1674r1122b1766],
32	for	IN	O	for	_	0	SENT_105	[p7l972t1674r1122b1766],
33	details	NNS	O	detail	prep_for	31	SENT_105	[p7l1151t1675r1460b1771],
34	,	,	O	,	_	0	SENT_105	[p7l1151t1675r1460b1771],
35	see	VBP	O	see	ccomp	25	SENT_105	[p7l1499t1701r1630b1753],
36	the	DT	O	the	det	39	SENT_105	[p7l1662t1675r1796b1753],
37	Supplementary	NNP	O	Supplementary	nn	39	SENT_105	[p7l1830t1675r2148b1775, p7l10t1821r373b1904],
38	Appendix	NNP	O	Appendix	nn	39	SENT_105	[p7l414t1804r884b1904],
39	)	NN	O	)	dobj	35	SENT_105	[p7l414t1804r884b1904],
40	.	.	O	.	_	0	SENT_105	[p7l414t1804r884b1904],

1	Patients	NNS	O	patient	nsubjpass	8	SENT_106	[p7l938t1805r1280b1882],
2	who	WP	O	who	nsubj	3	SENT_106	[p7l1327t1804r1512b1883],
3	had	VBD	O	have	rcmod	1	SENT_106	[p7l1563t1804r1720b1883],
4	a	DT	O	a	det	6	SENT_106	[p7l1769t1830r1814b1882],
5	partial	JJ	O	partial	amod	6	SENT_106	[p7l1861t1804r2150b1904],
6	response	NN	O	response	dobj	3	SENT_106	[p7l10t1959r394b2034],
7	were	VBD	O	be	auxpass	8	SENT_106	[p7l438t1959r642b2013],
8	scheduled	VBN	O	schedule	_	0	SENT_106	[p7l692t1933r1123b2013],
9	to	TO	O	to	aux	10	SENT_106	[p7l1171t1950r1253b2013],
10	undergo	VB	O	undergo	xcomp	8	SENT_106	[p7l1303t1933r1662b2035],
11	confirmatory	JJ	O	confirmatory	amod	12	SENT_106	[p7l1713t1932r2148b2013, p7l11t2078r184b2161],
12	scans	NNS	O	scan	dobj	10	SENT_106	[p7l211t2087r447b2139],
13	at	IN	DURATION	at	quantmod	15	SENT_106	[p7l479t2078r559b2139],
14	least	JJS	DURATION	least	mwe	13	SENT_106	[p7l583t2061r783b2139],
15	4	CD	DURATION	4	num	16	SENT_106	[p7l807t2067r857b2140],
16	weeks	NNS	NUMBER	week	npadvmod	10	SENT_106	[p7l883t2061r1146b2141],
17	after	IN	O	after	_	0	SENT_106	[p7l1178t2060r1382b2139],
18	the	DT	O	the	det	21	SENT_106	[p7l1410t2061r1543b2139],
19	initial	JJ	O	initial	amod	21	SENT_106	[p7l1574t2061r1832b2139],
20	partial	JJ	O	partial	amod	21	SENT_106	[p7l1860t2061r2149b2161],
21	response	NN	O	response	prep_after	10	SENT_106	[p7l10t2216r417b2291],
22	.	.	O	.	_	0	SENT_106	[p7l10t2216r417b2291],

1	A	DT	O	a	det	2	SENT_107	[p7l475t2198r542b2268],
2	window	NN	O	window	nsubjpass	12	SENT_107	[p7l590t2190r942b2270],
3	for	IN	O	for	_	0	SENT_107	[p7l994t2189r1118b2270],
4	radiologic	JJ	O	radiologic	amod	5	SENT_107	[p7l1171t2190r1605b2292],
5	assessment	NN	O	assessment	prep_for	2	SENT_107	[p7l1659t2207r2154b2269],
6	that	WDT	O	that	nsubj	7	SENT_107	[p7l11t2319r181b2397],
7	varied	VBD	O	vary	rcmod	5	SENT_107	[p7l201t2319r459b2398],
8	by	IN	O	by	_	0	SENT_107	[p7l489t2319r586b2419],
9	1	CD	DURATION	1	prep_by	7	SENT_107	[p7l614t2325r659b2397],
10	week	NN	NUMBER	week	tmod	7	SENT_107	[p7l684t2319r906b2399],
11	was	VBD	O	be	auxpass	12	SENT_107	[p7l926t2345r1088b2399],
12	allowed	VBN	O	allow	_	0	SENT_107	[p7l1119t2319r1471b2398],
13	.	.	O	.	_	0	SENT_107	[p7l1119t2319r1471b2398],

1	However	RB	O	however	advmod	5	SENT_108	[p7l1506t2327r1896b2415],
2	,	,	O	,	_	0	SENT_108	[p7l1506t2327r1896b2415],
3	three	CD	NUMBER	three	num	4	SENT_108	[p7l1931t2319r2149b2397],
4	patients	NNS	O	patient	nsubjpass	19	SENT_108	[p7l9t2449r352b2548],
5	underwent	VBD	O	undergo	_	0	SENT_108	[p7l394t2448r862b2527],
6	computed	JJ	O	computed	amod	11	SENT_108	[p7l897t2448r1326b2548],
7	tomographic	JJ	O	tomographic	amod	11	SENT_108	[p7l1365t2448r1923b2549],
8	(	NN	O	(	nn	11	SENT_108	[p7l1966t2454r2144b2539],
9	CT	NN	O	ct	nn	11	SENT_108	[p7l1966t2454r2144b2539],
10	)	CD	NUMBER	)	num	11	SENT_108	[p7l1966t2454r2144b2539],
11	scanning	NN	O	scanning	dobj	5	SENT_108	[p7l12t2577r412b2678],
12	6	CD	DURATION	6	num	13	SENT_108	[p7l450t2582r498b2656],
13	weeks	NNS	NUMBER	week	tmod	11	SENT_108	[p7l535t2576r798b2656],
14	after	IN	O	after	_	0	SENT_108	[p7l842t2575r1045b2655],
15	treatment	NN	O	treatment	nn	16	SENT_108	[p7l1084t2593r1512b2655],
16	initiation	NN	O	initiation	prep_after	5	SENT_108	[p7l1547t2577r1949b2656],
17	and	CC	O	and	_	0	SENT_108	[p7l1990t2576r2149b2656],
18	were	VBD	O	be	auxpass	19	SENT_108	[p7l6t2731r209b2785],
19	classified	VBN	O	classify	conj_and	5	SENT_108	[p7l262t2704r670b2785],
20	as	IN	O	as	_	0	SENT_108	[p7l721t2732r807b2784],
21	having	VBG	O	have	prepc_as	19	SENT_108	[p7l860t2705r1154b2807],
22	stable	JJ	O	stable	amod	23	SENT_108	[p7l1204t2705r1453b2785],
23	disease	NN	O	disease	dobj	21	SENT_108	[p7l1506t2705r1842b2785],
24	.	.	O	.	_	0	SENT_108	[p7l1506t2705r1842b2785],

1	These	DT	O	these	det	3	SENT_109	[p7l1896t2705r2149b2784],
2	three	CD	NUMBER	three	num	3	SENT_109	[p7l11t2834r236b2912],
3	patients	NNS	O	patient	nsubjpass	6	SENT_109	[p7l275t2835r626b2934],
4	were	VBD	O	be	auxpass	6	SENT_109	[p7l664t2860r870b2913],
5	not	RB	O	not	neg	6	SENT_109	[p7l910t2851r1056b2913],
6	included	VBN	O	include	_	0	SENT_109	[p7l1090t2834r1467b2913],
7	in	IN	O	in	_	0	SENT_109	[p7l1506t2835r1591b2912],
8	the	DT	O	the	det	9	SENT_109	[p7l1631t2834r1767b2912],
9	calculation	NN	O	calculation	prep_in	6	SENT_109	[p7l1808t2834r2148b2913, p7l11t2963r184b3041],
10	of	IN	O	of	_	0	SENT_109	[p7l250t2961r352b3041],
11	the	DT	O	the	det	16	SENT_109	[p7l400t2962r536b3040],
12	disease	NN	O	disease	nn	16	SENT_109	[p7l603t2962r1281b3041],
13	—	NN	O	—	nn	16	SENT_109	[p7l603t2962r1281b3041],
14	control	NN	O	control	nn	16	SENT_109	[p7l603t2962r1281b3041],
15	rate	NN	O	rate	nn	16	SENT_109	[p7l1346t2979r1511b3040],
16	(	NN	O	(	prep_of	9	SENT_109	[p7l1581t2961r1734b3053],
17	for	IN	O	for	_	0	SENT_109	[p7l1581t2961r1734b3053],
18	patients	NNS	O	patient	prep_for	16	SENT_109	[p7l1796t2963r2148b3062],
19	with	IN	O	with	_	0	SENT_109	[p7l6t3091r205b3170],
20	a	DT	O	a	det	24	SENT_109	[p7l239t3117r283b3169],
21	complete	JJ	O	complete	amod	24	SENT_109	[p7l314t3091r705b3191],
22	or	CC	O	or	_	0	SENT_109	[p7l738t3117r827b3170],
23	partial	JJ	O	partial	conj_or	21	SENT_109	[p7l854t3091r1143b3191],
24	response	NN	O	response	prep_with	6	SENT_109	[p7l1174t3117r1557b3191],
25	or	CC	O	or	_	0	SENT_109	[p7l1590t3117r1679b3170],
26	stable	JJ	O	stable	amod	28	SENT_109	[p7l1709t3091r1959b3170],
27	disease	NN	O	disease	nn	28	SENT_109	[p7l1991t3091r2148b3170, p7l11t3227r218b3311],
28	)	NN	O	)	prep_with	6	SENT_109	[p7l1991t3091r2148b3170, p7l11t3227r218b3311],
29	at	IN	O	at	_	0	SENT_109	[p7l261t3237r341b3298],
30	8	CD	DURATION	8	num	31	SENT_109	[p7l377t3226r422b3299],
31	weeks	NNS	NUMBER	week	prep_at	24	SENT_109	[p7l461t3220r754b3300],
32	.	.	O	.	_	0	SENT_109	[p7l461t3220r754b3300],

1	At	IN	O	at	_	0	SENT_110	[p7l796t3228r898b3298],
2	the	DT	O	the	det	3	SENT_110	[p7l933t3220r1069b3298],
3	discretion	NN	O	discretion	pobj	1	SENT_110	[p7l1110t3220r1552b3299],
4	of	IN	O	of	_	0	SENT_110	[p7l1593t3219r1695b3299],
5	the	DT	O	the	det	6	SENT_110	[p7l1717t3220r1853b3298],
6	investigator	NN	O	investigator	prep_of	3	SENT_110	[p7l1892t3221r2148b3300, p7l11t3350r308b3451],
7	,	,	O	,	_	0	SENT_110	[p7l1892t3221r2148b3300, p7l11t3350r308b3451],
8	18F	NN	O	18f	nn	10	SENT_110	[p7l347t3348r2149b3451],
9	—	NN	O	—	nn	10	SENT_110	[p7l347t3348r2149b3451],
10	fluorodeoxyglucose	NN	O	fluorodeoxyglucose	dep	15	SENT_110	[p7l347t3348r2149b3451],
11	—	CD	NUMBER	—	num	12	SENT_110	[p7l347t3348r2149b3451],
12	positron	NN	O	positron	dep	10	SENT_110	[p7l347t3348r2149b3451],
13	—	CD	NUMBER	—	num	15	SENT_110	[p7l347t3348r2149b3451],
14	emission	NN	O	emission	nn	15	SENT_110	[p7l347t3348r2149b3451],
15	tomography	NN	O	tomography	dep	3	SENT_110	[p7l11t3478r529b3580],
16	(	CD	NUMBER	(	num	17	SENT_110	[p7l561t3484r1105b3575],
17	18FDG	NN	O	18fdg	dep	15	SENT_110	[p7l561t3484r1105b3575],
18	.	.	O	.	_	0	SENT_110	[p7l561t3484r1105b3575],

1	—	NN	O	—	_	0	SENT_111	[p7l561t3484r1105b3575],
2	.	.	O	.	_	0	SENT_111	[p7l561t3484r1105b3575],

1	PET	NN	O	pet	nn	2	SENT_112	[p7l561t3484r1105b3575],
2	)	NN	O	)	_	0	SENT_112	[p7l561t3484r1105b3575],
3	,	,	O	,	_	0	SENT_112	[p7l561t3484r1105b3575],
4	18F	NN	O	18f	appos	2	SENT_112	[p7l1145t3476r2148b3579],
5	.	.	O	.	_	0	SENT_112	[p7l1145t3476r2148b3579],

1	—	NN	O	—	_	0	SENT_113	[p7l1145t3476r2148b3579],
2	.	.	O	.	_	0	SENT_113	[p7l1145t3476r2148b3579],

1	fluoro-3	NN	O	fluoro-3	_	0	SENT_114	[p7l1145t3476r2148b3579],
2	’	NN	O	’	dep	1	SENT_114	[p7l1145t3476r2148b3579],
3	.	.	O	.	_	0	SENT_114	[p7l1145t3476r2148b3579],

1	—	NN	O	—	_	0	SENT_115	[p7l1145t3476r2148b3579],
2	.	.	O	.	_	0	SENT_115	[p7l1145t3476r2148b3579],

1	deoxy	NN	O	deoxy	_	0	SENT_116	[p7l1145t3476r2148b3579],
2	.	.	O	.	_	0	SENT_116	[p7l1145t3476r2148b3579],

1	—	NN	O	—	_	0	SENT_117	[p7l1145t3476r2148b3579],
2	.	.	O	.	_	0	SENT_117	[p7l1145t3476r2148b3579],

1	3	CD	NUMBER	3	_	0	SENT_118	[p7l1145t3476r2148b3579],
2	’	NN	O	’	dep	1	SENT_118	[p7l1145t3476r2148b3579],
3	.	.	O	.	_	0	SENT_118	[p7l1145t3476r2148b3579],

1	—	NN	O	—	_	0	SENT_119	[p7l1145t3476r2148b3579],
2	.	.	O	.	_	0	SENT_119	[p7l1145t3476r2148b3579],

1	L	NN	O	l	_	0	SENT_120	[p7l1145t3476r2148b3579],
2	fluorothymidine	NN	O	fluorothymidine	dep	1	SENT_120	[p7l10t3605r932b3706],
3	.	.	O	.	_	0	SENT_120	[p7l10t3605r932b3706],

1	—	NN	O	—	_	0	SENT_121	[p7l10t3605r932b3706],
2	.	.	O	.	_	0	SENT_121	[p7l10t3605r932b3706],

1	PET	NN	O	pet	_	0	SENT_122	[p7l10t3605r932b3706],
2	(	CD	NUMBER	(	num	1	SENT_122	[p7l989t3611r1495b3702],
3	18FLT	NNP	O	18FLT	dep	1	SENT_122	[p7l989t3611r1495b3702],
4	.	.	O	.	_	0	SENT_122	[p7l989t3611r1495b3702],

1	—	NN	O	—	_	0	SENT_123	[p7l989t3611r1495b3702],
2	.	.	O	.	_	0	SENT_123	[p7l989t3611r1495b3702],

1	PET	NN	O	pet	nn	2	SENT_124	[p7l989t3611r1495b3702],
2	)	NN	O	)	nsubjpass	7	SENT_124	[p7l989t3611r1495b3702],
3	,	,	O	,	_	0	SENT_124	[p7l989t3611r1495b3702],
4	or	CC	O	or	_	0	SENT_124	[p7l1556t3632r1645b3685],
5	both	DT	O	both	conj_or	2	SENT_124	[p7l1697t3606r1896b3685],
6	were	VBD	O	be	auxpass	7	SENT_124	[p7l1946t3632r2149b3686],
7	performed	VBN	O	perform	_	0	SENT_124	[p8l8t20r492b121],
8	.	.	O	.	_	0	SENT_124	[p8l8t20r492b121],

1	Graded	VBN	O	grade	_	0	SENT_125	[p8l538t21r852b100],
2	adverse	JJ	O	adverse	amod	3	SENT_125	[p8l890t21r1208b101],
3	events	NNS	O	event	dobj	1	SENT_125	[p8l1249t38r1513b101],
4	were	VBD	O	be	auxpass	5	SENT_125	[p8l1551t47r1755b101],
5	summarized	VBN	O	summarize	auxpass	1	SENT_125	[p8l1795t47r2148b101, p8l10t150r228b229],
6	and	CC	O	and	_	0	SENT_125	[p8l290t150r449b229],
7	reported	VBN	O	report	conj_and	5	SENT_125	[p8l512t150r881b250],
8	according	VBG	O	accord	_	0	SENT_125	[p8l943t150r1373b251],
9	to	TO	O	to	prepc_according_to	5	SENT_125	[p8l1432t167r1515b229],
10	the	DT	O	the	det	13	SENT_125	[p8l1579t150r1712b229],
11	National	NNP	ORGANIZATION	National	nn	13	SENT_125	[p8l1774t150r2150b229],
12	Cancer	NNP	ORGANIZATION	Cancer	nn	13	SENT_125	[p8l10t284r312b357],
13	Institute	NNP	ORGANIZATION	Institute	poss	16	SENT_125	[p8l339t279r770b357],
14	’s	POS	O	’s	_	0	SENT_125	[p8l339t279r770b357],
15	Common	JJ	O	common	amod	16	SENT_125	[p8l804t284r1209b357],
16	Terminology	NN	O	terminology	pobj	5	SENT_125	[p8l1237t278r1798b379],
17	Criteria	NNS	O	criterion	nsubjpass	1	SENT_125	[p8l1826t279r2151b357],
18	for	IN	O	for	_	0	SENT_125	[p8l10t404r134b484],
19	Adverse	JJ	O	adverse	amod	20	SENT_125	[p8l160t405r498b485],
20	Events	NNS	O	event	prep_for	17	SENT_125	[p8l529t413r829b501],
21	,	,	O	,	_	0	SENT_125	[p8l529t413r829b501],
22	version	NN	O	version	appos	17	SENT_125	[p8l863t406r1174b484],
23	3.0	CD	NUMBER	3.0	num	22	SENT_125	[p8l1207t411r1332b484],
24	(	CD	NUMBER	(	num	25	SENT_125	[p8l1370t405r2152b505],
25	http://ctep.cancer	NN	O	http://ctep.cancer	dep	22	SENT_125	[p8l1370t405r2152b505],
26	.	.	O	.	_	0	SENT_125	[p8l14t534r2140b635],

1	gov/protocolDevelopment/electronic	JJ	O	gov/protocoldevelopment/electronic	amod	3	SENT_126	[p8l14t534r2140b635],
2	_	NN	O	_	nn	3	SENT_126	[p8l14t534r2140b635],
3	applications	NNS	O	application	_	0	SENT_126	[p8l14t534r2140b635],
4	/	:	O	/	punct	5	SENT_126	[p8l14t534r2140b635],
5	docs/ctcaev3	NN	O	docs/ctcaev3	dep	3	SENT_126	[p8l11t660r786b761],
6	.	.	O	.	_	0	SENT_126	[p8l11t660r786b761],

1	pdf	NN	O	pdf	_	0	SENT_127	[p8l11t660r786b761],
2	)	NN	O	)	dep	1	SENT_127	[p8l11t660r786b761],
3	.	.	O	.	_	0	SENT_127	[p8l11t660r786b761],

1	STATISTICAL	JJ	O	statistical	amod	2	SENT_128	[p8l10t937r503b988],
2	ANALYSIS	NN	O	analysis	nsubj	4	SENT_128	[p8l534t937r911b988],
3	We	PRP	O	we	nsubj	4	SENT_128	[p8l6t1045r140b1116],
4	calculated	VBD	O	calculate	_	0	SENT_128	[p8l176t1037r615b1117],
5	progression	NN	O	progression	npadvmod	7	SENT_128	[p8l648t1036r1362b1139],
6	—	CD	NUMBER	—	num	5	SENT_128	[p8l648t1036r1362b1139],
7	free	JJ	O	free	amod	8	SENT_128	[p8l648t1036r1362b1139],
8	survival	NN	O	survival	dobj	4	SENT_128	[p8l1399t1037r1733b1117],
9	from	IN	O	from	_	0	SENT_128	[p8l1768t1036r1980b1117],
10	the	DT	O	the	det	11	SENT_128	[p8l2016t1037r2149b1116],
11	date	NN	O	date	prep_from	4	SENT_128	[p8l11t1167r187b1247],
12	of	IN	O	of	_	0	SENT_128	[p8l222t1166r321b1247],
13	the	DT	O	the	det	15	SENT_128	[p8l337t1167r469b1246],
14	first	JJ	ORDINAL	first	amod	15	SENT_128	[p8l503t1166r685b1246],
15	administration	NN	O	administration	prep_of	11	SENT_128	[p8l713t1167r1350b1247],
16	of	IN	O	of	_	0	SENT_128	[p8l1385t1166r1484b1247],
17	crizotinib	NN	O	crizotinib	prep_of	15	SENT_128	[p8l1501t1167r1915b1247],
18	until	IN	O	until	_	0	SENT_128	[p8l1950t1167r2150b1247],
19	the	DT	O	the	det	20	SENT_128	[p8l11t1296r142b1375],
20	date	NN	O	date	prep_until	4	SENT_128	[p8l179t1296r355b1376],
21	of	IN	O	of	_	0	SENT_128	[p8l391t1295r490b1376],
22	objective	JJ	O	objective	amod	24	SENT_128	[p8l508t1296r876b1397],
23	disease	NN	O	disease	nn	24	SENT_128	[p8l912t1296r1218b1376],
24	progression	NN	O	progression	prep_of	20	SENT_128	[p8l1253t1297r1757b1398],
25	or	CC	O	or	_	0	SENT_128	[p8l1794t1322r1881b1376],
26	death	NN	O	death	prep_of	20	SENT_128	[p8l1915t1296r2150b1376],
27	from	IN	O	from	_	0	SENT_128	[p8l10t1423r218b1503],
28	any	DT	O	any	det	29	SENT_128	[p8l250t1450r400b1524],
29	cause	NN	O	cause	prep_from	4	SENT_128	[p8l428t1450r681b1504],
30	.	.	O	.	_	0	SENT_128	[p8l428t1450r681b1504],

1	We	PRP	O	we	nsubj	2	SENT_129	[p8l716t1432r849b1502],
2	used	VBD	O	use	_	0	SENT_129	[p8l881t1424r1076b1504],
3	the	DT	O	the	det	4	SENT_129	[p8l1109t1424r1240b1502],
4	Kaplan	NNP	PERSON	Kaplan	dobj	2	SENT_129	[p8l1272t1424r1868b1524],
5	.	.	O	.	_	0	SENT_129	[p8l1272t1424r1868b1524],

1	—	NN	O	—	_	0	SENT_130	[p8l1272t1424r1868b1524],
2	.	.	O	.	_	0	SENT_130	[p8l1272t1424r1868b1524],

1	Meier	JJR	PERSON	meier	amod	2	SENT_131	[p8l1272t1424r1868b1524],
2	method	NN	O	method	nsubj	7	SENT_131	[p8l1898t1424r2148b1502, p8l11t1553r117b1633],
3	to	TO	O	to	aux	4	SENT_131	[p8l149t1570r231b1633],
4	estimate	VB	O	estimate	infmod	2	SENT_131	[p8l266t1554r634b1632],
5	progression	NN	O	progression	dobj	4	SENT_131	[p8l665t1552r1379b1655],
6	—	RB	O	—	advmod	4	SENT_131	[p8l665t1552r1379b1655],
7	free	JJ	O	free	_	0	SENT_131	[p8l665t1552r1379b1655],
8	survival	NN	O	survival	dobj	7	SENT_131	[p8l1413t1553r1770b1633],
9	.	.	O	.	_	0	SENT_131	[p8l1413t1553r1770b1633],

1	All	DT	O	all	det	3	SENT_132	[p8l1804t1553r1931b1631],
2	confidence	NN	O	confidence	nn	3	SENT_132	[p8l1963t1579r2148b1633, p8l10t1680r326b1760],
3	intervals	NNS	O	interval	nsubj	10	SENT_132	[p8l358t1681r729b1761],
4	that	WDT	O	that	nsubjpass	6	SENT_132	[p8l765t1681r938b1759],
5	are	VBP	O	be	auxpass	6	SENT_132	[p8l966t1707r1096b1759],
6	reported	VBN	O	report	rcmod	3	SENT_132	[p8l1130t1681r1499b1781],
7	are	VBP	O	be	cop	9	SENT_132	[p8l1531t1707r1661b1759],
8	two	CD	NUMBER	two	npadvmod	9	SENT_132	[p8l1696t1681r2144b1761],
9	—	JJ	O	—	ccomp	6	SENT_132	[p8l1696t1681r2144b1761],
10	sided	VBD	O	side	_	0	SENT_132	[p8l1696t1681r2144b1761],
11	.	.	O	.	_	0	SENT_132	[p8l1696t1681r2144b1761],

1	All	DT	O	all	det	2	SENT_133	[p8l6t1809r132b1887],
2	analyses	NNS	O	analysis	nsubjpass	4	SENT_133	[p8l167t1809r529b1909],
3	were	VBD	O	be	auxpass	4	SENT_133	[p8l561t1835r764b1889],
4	performed	VBN	O	perform	_	0	SENT_133	[p8l798t1808r1258b1909],
5	with	IN	O	with	_	0	SENT_133	[p8l1289t1809r1486b1889],
6	the	DT	O	the	det	7	SENT_133	[p8l1521t1809r1655b1887],
7	use	NN	O	use	prep_with	4	SENT_133	[p8l1690t1835r1832b1889],
8	of	IN	O	of	_	0	SENT_133	[p8l1868t1808r1968b1888],
9	SAS	NNP	ORGANIZATION	SAS	nn	11	SENT_133	[p8l1987t1815r2146b1888],
10	statistical	JJ	O	statistical	amod	11	SENT_133	[p8l11t1939r430b2018],
11	software	NN	O	software	prep_of	7	SENT_133	[p8l466t1938r865b2036],
12	,	,	O	,	_	0	SENT_133	[p8l466t1938r865b2036],
13	version	NN	O	version	appos	11	SENT_133	[p8l901t1940r1212b2019],
14	9.2	CD	NUMBER	9.2	number	15	SENT_133	[p8l1246t1946r1371b2019],
15	(	CD	NUMBER	(	dep	13	SENT_133	[p8l1412t1946r1600b2031],
16	SAS	NNP	ORGANIZATION	SAS	nn	18	SENT_133	[p8l1412t1946r1600b2031],
17	Institute	NNP	ORGANIZATION	Institute	nn	18	SENT_133	[p8l1636t1940r2054b2031],
18	)	NN	O	)	dep	15	SENT_133	[p8l1636t1940r2054b2031],
19	.	.	O	.	_	0	SENT_133	[p8l1636t1940r2054b2031],

1	RESULTS	NNS	O	result	_	0	SENT_134	[p8l841t2239r1320b2298],

1	CLINICOPATHOLOGICAL	JJ	O	clinicopathological	amod	2	SENT_135	[p8l11t2475r979b2526],
2	CHARACTERISTICS	NNS	O	characteristic	nsubj	27	SENT_135	[p8l1011t2475r1744b2526],
3	Two	CD	NUMBER	two	num	4	SENT_135	[p8l6t2581r184b2654],
4	patients	NNS	O	patient	advmod	2	SENT_135	[p8l246t2576r590b2675],
5	with	IN	O	with	_	0	SENT_135	[p8l649t2575r846b2654],
6	non	JJ	O	non	amod	12	SENT_135	[p8l908t2575r1555b2654],
7	—	JJ	O	—	amod	12	SENT_135	[p8l908t2575r1555b2654],
8	small	JJ	O	small	amod	12	SENT_135	[p8l908t2575r1555b2654],
9	—	NN	O	—	nn	12	SENT_135	[p8l908t2575r1555b2654],
10	cell	NN	O	cell	nn	12	SENT_135	[p8l908t2575r1555b2654],
11	lung	NN	O	lung	nn	12	SENT_135	[p8l1615t2575r1810b2676],
12	cancer	NN	O	cancer	prep_with	4	SENT_135	[p8l1869t2601r2153b2653],
13	with	IN	O	with	_	0	SENT_135	[p8l6t2703r202b2783],
14	FISH-positive	JJ	O	fish-positive	amod	15	SENT_135	[p8l232t2704r811b2804],
15	results	NNS	O	result	prep_with	12	SENT_135	[p8l843t2703r1128b2783],
16	for	IN	O	for	_	0	SENT_135	[p8l1162t2702r1287b2783],
17	ALK	NNP	O	ALK	nn	18	SENT_135	[p8l1309t2709r1485b2782],
18	rearrangement	NN	O	rearrangement	prep_for	15	SENT_135	[p8l1508t2720r2154b2805],
19	who	WP	O	who	nsubjpass	21	SENT_135	[p8l6t2832r190b2911],
20	were	VBD	O	be	auxpass	21	SENT_135	[p8l220t2858r424b2911],
21	treated	VBN	O	treat	rcmod	2	SENT_135	[p8l458t2832r759b2911],
22	with	IN	O	with	_	0	SENT_135	[p8l788t2832r984b2911],
23	crizotinib	NN	O	crizotinib	prep_with	21	SENT_135	[p8l1019t2832r1443b2911],
24	during	IN	O	during	_	0	SENT_135	[p8l1478t2832r1769b2933],
25	dose	NN	O	dose	nn	26	SENT_135	[p8l1800t2832r1996b2911],
26	escalation	NN	O	escalation	prep_during	21	SENT_135	[p8l2030t2858r2148b2910, p8l11t2960r349b3039],
27	had	VBD	O	have	_	0	SENT_135	[p8l379t2960r535b3039],
28	dramatic	JJ	O	dramatic	amod	29	SENT_135	[p8l566t2960r946b3039],
29	improvement	NN	O	improvement	dobj	27	SENT_135	[p8l975t2961r1543b3060],
30	in	IN	O	in	_	0	SENT_135	[p8l1567t2961r1650b3038],
31	symptoms	NNS	O	symptom	prep_in	29	SENT_135	[p8l1682t2977r2144b3060],
32	,	,	O	,	_	0	SENT_135	[p8l1682t2977r2144b3060],
33	prompting	VBG	O	prompt	partmod	27	SENT_135	[p8l9t3090r477b3191],
34	large-scale	JJ	O	large-scale	amod	36	SENT_135	[p8l517t3089r984b3191],
35	prospective	JJ	O	prospective	amod	36	SENT_135	[p8l1028t3090r1521b3190],
36	screening	NN	O	screening	dobj	33	SENT_135	[p8l1567t3090r1988b3191],
37	for	IN	O	for	_	0	SENT_135	[p8l2029t3088r2153b3169],
38	non	JJ	O	non	amod	44	SENT_135	[p8l10t3218r658b3297],
39	—	JJ	O	—	amod	44	SENT_135	[p8l10t3218r658b3297],
40	small	JJ	O	small	amod	44	SENT_135	[p8l10t3218r658b3297],
41	—	NN	O	—	nn	44	SENT_135	[p8l10t3218r658b3297],
42	cell	NN	O	cell	nn	44	SENT_135	[p8l10t3218r658b3297],
43	lung	NN	O	lung	nn	44	SENT_135	[p8l690t3218r885b3319],
44	cancers	NNS	O	cancer	prep_for	36	SENT_135	[p8l916t3244r1239b3296],
45	with	IN	O	with	_	0	SENT_135	[p8l1270t3218r1466b3297],
46	ALK	NN	O	alk	nn	47	SENT_135	[p8l1493t3224r1669b3296],
47	rearrangement	NN	O	rearrangement	prep_with	44	SENT_135	[p8l1695t3244r2148b3319, p8l10t3363r232b3424],
48	and	CC	O	and	_	0	SENT_135	[p8l269t3346r428b3425],
49	enrollment	NN	O	enrollment	prep_with	44	SENT_135	[p8l470t3346r951b3425],
50	into	IN	O	into	_	0	SENT_135	[p8l988t3347r1158b3425],
51	an	DT	O	a	det	54	SENT_135	[p8l1201t3372r1304b3424],
52	expanded	VBN	O	expand	amod	54	SENT_135	[p8l1347t3346r1761b3446],
53	molecular	JJ	O	molecular	amod	54	SENT_135	[p8l1803t3346r2148b3425, p8l9t3475r126b3553],
54	cohort	NN	O	cohort	prep_into	33	SENT_135	[p8l164t3475r468b3554],
55	.	.	O	.	_	0	SENT_135	[p8l164t3475r468b3554],

1	From	IN	O	from	_	0	SENT_136	[p8l513t3483r741b3554],
2	August	NNP	DATE	August	prep_from	10	SENT_136	[p8l777t3483r1089b3576],
3	2008	CD	DATE	2008	num	2	SENT_136	[p8l1124t3481r1332b3554],
4	through	IN	O	through	_	0	SENT_136	[p8l1375t3475r1726b3576],
5	February	NNP	DATE	February	prep_through	2	SENT_136	[p8l1765t3475r2154b3575],
6	2010	CD	DATE	2010	num	5	SENT_136	[p8l10t3609r233b3699],
7	,	,	O	,	_	0	SENT_136	[p8l10t3609r233b3699],
8	the	DT	O	the	det	9	SENT_136	[p8l289t3603r422b3681],
9	study	NN	O	study	nsubj	10	SENT_136	[p8l474t3603r706b3703],
10	centers	VBZ	O	center	_	0	SENT_136	[p8l751t3620r1055b3681],
11	screened	VBN	O	screen	dep	10	SENT_136	[p8l1108t3603r1484b3682],
12	approximately	RB	O	approximately	advmod	11	SENT_136	[p8l1533t3603r2154b3703],

1	1500	CD	NUMBER	1500	num	2	SENT_137	[p9l14t27r218b100],
2	patients	NNS	O	patient	_	0	SENT_137	[p9l263t22r608b121],
3	with	IN	O	with	_	0	SENT_137	[p9l651t21r849b100],
4	non	JJ	O	non	amod	10	SENT_137	[p9l894t21r1542b100],
5	—	JJ	O	—	amod	10	SENT_137	[p9l894t21r1542b100],
6	small	JJ	O	small	amod	10	SENT_137	[p9l894t21r1542b100],
7	—	NN	O	—	nn	10	SENT_137	[p9l894t21r1542b100],
8	cell	NN	O	cell	nn	10	SENT_137	[p9l894t21r1542b100],
9	lung	NN	O	lung	nn	10	SENT_137	[p9l1586t21r1781b122],
10	cancers	NNS	O	cancer	prep_with	2	SENT_137	[p9l1824t47r2147b100],
11	for	IN	O	for	_	0	SENT_137	[p9l10t148r134b229],
12	ALK	NNP	O	ALK	nn	13	SENT_137	[p9l157t155r333b228],
13	rearrangement	NN	O	rearrangement	prep_for	10	SENT_137	[p9l357t166r1004b251],
14	with	IN	O	with	_	0	SENT_137	[p9l1026t149r1223b229],
15	the	DT	O	the	det	16	SENT_137	[p9l1256t149r1390b229],
16	use	NN	O	use	prep_with	2	SENT_137	[p9l1423t175r1564b229],
17	of	IN	O	of	_	0	SENT_137	[p9l1597t148r1698b229],
18	FISH	NN	O	fish	nn	20	SENT_137	[p9l1710t155r1922b229],
19	(	CD	NUMBER	(	num	20	SENT_137	[p9l1960t150r2144b251],
20	Fig	NN	O	fig	prep_of	16	SENT_137	[p9l1960t150r2144b251],
21	.	.	O	.	_	0	SENT_137	[p9l1960t150r2144b251],

1	1A	NN	O	1a	_	0	SENT_138	[p9l14t284r180b369],
2	)	NN	O	)	dep	1	SENT_138	[p9l14t284r180b369],
3	.	.	O	.	_	0	SENT_138	[p9l14t284r180b369],

1	The	DT	O	the	det	2	SENT_139	[p9l228t278r391b357],
2	protocol	NN	O	protocol	nsubj	3	SENT_139	[p9l435t278r799b378],
3	placed	VBD	O	place	_	0	SENT_139	[p9l843t278r1122b378],
4	no	DT	O	no	det	5	SENT_139	[p9l1168t304r1274b357],
5	restrictions	NNS	O	restriction	dobj	3	SENT_139	[p9l1322t279r1813b357],
6	on	IN	O	on	_	0	SENT_139	[p9l1862t304r1969b357],
7	the	DT	O	the	prep_on	3	SENT_139	[p9l2016t278r2149b356],

1	N	NN	O	n	nn	2	SENT_140	[p9l546t464r560b479],
2	ENGLJ	NN	O	englj	_	0	SENT_140	[p9l574t464r652b486],
3	MED	VBD	O	med	rcmod	2	SENT_140	[p9l667t464r719b479],
4	36338	CD	NUMBER	36338	advmod	3	SENT_140	[p9l729t458r806b486],
5	NI	SYM	O	ni	dep	3	SENT_140	[p9l841t464r965b486],
6	-	:	O	-	_	0	SENT_140	[p9l841t464r965b486],
7	:	:	O	:	_	0	SENT_140	[p9l841t464r965b486],
8	JM	NN	O	jm	dep	2	SENT_140	[p9l841t464r965b486],
9	,	,	O	,	_	0	SENT_140	[p9l841t464r965b486],
10	oRG	NNP	O	oRG	nn	11	SENT_140	[p9l841t464r965b486],
11	OCTOBER	NNP	DATE	OCTOBER	appos	8	SENT_140	[p9l1000t464r1112b480],
12	28	CD	DATE	28	num	11	SENT_140	[p9l1122t458r1158b484],
13	,	,	DATE	,	_	0	SENT_140	[p9l1122t458r1158b484],
14	2010	CD	DATE	2010	num	11	SENT_140	[p9l1169t464r1229b480],
15	1595	CD	DATE	1595	dep	11	SENT_140	[p9l1940t453r2015b477],

1	The	DT	O	the	det	4	SENT_141	[p9l702t497r753b521],
2	New	NNP	O	New	nn	4	SENT_141	[p9l762t498r824b521],
3	England	NNP	O	England	nn	4	SENT_141	[p9l833t497r944b528],
4	Journal	NNP	O	Journal	_	0	SENT_141	[p9l953t497r1050b521],
5	of	IN	O	of	_	0	SENT_141	[p9l1060t497r1089b521],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_141	[p9l1095t497r1220b521],

1	The	DT	O	the	det	4	SENT_142	[p9l673t621r718b642],
2	NEW	NNP	O	NEW	nn	4	SENT_142	[p9l737t623r822b642],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_142	[p9l841t623r1029b642],
4	IOURNAL	NNP	O	IOURNAL	_	0	SENT_142	[p9l1048t623r1228b649],
5	of	IN	O	of	_	0	SENT_142	[p9l1247t621r1276b648],
6	MEDICINE	NNP	O	MEDICINE	prep_of	4	SENT_142	[p9l1288t623r1487b642],

1	EML4	NN	O	eml4	nn	2	SENT_143	[p9l430t1575r498b1595],
2	exon	NN	O	exon	_	0	SENT_143	[p9l506t1581r559b1595],
3	6b	NN	O	6b	nn	5	SENT_143	[p9l570t1573r597b1595],
4	ALK	NN	O	alk	nn	5	SENT_143	[p9l836t1575r886b1595],
5	exon	NN	O	exon	dep	2	SENT_143	[p9l893t1581r946b1595],
6	20	CD	NUMBER	20	dep	2	SENT_143	[p9l956t1575r984b1595],

1	AAAAA	NNP	O	AAAAA	_	0	SENT_144	[p9l302t1633r440b1653],
2	ACAG	NN	O	acag	nn	3	SENT_144	[p9l460t1633r565b1654],
3	C	NN	O	c	dep	1	SENT_144	[p9l585t1634r601b1654],
4	CA	NNP	O	CA	nn	6	SENT_144	[p9l622t1633r670b1654],
5	A	NNP	O	A	nn	6	SENT_144	[p9l692t1633r708b1653],
6	GTGTACCGCCGG	NNP	O	GTGTACCGCCGG	dep	1	SENT_144	[p9l730t1633r1023b1654],

1	Figure	NNP	O	Figure	_	0	SENT_145	[p9l266t2076r350b2108],
2	1	CD	NUMBER	1	dep	1	SENT_145	[p9l362t2077r384b2100],
3	.	.	O	.	_	0	SENT_145	[p9l362t2077r384b2100],

1	Diagnosis	NN	O	diagnosis	_	0	SENT_146	[p9l397t2075r533b2108],
2	of	IN	O	of	_	0	SENT_146	[p9l543t2075r575b2100],
3	an	DT	O	a	det	4	SENT_146	[p9l580t2083r611b2100],
4	EML4-ALK	NN	O	eml4-alk	prep_of	1	SENT_146	[p9l624t2076r897b2100],
5	.	.	O	.	_	0	SENT_146	[p9l624t2076r897b2100],

1	—	NN	O	—	_	0	SENT_147	[p9l624t2076r897b2100],
2	.	.	O	.	_	0	SENT_147	[p9l624t2076r897b2100],

1	Positive	JJ	O	positive	amod	2	SENT_148	[p9l624t2076r897b2100],
2	Non	NN	O	non	_	0	SENT_148	[p9l909t2075r1125b2100],
3	.	.	O	.	_	0	SENT_148	[p9l909t2075r1125b2100],

1	—	NN	O	—	_	0	SENT_149	[p9l909t2075r1125b2100],
2	.	.	O	.	_	0	SENT_149	[p9l909t2075r1125b2100],

1	Sma	NN	O	sma	_	0	SENT_150	[p9l909t2075r1125b2100],
2	|	CD	NUMBER	|	num	1	SENT_150	[p9l909t2075r1125b2100],
3	|	SYM	O	|	dep	1	SENT_150	[p9l909t2075r1125b2100],
4	-	:	O	-	_	0	SENT_150	[p9l909t2075r1125b2100],
5	Cell	NN	O	cell	nn	6	SENT_150	[p9l909t2075r1125b2100],
6	Lung	NN	O	lung	dep	1	SENT_150	[p9l1139t2077r1206b2108],
7	Cancer	NN	O	cancer	rcmod	6	SENT_150	[p9l1216t2077r1312b2100],
8	in	IN	O	in	dep	7	SENT_150	[p9l1323t2075r1346b2100],
9	a	DT	O	a	det	12	SENT_150	[p9l1358t2083r1372b2100],
10	Single	JJ	O	single	amod	12	SENT_150	[p9l1382t2075r1467b2108],
11	Representative	NNP	O	Representative	nn	12	SENT_150	[p9l1479t2076r1684b2108],
12	Patient	NN	O	patient	pobj	8	SENT_150	[p9l1696t2076r1800b2100],
13	.	.	O	.	_	0	SENT_150	[p9l1696t2076r1800b2100],

1	Panel	NN	O	panel	nn	2	SENT_151	[p9l266t2125r338b2150],
2	A	NN	O	a	nsubj	3	SENT_151	[p9l349t2127r369b2150],
3	shows	VBZ	O	show	_	0	SENT_151	[p9l380t2125r465b2150],
4	the	DT	O	the	det	5	SENT_151	[p9l477t2125r520b2150],
5	results	NNS	O	result	nsubj	6	SENT_151	[p9l533t2125r623b2150],
6	ofa	VBP	O	ofa	ccomp	3	SENT_151	[p9l635t2125r685b2150],
7	break-apart	JJ	O	break-apart	amod	8	SENT_151	[p9l698t2125r855b2158],
8	fluorescence	NN	O	fluorescence	dep	10	SENT_151	[p9l865t2125r1042b2150],
9	in	FW	O	in	nn	10	SENT_151	[p9l1055t2127r1076b2150],
10	situ	FW	O	situ	advmod	6	SENT_151	[p9l1090t2127r1137b2150],
11	hybridization	NN	O	hybridization	nn	14	SENT_151	[p9l1151t2125r1330b2158],
12	assay	NN	O	assay	nn	14	SENT_151	[p9l1343t2134r1417b2158],
13	oftumor	NN	O	oftumor	nn	14	SENT_151	[p9l1427t2125r1549b2150],
14	cells	NNS	O	cell	dobj	6	SENT_151	[p9l1560t2125r1619b2150],
15	from	IN	O	from	_	0	SENT_151	[p9l1630t2125r1695b2150],
16	a	DT	O	a	det	17	SENT_151	[p9l1708t2134r1721b2150],
17	patient	NN	O	patient	prep_from	14	SENT_151	[p9l1734t2127r1830b2158],
18	with	IN	O	with	_	0	SENT_151	[p9l1839t2125r1897b2150],
19	rearrangement	NN	O	rearrangement	nn	21	SENT_151	[p9l265t2171r470b2200],
20	ofthe	NN	O	ofthe	nn	21	SENT_151	[p9l481t2166r560b2192],
21	gene	NN	O	gene	prep_with	17	SENT_151	[p9l572t2175r637b2200],
22	encoding	VBG	O	encode	partmod	21	SENT_151	[p9l648t2166r776b2200],
23	anaplastic	JJ	O	anaplastic	amod	27	SENT_151	[p9l787t2166r927b2199],
24	lymphoma	NN	O	lymphoma	nn	27	SENT_151	[p9l939t2167r1085b2200],
25	kinase	NN	O	kinase	nn	27	SENT_151	[p9l1098t2167r1184b2192],
26	(	NN	O	(	nn	27	SENT_151	[p9l1198t2168r1282b2200],
27	ALK	NN	O	alk	dobj	22	SENT_151	[p9l1198t2168r1282b2200],
28	)	CD	NUMBER	)	tmod	22	SENT_151	[p9l1198t2168r1282b2200],
29	.	.	O	.	_	0	SENT_151	[p9l1198t2168r1282b2200],

1	The	DT	O	the	det	3	SENT_152	[p9l1294t2166r1345b2192],
2	green	JJ	O	green	amod	3	SENT_152	[p9l1357t2175r1432b2200],
3	probe	NN	O	probe	nsubj	4	SENT_152	[p9l1446t2167r1525b2199],
4	hybridizes	VBZ	O	hybridize	_	0	SENT_152	[p9l1537t2166r1676b2200],
5	to	TO	O	to	_	0	SENT_152	[p9l1687t2171r1714b2192],
6	the	DT	O	the	det	7	SENT_152	[p9l1724t2166r1768b2192],
7	region	NN	O	region	prep_to	4	SENT_152	[p9l1781t2169r1865b2200],
8	immediately	RB	O	immediately	advmod	7	SENT_152	[p9l265t2208r435b2241],
9	5	CD	NUMBER	5	num	10	SENT_152	[p9l446t2208r469b2234],
10	’	NN	O	’	pobj	8	SENT_152	[p9l446t2208r469b2234],
11	to	TO	O	to	_	0	SENT_152	[p9l483t2213r509b2234],
12	ALK	NNP	O	ALK	prep_to	8	SENT_152	[p9l519t2210r582b2238],
13	,	,	O	,	_	0	SENT_152	[p9l519t2210r582b2238],
14	and	CC	O	and	_	0	SENT_152	[p9l596t2208r644b2234],
15	the	DT	O	the	det	17	SENT_152	[p9l656t2208r700b2234],
16	red	JJ	O	red	amod	17	SENT_152	[p9l712t2208r753b2234],
17	probe	NN	O	probe	conj_and	7	SENT_152	[p9l767t2208r846b2241],
18	to	TO	O	to	_	0	SENT_152	[p9l856t2213r883b2234],
19	the	DT	O	the	det	22	SENT_152	[p9l893t2208r937b2234],
20	3	CD	NUMBER	3	num	22	SENT_152	[p9l948t2208r972b2233],
21	'	''	O	'	_	0	SENT_152	[p9l948t2208r972b2233],
22	region	NN	O	region	prep_to	17	SENT_152	[p9l988t2211r1082b2242],
23	.	.	O	.	_	0	SENT_152	[p9l988t2211r1082b2242],

1	The	DT	O	the	det	2	SENT_153	[p9l1093t2208r1144b2234],
2	separation	NN	O	separation	nsubj	9	SENT_153	[p9l1156t2211r1301b2241],
3	of	IN	O	of	_	0	SENT_153	[p9l1313t2208r1343b2234],
4	red	JJ	O	red	amod	8	SENT_153	[p9l1351t2208r1392b2234],
5	and	CC	O	and	_	0	SENT_153	[p9l1405t2208r1454b2233],
6	green	JJ	O	green	amod	8	SENT_153	[p9l1467t2217r1542b2242],
7	probe	NN	O	probe	nn	8	SENT_153	[p9l1556t2208r1635b2241],
8	signals	NNS	O	signal	prep_of	2	SENT_153	[p9l1646t2208r1741b2242],
9	(	VBP	O	(	_	0	SENT_153	[p9l1756t2210r1865b2241],
10	arrows	NNS	O	arrow	nsubj	12	SENT_153	[p9l1756t2210r1865b2241],
11	)	RB	O	)	advmod	12	SENT_153	[p9l1756t2210r1865b2241],
12	indicates	VBZ	O	indicate	ccomp	9	SENT_153	[p9l265t2250r387b2275],
13	a	DT	O	a	det	15	SENT_153	[p9l400t2259r412b2275],
14	chromosomal	JJ	O	chromosomal	amod	15	SENT_153	[p9l424t2250r616b2275],
15	rearrangement	NN	O	rearrangement	dobj	12	SENT_153	[p9l630t2255r835b2283],
16	involving	VBG	O	involve	_	0	SENT_153	[p9l847t2250r971b2283],
17	ALK	NNP	O	ALK	prep_involving	15	SENT_153	[p9l980t2252r1043b2275],
18	.	.	O	.	_	0	SENT_153	[p9l980t2252r1043b2275],

1	Close	JJ	O	close	amod	2	SENT_154	[p9l1055t2250r1130b2275],
2	apposition	NN	O	apposition	nsubj	9	SENT_154	[p9l1142t2252r1287b2283],
3	of	IN	O	of	_	0	SENT_154	[p9l1300t2250r1330b2275],
4	red	JJ	O	red	amod	8	SENT_154	[p9l1338t2250r1379b2275],
5	and	CC	O	and	_	0	SENT_154	[p9l1392t2250r1441b2275],
6	green	JJ	O	green	conj_and	4	SENT_154	[p9l1454t2259r1529b2283],
7	probe	NN	O	probe	nn	8	SENT_154	[p9l1543t2250r1621b2283],
8	signals	NNS	O	signal	prep_of	2	SENT_154	[p9l1633t2250r1728b2283],
9	indicates	VBZ	O	indicate	_	0	SENT_154	[p9l1741t2250r1863b2275],
10	an	DT	O	a	det	14	SENT_154	[p9l264t2300r294b2317],
11	intact	JJ	O	intact	amod	12	SENT_154	[p9l308t2294r386b2317],
12	wild-type	JJ	O	wild-type	amod	14	SENT_154	[p9l395t2292r522b2325],
13	copy	NN	O	copy	nn	14	SENT_154	[p9l534t2300r597b2325],
14	ofALK	NN	O	ofalk	dobj	9	SENT_154	[p9l607t2291r705b2317],
15	.	.	O	.	_	0	SENT_154	[p9l607t2291r705b2317],

1	The	DT	O	the	det	2	SENT_155	[p9l717t2292r768b2317],
2	probe	NN	O	probe	nsubj	12	SENT_155	[p9l781t2292r859b2324],
3	that	WDT	O	that	nsubjpass	5	SENT_155	[p9l869t2292r924b2317],
4	was	VBD	O	be	auxpass	5	SENT_155	[p9l934t2300r985b2317],
5	used	VBN	O	use	rcmod	2	SENT_155	[p9l999t2292r1061b2317],
6	was	VBD	O	be	cop	12	SENT_155	[p9l1073t2300r1125b2317],
7	the	DT	O	the	det	12	SENT_155	[p9l1136t2292r1179b2317],
8	Vysis	NNP	ORGANIZATION	Vysis	nn	12	SENT_155	[p9l1190t2294r1259b2325],
9	LSI	NNP	ORGANIZATION	LSI	nn	12	SENT_155	[p9l1274t2294r1312b2317],
10	ALK	NNP	O	ALK	nn	12	SENT_155	[p9l1325t2293r1380b2316],
11	Dual	JJ	O	dual	amod	12	SENT_155	[p9l1393t2292r1454b2317],
12	Color	NN	O	color	_	0	SENT_155	[p9l1467t2292r1546b2321],
13	,	,	O	,	_	0	SENT_155	[p9l1467t2292r1546b2321],
14	Break	VB	O	break	appos	12	SENT_155	[p9l1561t2292r1636b2317],
15	Apart	RB	O	apart	advmod	14	SENT_155	[p9l1646t2293r1723b2324],
16	Rearrangement	NN	O	rearrangement	dobj	14	SENT_155	[p9l1736t2294r1884b2325, p9l265t2338r336b2359],
17	Probe	NN	O	probe	nn	19	SENT_155	[p9l349t2333r427b2359],
18	(	CD	NUMBER	(	num	19	SENT_155	[p9l441t2333r545b2366],
19	Abbott	NNP	ORGANIZATION	Abbott	dep	16	SENT_155	[p9l441t2333r545b2366],
20	Molecular	JJ	ORGANIZATION	molecular	amod	21	SENT_155	[p9l558t2333r713b2366],
21	)	NN	O	)	dep	19	SENT_155	[p9l558t2333r713b2366],
22	.	.	O	.	_	0	SENT_155	[p9l558t2333r713b2366],

1	Panel	NN	O	panel	nn	2	SENT_156	[p9l728t2333r799b2359],
2	B	NN	O	b	nsubj	3	SENT_156	[p9l814t2336r829b2358],
3	shows	VBZ	O	show	_	0	SENT_156	[p9l841t2333r927b2359],
4	a	DT	O	a	det	9	SENT_156	[p9l939t2342r952b2359],
5	light	JJ	O	light	amod	9	SENT_156	[p9l965t2333r1025b2367],
6	micrograph	JJ	O	micrograph	amod	9	SENT_156	[p9l1037t2333r1194b2367],
7	ofthe	NN	O	ofthe	nn	9	SENT_156	[p9l1207t2333r1286b2359],
8	same	JJ	O	same	amod	9	SENT_156	[p9l1298t2342r1370b2359],
9	tumor	NN	O	tumor	dobj	3	SENT_156	[p9l1381t2338r1472b2363],
10	,	,	O	,	_	0	SENT_156	[p9l1381t2338r1472b2363],
11	revealing	VBG	O	reveal	partmod	3	SENT_156	[p9l1486t2333r1609b2367],
12	adenocarcinoma	NN	O	adenocarcinoma	nn	14	SENT_156	[p9l1620t2333r1852b2359],
13	(	NN	O	(	nn	14	SENT_156	[p9l267t2375r444b2408],
14	hematoxylin	NN	O	hematoxylin	dobj	11	SENT_156	[p9l267t2375r444b2408],
15	and	CC	O	and	_	0	SENT_156	[p9l457t2375r505b2400],
16	eosin	NN	O	eosin	nn	17	SENT_156	[p9l518t2377r609b2408],
17	)	NN	O	)	dobj	11	SENT_156	[p9l518t2377r609b2408],
18	.	.	O	.	_	0	SENT_156	[p9l518t2377r609b2408],

1	Panel	NN	O	panel	nn	2	SENT_157	[p9l624t2375r695b2400],
2	C	NN	O	c	nsubj	3	SENT_157	[p9l708t2377r726b2400],
3	shows	VBZ	O	show	_	0	SENT_157	[p9l738t2375r823b2400],
4	a	DT	O	a	det	12	SENT_157	[p9l836t2384r849b2400],
5	representative	JJ	O	representative	amod	12	SENT_157	[p9l862t2377r1058b2408],
6	sequence	NN	O	sequence	nn	12	SENT_157	[p9l1070t2384r1200b2408],
7	electropherogram	NN	O	electropherogram	nn	12	SENT_157	[p9l1212t2375r1460b2408],
8	ofa	NN	O	ofa	nn	12	SENT_157	[p9l1473t2375r1523b2400],
9	reverse-transcriptase	NN	O	reverse-transcriptase	nn	12	SENT_157	[p9l1536t2377r1847b2408],
10	—	CD	NUMBER	—	num	12	SENT_157	[p9l1536t2377r1847b2408],
11	polymerase-chain-reaction	JJ	O	polymerase-chain-reaction	amod	12	SENT_157	[p9l265t2417r636b2450],
12	assay	NN	O	assay	dobj	3	SENT_157	[p9l649t2425r722b2450],
13	of	IN	O	of	_	0	SENT_157	[p9l733t2416r763b2442],
14	EML4-ALK	NN	O	eml4-alk	prep_of	12	SENT_157	[p9l771t2418r922b2442],
15	.	.	O	.	_	0	SENT_157	[p9l771t2418r922b2442],

1	The	DT	O	the	det	4	SENT_158	[p9l933t2417r985b2442],
2	sequence	NN	O	sequence	nn	4	SENT_158	[p9l997t2425r1127b2449],
3	ofa	NN	O	ofa	nn	4	SENT_158	[p9l1138t2416r1187b2442],
4	junction	NN	O	junction	nsubjpass	14	SENT_158	[p9l1198t2419r1312b2450],
5	between	IN	O	between	_	0	SENT_158	[p9l1326t2417r1441b2442],
6	EML4	NN	O	eml4	nn	8	SENT_158	[p9l1455t2419r1532b2441],
7	exon	NN	O	exon	nn	8	SENT_158	[p9l1542t2425r1605b2442],
8	6b	NN	O	6b	prep_between	4	SENT_158	[p9l1618t2417r1650b2442],
9	and	CC	O	and	_	0	SENT_158	[p9l1662t2417r1710b2442],
10	ALK	NN	ORGANIZATION	alk	nn	11	SENT_158	[p9l1722t2418r1780b2441],
11	exon	NN	O	exon	prep_between	4	SENT_158	[p9l1788t2425r1851b2442],
12	20	CD	NUMBER	20	dep	8	SENT_158	[p9l1864t2418r1895b2442],
13	is	VBZ	O	be	auxpass	14	SENT_158	[p9l265t2461r284b2484],
14	shown	VBN	O	show	_	0	SENT_158	[p9l297t2458r394b2484],
15	.	.	O	.	_	0	SENT_158	[p9l297t2458r394b2484],

1	Panel	NN	O	panel	nn	2	SENT_159	[p9l408t2458r480b2484],
2	D	NN	O	d	nsubj	3	SENT_159	[p9l495t2461r514b2483],
3	shows	VBZ	O	show	_	0	SENT_159	[p9l526t2458r612b2484],
4	immunohistochemical	JJ	O	immunohistochemical	amod	8	SENT_159	[p9l625t2458r936b2484],
5	analysis	NN	O	analysis	nn	8	SENT_159	[p9l949t2458r1057b2491],
6	ofALK	NN	O	ofalk	nn	8	SENT_159	[p9l1069t2458r1160b2484],
7	protein	NN	O	protein	nn	8	SENT_159	[p9l1172t2461r1267b2491],
8	expression	NN	O	expression	dobj	3	SENT_159	[p9l1280t2461r1427b2491],
9	in	IN	O	in	_	0	SENT_159	[p9l1441t2461r1462b2483],
10	tumor	NN	O	tumor	nn	11	SENT_159	[p9l1474t2463r1561b2484],
11	cells	NNS	O	cell	prep_in	3	SENT_159	[p9l1571t2458r1630b2484],
12	(	VBP	O	(	dep	11	SENT_159	[p9l1645t2458r1749b2491],
13	brown	JJ	O	brown	amod	14	SENT_159	[p9l1645t2458r1749b2491],
14	)	NN	O	)	dobj	12	SENT_159	[p9l1645t2458r1749b2491],
15	but	CC	O	but	_	0	SENT_159	[p9l1765t2458r1809b2484],
16	not	RB	O	not	_	0	SENT_159	[p9l1821t2463r1865b2484],
17	in	IN	O	in	_	0	SENT_159	[p9l1877t2461r1898b2483],
18	adjacent	JJ	O	adjacent	amod	24	SENT_159	[p9l264t2500r381b2533],
19	normal	JJ	O	normal	amod	24	SENT_159	[p9l393t2500r489b2525],
20	bronchial	JJ	O	bronchial	amod	24	SENT_159	[p9l503t2500r630b2525],
21	epithelium	NN	O	epithelium	nn	24	SENT_159	[p9l642t2500r789b2533],
22	(	NN	O	(	nn	24	SENT_159	[p9l805t2500r1082b2533],
23	diaminobenzidine	NN	O	diaminobenzidine	nn	24	SENT_159	[p9l805t2500r1082b2533],
24	)	NN	O	)	conj_negcc	11	SENT_159	[p9l805t2500r1082b2533],
25	.	.	O	.	_	0	SENT_159	[p9l805t2500r1082b2533],

1	subtypes	NNS	O	subtype	_	0	SENT_160	[p9l13t2703r389b2803],
2	of	IN	O	of	_	0	SENT_160	[p9l422t2702r522b2782],
3	non	JJ	O	non	amod	9	SENT_160	[p9l535t2703r1177b2782],
4	—	JJ	O	—	amod	9	SENT_160	[p9l535t2703r1177b2782],
5	small	JJ	O	small	amod	9	SENT_160	[p9l535t2703r1177b2782],
6	—	NN	O	—	nn	9	SENT_160	[p9l535t2703r1177b2782],
7	cell	NN	O	cell	nn	9	SENT_160	[p9l535t2703r1177b2782],
8	lung	NN	O	lung	nn	9	SENT_160	[p9l1207t2703r1400b2804],
9	cancer	NN	O	cancer	prep_of	1	SENT_160	[p9l1429t2729r1710b2781],
10	that	WDT	O	that	nsubjpass	12	SENT_160	[p9l1738t2703r1910b2781],
11	were	VBD	O	be	auxpass	12	SENT_160	[p9l1931t2729r2133b2782],
12	submitted	VBN	O	submit	rcmod	9	SENT_160	[p9l13t2831r446b2910],
13	for	IN	O	for	_	0	SENT_160	[p9l476t2830r599b2910],
14	screening	NN	O	screening	prep_for	12	SENT_160	[p9l628t2832r1064b2932],
15	.	.	O	.	_	0	SENT_160	[p9l628t2832r1064b2932],

1	However	RB	O	however	advmod	22	SENT_161	[p9l1099t2839r1493b2927],
2	,	,	O	,	_	0	SENT_161	[p9l1099t2839r1493b2927],
3	as	IN	O	as	_	0	SENT_161	[p9l1529t2857r1614b2909],
4	the	DT	O	the	det	5	SENT_161	[p9l1646t2831r1779b2909],
5	clinico	NN	O	clinico	prep_as	22	SENT_161	[p9l1810t2831r2133b2910],
6	—	CD	NUMBER	—	num	8	SENT_161	[p9l1810t2831r2133b2910],
7	pathological	JJ	O	pathological	amod	8	SENT_161	[p9l11t2959r548b3060],
8	features	NNS	O	feature	nsubj	13	SENT_161	[p9l595t2958r937b3038],
9	associated	VBN	O	associate	partmod	8	SENT_161	[p9l986t2959r1431b3038],
10	with	IN	O	with	_	0	SENT_161	[p9l1474t2959r1669b3038],
11	ALK	NN	O	alk	nn	12	SENT_161	[p9l1711t2965r1885b3037],
12	positivity	NN	O	positivity	prep_with	9	SENT_161	[p9l1922t2960r2133b3059, p9l12t3088r229b3187],
13	emerged	VBD	O	emerge	rcmod	5	SENT_161	[p9l252t3087r643b3188],
14	,	,	O	,	_	0	SENT_161	[p9l252t3087r643b3188],
15	tumor	NN	O	tumor	nn	16	SENT_161	[p9l675t3104r943b3166],
16	samples	NNS	O	sample	nsubj	22	SENT_161	[p9l968t3087r1313b3187],
17	that	WDT	O	that	nsubjpass	19	SENT_161	[p9l1342t3087r1515b3165],
18	were	VBD	O	be	auxpass	19	SENT_161	[p9l1531t3113r1733b3166],
19	screened	VBN	O	screen	rcmod	16	SENT_161	[p9l1761t3087r2134b3166],
20	were	VBD	O	be	cop	22	SENT_161	[p9l7t3241r209b3294],
21	increasingly	RB	O	increasingly	advmod	22	SENT_161	[p9l243t3215r767b3316],
22	adenocarcinomas	NNS	O	adenocarcinoma	_	0	SENT_161	[p9l796t3215r1577b3294],
23	.	.	O	.	_	0	SENT_161	[p9l796t3215r1577b3294],

1	The	DT	O	the	det	2	SENT_162	[p9l137t3342r298b3420],
2	characteristics	NNS	O	characteristic	nsubjpass	16	SENT_162	[p9l358t3342r978b3420],
3	of	IN	O	of	_	0	SENT_162	[p9l1040t3341r1140b3421],
4	82	CD	NUMBER	82	num	5	SENT_162	[p9l1181t3348r1279b3421],
5	patients	NNS	O	patient	prep_of	2	SENT_162	[p9l1337t3343r1678b3442],
6	who	WP	O	who	nsubj	7	SENT_162	[p9l1734t3342r1917b3422],
7	had	VBD	O	have	rcmod	5	SENT_162	[p9l1978t3342r2134b3421],
8	tumors	NNS	O	tumor	dobj	7	SENT_162	[p9l12t3488r320b3550],
9	with	IN	O	with	_	0	SENT_162	[p9l381t3471r576b3550],
10	FISH	NN	O	fish	nn	14	SENT_162	[p9l637t3472r1212b3571],
11	—	CD	NUMBER	—	num	14	SENT_162	[p9l637t3472r1212b3571],
12	positive	JJ	O	positive	amod	14	SENT_162	[p9l637t3472r1212b3571],
13	ALK	NN	O	alk	nn	14	SENT_162	[p9l1268t3477r1443b3549],
14	rearrangement	NN	O	rearrangement	prep_with	8	SENT_162	[p9l1497t3488r2139b3572],
15	are	VBP	O	be	auxpass	16	SENT_162	[p9l11t3626r140b3678],
16	summarized	VBN	O	summarize	_	0	SENT_162	[p9l191t3600r733b3679],
17	in	IN	O	in	_	0	SENT_162	[p9l782t3601r865b3678],
18	Table	NNP	O	Table	prep_in	16	SENT_162	[p9l911t3600r1145b3679],
19	1	CD	NUMBER	1	num	18	SENT_162	[p9l1200t3606r1269b3679],
20	.	.	O	.	_	0	SENT_162	[p9l1200t3606r1269b3679],

1	Patients	NNS	O	patient	nsubj	2	SENT_163	[p9l1322t3601r1662b3678],
2	tended	VBD	O	tend	_	0	SENT_163	[p9l1713t3600r2001b3679],
3	to	TO	O	to	aux	5	SENT_163	[p9l2051t3617r2133b3679],
4	be	VB	O	be	cop	5	SENT_163	[p10l12t32r109b111],
5	younger	JJR	O	younger	xcomp	2	SENT_163	[p10l140t58r489b133],
6	than	IN	O	than	_	0	SENT_163	[p10l521t32r718b110],
7	the	DT	O	the	det	9	SENT_163	[p10l752t32r886b110],
8	average	JJ	O	average	amod	9	SENT_163	[p10l920t58r1238b133],
9	age	NN	O	age	prep_than	5	SENT_163	[p10l1272t58r1415b133],
10	of	IN	O	of	_	0	SENT_163	[p10l1450t31r1551b111],
11	patients	NNS	O	patient	prep_of	9	SENT_163	[p10l1565t33r1907b132],
12	with	IN	O	with	_	0	SENT_163	[p10l1939t32r2134b111],
13	lung	NN	O	lung	nn	14	SENT_163	[p10l11t160r204b261],
14	cancer	NN	O	cancer	prep_with	11	SENT_163	[p10l273t186r572b256],
15	,	,	O	,	_	0	SENT_163	[p10l273t186r572b256],
16	with	IN	O	with	_	0	SENT_163	[p10l644t160r839b239],
17	a	DT	O	a	det	18	SENT_163	[p10l910t186r954b238],
18	history	NN	O	history	prep_with	5	SENT_163	[p10l1024t160r1328b260],
19	of	IN	O	of	_	0	SENT_163	[p10l1396t159r1496b239],
20	never	RB	O	never	neg	22	SENT_163	[p10l1549t186r1778b239],
21	having	VBG	O	have	aux	22	SENT_163	[p10l1846t160r2138b261],
22	smoked	VBN	O	smoke	prepc_of	18	SENT_163	[p10l13t288r345b367],
23	or	CC	O	or	dep	30	SENT_163	[p10l396t314r484b367],
24	of	IN	O	of	_	0	SENT_163	[p10l532t287r631b367],
25	former	JJ	O	former	amod	28	SENT_163	[p10l662t287r958b367],
26	light	JJ	O	light	amod	28	SENT_163	[p10l1004t288r1205b389],
27	smoking	NN	O	smoking	nn	28	SENT_163	[p10l1251t288r1628b389],
28	(	NN	O	(	prep_of	30	SENT_163	[p10l1679t294r1859b379],
29	510	CD	NUMBER	510	num	30	SENT_163	[p10l1679t294r1859b379],
30	packyears	NNS	O	packyear	dep	22	SENT_163	[p10l1908t288r2133b388, p10l7t422r278b515],
31	)	CD	NUMBER	)	dep	30	SENT_163	[p10l1908t288r2133b388, p10l7t422r278b515],
32	.	.	O	.	_	0	SENT_163	[p10l1908t288r2133b388, p10l7t422r278b515],

1	However	RB	O	however	advmod	5	SENT_164	[p10l337t423r732b511],
2	,	,	O	,	_	0	SENT_164	[p10l337t423r732b511],
3	five	CD	NUMBER	five	num	4	SENT_164	[p10l791t414r944b494],
4	patients	NNS	O	patient	nsubj	5	SENT_164	[p10l996t416r1337b515],
5	had	VBD	O	have	_	0	SENT_164	[p10l1393t415r1550b494],
6	a	DT	O	a	det	7	SENT_164	[p10l1602t441r1647b493],
7	history	NN	O	history	dobj	5	SENT_164	[p10l1699t415r2003b515],
8	of	IN	O	of	_	0	SENT_164	[p10l2053t414r2152b494],
9	more	JJR	O	more	mwe	10	SENT_164	[p10l12t570r231b623],
10	than	IN	O	than	quantmod	11	SENT_164	[p10l287t544r483b622],
11	10	CD	NUMBER	10	num	12	SENT_164	[p10l541t550r634b623],
12	pack	NN	O	pack	prep_of	7	SENT_164	[p10l688t544r1158b644],
13	—	CD	NUMBER	—	num	14	SENT_164	[p10l688t544r1158b644],
14	years	NNS	NUMBER	year	tmod	12	SENT_164	[p10l688t544r1158b644],
15	,	,	O	,	_	0	SENT_164	[p10l688t544r1158b644],
16	including	VBG	O	include	_	0	SENT_164	[p10l1218t544r1628b645],
17	three	CD	NUMBER	three	prep_including	5	SENT_164	[p10l1680t544r1899b622],
18	who	WP	O	who	nsubj	20	SENT_164	[p10l1950t544r2133b623],
19	had	VBD	O	have	aux	20	SENT_164	[p10l12t671r168b750],
20	smoked	VBN	O	smoke	rcmod	17	SENT_164	[p10l220t671r552b751],
21	for	IN	O	for	_	0	SENT_164	[p10l601t670r724b750],
22	at	IN	O	at	quantmod	24	SENT_164	[p10l770t688r849b749],
23	least	JJS	O	least	mwe	22	SENT_164	[p10l893t671r1092b749],
24	35	CD	NUMBER	35	num	25	SENT_164	[p10l1137t678r1230b750],
25	pacl	NN	O	pacl	npadvmod	26	SENT_164	[p10l1281t671r1751b771],
26	<	JJR	O	<	prep_for	20	SENT_164	[p10l1281t671r1751b771],
27	.	.	O	.	_	0	SENT_164	[p10l1281t671r1751b771],

1	—	NN	O	—	_	0	SENT_165	[p10l1281t671r1751b771],
2	.	.	O	.	_	0	SENT_165	[p10l1281t671r1751b771],

1	years	NNS	DURATION	year	_	0	SENT_166	[p10l1281t671r1751b771],
2	.	.	O	.	_	0	SENT_166	[p10l1281t671r1751b771],

1	Tumors	NNS	O	tumor	nsubjpass	3	SENT_167	[p10l1803t678r2132b750],
2	were	VBD	O	be	auxpass	3	SENT_167	[p10l6t825r209b879],
3	found	VBN	O	find	_	0	SENT_167	[p10l259t798r512b878],
4	to	TO	O	to	aux	6	SENT_167	[p10l561t816r643b878],
5	be	VB	O	be	cop	6	SENT_167	[p10l694t799r791b878],
6	predominantly	RB	O	predominantly	xcomp	3	SENT_167	[p10l838t799r1484b899],
7	adenocarcino	JJ	O	adenocarcino	amod	9	SENT_167	[p10l1528t799r2143b878],
8	—	NN	O	—	nn	9	SENT_167	[p10l1528t799r2143b878],
9	mas	NNS	O	ma	nsubj	13	SENT_167	[p10l11t954r185b1006],
10	on	IN	O	on	_	0	SENT_167	[p10l224t954r330b1007],
11	histologic	JJ	O	histologic	amod	12	SENT_167	[p10l365t928r793b1029],
12	analyses	NNS	O	analysis	prep_on	9	SENT_167	[p10l826t928r1187b1028],
13	(	VBP	O	(	ccomp	6	SENT_167	[p10l1230t929r1413b1029],
14	Fig	NN	O	fig	dobj	13	SENT_167	[p10l1230t929r1413b1029],
15	.	.	O	.	_	0	SENT_167	[p10l1230t929r1413b1029],

1	1B	NN	O	1b	nsubj	18	SENT_168	[p10l1459t934r1592b1024],
2	,	,	O	,	_	0	SENT_168	[p10l1459t934r1592b1024],
3	and	CC	O	and	_	0	SENT_168	[p10l1633t928r1791b1007],
4	Table	NNP	O	Table	conj_and	1	SENT_168	[p10l1822t928r2058b1007],
5	1	CD	NUMBER	1	num	4	SENT_168	[p10l2099t934r2143b1005],
6	in	IN	O	in	_	0	SENT_168	[p10l10t1057r93b1134],
7	the	DT	O	the	det	10	SENT_168	[p10l129t1056r260b1134],
8	Supplementary	NNP	O	Supplementary	nn	10	SENT_168	[p10l298t1056r935b1156],
9	Appendix	NNP	O	Appendix	nn	10	SENT_168	[p10l962t1056r1420b1156],
10	)	NNP	O	)	prep_in	4	SENT_168	[p10l962t1056r1420b1156],
11	,	,	O	,	_	0	SENT_168	[p10l962t1056r1420b1156],
12	with	IN	O	with	_	0	SENT_168	[p10l1457t1056r1650b1135],
13	signet	NN	O	signet	nn	16	SENT_168	[p10l1687t1057r2148b1157],
14	—	CD	NUMBER	—	num	16	SENT_168	[p10l1687t1057r2148b1157],
15	ring	NN	O	ring	nn	16	SENT_168	[p10l1687t1057r2148b1157],
16	cells	NNS	O	cell	prep_with	1	SENT_168	[p10l12t1183r199b1261],
17	frequently	RB	O	frequently	advmod	18	SENT_168	[p10l244t1182r686b1283],
18	seen	VBN	O	see	_	0	SENT_168	[p10l724t1189r1016b1262],
19	.2	NN	NUMBER	.2	dobj	18	SENT_168	[p10l724t1189r1016b1262],
20	°	CD	NUMBER	°	num	21	SENT_168	[p10l724t1189r1016b1262],
21	Information	NN	O	information	nsubj	26	SENT_168	[p10l1057t1182r1589b1262],
22	on	IN	O	on	_	0	SENT_168	[p10l1632t1209r1738b1262],
23	previous	JJ	O	previous	amod	24	SENT_168	[p10l1778t1184r2143b1283],
24	therapy	NN	O	therapy	prep_on	21	SENT_168	[p10l11t1311r341b1411],
25	was	VBD	O	be	cop	26	SENT_168	[p10l384t1337r550b1391],
26	available	JJ	O	available	rcmod	19	SENT_168	[p10l604t1311r986b1391],
27	for	IN	O	for	_	0	SENT_168	[p10l1038t1310r1164b1390],
28	81	CD	NUMBER	81	num	29	SENT_168	[p10l1214t1317r1313b1390],
29	patients	NNS	O	patient	prep_for	26	SENT_168	[p10l1365t1312r1741b1411],
30	,	,	O	,	_	0	SENT_168	[p10l1365t1312r1741b1411],
31	with	IN	O	with	_	0	SENT_168	[p10l1795t1311r1994b1391],
32	76	CD	NUMBER	76	num	33	SENT_168	[p10l2048t1317r2143b1390],
33	patients	NNS	O	patient	nsubj	39	SENT_168	[p10l10t1441r352b1540],
34	(	IN	O	(	_	0	SENT_168	[p10l395t1445r631b1531],
35	94	CD	PERCENT	94	num	36	SENT_168	[p10l395t1445r631b1531],
36	%	NN	PERCENT	%	prep_(	33	SENT_168	[p10l395t1445r631b1531],
37	)	CD	NUMBER	)	dep	36	SENT_168	[p10l395t1445r631b1531],
38	having	VBG	O	have	aux	39	SENT_168	[p10l671t1440r963b1541],
39	received	VBN	O	receive	prepc_with	26	SENT_168	[p10l995t1440r1342b1519],
40	at	IN	O	at	quantmod	42	SENT_168	[p10l1375t1457r1454b1518],
41	least	JJS	O	least	mwe	40	SENT_168	[p10l1483t1440r1683b1518],
42	one	CD	NUMBER	one	num	44	SENT_168	[p10l1713t1466r1865b1519],
43	previous	JJ	O	previous	amod	44	SENT_168	[p10l1899t1441r2143b1540, p10l12t1594r158b1647],
44	therapy	NN	O	therapy	dobj	39	SENT_168	[p10l224t1568r547b1668],
45	and	CC	O	and	_	0	SENT_168	[p10l605t1568r763b1647],
46	5	CD	NUMBER	5	dobj	18	SENT_168	[p10l828t1576r871b1647],
47	receiving	VBG	O	receive	partmod	46	SENT_168	[p10l938t1569r1330b1669],
48	first	JJ	ORDINAL	first	amod	51	SENT_168	[p10l1390t1567r1762b1646],
49	—	NN	O	—	nn	51	SENT_168	[p10l1390t1567r1762b1646],
50	line	NN	O	line	nn	51	SENT_168	[p10l1390t1567r1762b1646],
51	therapy	NN	O	therapy	dobj	47	SENT_168	[p10l1825t1568r2149b1668],
52	with	IN	O	with	_	0	SENT_168	[p10l6t1696r206b1775],
53	crizotinib	NN	O	crizotinib	prep_with	51	SENT_168	[p10l269t1696r701b1775],
54	(	CD	NUMBER	(	num	53	SENT_168	[p10l769t1696r1033b1787],
55	Table	NNP	O	Table	dep	19	SENT_168	[p10l769t1696r1033b1787],
56	1	CD	NUMBER	1	num	55	SENT_168	[p10l1099t1702r1168b1792],
57	,	,	O	,	_	0	SENT_168	[p10l1099t1702r1168b1792],
58	and	CC	O	and	_	0	SENT_168	[p10l1235t1696r1396b1775],
59	Table	NNP	O	Table	conj_and	19	SENT_168	[p10l1454t1696r1689b1775],
60	2	CD	NUMBER	2	num	59	SENT_168	[p10l1751t1702r1799b1774],
61	in	IN	O	in	_	0	SENT_168	[p10l1861t1697r1946b1774],
62	the	DT	O	the	det	65	SENT_168	[p10l2009t1696r2144b1774],
63	Supplementary	NNP	O	Supplementary	nn	65	SENT_168	[p10l13t1825r663b1925],
64	Appendix	NNP	O	Appendix	nn	65	SENT_168	[p10l694t1825r1163b1925],
65	)	NN	O	)	prep_in	59	SENT_168	[p10l694t1825r1163b1925],
66	.	.	O	.	_	0	SENT_168	[p10l694t1825r1163b1925],

1	RESPONSE	NN	O	response	_	0	SENT_169	[p10l16t2101r428b2152],
2	TO	TO	O	to	infmod	1	SENT_169	[p10l460t2101r564b2152],
3	ALK	NNP	O	ALK	nn	4	SENT_169	[p10l596t2102r737b2151],
4	INHIBITION	NNP	O	INHIBITION	dobj	2	SENT_169	[p10l777t2101r1240b2152],
5	We	PRP	O	we	nsubj	6	SENT_169	[p10l7t2219r141b2289],
6	evaluated	VBD	O	evaluate	dep	1	SENT_169	[p10l180t2211r583b2290],
7	82	CD	NUMBER	82	num	8	SENT_169	[p10l622t2217r719b2290],
8	patients	NNS	O	patient	dobj	6	SENT_169	[p10l757t2212r1100b2311],
9	with	IN	O	with	_	0	SENT_169	[p10l1135t2211r1331b2290],
10	FISH	NN	O	fish	npadvmod	12	SENT_169	[p10l1368t2212r1946b2311],
11	—	CD	NUMBER	—	num	10	SENT_169	[p10l1368t2212r1946b2311],
12	positive	JJ	O	positive	amod	14	SENT_169	[p10l1368t2212r1946b2311],
13	ALK	NN	O	alk	nn	14	SENT_169	[p10l1977t2217r2153b2289],
14	rearrangements	NNS	O	rearrangement	prep_with	6	SENT_169	[p10l11t2357r720b2441],
15	,	,	O	,	_	0	SENT_169	[p10l11t2357r720b2441],
16	including	VBG	O	include	_	0	SENT_169	[p10l781t2340r1194b2441],
17	2	CD	NUMBER	2	prep_including	6	SENT_169	[p10l1247t2346r1295b2417],
18	who	WP	O	who	nsubjpass	20	SENT_169	[p10l1348t2340r1531b2419],
19	were	VBD	O	be	auxpass	20	SENT_169	[p10l1585t2366r1788b2419],
20	treated	VBN	O	treat	rcmod	17	SENT_169	[p10l1844t2340r2144b2419],
21	during	IN	O	during	_	0	SENT_169	[p10l12t2468r302b2569],
22	dose	NN	O	dose	nn	23	SENT_169	[p10l340t2468r535b2547],
23	escalation	NN	O	escalation	prep_during	20	SENT_169	[p10l578t2468r1037b2564],
24	,	,	O	,	_	0	SENT_169	[p10l578t2468r1037b2564],
25	for	IN	O	for	_	0	SENT_169	[p10l1084t2467r1208b2547],
26	response	NN	O	response	prep_for	1	SENT_169	[p10l1247t2494r1629b2568],
27	and	CC	O	and	_	0	SENT_169	[p10l1670t2468r1829b2547],
28	safety	NN	O	safety	conj_and	26	SENT_169	[p10l1871t2467r2138b2568],
29	.	.	O	.	_	0	SENT_169	[p10l1871t2467r2138b2568],

1	1696	CD	DATE	1696	num	3	SENT_170	[p10l149t2644r225b2668],
2	NENGLJ	NNP	O	NENGLJ	nn	3	SENT_170	[p10l938t2655r1044b2677],
3	MED363	NN	O	med363	_	0	SENT_170	[p10l1059t2649r1197b2677],
4	;	:	O	;	_	0	SENT_170	[p10l1059t2649r1197b2677],
5	18	CD	NUMBER	18	num	7	SENT_170	[p10l1059t2649r1197b2677],
6	NEJM.ORG	NN	O	nejm.org	nn	7	SENT_170	[p10l1232t2655r1356b2677],
7	OCTOBER28	NN	O	october28	dep	3	SENT_170	[p10l1392t2649r1549b2675],
8	,	,	O	,	_	0	SENT_170	[p10l1392t2649r1549b2675],
9	2010	CD	DATE	2010	appos	7	SENT_170	[p10l1560t2655r1621b2671],

1	The	DT	O	the	det	4	SENT_171	[p10l935t2688r986b2712],
2	New	NNP	O	New	nn	4	SENT_171	[p10l995t2689r1057b2712],
3	England	NNP	O	England	nn	4	SENT_171	[p10l1066t2688r1177b2719],
4	Journal	NNP	O	Journal	_	0	SENT_171	[p10l1186t2688r1283b2712],
5	of	IN	O	of	_	0	SENT_171	[p10l1293t2688r1322b2712],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_171	[p10l1329t2688r1454b2712],

1	ALK	NNP	O	ALK	nn	2	SENT_172	[p10l627t2876r691b2895],
2	INHIBITION	NNP	O	INHIBITION	_	0	SENT_172	[p10l705t2876r908b2895],
3	IN	IN	O	in	_	0	SENT_172	[p10l924t2876r961b2895],
4	NON	NNP	O	NON	prep_in	2	SENT_172	[p10l977t2876r1279b2895],
5	.	.	O	.	_	0	SENT_172	[p10l977t2876r1279b2895],

1	—	NN	O	—	_	0	SENT_173	[p10l977t2876r1279b2895],
2	.	.	O	.	_	0	SENT_173	[p10l977t2876r1279b2895],

1	SMALL-CELL	NN	O	small-cell	nn	2	SENT_174	[p10l977t2876r1279b2895],
2	LUNG	NN	O	lung	_	0	SENT_174	[p10l1293t2876r1385b2895],
3	CANCER	NNP	O	CANCER	dep	2	SENT_174	[p10l1399t2876r1533b2895],

1	Of	IN	O	of	_	0	SENT_175	[p10l10t3089r131b3169],
2	these	DT	O	these	det	3	SENT_175	[p10l159t3090r383b3168],
3	patients	NNS	O	patient	prep_of	18	SENT_175	[p10l427t3091r794b3190],
4	,	,	O	,	_	0	SENT_175	[p10l427t3091r794b3190],
5	46	CD	NUMBER	46	nsubj	18	SENT_175	[p10l843t3096r947b3169],
6	from	IN	O	from	_	0	SENT_175	[p10l993t3089r1204b3169],
7	study	NN	O	study	nn	8	SENT_175	[p10l1251t3090r1481b3190],
8	centers	NNS	O	center	prep_from	5	SENT_175	[p10l1523t3107r1826b3168],
9	in	IN	O	in	_	0	SENT_175	[p10l1873t3091r1957b3168],
10	the	DT	O	the	det	12	SENT_175	[p10l2003t3090r2135b3168],
11	United	NNP	LOCATION	United	nn	12	SENT_175	[p10l10t3219r297b3298],
12	States	NNPS	LOCATION	States	prep_in	8	SENT_175	[p10l340t3225r613b3315],
13	,	,	O	,	_	0	SENT_175	[p10l340t3225r613b3315],
14	Australia	NNP	LOCATION	Australia	conj_and	12	SENT_175	[p10l656t3219r1072b3315],
15	,	,	O	,	_	0	SENT_175	[p10l656t3219r1072b3315],
16	and	CC	O	and	_	0	SENT_175	[p10l1118t3219r1276b3298],
17	Korea	NNP	LOCATION	Korea	conj_and	12	SENT_175	[p10l1316t3227r1567b3300],
18	met	VBD	O	meet	_	0	SENT_175	[p10l1605t3236r1771b3297],
19	RECIST	NNP	O	RECIST	nn	20	SENT_175	[p10l1804t3225r2138b3302],
20	criteria	NNS	O	criterion	dobj	18	SENT_175	[p10l11t3348r321b3425],
21	for	IN	O	for	_	0	SENT_175	[p10l373t3346r498b3426],
22	a	DT	O	a	det	25	SENT_175	[p10l547t3373r592b3425],
23	confirmed	VBN	O	confirm	amod	25	SENT_175	[p10l644t3346r1107b3426],
24	partial	JJ	O	partial	amod	25	SENT_175	[p10l1158t3347r1452b3447],
25	response	NN	O	response	prep_for	18	SENT_175	[p10l1504t3373r1917b3447],
26	,	,	O	,	_	0	SENT_175	[p10l1504t3373r1917b3447],
27	and	CC	O	and	_	0	SENT_175	[p10l1975t3347r2135b3426],
28	1	CD	NUMBER	1	nsubj	29	SENT_175	[p10l14t3481r58b3553],
29	met	VBD	O	meet	conj_and	18	SENT_175	[p10l93t3492r258b3553],
30	the	DT	O	the	det	31	SENT_175	[p10l286t3475r418b3553],
31	criteria	NNS	O	criterion	dobj	29	SENT_175	[p10l453t3476r757b3553],
32	for	IN	O	for	_	0	SENT_175	[p10l787t3474r911b3554],
33	a	DT	O	a	det	35	SENT_175	[p10l940t3501r984b3553],
34	complete	JJ	O	complete	amod	35	SENT_175	[p10l1016t3475r1405b3575],
35	response	NN	O	response	prep_for	29	SENT_175	[p10l1437t3501r1842b3575],
36	,	,	O	,	_	0	SENT_175	[p10l1437t3501r1842b3575],
37	for	IN	O	for	_	0	SENT_175	[p10l1880t3474r2003b3554],
38	an	DT	O	a	det	41	SENT_175	[p10l2033t3501r2135b3553],
39	overall	JJ	O	overall	amod	41	SENT_175	[p10l11t3603r297b3683],
40	response	NN	O	response	nn	41	SENT_175	[p10l328t3629r710b3703],
41	rate	NN	O	rate	prep_for	29	SENT_175	[p10l742t3620r902b3681],
42	of	IN	O	of	_	0	SENT_175	[p10l935t3602r1035b3682],
43	57	CD	PERCENT	57	num	44	SENT_175	[p10l1051t3608r1235b3682],
44	%	NN	PERCENT	%	nn	49	SENT_175	[p10l1051t3608r1235b3682],
45	(	CD	PERCENT	(	number	46	SENT_175	[p10l1272t3608r1483b3694],
46	95	CD	PERCENT	95	dep	47	SENT_175	[p10l1272t3608r1483b3694],
47	%	NN	PERCENT	%	dep	49	SENT_175	[p10l1272t3608r1483b3694],
48	confidence	NN	O	confidence	nn	49	SENT_175	[p10l1515t3602r1988b3682],
49	interval	NN	O	interval	prep_of	41	SENT_175	[p10l2020t3604r2134b3681, p11l11t22r249b101],

1	[	NN	O	[	nn	3	SENT_176	[p11l298t28r474b118],
2	CI	NN	O	ci	nn	3	SENT_176	[p11l298t28r474b118],
3	]	NN	O	]	_	0	SENT_176	[p11l298t28r474b118],
4	,	,	O	,	_	0	SENT_176	[p11l298t28r474b118],
5	46	CD	NUMBER	46	appos	3	SENT_176	[p11l517t28r620b101],
6	to	TO	O	to	_	0	SENT_176	[p11l662t39r743b101],
7	68	CD	NUMBER	68	num	8	SENT_176	[p11l785t28r938b113],
8	)	CD	NUMBER	)	prep_to	5	SENT_176	[p11l785t28r938b113],
9	.	.	O	.	_	0	SENT_176	[p11l785t28r938b113],

1	An	DT	O	a	det	3	SENT_177	[p11l980t30r1103b100],
2	additional	JJ	O	additional	amod	3	SENT_177	[p11l1143t22r1581b101],
3	group	NN	O	group	nsubj	11	SENT_177	[p11l1619t48r1873b123],
4	of	IN	O	of	_	0	SENT_177	[p11l1915t21r2015b101],
5	27	CD	NUMBER	27	num	6	SENT_177	[p11l2037t28r2135b100],
6	patients	NNS	O	patient	prep_of	3	SENT_177	[p11l8t150r350b249],
7	(	CD	PERCENT	(	number	8	SENT_177	[p11l393t154r628b240],
8	33	CD	PERCENT	33	num	9	SENT_177	[p11l393t154r628b240],
9	%	NN	PERCENT	%	dep	6	SENT_177	[p11l393t154r628b240],
10	)	CD	NUMBER	)	dep	9	SENT_177	[p11l393t154r628b240],
11	met	VBD	O	meet	_	0	SENT_177	[p11l669t166r833b227],
12	criteria	NNS	O	criterion	dobj	11	SENT_177	[p11l865t150r1169b227],
13	for	IN	O	for	_	0	SENT_177	[p11l1203t148r1326b228],
14	stable	JJ	O	stable	amod	15	SENT_177	[p11l1360t149r1608b228],
15	disease	NN	O	disease	prep_for	12	SENT_177	[p11l1644t149r1978b245],
16	,	,	O	,	_	0	SENT_177	[p11l1644t149r1978b245],
17	including	VBG	O	include	_	0	SENT_177	[p11l2019t150r2134b227, p11l11t278r333b379],
18	5	CD	NUMBER	5	prep_including	11	SENT_177	[p11l382t286r425b357],
19	who	WP	O	who	nsubj	20	SENT_177	[p11l474t278r657b357],
20	had	VBD	O	have	rcmod	18	SENT_177	[p11l709t278r865b357],
21	an	DT	O	a	det	24	SENT_177	[p11l914t304r1017b356],
22	unconfirmed	JJ	O	unconfirmed	amod	24	SENT_177	[p11l1068t277r1636b357],
23	partial	JJ	O	partial	amod	24	SENT_177	[p11l1685t278r1972b378],
24	response	NN	O	response	dobj	20	SENT_177	[p11l2021t304r2134b356, p11l11t432r306b506],
25	but	CC	O	but	_	0	SENT_177	[p11l348t406r488b485],
26	who	WP	O	who	nsubjpass	28	SENT_177	[p11l519t406r702b485],
27	were	VBD	O	be	auxpass	28	SENT_177	[p11l740t432r941b485],
28	classified	VBN	O	classify	rcmod	18	SENT_177	[p11l984t405r1389b485],
29	as	IN	O	as	_	0	SENT_177	[p11l1429t432r1515b484],
30	having	VBG	O	have	prepc_as	28	SENT_177	[p11l1557t406r1849b507],
31	stable	JJ	O	stable	amod	32	SENT_177	[p11l1888t406r2135b485],
32	disease	NN	O	disease	dobj	30	SENT_177	[p11l11t533r328b612],
33	because	IN	O	because	mark	39	SENT_177	[p11l382t533r724b612],
34	confirmatory	JJ	O	confirmatory	amod	36	SENT_177	[p11l778t532r1369b633],
35	CT	NN	O	ct	nn	36	SENT_177	[p11l1417t539r1541b612],
36	results	NNS	O	result	nsubj	39	SENT_177	[p11l1590t533r1880b613],
37	were	VBD	O	be	cop	39	SENT_177	[p11l1930t559r2135b613],
38	not	RB	O	not	neg	39	SENT_177	[p11l10t679r155b741],
39	available	JJ	O	available	advcl	28	SENT_177	[p11l200t662r580b741],
40	by	IN	O	by	_	0	SENT_177	[p11l632t662r730b762],
41	the	DT	O	the	det	45	SENT_177	[p11l777t662r912b740],
42	cutoff	NN	O	cutoff	nn	45	SENT_177	[p11l963t661r1241b741],
43	date	NN	O	date	nn	45	SENT_177	[p11l1273t662r1454b741],
44	(	CD	NUMBER	(	num	45	SENT_177	[p11l1510t663r1693b763],
45	Fig	NN	O	fig	prep_by	39	SENT_177	[p11l1510t663r1693b763],
46	.	.	O	.	_	0	SENT_177	[p11l1510t663r1693b763],

1	2A	NN	O	2a	_	0	SENT_178	[p11l1750t668r1920b753],
2	)	NN	O	)	dep	1	SENT_178	[p11l1750t668r1920b753],
3	.	.	O	.	_	0	SENT_178	[p11l1750t668r1920b753],

1	The	DT	O	the	det	5	SENT_179	[p11l1972t662r2135b740],
2	disease	NN	O	disease	nn	5	SENT_179	[p11l11t790r670b869],
3	—	NN	O	—	nn	5	SENT_179	[p11l11t790r670b869],
4	control	NN	O	control	nn	5	SENT_179	[p11l11t790r670b869],
5	rate	NN	O	rate	nsubj	11	SENT_179	[p11l698t807r859b868],
6	at	IN	O	at	_	0	SENT_179	[p11l888t807r966b868],
7	8	CD	DURATION	8	num	8	SENT_179	[p11l991t796r1037b869],
8	weeks	NNS	NUMBER	week	prep_at	5	SENT_179	[p11l1064t790r1325b870],
9	was	VBD	O	be	cop	11	SENT_179	[p11l1352t816r1515b870],
10	87	CD	PERCENT	87	num	11	SENT_179	[p11l1547t796r1732b869],
11	%	NN	PERCENT	%	_	0	SENT_179	[p11l1547t796r1732b869],
12	(	CD	NUMBER	(	number	13	SENT_179	[p11l1765t796r1895b881],
13	71	CD	NUMBER	71	num	11	SENT_179	[p11l1765t796r1895b881],
14	of	IN	O	of	_	0	SENT_179	[p11l1925t789r2025b869],
15	82	CD	NUMBER	82	num	16	SENT_179	[p11l2037t796r2134b869],
16	patients	NNS	O	patient	prep_of	11	SENT_179	[p11l9t920r402b1019],
17	)	CD	NUMBER	)	dep	16	SENT_179	[p11l9t920r402b1019],
18	.	.	O	.	_	0	SENT_179	[p11l9t920r402b1019],

1	A	DT	O	a	det	2	SENT_180	[p11l440t927r506b997],
2	subgroup	NN	O	subgroup	nsubjpass	8	SENT_180	[p11l542t919r945b1020],
3	of	IN	O	of	_	0	SENT_180	[p11l984t918r1084b998],
4	unselected	JJ	O	unselected	amod	5	SENT_180	[p11l1103t919r1559b998],
5	patients	NNS	O	patient	prep_of	2	SENT_180	[p11l1595t920r1936b1019],
6	was	VBD	O	be	auxpass	8	SENT_180	[p11l1971t945r2133b998],
7	also	RB	O	also	advmod	8	SENT_180	[p11l10t1047r181b1125],
8	evaluated	VBN	O	evaluate	_	0	SENT_180	[p11l223t1047r626b1126],
9	by	IN	O	by	_	0	SENT_180	[p11l666t1047r763b1146],
10	18FDG-PET	NNP	O	18FDG-PET	agent	8	SENT_180	[p11l801t1052r1290b1142],
11	,	,	O	,	_	0	SENT_180	[p11l801t1052r1290b1142],
12	and	CC	O	and	_	0	SENT_180	[p11l1335t1047r1493b1125],
13	representative	JJ	O	representative	amod	15	SENT_180	[p11l1533t1048r2135b1146],
14	radiographic	JJ	O	radiographic	amod	15	SENT_180	[p11l10t1175r561b1276],
15	images	NNS	O	image	nsubjpass	21	SENT_180	[p11l598t1176r903b1276],
16	of	IN	O	of	_	0	SENT_180	[p11l944t1174r1045b1254],
17	responses	NNS	O	response	prep_of	15	SENT_180	[p11l1064t1201r1488b1275],
18	to	TO	O	to	_	0	SENT_180	[p11l1529t1192r1611b1254],
19	therapy	NN	O	therapy	prep_to	17	SENT_180	[p11l1651t1175r1973b1275],
20	are	VBP	O	be	auxpass	21	SENT_180	[p11l2007t1201r2135b1253],
21	shown	VBN	O	show	conj_and	8	SENT_180	[p11l11t1303r294b1382],
22	in	IN	O	in	_	0	SENT_180	[p11l341t1304r425b1381],
23	Figure	NNP	O	Figure	nn	25	SENT_180	[p11l472t1304r750b1404],
24	2B	NN	O	2b	nn	25	SENT_180	[p11l800t1309r910b1381],
25	(	NN	O	(	prep_in	21	SENT_180	[p11l967t1303r1149b1394],
26	and	CC	O	and	_	0	SENT_180	[p11l967t1303r1149b1394],
27	Fig	NN	O	fig	conj_and	25	SENT_180	[p11l1196t1304r1350b1404],
28	.	.	O	.	_	0	SENT_180	[p11l1196t1304r1350b1404],

1	2	CD	NUMBER	2	_	0	SENT_181	[p11l1406t1309r1453b1381],
2	in	IN	O	in	_	0	SENT_181	[p11l1503t1304r1586b1381],
3	the	DT	O	the	det	6	SENT_181	[p11l1635t1303r1768b1381],
4	Supplementary	NNP	O	Supplementary	nn	6	SENT_181	[p11l1818t1303r2134b1403, p11l10t1448r370b1530],
5	Appendix	NNP	O	Appendix	nn	6	SENT_181	[p11l398t1431r865b1530],
6	)	NN	O	)	prep_in	1	SENT_181	[p11l398t1431r865b1530],
7	.	.	O	.	_	0	SENT_181	[p11l398t1431r865b1530],

1	Exploratory	JJ	O	exploratory	_	0	SENT_182	[p11l905t1431r1408b1530],
2	18FLT	NNP	O	18FLT	dep	1	SENT_182	[p11l1441t1436r1865b1508],
3	.	.	O	.	_	0	SENT_182	[p11l1441t1436r1865b1508],

1	—	NN	O	—	_	0	SENT_183	[p11l1441t1436r1865b1508],
2	.	.	O	.	_	0	SENT_183	[p11l1441t1436r1865b1508],

1	PET	NN	O	pet	nn	2	SENT_184	[p11l1441t1436r1865b1508],
2	scans	NNS	O	scan	nsubjpass	4	SENT_184	[p11l1899t1457r2134b1508],
3	were	VBD	O	be	auxpass	4	SENT_184	[p11l6t1584r208b1638],
4	performed	VBN	O	perform	_	0	SENT_184	[p11l254t1557r711b1658],
5	after	IN	O	after	_	0	SENT_184	[p11l758t1557r960b1636],
6	one	CD	NUMBER	one	num	7	SENT_184	[p11l1006t1584r1157b1637],
7	cycle	NN	O	cycle	prep_after	4	SENT_184	[p11l1205t1558r1408b1658],
8	of	IN	O	of	_	0	SENT_184	[p11l1457t1557r1557b1637],
9	treatment	NN	O	treatment	prep_of	7	SENT_184	[p11l1586t1575r2011b1636],
10	in	IN	O	in	_	0	SENT_184	[p11l2052t1559r2136b1636],
11	several	JJ	O	several	amod	13	SENT_184	[p11l11t1687r303b1766],
12	unselected	JJ	O	unselected	amod	13	SENT_184	[p11l337t1687r793b1766],
13	patients	NNS	O	patient	prep_in	4	SENT_184	[p11l825t1688r1192b1786],
14	,	,	O	,	_	0	SENT_184	[p11l825t1688r1192b1786],
15	with	IN	O	with	_	0	SENT_184	[p11l1227t1687r1422b1766],
16	results	NNS	O	result	prep_with	4	SENT_184	[p11l1456t1687r1740b1766],
17	supporting	VBG	O	support	partmod	16	SENT_184	[p11l1777t1704r2134b1786, p11l10t1816r149b1916],
18	the	DT	O	the	det	20	SENT_184	[p11l175t1815r308b1893],
19	clinical	JJ	O	clinical	amod	20	SENT_184	[p11l338t1815r652b1893],
20	impression	NN	O	impression	dobj	17	SENT_184	[p11l679t1816r1157b1915],
21	that	IN	O	that	complm	30	SENT_184	[p11l1187t1815r1360b1893],
22	responses	NNS	O	response	nsubj	30	SENT_184	[p11l1383t1841r1807b1915],
23	to	TO	O	to	_	0	SENT_184	[p11l1839t1832r1921b1894],
24	ALK	NN	O	alk	nn	25	SENT_184	[p11l1947t1822r2139b1896],
25	inhibition	NN	O	inhibition	prep_to	22	SENT_184	[p11l10t1943r439b2022],
26	can	MD	O	can	aux	30	SENT_184	[p11l472t1969r621b2021],
27	be	VB	O	be	cop	30	SENT_184	[p11l655t1943r751b2022],
28	rapid	JJ	O	rapid	amod	30	SENT_184	[p11l784t1943r1002b2043],
29	(	NN	O	(	nn	30	SENT_184	[p11l1040t1944r1223b2044],
30	Fig	NN	O	fig	ccomp	17	SENT_184	[p11l1040t1944r1223b2044],
31	.	.	O	.	_	0	SENT_184	[p11l1040t1944r1223b2044],

1	3	CD	NUMBER	3	_	0	SENT_185	[p11l1264t1949r1308b2022],
2	in	IN	O	in	_	0	SENT_185	[p11l1345t1944r1428b2021],
3	the	DT	O	the	det	6	SENT_185	[p11l1462t1943r1594b2021],
4	Supplementary	NNP	O	Supplementary	nn	6	SENT_185	[p11l1630t1943r2134b2043, p11l11t2088r181b2170],
5	Appendix	NNP	O	Appendix	nn	6	SENT_185	[p11l207t2071r674b2170],
6	)	NN	O	)	prep_in	1	SENT_185	[p11l207t2071r674b2170],
7	.	.	O	.	_	0	SENT_185	[p11l207t2071r674b2170],

1	Of	IN	O	of	_	0	SENT_186	[p11l139t2197r261b2277],
2	the	DT	O	the	det	4	SENT_186	[p11l292t2198r425b2276],
3	82	CD	NUMBER	82	num	4	SENT_186	[p11l476t2204r573b2277],
4	patients	NNS	O	patient	prep_of	11	SENT_186	[p11l622t2199r989b2298],
5	,	,	O	,	_	0	SENT_186	[p11l622t2199r989b2298],
6	6	CD	NUMBER	6	num	7	SENT_186	[p11l1044t2204r1091b2277],
7	(	NN	O	(	nsubj	11	SENT_186	[p11l1147t2204r1334b2289],
8	7	CD	PERCENT	7	number	9	SENT_186	[p11l1147t2204r1334b2289],
9	%	NN	PERCENT	%	amod	7	SENT_186	[p11l1147t2204r1334b2289],
10	)	CD	NUMBER	)	dep	7	SENT_186	[p11l1147t2204r1334b2289],
11	had	VBD	O	have	_	0	SENT_186	[p11l1389t2198r1546b2277],
12	disease	NN	O	disease	nn	13	SENT_186	[p11l1596t2198r1907b2277],
13	progression	NN	O	progression	dobj	11	SENT_186	[p11l1955t2224r2134b2298, p11l10t2328r365b2428],
14	at	IN	O	at	_	0	SENT_186	[p11l398t2344r476b2405],
15	the	DT	O	the	det	16	SENT_186	[p11l505t2327r635b2405],
16	time	NN	O	time	prep_at	13	SENT_186	[p11l670t2328r859b2406],
17	of	IN	O	of	_	0	SENT_186	[p11l894t2326r993b2406],
18	their	PRP$	O	they	poss	21	SENT_186	[p11l1008t2327r1208b2405],
19	first	JJ	ORDINAL	first	amod	21	SENT_186	[p11l1238t2326r1418b2405],
20	restaging	NN	O	restaging	nn	21	SENT_186	[p11l1447t2328r1844b2428],
21	scans	NNS	O	scan	prep_of	16	SENT_186	[p11l1876t2353r2130b2406],
22	.	.	O	.	_	0	SENT_186	[p11l1876t2353r2130b2406],

1	Two	CD	NUMBER	two	num	2	SENT_187	[p11l7t2461r183b2534],
2	patients	NNS	O	patient	nsubj	9	SENT_187	[p11l225t2456r567b2554],
3	(	CD	NUMBER	(	num	4	SENT_187	[p11l616t2456r985b2545],
4	Patients	NNS	O	patient	dep	2	SENT_187	[p11l616t2456r985b2545],
5	1	CD	NUMBER	1	dep	2	SENT_187	[p11l1033t2461r1077b2532],
6	and	CC	O	and	_	0	SENT_187	[p11l1119t2455r1277b2533],
7	2	CD	NUMBER	2	num	8	SENT_187	[p11l1319t2461r1393b2545],
8	)	NN	O	)	dep	2	SENT_187	[p11l1319t2461r1393b2545],
9	had	VBD	O	have	_	0	SENT_187	[p11l1441t2455r1597b2533],
10	an	DT	O	a	det	11	SENT_187	[p11l1639t2481r1741b2532],
11	increase	NN	O	increase	dobj	9	SENT_187	[p11l1783t2456r2135b2533],
12	of	IN	O	of	_	0	SENT_187	[p11l11t2582r111b2662],
13	more	JJR	O	more	mwe	14	SENT_187	[p11l140t2609r360b2662],
14	than	IN	O	than	quantmod	15	SENT_187	[p11l409t2583r605b2661],
15	20	CD	PERCENT	20	num	16	SENT_187	[p11l653t2588r841b2662],
16	%	NN	PERCENT	%	prep_of	11	SENT_187	[p11l653t2588r841b2662],
17	in	IN	O	in	_	0	SENT_187	[p11l887t2584r970b2661],
18	disease	NN	O	disease	nn	19	SENT_187	[p11l1019t2583r1329b2662],
19	burden	NN	O	burden	prep_in	16	SENT_187	[p11l1379t2583r1681b2662],
20	after	IN	O	after	_	0	SENT_187	[p11l1729t2582r1931b2661],
21	two	CD	NUMBER	two	num	22	SENT_187	[p11l1976t2600r2134b2662],
22	cycles	NNS	O	cycle	prep_after	9	SENT_187	[p11l11t2711r257b2811],
23	of	IN	O	of	_	0	SENT_187	[p11l310t2710r410b2790],
24	therapy	NN	O	therapy	nn	26	SENT_187	[p11l443t2711r765b2811],
25	(	CD	NUMBER	(	num	26	SENT_187	[p11l816t2712r998b2812],
26	Fig	NN	O	fig	prep_of	22	SENT_187	[p11l816t2712r998b2812],
27	.	.	O	.	_	0	SENT_187	[p11l816t2712r998b2812],

1	2A	NN	O	2a	_	0	SENT_188	[p11l1057t2717r1226b2802],
2	)	NN	O	)	dep	1	SENT_188	[p11l1057t2717r1226b2802],
3	.	.	O	.	_	0	SENT_188	[p11l1057t2717r1226b2802],

1	Three	CD	NUMBER	three	num	2	SENT_189	[p11l1278t2711r1526b2790],
2	patients	NNS	O	patient	nsubj	20	SENT_189	[p11l1576t2712r1918b2811],
3	(	CD	NUMBER	(	num	4	SENT_189	[p11l1976t2718r2134b2802, p11l11t2840r247b2917],
4	Patients	NNS	O	patient	dep	2	SENT_189	[p11l1976t2718r2134b2802, p11l11t2840r247b2917],
5	4	CD	NUMBER	4	dep	2	SENT_189	[p11l291t2845r363b2935],
6	,	,	O	,	_	0	SENT_189	[p11l291t2845r363b2935],
7	8	CD	NUMBER	8	num	5	SENT_189	[p11l413t2845r483b2935],
8	,	,	O	,	_	0	SENT_189	[p11l413t2845r483b2935],
9	and	CC	NUMBER	and	_	0	SENT_189	[p11l532t2839r690b2918],
10	20	CD	NUMBER	20	dep	2	SENT_189	[p11l733t2845r860b2930],
11	)	NN	O	)	dep	5	SENT_189	[p11l733t2845r860b2930],
12	had	VBD	O	have	_	0	SENT_189	[p11l909t2839r1066b2918],
13	stable	JJ	O	stable	amod	14	SENT_189	[p11l1110t2839r1358b2918],
14	disease	NN	O	disease	dobj	12	SENT_189	[p11l1403t2839r1714b2918],
15	in	IN	O	in	_	0	SENT_189	[p11l1757t2840r1841b2917],
16	target	NN	O	target	nn	17	SENT_189	[p11l1884t2856r2141b2940],
17	lesions	NNS	O	lesion	prep_in	14	SENT_189	[p11l9t2966r303b3045],
18	but	CC	O	but	_	0	SENT_189	[p11l338t2966r479b3045],
19	concurrently	RB	O	concurrently	advmod	12	SENT_189	[p11l506t2966r1054b3066],
20	had	VBD	O	have	conj_but	12	SENT_189	[p11l1081t2966r1237b3045],
21	development	NN	O	development	dobj	20	SENT_189	[p11l1270t2966r1820b3066],
22	of	IN	O	of	_	0	SENT_189	[p11l1848t2965r1948b3045],
23	new	JJ	O	new	amod	24	SENT_189	[p11l1962t2992r2140b3046],
24	lesions	NNS	O	lesion	prep_of	21	SENT_189	[p11l9t3095r328b3191],
25	,	,	O	,	_	0	SENT_189	[p11l9t3095r328b3191],
26	so	RB	O	so	advmod	12	SENT_189	[p11l395t3121r485b3174],
27	these	DT	O	these	det	28	SENT_189	[p11l547t3095r770b3173],
28	patients	NNS	O	patient	nsubjpass	30	SENT_189	[p11l829t3096r1170b3195],
29	were	VBD	O	be	auxpass	30	SENT_189	[p11l1228t3121r1430b3174],
30	categorized	VBN	O	categorize	ccomp	12	SENT_189	[p11l1490t3095r1989b3196],
31	as	IN	O	as	_	0	SENT_189	[p11l2048t3121r2134b3173],
32	having	VBG	O	have	prepc_as	30	SENT_189	[p11l10t3223r302b3324],
33	progressive	JJ	O	progressive	amod	34	SENT_189	[p11l339t3224r829b3324],
34	disease	NN	O	disease	dobj	32	SENT_189	[p11l872t3223r1206b3302],
35	.	.	O	.	_	0	SENT_189	[p11l872t3223r1206b3302],

1	One	CD	NUMBER	one	num	2	SENT_190	[p11l1254t3229r1426b3302],
2	patient	NN	O	patient	nsubj	25	SENT_190	[p11l1467t3224r1769b3323],
3	(	CD	NUMBER	(	num	4	SENT_190	[p11l1811t3224r2140b3314],
4	Patient	NN	O	patient	dep	2	SENT_190	[p11l1811t3224r2140b3314],
5	16	CD	NUMBER	16	num	6	SENT_190	[p11l14t3357r136b3442],
6	)	NN	O	)	dep	2	SENT_190	[p11l14t3357r136b3442],
7	had	VBD	O	have	_	0	SENT_190	[p11l176t3351r333b3430],
8	tumor	NN	O	tumor	nn	9	SENT_190	[p11l369t3368r638b3430],
9	regression	NN	O	regression	dobj	7	SENT_190	[p11l670t3352r1117b3452],
10	of	IN	O	of	_	0	SENT_190	[p11l1153t3350r1254b3430],
11	25	CD	PERCENT	25	num	12	SENT_190	[p11l1271t3356r1457b3430],
12	%	NN	PERCENT	%	prep_of	9	SENT_190	[p11l1271t3356r1457b3430],
13	on	IN	O	on	_	0	SENT_190	[p11l1493t3377r1598b3430],
14	the	DT	O	the	det	15	SENT_190	[p11l1635t3351r1767b3429],
15	basis	NN	O	basis	prep_on	12	SENT_190	[p11l1804t3351r2015b3430],
16	of	IN	O	of	_	0	SENT_190	[p11l2053t3350r2153b3430],
17	early	JJ	O	early	amod	19	SENT_190	[p11l11t3479r212b3579],
18	CT	NN	O	ct	nn	19	SENT_190	[p11l244t3485r367b3558],
19	scanning	NN	O	scanning	prep_of	15	SENT_190	[p11l401t3480r792b3580],
20	during	IN	O	during	_	0	SENT_190	[p11l825t3479r1109b3580],
21	cycle	NN	O	cycle	prep_during	7	SENT_190	[p11l1143t3479r1342b3579],
22	1	CD	NUMBER	1	num	21	SENT_190	[p11l1382t3485r1426b3557],
23	but	CC	O	but	_	0	SENT_190	[p11l1464t3479r1602b3558],
24	subsequently	RB	O	subsequently	advmod	7	SENT_190	[p11l1635t3479r2134b3579, p11l9t3606r80b3706],
25	had	VBD	O	have	conj_but	7	SENT_190	[p11l108t3606r265b3685],
26	an	DT	O	a	det	27	SENT_190	[p11l298t3632r400b3684],
27	increase	NN	O	increase	dobj	25	SENT_190	[p11l433t3607r785b3684],
28	in	IN	O	in	_	0	SENT_190	[p11l818t3607r901b3684],
29	tumor	NN	O	tumor	nn	30	SENT_190	[p11l935t3623r1203b3686],
30	burden	NN	O	burden	prep_in	27	SENT_190	[p11l1234t3606r1537b3686],
31	of	IN	O	of	_	0	SENT_190	[p11l1570t3605r1670b3685],
32	more	JJR	O	more	prep_of	30	SENT_190	[p11l1685t3632r1905b3685],
33	than	IN	O	than	prep	25	SENT_190	[p11l1938t3606r2135b3684],

1	20	CD	PERCENT	20	num	2	SENT_191	[p12l10t27r197b101],
2	%	NN	PERCENT	%	_	0	SENT_191	[p12l10t27r197b101],
3	at	IN	O	at	_	0	SENT_191	[p12l237t39r316b100],
4	the	DT	O	the	det	5	SENT_191	[p12l351t22r484b100],
5	time	NN	O	time	prep_at	2	SENT_191	[p12l525t23r718b100],
6	of	IN	O	of	_	0	SENT_191	[p12l759t21r859b101],
7	protocol	NN	O	protocol	prep_of	2	SENT_191	[p12l879t21r1665b122],
8	—	CD	NUMBER	—	num	10	SENT_191	[p12l879t21r1665b122],
9	specif1ed	JJ	O	specif1ed	amod	10	SENT_191	[p12l879t21r1665b122],
10	restaging	NN	O	restaging	dep	7	SENT_191	[p12l1705t23r2130b123],
11	.	.	O	.	_	0	SENT_191	[p12l1705t23r2130b123],

1	Two	CD	NUMBER	two	num	2	SENT_192	[p12l7t156r183b229],
2	patients	NNS	O	patient	nsubjpass	30	SENT_192	[p12l237t151r580b249],
3	had	VBD	O	have	_	0	SENT_192	[p12l636t150r793b228],
4	abrupt	JJ	O	abrupt	amod	6	SENT_192	[p12l846t150r1131b249],
5	clinical	JJ	O	clinical	amod	6	SENT_192	[p12l1181t150r1494b227],
6	deterioration	NN	O	deterioration	dobj	3	SENT_192	[p12l1550t150r2130b245],
7	,	,	O	,	_	0	SENT_192	[p12l1550t150r2130b245],
8	which	WDT	O	which	nsubjpass	11	SENT_192	[p12l6t278r268b357],
9	was	VBD	O	be	auxpass	11	SENT_192	[p12l316t304r478b357],
10	probably	RB	O	probably	advmod	11	SENT_192	[p12l530t278r908b377],
11	caused	VBN	O	cause	rcmod	6	SENT_192	[p12l955t278r1245b357],
12	by	IN	O	by	_	0	SENT_192	[p12l1297t278r1395b377],
13	acute	JJ	O	acute	amod	14	SENT_192	[p12l1441t295r1663b357],
14	complications	NNS	O	complication	agent	11	SENT_192	[p12l1715t278r2134b377, p12l11t406r222b484],
15	of	IN	O	of	_	0	SENT_192	[p12l275t404r374b484],
16	disease	NN	O	disease	nn	18	SENT_192	[p12l407t405r718b484],
17	(	NN	O	(	nn	18	SENT_192	[p12l772t405r1289b496],
18	thrombosis	NN	O	thrombosis	prep_of	14	SENT_192	[p12l772t405r1289b496],
19	and	CC	O	and	_	0	SENT_192	[p12l1341t405r1499b484],
20	acute	JJ	O	acute	amod	23	SENT_192	[p12l1548t422r1771b485],
21	pulmonary	JJ	O	pulmonary	amod	23	SENT_192	[p12l1819t405r2134b505, p12l10t560r204b634],
22	hemorrhage	NN	O	hemorrhage	nn	23	SENT_192	[p12l237t534r810b635],
23	)	NN	O	)	conj_and	18	SENT_192	[p12l237t534r810b635],
24	,	,	O	,	_	0	SENT_192	[p12l237t534r810b635],
25	and	CC	O	and	_	0	SENT_192	[p12l852t534r1010b613],
26	could	MD	O	could	aux	30	SENT_192	[p12l1047t534r1281b613],
27	not	RB	O	not	neg	30	SENT_192	[p12l1318t551r1462b613],
28	be	VB	O	be	auxpass	30	SENT_192	[p12l1494t534r1590b613],
29	radiographically	RB	O	radiographically	advmod	30	SENT_192	[p12l1627t534r2134b635, p12l10t661r236b761],
30	evaluated	VBN	O	evaluate	conj_and	3	SENT_192	[p12l272t661r675b740],
31	for	IN	O	for	_	0	SENT_192	[p12l714t660r838b740],
32	response	NN	O	response	prep_for	30	SENT_192	[p12l874t687r1279b761],
33	.	.	O	.	_	0	SENT_192	[p12l874t687r1279b761],

1	MOLECULAR	JJ	O	molecular	amod	2	SENT_193	[p12l17t936r497b987],
2	ANALYSIS	NN	O	analysis	_	0	SENT_193	[p12l529t936r904b987],
3	or	CC	O	or	_	0	SENT_193	[p12l939t936r1041b987],
4	EML4	NN	O	eml4	conj_or	2	SENT_193	[p12l1076t936r1493b989],
5	.	.	O	.	_	0	SENT_193	[p12l1076t936r1493b989],

1	—	NN	O	—	_	0	SENT_194	[p12l1076t936r1493b989],
2	.	.	O	.	_	0	SENT_194	[p12l1076t936r1493b989],

1	ALK	NNP	O	ALK	nn	4	SENT_195	[p12l1076t936r1493b989],
2	BREAKPOINTS	NNP	O	BREAKPOINTS	nn	4	SENT_195	[p12l1528t936r2077b987],
3	The	NNP	O	The	nn	4	SENT_195	[p12l6t1035r168b1113],
4	breal	NN	O	breal	dep	5	SENT_195	[p12l203t1035r699b1135],
5	<	JJR	O	<	_	0	SENT_195	[p12l203t1035r699b1135],
6	.	.	O	.	_	0	SENT_195	[p12l203t1035r699b1135],

1	—	NN	O	—	_	0	SENT_196	[p12l203t1035r699b1135],
2	.	.	O	.	_	0	SENT_196	[p12l203t1035r699b1135],

1	apart	RB	O	apart	advmod	4	SENT_197	[p12l203t1035r699b1135],
2	FISH	NN	O	fish	nn	3	SENT_197	[p12l728t1041r938b1114],
3	assay	NN	O	assay	nsubj	13	SENT_197	[p12l973t1061r1201b1135],
4	detects	VBZ	O	detect	_	0	SENT_197	[p12l1233t1035r1531b1114],
5	disruption	NN	O	disruption	dobj	4	SENT_197	[p12l1569t1035r2018b1135],
6	of	IN	O	of	_	0	SENT_197	[p12l2053t1034r2153b1114],
7	the	DT	O	the	det	9	SENT_197	[p12l11t1164r143b1242],
8	ALK	NN	O	alk	nn	9	SENT_197	[p12l174t1170r349b1242],
9	locus	NN	O	locus	prep_of	5	SENT_197	[p12l377t1164r599b1243],
10	but	CC	O	but	_	0	SENT_197	[p12l640t1164r780b1243],
11	does	VBZ	O	do	aux	13	SENT_197	[p12l813t1164r1006b1243],
12	not	RB	O	not	neg	13	SENT_197	[p12l1046t1181r1189b1243],
13	confirm	VB	O	confirm	conj_but	4	SENT_197	[p12l1222t1163r1574b1243],
14	EML4	NN	O	eml4	dobj	13	SENT_197	[p12l1610t1171r1842b1243],
15	as	IN	O	as	_	0	SENT_197	[p12l1877t1190r1962b1242],
16	the	DT	O	the	det	19	SENT_197	[p12l2003t1164r2135b1242],
17	partner	NN	O	partner	nn	19	SENT_197	[p12l9t1309r331b1392],
18	fusion	NN	O	fusion	nn	19	SENT_197	[p12l359t1291r629b1371],
19	gene	NN	O	gene	prep_as	13	SENT_197	[p12l659t1318r882b1393],
20	.	.	O	.	_	0	SENT_197	[p12l659t1318r882b1393],

1	Therefore	RB	O	therefore	advmod	5	SENT_198	[p12l914t1291r1355b1388],
2	,	,	O	,	_	0	SENT_198	[p12l914t1291r1355b1388],
3	RT-PCR	NN	O	rt-pcr	nsubjpass	5	SENT_198	[p12l1389t1298r1727b1375],
4	Was	VBD	O	be	auxpass	5	SENT_198	[p12l1742t1318r1905b1371],
5	used	VBN	O	use	_	0	SENT_198	[p12l1938t1292r2135b1371],
6	to	TO	O	to	aux	7	SENT_198	[p12l11t1437r92b1498],
7	analyze	VB	O	analyze	xcomp	5	SENT_198	[p12l134t1420r457b1519],
8	exon	NN	O	exon	nn	9	SENT_198	[p12l499t1446r699b1498],
9	breakpoints	NNS	O	breakpoint	dobj	7	SENT_198	[p12l741t1420r1256b1519],
10	in	IN	O	in	_	0	SENT_198	[p12l1299t1421r1382b1497],
11	31	CD	NUMBER	31	num	12	SENT_198	[p12l1424t1426r1519b1499],
12	patients	NNS	O	patient	prep_in	7	SENT_198	[p12l1560t1421r1901b1519],
13	with	IN	O	with	_	0	SENT_198	[p12l1940t1420r2135b1499],
14	FISH	NN	O	fish	npadvmod	16	SENT_198	[p12l8t1549r584b1648],
15	—	CD	NUMBER	—	num	14	SENT_198	[p12l8t1549r584b1648],
16	positive	JJ	O	positive	amod	18	SENT_198	[p12l8t1549r584b1648],
17	ALK	NN	O	alk	nn	18	SENT_198	[p12l620t1554r794b1626],
18	rearrangements	NNS	O	rearrangement	prep_with	12	SENT_198	[p12l829t1565r1511b1649],
19	who	WP	O	who	nsubj	20	SENT_198	[p12l1551t1548r1734b1627],
20	had	VBD	O	have	rcmod	12	SENT_198	[p12l1778t1548r1935b1627],
21	suf	NN	O	suf	nn	23	SENT_198	[p12l1978t1547r2134b1627],
22	ficient	JJ	O	ficient	amod	23	SENT_198	[p12l10t1675r286b1754],
23	amounts	NNS	O	amount	dobj	20	SENT_198	[p12l317t1693r693b1755],
24	of	IN	O	of	_	0	SENT_198	[p12l733t1675r833b1755],
25	FFPE	NN	O	ffpe	nn	27	SENT_198	[p12l849t1683r1058b1754],
26	tumor	NN	O	tumor	nn	27	SENT_198	[p12l1097t1693r1365b1755],
27	material	NN	O	material	prep_of	23	SENT_198	[p12l1400t1676r1758b1754],
28	(	CD	NUMBER	(	num	29	SENT_198	[p12l1799t1677r1982b1777],
29	Fig	NN	O	fig	dep	27	SENT_198	[p12l1799t1677r1982b1777],
30	.	.	O	.	_	0	SENT_198	[p12l1799t1677r1982b1777],

1	1C	NN	O	1c	_	0	SENT_199	[p12l2030t1682r2134b1755],
2	and	CC	O	and	_	0	SENT_199	[p12l10t1804r170b1883],
3	3	CD	NUMBER	3	num	4	SENT_199	[p12l213t1810r311b1895],
4	)	NN	O	)	conj_and	1	SENT_199	[p12l213t1810r311b1895],
5	.	.	O	.	_	0	SENT_199	[p12l213t1810r311b1895],

1	The	DT	O	the	det	5	SENT_200	[p12l354t1804r515b1882],
2	most	RBS	O	most	advmod	3	SENT_200	[p12l556t1821r772b1883],
3	frequently	RB	O	frequently	advmod	4	SENT_200	[p12l808t1803r1248b1904],
4	identified	VBN	O	identify	amod	5	SENT_200	[p12l1283t1803r1701b1883],
5	genotype	NN	O	genotype	nsubj	7	SENT_200	[p12l1741t1821r2135b1905],
6	was	VBD	O	be	cop	7	SENT_200	[p12l6t1958r169b2012],
7	exon	NN	O	exon	_	0	SENT_200	[p12l205t1958r405b2011],
8	13	CD	NUMBER	13	num	7	SENT_200	[p12l443t1938r537b2011],
9	of	IN	O	of	_	0	SENT_200	[p12l576t1931r676b2011],
10	EML4	NN	O	eml4	prep_of	7	SENT_200	[p12l689t1939r922b2012],
11	fused	VBN	O	fuse	partmod	10	SENT_200	[p12l954t1931r1188b2012],
12	to	TO	O	to	_	0	SENT_200	[p12l1223t1949r1304b2011],
13	exon	NN	O	exon	prep_to	11	SENT_200	[p12l1340t1958r1541b2011],
14	20	CD	NUMBER	20	num	13	SENT_200	[p12l1575t1938r1674b2011],
15	of	IN	O	of	_	0	SENT_200	[p12l1710t1931r1810b2011],
16	ALK	NNP	O	ALK	prep_of	13	SENT_200	[p12l1819t1938r1994b2010],
17	(	CD	NUMBER	(	num	16	SENT_200	[p12l2024t1933r2135b2023],
18	in	IN	O	in	_	0	SENT_200	[p12l2024t1933r2135b2023],
19	13	CD	NUMBER	13	prep_in	11	SENT_200	[p12l14t2066r108b2139],
20	of	IN	O	of	_	0	SENT_200	[p12l148t2059r248b2139],
21	29	CD	NUMBER	29	num	22	SENT_200	[p12l265t2066r365b2139],
22	patients	NNS	O	patient	prep_of	19	SENT_200	[p12l400t2061r793b2160],
23	)	CD	NUMBER	)	dep	22	SENT_200	[p12l400t2061r793b2160],
24	.	.	O	.	_	0	SENT_200	[p12l400t2061r793b2160],

1	EML4	NN	O	eml4	nn	2	SENT_201	[p12l833t2067r1064b2139],
2	exon	NN	O	exon	nsubj	16	SENT_201	[p12l1100t2086r1300b2139],
3	6	CD	NUMBER	6	dep	2	SENT_201	[p12l1336t2066r1407b2156],
4	,	,	O	,	_	0	SENT_201	[p12l1336t2066r1407b2156],
5	alternative	JJ	O	alternative	amod	7	SENT_201	[p12l1447t2060r1899b2139],
6	exon	NN	O	exon	nn	7	SENT_201	[p12l1936t2086r2136b2139],
7	6b	NN	O	6b	nsubj	16	SENT_201	[p12l10t2189r134b2284],
8	,	,	O	,	_	0	SENT_201	[p12l10t2189r134b2284],
9	exon	NN	O	exon	appos	7	SENT_201	[p12l180t2215r381b2267],
10	18	CD	NUMBER	18	num	9	SENT_201	[p12l424t2195r543b2284],
11	,	,	O	,	_	0	SENT_201	[p12l424t2195r543b2284],
12	and	CC	O	and	_	0	SENT_201	[p12l588t2189r746b2267],
13	exon	NN	O	exon	conj_and	2	SENT_201	[p12l786t2215r987b2267],
14	20	CD	NUMBER	20	num	15	SENT_201	[p12l1027t2195r1126b2267],
15	breakpoints	NNS	O	breakpoint	dep	13	SENT_201	[p12l1168t2189r1683b2288],
16	were	VBD	O	be	_	0	SENT_201	[p12l1721t2215r1923b2268],
17	also	RB	O	also	advmod	16	SENT_201	[p12l1963t2189r2134b2267],

1	Table	NNP	O	Table	_	0	SENT_202	[p13l77t173r269b237],
2	1	CD	NUMBER	1	dep	1	SENT_202	[p13l296t179r350b237],
3	.	.	O	.	_	0	SENT_202	[p13l296t179r350b237],

1	Demographic	JJ	MISC	demographic	amod	4	SENT_203	[p13l381t173r859b257],
2	and	CC	O	and	_	0	SENT_203	[p13l882t172r1008b238],
3	Clinicopathological	JJ	O	clinicopathological	conj_and	1	SENT_203	[p13l1035t172r1710b257],
4	Characteristics	NNS	O	characteristic	_	0	SENT_203	[p13l78t280r604b345],
5	of	IN	O	of	_	0	SENT_203	[p13l628t280r709b345],
6	the	DT	O	the	det	8	SENT_203	[p13l715t280r829b345],
7	82	CD	NUMBER	82	num	8	SENT_203	[p13l852t285r934b346],
8	Patients	NNS	O	patient	prep_of	4	SENT_203	[p13l964t282r1265b345],
9	.	.	O	.	_	0	SENT_203	[p13l964t282r1265b345],

1	Characteristic	JJ	O	characteristic	amod	3	SENT_204	[p13l78t473r567b538],
2	Male	JJ	O	male	amod	3	SENT_204	[p13l86t622r252b687],
3	sex	NN	O	sex	dep	9	SENT_204	[p13l279t645r388b687],
4	—	JJ	O	—	amod	5	SENT_204	[p13l408t662r495b668],
5	no.	NN	O	no.	dep	3	SENT_204	[p13l522t645r624b687],
6	(	CD	PERCENT	(	num	7	SENT_204	[p13l661t626r775b708],
7	%	NN	PERCENT	%	dep	9	SENT_204	[p13l661t626r775b708],
8	)	CD	NUMBER	)	num	9	SENT_204	[p13l661t626r775b708],
9	Age	NNP	O	Age	dep	13	SENT_204	[p13l77t776r209b857],
10	—	CD	NUMBER	—	num	9	SENT_204	[p13l232t812r319b818],
11	yr	NN	DURATION	yr	nn	12	SENT_204	[p13l339t794r402b857],
12	Mean	NN	O	mean	dep	9	SENT_204	[p13l215t927r404b986],
13	Range	NNP	O	Range	_	0	SENT_204	[p13l215t1076r426b1156],

1	Race	NN	O	race	nn	3	SENT_205	[p13l86t1225r244b1284],
2	—	CD	NUMBER	—	num	3	SENT_205	[p13l266t1259r353b1265],
3	no.	NN	O	no.	_	0	SENT_205	[p13l380t1242r482b1284],
4	(	CD	PERCENT	(	num	5	SENT_205	[p13l519t1223r686b1305],
5	%	NN	PERCENT	%	dep	3	SENT_205	[p13l519t1223r686b1305],
6	)	CD	NUMBER	)	dep	5	SENT_205	[p13l519t1223r686b1305],
7	"	``	O	"	punct	8	SENT_205	[p13l519t1223r686b1305],
8	‘	NN	O	‘	dep	3	SENT_205	[p13l519t1223r686b1305],

1	White	JJ	MISC	white	_	0	SENT_206	[p13l206t1369r413b1433],
2	Asian	JJ	MISC	asian	dep	1	SENT_206	[p13l206t1522r399b1583],
3	Other	JJ	MISC	other	dep	1	SENT_206	[p13l210t1667r415b1732],

1	ECOG	NN	ORGANIZATION	ecog	_	0	SENT_207	[p13l86t1821r295b1881],
2	performance	NN	O	performance	nn	3	SENT_207	[p13l329t1816r775b1901],
3	status	NN	O	status	dep	1	SENT_207	[p13l803t1829r1012b1881],
4	—	CD	NUMBER	—	rcmod	3	SENT_207	[p13l1036t1856r1124b1863],
5	no.	NN	O	no.	prep	4	SENT_207	[p13l1150t1839r1252b1881],
6	(	CD	PERCENT	(	num	7	SENT_207	[p13l1289t1820r1459b1902],
7	%	NN	PERCENT	%	dep	5	SENT_207	[p13l1289t1820r1459b1902],
8	)	NN	O	)	dep	4	SENT_207	[p13l1289t1820r1459b1902],
9	'	''	O	'	_	0	SENT_207	[p13l1289t1820r1459b1902],
10	i	FW	O	i	dep	8	SENT_207	[p13l1289t1820r1459b1902],
11	'	''	O	'	_	0	SENT_207	[p13l1289t1820r1459b1902],

1	No.	NN	O	no.	dep	8	SENT_208	[p13l86t2569r204b2628],
2	of	IN	O	of	_	0	SENT_208	[p13l233t2562r310b2628],
3	previous	JJ	O	previous	amod	4	SENT_208	[p13l327t2569r623b2648],
4	therapies	NNS	O	therapy	prep_of	1	SENT_208	[p13l649t2563r974b2648],
5	—	JJ	O	—	amod	6	SENT_208	[p13l999t2603r1086b2609],
6	no.	NN	O	no.	dep	8	SENT_208	[p13l1113t2586r1214b2628],
7	(	CD	PERCENT	(	num	8	SENT_208	[p13l1251t2566r1366b2648],
8	%	NN	PERCENT	%	_	0	SENT_208	[p13l1251t2566r1366b2648],
9	)	CD	NUMBER	)	dep	8	SENT_208	[p13l1251t2566r1366b2648],

1	O	NN	O	o	_	0	SENT_209	[p13l209t2716r248b2777],
2	1	CD	NUMBER	1	num	1	SENT_209	[p13l214t2868r243b2925],

1	23	CD	NUMBER	23	_	0	SENT_210	[p13l209t3166r289b3224],
2	Not	RB	O	not	neg	3	SENT_210	[p13l215t3316r343b3374],
3	reported	VBN	O	report	dep	1	SENT_210	[p13l371t3309r663b3394],

1	Histologic	JJ	O	histologic	amod	2	SENT_211	[p13l86t3458r445b3544],
2	analysis	NN	O	analysis	_	0	SENT_211	[p13l470t3459r744b3544],
3	—	CD	NUMBER	—	num	4	SENT_211	[p13l769t3499r856b3505],
4	no.	NN	O	no.	dep	2	SENT_211	[p13l882t3482r985b3523],
5	(	CD	PERCENT	(	num	6	SENT_211	[p13l1021t3462r1136b3544],
6	%	NN	PERCENT	%	dep	4	SENT_211	[p13l1021t3462r1136b3544],
7	)	CD	NUMBER	)	dep	2	SENT_211	[p13l1021t3462r1136b3544],

1	Adenocarcinoma	NN	O	adenocarcinoma	_	0	SENT_212	[p13l206t3608r809b3673],
2	Squamous-cell	JJ	O	squamous-cell	amod	3	SENT_212	[p13l210t3757r726b3834],
3	carcinoma	NN	O	carcinoma	dep	1	SENT_212	[p13l757t3764r1125b3822],

1	Value	NNP	O	Value	_	0	SENT_213	[p13l1767t473r1964b538],
2	43	CD	NUMBER	43	number	3	SENT_213	[p13l1740t628r1817b687],
3	(	CD	NUMBER	(	dep	1	SENT_213	[p13l1855t628r1984b708],
4	52	CD	NUMBER	52	num	5	SENT_213	[p13l1855t628r1984b708],
5	)	NN	O	)	dep	3	SENT_213	[p13l1855t628r1984b708],

1	Other	JJ	O	other	_	0	SENT_214	[p14l210t78r415b144],
2	2	CD	NUMBER	2	num	3	SENT_214	[p14l1787t85r1822b142],
3	(	NN	O	(	dep	1	SENT_214	[p14l1858t84r1942b164],
4	2	CD	NUMBER	2	num	5	SENT_214	[p14l1858t84r1942b164],
5	)	NN	O	)	dep	1	SENT_214	[p14l1858t84r1942b164],

1	Smoking	NN	O	smoking	dep	6	SENT_215	[p14l81t228r392b313],
2	history	NN	O	history	dep	1	SENT_215	[p14l420t228r762b313],
3	—	CD	NUMBER	—	num	4	SENT_215	[p14l420t228r762b313],
4	no.	NN	O	no.	dep	6	SENT_215	[p14l789t251r892b292],
5	(	CD	PERCENT	(	num	6	SENT_215	[p14l928t231r1098b313],
6	%	NN	PERCENT	%	dep	9	SENT_215	[p14l928t231r1098b313],
7	)	CD	NUMBER	)	dep	6	SENT_215	[p14l928t231r1098b313],
8	:	:	O	:	_	0	SENT_215	[p14l928t231r1098b313],
9	i2	NN	O	i2	_	0	SENT_215	[p14l928t231r1098b313],

1	Never	RB	O	never	neg	5	SENT_216	[p14l215t383r420b442],
2	62	CD	NUMBER	62	num	3	SENT_216	[p14l1745t383r1822b443],
3	(	CD	NUMBER	(	pobj	1	SENT_216	[p14l1858t383r1985b462],
4	76	CD	NUMBER	76	num	5	SENT_216	[p14l1858t383r1985b462],
5	)	NN	O	)	_	0	SENT_216	[p14l1858t383r1985b462],

1	$	$	MONEY	$	_	0	SENT_217	[p14l209t531r338b592],
2	10	CD	MONEY	10	num	1	SENT_217	[p14l209t531r338b592],
3	pack-yr	NN	O	pack-yr	dep	1	SENT_217	[p14l367t527r613b612],
4	15	CD	NUMBER	15	num	3	SENT_217	[p14l1749t533r1819b592],
5	(	CD	NUMBER	(	number	6	SENT_217	[p14l1858t531r1985b611],
6	18	CD	NUMBER	18	num	7	SENT_217	[p14l1858t531r1985b611],
7	)	NN	O	)	dep	3	SENT_217	[p14l1858t531r1985b611],

1	>	JJR	O	>	_	0	SENT_218	[p14l209t680r338b741],
2	10	CD	NUMBER	10	num	3	SENT_218	[p14l209t680r338b741],
3	pack-yr	NN	O	pack-yr	dep	1	SENT_218	[p14l367t676r613b761],
4	5	CD	NUMBER	5	num	5	SENT_218	[p14l1788t682r1819b741],
5	(	NN	O	(	dep	3	SENT_218	[p14l1858t681r1942b761],
6	6	CD	NUMBER	6	num	7	SENT_218	[p14l1858t681r1942b761],
7	)	NN	O	)	dep	1	SENT_218	[p14l1858t681r1942b761],

1	7	CD	NUMBER	7	dep	6	SENT_219	[p14l10t902r49b939],
2	'	''	O	'	_	0	SENT_219	[p14l10t902r49b939],
3	‘	CD	NUMBER	‘	num	4	SENT_219	[p14l10t902r49b939],
4	Race	NN	O	race	nsubj	6	SENT_219	[p14l82t902r240b961],
5	was	VBD	O	be	cop	6	SENT_219	[p14l267t919r399b961],
6	self-reported	JJ	O	self-reported	_	0	SENT_219	[p14l433t895r897b980],
7	.	.	O	.	_	0	SENT_219	[p14l433t895r897b980],
8	'	''	O	'	_	0	SENT_219	[p14l12t999r53b1078],

1	i	LS	O	i	dep	12	SENT_220	[p14l12t999r53b1078],
2	'	''	O	'	_	0	SENT_220	[p14l12t999r53b1078],
3	The	DT	O	the	det	12	SENT_220	[p14l73t993r203b1057],
4	Eastern	NNP	ORGANIZATION	Eastern	nn	12	SENT_220	[p14l239t999r493b1057],
5	Cooperative	NNP	ORGANIZATION	Cooperative	nn	12	SENT_220	[p14l526t998r949b1077],
6	Oncology	NNP	ORGANIZATION	Oncology	nn	12	SENT_220	[p14l979t993r1317b1078],
7	Group	NNP	ORGANIZATION	Group	nn	12	SENT_220	[p14l1346t998r1568b1077],
8	(	CD	NUMBER	(	num	12	SENT_220	[p14l1606t998r1873b1077],
9	ECOG	NNP	ORGANIZATION	ECOG	nn	12	SENT_220	[p14l1606t998r1873b1077],
10	)	CD	NUMBER	)	num	12	SENT_220	[p14l1606t998r1873b1077],
11	performance	NN	O	performance	nn	12	SENT_220	[p14l1915t1016r2045b1077, p14l74t1087r409b1153],
12	score	NN	NUMBER	score	csubj	13	SENT_220	[p14l441t1111r625b1153],
13	ranges	VBZ	O	range	_	0	SENT_220	[p14l659t1111r887b1174],
14	from	IN	O	from	_	0	SENT_220	[p14l917t1087r1082b1153],
15	o	NN	O	o	prep_from	13	SENT_220	[p14l1115t1092r1153b1153],
16	to	TO	O	to	_	0	SENT_220	[p14l1180t1101r1248b1153],
17	5	CD	NUMBER	5	prep_to	13	SENT_220	[p14l1280t1094r1334b1165],
18	,	,	O	,	_	0	SENT_220	[p14l1280t1094r1334b1165],
19	with	IN	O	with	_	0	SENT_220	[p14l1365t1088r1510b1153],
20	higher	JJR	O	higher	amod	21	SENT_220	[p14l1547t1088r1767b1174],
21	scores	NNS	O	score	prep_with	13	SENT_220	[p14l1795t1111r2017b1153],
22	indicating	VBG	O	indicate	partmod	21	SENT_220	[p14l79t1184r418b1270],
23	a	DT	O	a	det	25	SENT_220	[p14l446t1207r478b1249],
24	greater	JJR	O	greater	amod	25	SENT_220	[p14l508t1197r750b1270],
25	degree	NN	O	degree	dobj	22	SENT_220	[p14l775t1184r1006b1270],
26	of	IN	O	of	_	0	SENT_220	[p14l1034t1183r1110b1249],
27	disability	NN	O	disability	prep_of	25	SENT_220	[p14l1126t1184r1447b1269],
28	.	.	O	.	_	0	SENT_220	[p14l1126t1184r1447b1269],

1	One	CD	NUMBER	one	num	2	SENT_221	[p14l1479t1189r1624b1249],
2	patient	NN	O	patient	nsubj	11	SENT_221	[p14l1656t1190r1893b1269],
3	with	IN	O	with	_	0	SENT_221	[p14l1916t1184r2059b1249],
4	an	DT	O	a	det	8	SENT_221	[p14l77t1304r154b1346],
5	ECOG	NN	O	ecog	nn	8	SENT_221	[p14l193t1286r402b1346],
6	performance	NN	O	performance	nn	8	SENT_221	[p14l441t1280r887b1365],
7	score	NN	NUMBER	score	nn	8	SENT_221	[p14l919t1304r1103b1346],
8	of2	NN	O	of2	prep_with	2	SENT_221	[p14l1133t1280r1263b1346],
9	at	IN	O	at	_	0	SENT_221	[p14l1295t1294r1358b1346],
10	enrollment	NN	O	enrollment	prep_at	8	SENT_221	[p14l1386t1281r1772b1346],
11	had	VBD	O	have	_	0	SENT_221	[p14l1804t1281r1925b1346],
12	a	DT	O	a	det	14	SENT_221	[p14l1960t1304r1992b1346],
13	score	NN	NUMBER	score	nn	14	SENT_221	[p14l77t1399r262b1441],
14	of3	NN	O	of3	dobj	11	SENT_221	[p14l292t1375r419b1441],
15	by	IN	O	by	_	0	SENT_221	[p14l456t1376r529b1462],
16	the	DT	O	the	det	17	SENT_221	[p14l555t1376r665b1441],
17	start	NN	O	start	prep_by	11	SENT_221	[p14l696t1389r852b1441],
18	of	IN	O	of	_	0	SENT_221	[p14l880t1375r958b1441],
19	treatment	NN	O	treatment	prep_of	17	SENT_221	[p14l972t1389r1339b1441],
20	.	.	O	.	_	0	SENT_221	[p14l972t1389r1339b1441],

1	Ii	NN	O	ii	_	0	SENT_222	[p14l12t1479r53b1558],
2	:	:	O	:	_	0	SENT_222	[p14l12t1479r53b1558],
3	Data	NNS	O	datum	dep	1	SENT_222	[p14l82t1479r239b1537],
4	on	IN	O	on	_	0	SENT_222	[p14l270t1496r353b1537],
5	patients	NNS	O	patient	prep_on	3	SENT_222	[p14l390t1478r688b1557],
6	’	CD	NUMBER	’	num	8	SENT_222	[p14l390t1478r688b1557],
7	smoking	NN	O	smoking	nn	8	SENT_222	[p14l723t1473r1025b1558],
8	history	NN	O	history	nsubjpass	10	SENT_222	[p14l1057t1473r1293b1558],
9	are	VBP	O	be	auxpass	10	SENT_222	[p14l1321t1496r1425b1537],
10	based	VBN	O	base	rcmod	3	SENT_222	[p14l1459t1473r1657b1537],
11	on	IN	O	on	_	0	SENT_222	[p14l1691t1496r1774b1537],
12	correspondence	NN	O	correspondence	prep_on	10	SENT_222	[p14l1808t1496r2008b1537, p14l78t1569r461b1653],

1	with	IN	O	with	_	0	SENT_223	[p14l489t1569r633b1634],
2	investigators	NNS	O	investigator	pobj	1	SENT_223	[p14l670t1575r1139b1654],
3	.	.	O	.	_	0	SENT_223	[p14l670t1575r1139b1654],

1	observed	VBN	O	observe	_	0	SENT_224	[p14l12t1834r401b1914],
2	(	RB	O	(	advmod	1	SENT_224	[p14l467t1835r581b1926],
3	in	IN	O	in	_	0	SENT_224	[p14l467t1835r581b1926],
4	7	CD	NUMBER	7	prep_in	1	SENT_224	[p14l643t1842r688b1913],
5	of	IN	O	of	_	0	SENT_224	[p14l751t1834r853b1913],
6	29	CD	NUMBER	29	num	7	SENT_224	[p14l895t1840r995b1913],
7	patients	NNS	O	patient	prep_of	4	SENT_224	[p14l1056t1835r1460b1935],
8	)	CD	NUMBER	)	dep	7	SENT_224	[p14l1056t1835r1460b1935],
9	.	.	O	.	_	0	SENT_224	[p14l1056t1835r1460b1935],

1	An	DT	O	a	det	2	SENT_225	[p14l1523t1842r1648b1912],
2	EML4	NN	O	eml4	_	0	SENT_225	[p14l1707t1840r2150b1913],
3	.	.	O	.	_	0	SENT_225	[p14l1707t1840r2150b1913],

1	—	NN	O	—	_	0	SENT_226	[p14l1707t1840r2150b1913],
2	.	.	O	.	_	0	SENT_226	[p14l1707t1840r2150b1913],

1	ALK	NN	O	alk	nn	3	SENT_227	[p14l1707t1840r2150b1913],
2	fusion	NN	O	fusion	nn	3	SENT_227	[p14l11t1962r287b2042],
3	transcript	NN	O	transcript	nsubjpass	7	SENT_227	[p14l350t1963r784b2063],
4	could	MD	O	could	aux	7	SENT_227	[p14l842t1963r1082b2042],
5	not	RB	O	not	neg	7	SENT_227	[p14l1144t1979r1289b2041],
6	be	VB	O	be	auxpass	7	SENT_227	[p14l1347t1963r1445b2041],
7	confirmed	VBN	O	confirm	_	0	SENT_227	[p14l1508t1962r1972b2041],
8	on	IN	O	on	_	0	SENT_227	[p14l2034t1988r2142b2041],
9	RT	NN	O	rt	prep_on	7	SENT_227	[p14l9t2096r353b2174],
10	.	.	O	.	_	0	SENT_227	[p14l9t2096r353b2174],

1	—	NN	O	—	_	0	SENT_228	[p14l9t2096r353b2174],
2	.	.	O	.	_	0	SENT_228	[p14l9t2096r353b2174],

1	PCR	NN	O	pcr	nsubj	9	SENT_229	[p14l9t2096r353b2174],
2	in	IN	O	in	_	0	SENT_229	[p14l381t2091r466b2168],
3	9	CD	NUMBER	9	num	4	SENT_229	[p14l504t2096r551b2169],
4	patients	NNS	O	patient	prep_in	1	SENT_229	[p14l590t2091r966b2191],
5	,	,	O	,	_	0	SENT_229	[p14l590t2091r966b2191],
6	and	CC	O	and	_	0	SENT_229	[p14l1009t2091r1170b2169],
7	the	DT	O	the	det	8	SENT_229	[p14l1209t2091r1345b2169],
8	analysis	NN	O	analysis	conj_and	4	SENT_229	[p14l1383t2090r1732b2191],
9	failed	VBD	O	fail	_	0	SENT_229	[p14l1772t2090r2019b2169],
10	in	IN	O	in	_	0	SENT_229	[p14l2057t2091r2142b2168],
11	2	CD	NUMBER	2	num	13	SENT_229	[p14l11t2224r58b2296],
12	additional	JJ	O	additional	amod	13	SENT_229	[p14l92t2219r531b2297],
13	patients	NNS	O	patient	prep_in	9	SENT_229	[p14l561t2219r929b2319],
14	.	.	O	.	_	0	SENT_229	[p14l561t2219r929b2319],

1	RT	NN	O	rt	_	0	SENT_230	[p14l965t2224r1303b2302],
2	.	.	O	.	_	0	SENT_230	[p14l965t2224r1303b2302],

1	—	NN	O	—	_	0	SENT_231	[p14l965t2224r1303b2302],
2	.	.	O	.	_	0	SENT_231	[p14l965t2224r1303b2302],

1	PCR	NN	O	pcr	nn	2	SENT_232	[p14l965t2224r1303b2302],
2	assays	NNS	O	assay	nsubj	4	SENT_232	[p14l1324t2245r1590b2319],
3	were	VBD	O	be	cop	4	SENT_232	[p14l1619t2245r1822b2298],
4	unable	JJ	O	unable	_	0	SENT_232	[p14l1854t2219r2142b2298],
5	to	TO	O	to	aux	6	SENT_232	[p14l11t2363r93b2425],
6	detect	VB	O	detect	xcomp	4	SENT_232	[p14l141t2347r401b2425],
7	all	DT	O	all	det	10	SENT_232	[p14l441t2346r546b2425],
8	known	JJ	O	known	amod	10	SENT_232	[p14l591t2347r890b2426],
9	ALK	NN	O	alk	nn	10	SENT_232	[p14l930t2352r1105b2425],
10	rearrangements	NNS	O	rearrangement	dobj	6	SENT_232	[p14l1143t2363r1851b2447],
11	.	.	O	.	_	0	SENT_232	[p14l1143t2363r1851b2447],

1	Thus	RB	O	thus	dep	4	SENT_233	[p14l1899t2347r2136b2442],
2	,	,	O	,	_	0	SENT_233	[p14l1899t2347r2136b2442],
3	the	DT	O	the	det	4	SENT_233	[p14l11t2475r144b2553],
4	presence	NN	O	presence	_	0	SENT_233	[p14l173t2500r549b2575],
5	of	IN	O	of	_	0	SENT_233	[p14l580t2474r680b2553],
6	RT	NN	O	rt	prep_of	4	SENT_233	[p14l689t2475r1424b2575],
7	.	.	O	.	_	0	SENT_233	[p14l689t2475r1424b2575],

1	—	NN	O	—	_	0	SENT_234	[p14l689t2475r1424b2575],
2	.	.	O	.	_	0	SENT_234	[p14l689t2475r1424b2575],

1	PCR	NN	O	pcr	_	0	SENT_235	[p14l689t2475r1424b2575],
2	.	.	O	.	_	0	SENT_235	[p14l689t2475r1424b2575],

1	—	NN	O	—	_	0	SENT_236	[p14l689t2475r1424b2575],
2	.	.	O	.	_	0	SENT_236	[p14l689t2475r1424b2575],

1	negative	JJ	O	negative	amod	2	SENT_237	[p14l689t2475r1424b2575],
2	results	NNS	O	result	nsubj	3	SENT_237	[p14l1454t2475r1738b2554],
3	suggests	VBZ	O	suggest	_	0	SENT_237	[p14l1771t2491r2139b2575],
4	that	IN	O	that	complm	10	SENT_237	[p14l11t2603r184b2681],
5	either	CC	O	either	advmod	10	SENT_237	[p14l219t2603r467b2681],
6	alternative	JJ	O	alternative	amod	8	SENT_237	[p14l504t2603r956b2682],
7	EML4	NN	O	eml4	nn	8	SENT_237	[p14l994t2610r1227b2681],
8	exons	NNS	O	exon	nsubjpass	10	SENT_237	[p14l1266t2628r1509b2681],
9	were	VBD	O	be	auxpass	10	SENT_237	[p14l1547t2629r1749b2682],
10	involved	VBN	O	involve	ccomp	3	SENT_237	[p14l1789t2603r2142b2682],
11	or	CC	O	or	_	0	SENT_237	[p14l12t2756r100b2809],
12	that	IN	O	that	complm	19	SENT_237	[p14l140t2731r313b2809],
13	EML4	NN	O	eml4	nsubj	19	SENT_237	[p14l349t2738r581b2809],
14	was	VBD	O	be	cop	19	SENT_237	[p14l618t2757r781b2810],
15	not	RB	O	not	neg	19	SENT_237	[p14l825t2747r969b2809],
16	the	DT	O	the	det	19	SENT_237	[p14l1007t2731r1139b2809],
17	ALK	NN	O	alk	nn	19	SENT_237	[p14l1175t2736r1350b2809],
18	fusion	NN	O	fusion	nn	19	SENT_237	[p14l1385t2730r1656b2810],
19	partner	NN	O	partner	ccomp	3	SENT_237	[p14l1696t2747r2020b2831],
20	in	IN	O	in	_	0	SENT_237	[p14l2058t2731r2142b2808],
21	these	DT	O	these	det	22	SENT_237	[p14l11t2859r235b2937],
22	patients	NNS	O	patient	prep_in	19	SENT_237	[p14l273t2859r640b2959],
23	.	.	O	.	_	0	SENT_237	[p14l273t2859r640b2959],

1	In	IN	O	in	_	0	SENT_238	[p14l683t2866r773b2936],
2	the	DT	O	the	det	5	SENT_238	[p14l811t2858r945b2937],
3	29	CD	NUMBER	29	num	5	SENT_238	[p14l983t2864r1083b2937],
4	analyzed	VBN	O	analyze	amod	5	SENT_238	[p14l1123t2858r1503b2959],
5	samples	NNS	O	sample	pobj	1	SENT_238	[p14l1544t2858r1915b2959],
6	,	,	O	,	_	0	SENT_238	[p14l1544t2858r1915b2959],
7	data	NNS	O	datum	appos	5	SENT_238	[p14l1959t2859r2143b2937],

1	N	NN	O	n	nn	3	SENT_239	[p14l546t3045r559b3060],
2	ENGLJ	NN	O	englj	nn	3	SENT_239	[p14l574t3045r652b3067],
3	MED	NN	O	med	_	0	SENT_239	[p14l667t3045r719b3060],
4	3	CD	NUMBER	3	dep	3	SENT_239	[p14l759t3039r805b3067],
5	;	:	O	;	_	0	SENT_239	[p14l759t3039r805b3067],
6	18	CD	NUMBER	18	num	8	SENT_239	[p14l759t3039r805b3067],
7	NEJM.ORG	NN	O	nejm.org	nn	8	SENT_239	[p14l841t3045r965b3067],
8	OCTOBER	NN	DATE	october	dep	3	SENT_239	[p14l1000t3045r1112b3061],
9	28	CD	DATE	28	dep	3	SENT_239	[p14l1122t3039r1157b3065],
10	,	,	DATE	,	_	0	SENT_239	[p14l1122t3039r1157b3065],
11	2010	CD	DATE	2010	num	12	SENT_239	[p14l1169t3045r1229b3061],
12	1697	CD	DATE	1697	appos	9	SENT_239	[p14l1940t3034r2016b3058],

1	e	LS	O	e	dep	4	SENT_240	[p14l739t3086r753b3102],
2	New	NNP	O	New	nn	4	SENT_240	[p14l762t3079r824b3102],
3	England	NNP	O	England	nn	4	SENT_240	[p14l833t3078r944b3109],
4	Journal	NNP	O	Journal	_	0	SENT_240	[p14l952t3078r1050b3102],
5	of	IN	O	of	prep	4	SENT_240	[p14l1059t3078r1088b3102],
6	Medicine	NNP	O	Medicine	dep	4	SENT_240	[p14l1095t3078r1220b3102],

1	The	DT	O	the	det	4	SENT_241	[p14l816t3202r862b3223],
2	NEW	NNP	O	NEW	nn	4	SENT_241	[p14l881t3204r965b3223],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_241	[p14l985t3204r1173b3223],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_241	[p14l1192t3204r1372b3230],
5	of	IN	O	of	_	0	SENT_241	[p14l1391t3202r1419b3229],
6	MEDICINE	NNP	O	MEDICINE	prep_of	4	SENT_241	[p14l1432t3204r1630b3223],

1	I	PRP	O	I	dep	7	SENT_242	[p15l531t86r556b112],
2	Disease	NN	O	disease	nn	3	SENT_242	[p15l570t88r662b108],
3	progression	NN	O	progression	dep	1	SENT_242	[p15l672t88r812b115],
4	I	PRP	O	I	dep	7	SENT_242	[p15l850t86r876b112],
5	Stable	JJ	O	stable	amod	7	SENT_242	[p15l889t86r961b108],
6	disease	NN	O	disease	nn	7	SENT_242	[p15l970t86r1058b108],
7	E	NN	O	e	dep	11	SENT_242	[p15l1096t86r1121b112],
8	Partial	JJ	O	partial	amod	10	SENT_242	[p15l1135t86r1207b108],
9	response	NN	O	response	nn	10	SENT_242	[p15l1219t93r1326b114],
10	[	NN	O	[	dep	7	SENT_242	[p15l1363t86r1389b112],
11	I	PRP	O	I	dep	13	SENT_242	[p15l1363t86r1389b112],
12	Complete	JJ	O	complete	amod	13	SENT_242	[p15l1401t86r1516b114],
13	response	NN	O	response	_	0	SENT_242	[p15l1527t93r1634b114],

1	A	DT	O	a	det	2	SENT_243	[p15l112t156r134b181],
2	Percent	NN	O	percent	_	0	SENT_243	[p15l162t160r257b181],
3	Change	NNP	O	Change	dep	2	SENT_243	[p15l266t158r363b188],
4	in	IN	O	in	_	0	SENT_243	[p15l373t158r394b181],
5	Tumor	NN	O	tumor	nn	6	SENT_243	[p15l404t160r491b181],
6	Burden	NN	O	burden	prep_in	3	SENT_243	[p15l500t157r591b181],

1	I	PRP	O	I	nsubj	2	SENT_244	[p15l376t344r388b364],
2	\	VBP	O	\	_	0	SENT_244	[p15l376t344r388b364],
3	)	CD	NUMBER	)	num	4	SENT_244	[p15l376t344r388b364],
4	o	NN	O	o	dobj	2	SENT_244	[p15l390t344r404b364],

1	Percent	NN	O	percent	_	0	SENT_245	[p15l304t592r326b687],
2	Change	NNP	O	Change	dep	1	SENT_245	[p15l302t486r333b583],
3	from	IN	O	from	_	0	SENT_245	[p15l302t418r326b478],
4	Baseline	NNP	O	Baseline	prep_from	2	SENT_245	[p15l302t300r326b406],

1	40	CD	NUMBER	40	num	2	SENT_246	[p15l1201t794r1229b814],
2	Patient	NN	O	patient	_	0	SENT_246	[p15l1152t843r1240b866],
3	No.	NN	O	no.	dep	2	SENT_246	[p15l1251t845r1294b866],
4	.	.	O	.	_	0	SENT_246	[p15l1251t845r1294b866],

1	CT	NN	O	ct	conj_and	1	SENT_247	[p15l154t947r190b969],
2	before	IN	O	before	_	0	SENT_247	[p15l199t945r278b969],
3	and	CC	O	and	_	0	SENT_247	[p15l287t946r333b969],
4	after	IN	O	after	_	0	SENT_247	[p15l344t945r402b969],
5	Crizotinib	NNP	O	Crizotinib	prep_after	1	SENT_247	[p15l410t946r534b969],

1	Figure	NN	O	figure	_	0	SENT_248	[p15l122t1880r206b1912],
2	2	CD	NUMBER	2	dep	1	SENT_248	[p15l216t1881r240b1904],
3	.	.	O	.	_	0	SENT_248	[p15l216t1881r240b1904],

1	Response	NN	O	response	_	0	SENT_249	[p15l254t1881r386b1912],
2	to	TO	O	to	_	0	SENT_249	[p15l395t1883r423b1904],
3	ALK	NNP	O	ALK	nn	4	SENT_249	[p15l433t1881r488b1904],
4	Inhibition	NN	O	inhibition	prep_to	1	SENT_249	[p15l500t1879r639b1904],
5	.	.	O	.	_	0	SENT_249	[p15l500t1879r639b1904],

1	Panel	NN	O	panel	nn	2	SENT_250	[p15l122t1929r194b1954],
2	A	NN	O	a	nsubj	3	SENT_250	[p15l206t1931r225b1954],
3	shows	VBZ	O	show	_	0	SENT_250	[p15l236t1929r321b1954],
4	the	DT	O	the	det	6	SENT_250	[p15l333t1929r376b1954],
5	best	JJS	O	best	amod	6	SENT_250	[p15l389t1929r446b1954],
6	response	NN	O	response	dobj	3	SENT_250	[p15l458t1938r583b1962],
7	of	IN	O	of	_	0	SENT_250	[p15l594t1929r624b1954],
8	patients	NNS	O	patient	prep_of	6	SENT_250	[p15l632t1931r742b1962],
9	with	IN	O	with	_	0	SENT_250	[p15l753t1929r810b1954],
10	ALK-positive	JJ	MISC	alk-positive	amod	11	SENT_250	[p15l821t1931r996b1962],
11	tumors	NNS	O	tumor	prep_with	8	SENT_250	[p15l1006t1934r1106b1954],
12	who	WP	O	who	nsubjpass	14	SENT_250	[p15l1117t1929r1175b1954],
13	were	VBD	O	be	auxpass	14	SENT_250	[p15l1185t1938r1250b1954],
14	treated	VBN	O	treat	rcmod	6	SENT_250	[p15l1261t1929r1357b1954],
15	with	IN	O	with	_	0	SENT_250	[p15l1369t1929r1426b1954],
16	crizotinib	NN	O	crizotinib	prep_with	14	SENT_250	[p15l1439t1929r1575b1959],
17	,	,	O	,	_	0	SENT_250	[p15l1439t1929r1575b1959],
18	as	IN	O	as	_	0	SENT_250	[p15l1588t1938r1615b1954],
19	compared	VBN	O	compare	prepc_as	3	SENT_250	[p15l1628t1929r1765b1962],
20	with	IN	O	with	pcomp	19	SENT_250	[p15l1777t1929r1834b1954],
21	pretreatment	NN	O	pretreatment	nn	22	SENT_250	[p15l1848t1934r2030b1962],
22	baseline	NN	O	baseline	pobj	20	SENT_250	[p15l121t1971r241b1996],
23	.	.	O	.	_	0	SENT_250	[p15l121t1971r241b1996],

1	Numbers	NNS	O	number	nsubj	6	SENT_251	[p15l256t1971r383b1996],
2	along	IN	O	along	_	0	SENT_251	[p15l396t1971r472b2004],
3	the	DT	O	the	det	5	SENT_251	[p15l481t1971r525b1996],
4	x	NN	O	x	nn	5	SENT_251	[p15l535t1980r548b1995],
5	axis	NN	O	axis	prep_along	1	SENT_251	[p15l559t1973r609b1996],
6	indicate	VBP	O	indicate	_	0	SENT_251	[p15l623t1971r730b1996],
7	arbitrarily	RB	O	arbitrarily	advmod	6	SENT_251	[p15l742t1971r875b2004],
8	assigned	VBN	O	assign	dep	6	SENT_251	[p15l885t1971r1005b2004],
9	subject	JJ	O	subject	amod	10	SENT_251	[p15l1019t1971r1119b2004],
10	numbers	NNS	O	number	dobj	8	SENT_251	[p15l1131t1971r1253b1996],
11	from	IN	O	from	_	0	SENT_251	[p15l1264t1970r1329b1996],
12	1	CD	NUMBER	1	number	14	SENT_251	[p15l1343t1973r1355b1995],
13	to	TO	NUMBER	to	dep	14	SENT_251	[p15l1366t1975r1393b1996],
14	79	CD	NUMBER	79	prep_from	8	SENT_251	[p15l1406t1973r1443b1996],
15	.	.	O	.	_	0	SENT_251	[p15l1406t1973r1443b1996],

1	The	DT	O	the	det	2	SENT_252	[p15l1454t1971r1506b1996],
2	bars	NNS	O	bar	nsubj	3	SENT_252	[p15l1518t1971r1574b1996],
3	indicate	VBP	O	indicate	_	0	SENT_252	[p15l1588t1971r1696b1996],
4	the	DT	O	the	det	6	SENT_252	[p15l1706t1971r1749b1996],
5	percent	NN	O	percent	nn	6	SENT_252	[p15l1762t1975r1865b2003],
6	change	NN	O	change	dobj	3	SENT_252	[p15l1876t1971r1974b2004],
7	in	IN	O	in	_	0	SENT_252	[p15l1987t1973r2008b1995],
8	tumor	NN	O	tumor	nn	9	SENT_252	[p15l119t2017r205b2038],
9	burden	NN	O	burden	prep_in	6	SENT_252	[p15l217t2012r312b2038],
10	from	IN	O	from	_	0	SENT_252	[p15l324t2012r389b2037],
11	baseline	NN	O	baseline	prep_from	3	SENT_252	[p15l403t2012r523b2038],
12	.	.	O	.	_	0	SENT_252	[p15l403t2012r523b2038],

1	Three	CD	NUMBER	three	num	3	SENT_253	[p15l534t2012r613b2038],
2	study	NN	O	study	nn	3	SENT_253	[p15l625t2012r699b2045],
3	patients	NNS	O	patient	nsubjpass	6	SENT_253	[p15l711t2015r821b2045],
4	are	VBP	O	be	auxpass	6	SENT_253	[p15l834t2021r874b2038],
5	not	RB	O	not	neg	6	SENT_253	[p15l887t2017r931b2037],
6	included	VBN	O	include	_	0	SENT_253	[p15l943t2012r1059b2038],
7	in	IN	O	in	_	0	SENT_253	[p15l1073t2015r1095b2037],
8	this	DT	O	this	det	9	SENT_253	[p15l1107t2012r1156b2038],
9	plot	NN	O	plot	prep_in	6	SENT_253	[p15l1170t2012r1230b2045],
10	:	:	O	:	_	0	SENT_253	[p15l1170t2012r1230b2045],
11	one	CD	NUMBER	one	num	12	SENT_253	[p15l1242t2021r1292b2038],
12	patient	NN	O	patient	nsubjpass	15	SENT_253	[p15l1305t2015r1400b2045],
13	was	VBD	O	be	auxpass	15	SENT_253	[p15l1410t2021r1462b2038],
14	clinically	RB	O	clinically	advmod	15	SENT_253	[p15l1474t2012r1592b2045],
15	assessed	VBN	O	assess	parataxis	6	SENT_253	[p15l1603t2012r1725b2038],
16	as	IN	O	as	_	0	SENT_253	[p15l1738t2021r1766b2038],
17	having	VBG	O	have	aux	18	SENT_253	[p15l1779t2012r1869b2046],
18	had	VBD	O	have	prepc_as	15	SENT_253	[p15l1881t2012r1928b2038],
19	a	DT	O	a	det	21	SENT_253	[p15l1941t2021r1954b2037],
20	partial	JJ	O	partial	amod	21	SENT_253	[p15l1967t2021r2018b2045, p15l119t2054r159b2079],
21	response	NN	O	response	dobj	18	SENT_253	[p15l173t2063r305b2087],
22	,	,	O	,	_	0	SENT_253	[p15l173t2063r305b2087],
23	although	IN	O	although	mark	26	SENT_253	[p15l318t2054r439b2087],
24	the	DT	O	the	det	25	SENT_253	[p15l451t2054r495b2079],
25	response	NN	O	response	nsubj	26	SENT_253	[p15l507t2063r632b2087],
26	was	VBD	O	be	advcl	15	SENT_253	[p15l642t2063r694b2079],
27	primarily	RB	O	primarily	advmod	26	SENT_253	[p15l707t2054r829b2087],
28	in	IN	O	in	_	0	SENT_253	[p15l841t2056r863b2079],
29	areas	NNS	O	area	prep_in	26	SENT_253	[p15l876t2063r947b2079],
30	of	IN	O	of	_	0	SENT_253	[p15l959t2054r989b2079],
31	nonmeasurable	JJ	O	nonmeasurable	amod	32	SENT_253	[p15l997t2054r1212b2079],
32	disease	NN	O	disease	prep_of	29	SENT_253	[p15l1223t2054r1333b2084],
33	,	,	O	,	_	0	SENT_253	[p15l1223t2054r1333b2084],
34	so	IN	O	so	mark	38	SENT_253	[p15l1346t2063r1376b2079],
35	the	DT	O	the	det	36	SENT_253	[p15l1386t2054r1430b2079],
36	patient	NN	O	patient	nsubjpass	38	SENT_253	[p15l1443t2056r1538b2087],
37	was	VBD	O	be	auxpass	38	SENT_253	[p15l1548t2063r1599b2079],
38	classified	VBN	O	classify	advcl	26	SENT_253	[p15l1612t2054r1739b2079],
39	as	IN	O	as	_	0	SENT_253	[p15l1752t2063r1780b2079],
40	having	VBG	O	have	prepc_as	38	SENT_253	[p15l1793t2054r1883b2087],
41	stable	JJ	O	stable	amod	42	SENT_253	[p15l1895t2054r1976b2079],
42	disease	NN	O	disease	dobj	40	SENT_253	[p15l1988t2054r2036b2079, p15l120t2104r188b2125],
43	;	:	O	;	_	0	SENT_253	[p15l1988t2054r2036b2079, p15l120t2104r188b2125],
44	two	CD	NUMBER	two	num	45	SENT_253	[p15l199t2100r250b2121],
45	patients	NNS	O	patient	nsubjpass	53	SENT_253	[p15l263t2098r373b2128],
46	with	IN	O	with	_	0	SENT_253	[p15l384t2096r441b2121],
47	abrupt	JJ	O	abrupt	amod	49	SENT_253	[p15l454t2096r545b2128],
48	clinical	JJ	O	clinical	amod	49	SENT_253	[p15l556t2096r650b2121],
49	deterioration	NN	O	deterioration	prep_with	45	SENT_253	[p15l663t2096r842b2121],
50	could	MD	O	could	aux	53	SENT_253	[p15l855t2096r928b2121],
51	not	RB	O	not	neg	53	SENT_253	[p15l943t2100r986b2121],
52	be	VB	O	be	auxpass	53	SENT_253	[p15l998t2096r1029b2121],
53	assessed	VBN	O	assess	parataxis	6	SENT_253	[p15l1041t2096r1172b2121],
54	.	.	O	.	_	0	SENT_253	[p15l1041t2096r1172b2121],

1	Four	CD	NUMBER	four	num	2	SENT_254	[p15l1186t2098r1247b2121],
2	patients	NNS	O	patient	nsubjpass	11	SENT_254	[p15l1259t2098r1369b2128],
3	had	VBD	O	have	_	0	SENT_254	[p15l1382t2096r1430b2121],
4	complete	JJ	O	complete	amod	8	SENT_254	[p15l1443t2096r1571b2128],
5	resolution	NN	O	resolution	nn	8	SENT_254	[p15l1584t2096r1721b2121],
6	oftheir	NN	O	oftheir	nn	8	SENT_254	[p15l1734t2095r1834b2121],
7	target	NN	O	target	nn	8	SENT_254	[p15l1843t2100r1925b2129],
8	lesions	NNS	O	lesion	dobj	3	SENT_254	[p15l1937t2096r2032b2121],
9	but	CC	O	but	_	0	SENT_254	[p15l121t2137r165b2163],
10	were	VBD	O	be	auxpass	11	SENT_254	[p15l175t2146r239b2163],
11	classified	VBN	O	classify	conj_but	3	SENT_254	[p15l251t2137r379b2163],
12	as	IN	O	as	_	0	SENT_254	[p15l392t2146r419b2163],
13	having	VBG	O	have	aux	14	SENT_254	[p15l433t2137r522b2171],
14	had	VBD	O	have	prepc_as	11	SENT_254	[p15l534t2137r582b2163],
15	a	DT	O	a	det	17	SENT_254	[p15l595t2146r608b2162],
16	partial	JJ	O	partial	amod	17	SENT_254	[p15l621t2137r706b2170],
17	response	NN	O	response	dobj	14	SENT_254	[p15l720t2146r845b2170],
18	on	IN	O	on	_	0	SENT_254	[p15l856t2146r889b2163],
19	the	DT	O	the	det	20	SENT_254	[p15l901t2137r944b2163],
20	basis	NN	O	basis	prep_on	17	SENT_254	[p15l957t2137r1024b2163],
21	of	IN	O	of	_	0	SENT_254	[p15l1037t2137r1066b2163],
22	stability	NN	O	stability	prep_of	20	SENT_254	[p15l1074t2137r1182b2170],
23	in	IN	O	in	_	0	SENT_254	[p15l1194t2140r1215b2162],
24	nontarget	JJ	O	nontarget	amod	25	SENT_254	[p15l1229t2142r1364b2171],
25	lesions	NNS	O	lesion	prep_in	11	SENT_254	[p15l1376t2137r1479b2163],
26	.	.	O	.	_	0	SENT_254	[p15l1376t2137r1479b2163],

1	Eight	CD	NUMBER	eight	num	2	SENT_255	[p15l1494t2137r1562b2171],
2	patients	NNS	O	patient	nsubjpass	13	SENT_255	[p15l1574t2140r1684b2170],
3	had	VBD	O	have	dep	24	SENT_255	[p15l1697t2137r1744b2163],
4	tumor	NN	O	tumor	nn	5	SENT_255	[p15l1756t2142r1843b2163],
5	shrinkage	NN	O	shrinkage	dobj	3	SENT_255	[p15l1854t2137r1986b2171],
6	of	IN	O	of	_	0	SENT_255	[p15l1998t2137r2028b2163],
7	more	JJR	O	more	mwe	8	SENT_255	[p15l121t2188r191b2204],
8	than	IN	O	than	quantmod	9	SENT_255	[p15l202t2179r262b2204],
9	30	CD	PERCENT	30	num	10	SENT_255	[p15l275t2180r336b2205],
10	%	NN	PERCENT	%	prep_of	5	SENT_255	[p15l275t2180r336b2205],
11	but	CC	O	but	_	0	SENT_255	[p15l348t2179r392b2204],
12	were	VBD	O	be	auxpass	13	SENT_255	[p15l402t2188r467b2204],
13	classified	VBN	O	classify	conj_but	3	SENT_255	[p15l478t2179r606b2204],
14	as	IN	O	as	_	0	SENT_255	[p15l619t2188r646b2204],
15	having	VBG	O	have	prepc_as	13	SENT_255	[p15l660t2179r750b2212],
16	stable	JJ	O	stable	amod	17	SENT_255	[p15l761t2179r843b2204],
17	disease	NN	O	disease	dobj	15	SENT_255	[p15l854t2179r956b2204],
18	either	CC	O	either	dep	15	SENT_255	[p15l967t2179r1047b2204],
19	because	IN	O	because	_	0	SENT_255	[p15l1059t2179r1170b2204],
20	conﬁrmatory	JJ	O	conﬁrmatory	amod	21	SENT_255	[p15l1182t2179r1362b2212],
21	scans	NNS	O	scan	prep_because	15	SENT_255	[p15l1373t2188r1449b2204],
22	were	VBD	O	be	cop	24	SENT_255	[p15l1461t2188r1525b2204],
23	not	RB	O	not	neg	24	SENT_255	[p15l1538t2184r1582b2204],
24	available	JJ	O	available	_	0	SENT_255	[p15l1593t2179r1712b2204],
25	by	IN	O	by	_	0	SENT_255	[p15l1724t2179r1753b2212],
26	the	DT	O	the	det	29	SENT_255	[p15l1763t2179r1806b2204],
27	data-cutoff	JJ	O	data-cutoff	amod	29	SENT_255	[p15l1817t2179r1974b2204],
28	point	NN	O	point	nn	29	SENT_255	[p15l121t2223r192b2253],
29	(	NN	O	(	prep_by	24	SENT_255	[p15l206t2220r253b2254],
30	for	IN	O	for	_	0	SENT_255	[p15l206t2220r253b2254],
31	five	CD	NUMBER	five	num	32	SENT_255	[p15l262t2220r311b2246],
32	patients	NNS	O	patient	prep_for	24	SENT_255	[p15l324t2223r443b2254],
33	)	CD	NUMBER	)	nsubjpass	38	SENT_255	[p15l324t2223r443b2254],
34	or	CC	O	or	_	0	SENT_255	[p15l457t2229r485b2246],
35	early	JJ	O	early	amod	36	SENT_255	[p15l495t2221r560b2254],
36	restaging	NN	O	restaging	nsubjpass	38	SENT_255	[p15l572t2223r700b2254],
37	was	VBD	O	be	auxpass	38	SENT_255	[p15l709t2229r761b2246],
38	performed	VBN	O	perform	rcmod	32	SENT_255	[p15l774t2220r920b2253],
39	at	IN	O	at	_	0	SENT_255	[p15l933t2225r957b2246],
40	6	CD	DURATION	6	num	41	SENT_255	[p15l969t2223r982b2246],
41	weeks	NNS	NUMBER	week	prep_at	38	SENT_255	[p15l993t2221r1077b2246],
42	after	IN	O	after	_	0	SENT_255	[p15l1089t2220r1153b2246],
43	crizotinib	JJ	O	crizotinib	amod	45	SENT_255	[p15l1163t2221r1292b2246],
44	initiation	NN	O	initiation	nn	45	SENT_255	[p15l1305t2223r1425b2246],
45	(	NN	O	(	prep_after	38	SENT_255	[p15l1441t2220r1488b2254],
46	for	IN	O	for	_	0	SENT_255	[p15l1441t2220r1488b2254],
47	three	CD	NUMBER	three	num	48	SENT_255	[p15l1497t2221r1568b2246],
48	patients	NNS	O	patient	prep_for	45	SENT_255	[p15l1581t2223r1709b2254],
49	)	CD	NUMBER	)	nsubj	24	SENT_255	[p15l1581t2223r1709b2254],
50	.	.	O	.	_	0	SENT_255	[p15l1581t2223r1709b2254],

1	The	DT	O	the	det	3	SENT_256	[p15l1720t2221r1772b2246],
2	dashed	VBN	O	dash	amod	3	SENT_256	[p15l1783t2221r1881b2246],
3	line	NN	O	line	nsubj	4	SENT_256	[p15l1895t2221r1942b2246],
4	indicates	VBZ	O	indicate	_	0	SENT_256	[p15l1955t2221r2014b2246, p15l120t2267r190b2288],
5	a	DT	O	a	det	7	SENT_256	[p15l202t2271r215b2288],
6	tumor	NN	O	tumor	nn	7	SENT_256	[p15l226t2267r313b2288],
7	reduction	NN	O	reduction	dobj	4	SENT_256	[p15l324t2262r455b2288],
8	of	IN	O	of	_	0	SENT_256	[p15l468t2262r498b2288],
9	30	CD	PERCENT	30	num	10	SENT_256	[p15l505t2264r565b2289],
10	%	NN	PERCENT	%	prep_of	7	SENT_256	[p15l505t2264r565b2289],
11	from	IN	O	from	_	0	SENT_256	[p15l576t2262r640b2288],
12	baseline	NN	O	baseline	prep_from	4	SENT_256	[p15l654t2262r774b2292],
13	,	,	O	,	_	0	SENT_256	[p15l654t2262r774b2292],
14	the	DT	O	the	det	17	SENT_256	[p15l786t2262r829b2288],
15	minimal	JJ	O	minimal	amod	17	SENT_256	[p15l842t2262r953b2288],
16	percent	NN	O	percent	nn	17	SENT_256	[p15l967t2267r1070b2295],
17	decrease	NN	O	decrease	appos	12	SENT_256	[p15l1081t2262r1203b2288],
18	that	WDT	O	that	nsubj	19	SENT_256	[p15l1213t2262r1268b2288],
19	constitutes	VBZ	O	constitute	rcmod	17	SENT_256	[p15l1278t2265r1432b2288],
20	a	DT	O	a	det	22	SENT_256	[p15l1444t2271r1457b2288],
21	partial	JJ	O	partial	amod	22	SENT_256	[p15l1470t2262r1555b2295],
22	response	NN	O	response	dobj	19	SENT_256	[p15l1569t2271r1701b2295],
23	,	,	O	,	_	0	SENT_256	[p15l1569t2271r1701b2295],
24	according	VBG	O	accord	_	0	SENT_256	[p15l1715t2262r1849b2296],
25	to	TO	O	to	prepc_according_to	4	SENT_256	[p15l1859t2267r1886b2288],
26	Response	NN	O	response	nn	28	SENT_256	[p15l1900t2265r2032b2295],
27	Evaluation	NN	O	evaluation	nn	28	SENT_256	[p15l122t2304r263b2329],
28	Criteria	NNS	O	criterion	pobj	4	SENT_256	[p15l276t2306r376b2329],
29	in	IN	O	in	_	0	SENT_256	[p15l389t2306r410b2329],
30	Solid	JJ	O	solid	amod	31	SENT_256	[p15l424t2304r491b2329],
31	Tumors	NNS	O	tumor	prep_in	28	SENT_256	[p15l502t2306r616b2329],
32	.	.	O	.	_	0	SENT_256	[p15l502t2306r616b2329],

1	Panel	NN	O	panel	nn	2	SENT_257	[p15l631t2304r702b2329],
2	B	NN	O	b	nsubj	3	SENT_257	[p15l718t2306r732b2329],
3	shows	VBZ	O	show	_	0	SENT_257	[p15l745t2304r830b2329],
4	the	DT	O	the	det	5	SENT_257	[p15l841t2304r885b2329],
5	results	NNS	O	result	dobj	3	SENT_257	[p15l898t2304r988b2329],
6	of	IN	O	of	_	0	SENT_257	[p15l1000t2304r1030b2329],
7	CT	NN	O	ct	prep_of	5	SENT_257	[p15l1037t2306r1075b2329],
8	with	IN	O	with	_	0	SENT_257	[p15l1085t2304r1142b2329],
9	coronal	JJ	O	coronal	amod	10	SENT_257	[p15l1155t2304r1256b2329],
10	reconstruction	NN	O	reconstruction	prep_with	3	SENT_257	[p15l1270t2306r1471b2329],
11	in	IN	O	in	_	0	SENT_257	[p15l1485t2306r1507b2329],
12	a	DT	O	a	det	14	SENT_257	[p15l1520t2313r1533b2329],
13	representative	JJ	O	representative	amod	14	SENT_257	[p15l1546t2306r1743b2337],
14	patient	NN	O	patient	prep_in	10	SENT_257	[p15l1755t2306r1851b2337],
15	at	IN	O	at	_	0	SENT_257	[p15l1862t2309r1886b2329],
16	baseline	NN	O	baseline	prep_at	14	SENT_257	[p15l1899t2304r2011b2329],
17	(	CD	NUMBER	(	num	16	SENT_257	[p15l123t2345r185b2379],
18	left	VBD	O	leave	partmod	16	SENT_257	[p15l123t2345r185b2379],
19	)	CD	NUMBER	)	dobj	18	SENT_257	[p15l123t2345r185b2379],
20	and	CC	O	and	_	0	SENT_257	[p15l200t2346r248b2371],
21	after	IN	O	after	_	0	SENT_257	[p15l261t2345r325b2371],
22	two	CD	NUMBER	two	num	23	SENT_257	[p15l334t2350r385b2371],
23	cycles	NNS	O	cycle	npadvmod	24	SENT_257	[p15l396t2346r478b2379],
24	oftherapy	JJ	O	oftherapy	amod	27	SENT_257	[p15l490t2345r630b2379],
25	(	RB	O	(	advmod	26	SENT_257	[p15l643t2346r734b2379],
26	right	JJ	O	right	amod	27	SENT_257	[p15l643t2346r734b2379],
27	)	NN	O	)	prep_after	14	SENT_257	[p15l643t2346r734b2379],
28	.	.	O	.	_	0	SENT_257	[p15l643t2346r734b2379],

1	This	DT	O	this	det	2	SENT_258	[p15l745t2346r803b2371],
2	patient	NN	O	patient	nsubj	4	SENT_258	[p15l816t2348r912b2378],
3	had	VBD	O	have	aux	4	SENT_258	[p15l924t2346r971b2371],
4	undergone	VBN	O	undergo	_	0	SENT_258	[p15l985t2346r1134b2379],
5	previous	JJ	O	previous	nsubj	6	SENT_258	[p15l1147t2348r1263b2378],
6	left	VBD	O	leave	ccomp	4	SENT_258	[p15l1277t2345r1320b2371],
7	lower	JJR	O	lower	amod	8	SENT_258	[p15l1332t2346r1406b2371],
8	lobectomy	NN	O	lobectomy	dobj	6	SENT_258	[p15l1418t2346r1568b2379],
9	.	.	O	.	_	0	SENT_258	[p15l1418t2346r1568b2379],

1	were	VBD	O	be	cop	2	SENT_259	[p15l379t2502r457b2522],
2	insufficient	JJ	O	insufficient	dep	31	SENT_259	[p15l471t2491r665b2522],
3	to	TO	O	to	aux	4	SENT_259	[p15l677t2498r709b2522],
4	correlate	VB	O	correlate	xcomp	2	SENT_259	[p15l723t2491r869b2522],
5	the	DT	O	the	det	6	SENT_259	[p15l883t2491r934b2522],
6	presence	NN	O	presence	dobj	4	SENT_259	[p15l947t2501r1093b2530],
7	of	IN	O	of	_	0	SENT_259	[p15l1107t2491r1146b2522],
8	the	DT	O	the	det	10	SENT_259	[p15l1152t2491r1204b2522],
9	cal	JJ	O	cal	amod	10	SENT_259	[p15l1244t2491r1291b2522],
10	analysis	NN	O	analysis	prep_of	6	SENT_259	[p15l1305t2491r1436b2530],
11	of	IN	O	of	_	0	SENT_259	[p15l1452t2491r1491b2522],
12	ALK	NNP	O	ALK	prep_of	10	SENT_259	[p15l1496t2494r1570b2523],
13	in	IN	O	in	_	0	SENT_259	[p15l1583t2492r1616b2521],
14	FFPE	NNP	O	FFPE	nn	16	SENT_259	[p15l1629t2494r1710b2521],
15	tumor	NN	O	tumor	nn	16	SENT_259	[p15l1726t2498r1829b2522],
16	sections	NNS	O	section	prep_in	12	SENT_259	[p15l1843t2492r1978b2522],
17	with	IN	O	with	_	0	SENT_259	[p15l1991t2491r2067b2522],
18	EML4-ALK	NN	O	eml4-alk	nn	19	SENT_259	[p15l380t2543r549b2571],
19	breakpoint	NN	O	breakpoint	prep_with	4	SENT_259	[p15l565t2541r750b2580],
20	with	IN	O	with	_	0	SENT_259	[p15l766t2541r842b2572],
21	either	CC	O	either	dep	22	SENT_259	[p15l862t2541r958b2571],
22	smoking	NN	O	smoking	prep_with	4	SENT_259	[p15l977t2541r1123b2580],
23	his	PRP$	O	he	dep	22	SENT_259	[p15l1142t2541r1204b2571],
24	-	:	O	-	_	0	SENT_259	[p15l1142t2541r1204b2571],
25	an	DT	O	a	det	27	SENT_259	[p15l1243t2551r1283b2571],
26	anti-ALK	JJ	O	anti-alk	amod	27	SENT_259	[p15l1292t2541r1439b2572],
27	rabbit	NN	O	rabbit	dep	22	SENT_259	[p15l1447t2541r1543b2571],
28	monoclonal	JJ	O	monoclonal	amod	30	SENT_259	[p15l1551t2541r1745b2571],
29	antibody	NN	O	antibody	nn	30	SENT_259	[p15l1755t2541r1924b2580],
30	”	NN	O	”	nsubj	31	SENT_259	[p15l1755t2541r1924b2580],
31	revealed	VBD	O	reveal	_	0	SENT_259	[p15l1934t2541r2067b2572],
32	tory	JJ	O	tory	amod	37	SENT_259	[p15l381t2596r446b2629],
33	or	CC	O	or	_	0	SENT_259	[p15l457t2600r491b2620],
34	response	NN	O	response	conj_or	32	SENT_259	[p15l501t2600r645b2629],
35	rate	NN	O	rate	nn	37	SENT_259	[p15l657t2596r718b2620],
36	(	CD	NUMBER	(	num	37	SENT_259	[p15l731t2590r799b2629],
37	Fig	NN	O	fig	dobj	31	SENT_259	[p15l731t2590r799b2629],
38	.	.	O	.	_	0	SENT_259	[p15l731t2590r799b2629],

1	3	CD	NUMBER	3	_	0	SENT_260	[p15l813t2592r850b2625],
2	)	NN	O	)	dep	1	SENT_260	[p15l813t2592r850b2625],
3	.	.	O	.	_	0	SENT_260	[p15l813t2592r850b2625],

1	Immunohistochemi	SYM	LOCATION	immunohistochemi	_	0	SENT_261	[p15l863t2590r1204b2621],
2	-	:	O	-	_	0	SENT_261	[p15l863t2590r1204b2621],
3	positive	JJ	O	positive	amod	5	SENT_261	[p15l1243t2590r1372b2629],
4	ALK	NN	O	alk	nn	5	SENT_261	[p15l1381t2593r1456b2621],
5	protein	NN	O	protein	dep	6	SENT_261	[p15l1465t2590r1586b2629],
6	expression	NN	O	expression	npadvmod	7	SENT_261	[p15l1598t2590r1775b2629],
7	in	IN	O	in	dep	1	SENT_261	[p15l1786t2590r1818b2620],
8	all	DT	O	all	det	10	SENT_261	[p15l1829t2590r1870b2620],
9	25	CD	NUMBER	25	num	10	SENT_261	[p15l1881t2592r1919b2621],
10	samples	NNS	O	sample	pobj	7	SENT_261	[p15l1932t2590r2066b2629],

1	1698	CD	DATE	1698	num	2	SENT_262	[p15l94t2704r170b2727],
2	NENGLJMED363	NN	O	nengljmed363	_	0	SENT_262	[p15l883t2708r1143b2736],
3	;	:	O	;	_	0	SENT_262	[p15l883t2708r1143b2736],
4	‘	CD	NUMBER	‘	num	5	SENT_262	[p15l883t2708r1143b2736],
5	l8	NN	O	l8	dep	2	SENT_262	[p15l883t2708r1143b2736],
6	NE	NN	O	ne	nn	9	SENT_262	[p15l1178t2714r1302b2736],
7	}	CD	NUMBER	}	num	9	SENT_262	[p15l1178t2714r1302b2736],
8	M.ORG	NN	O	m.org	nn	9	SENT_262	[p15l1178t2714r1302b2736],
9	OCTOBER23	NN	O	october23	dep	5	SENT_262	[p15l1337t2708r1567b2734],
10	,201	CD	NUMBER	,201	num	11	SENT_262	[p15l1337t2708r1567b2734],
11	O	NN	O	o	dep	5	SENT_262	[p15l1337t2708r1567b2734],

1	The	DT	O	the	det	4	SENT_263	[p15l881t2772r932b2795],
2	New	NNP	O	New	nn	4	SENT_263	[p15l941t2772r1003b2795],
3	England	NNP	O	England	nn	4	SENT_263	[p15l1012t2772r1123b2802],
4	Journal	NNP	O	Journal	_	0	SENT_263	[p15l1132t2772r1229b2795],
5	of	IN	O	of	_	0	SENT_263	[p15l1239t2772r1268b2795],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_263	[p15l1274t2772r1400b2795],

1	ALK	NNP	O	ALK	nn	2	SENT_264	[p15l484t2896r548b2915],
2	INHIBITION	NNP	O	INHIBITION	_	0	SENT_264	[p15l561t2896r764b2915],
3	IN	IN	O	in	_	0	SENT_264	[p15l780t2896r817b2915],
4	NON	NNP	O	NON	prep_in	2	SENT_264	[p15l833t2896r1136b2915],
5	.	.	O	.	_	0	SENT_264	[p15l833t2896r1136b2915],

1	—	NN	O	—	_	0	SENT_265	[p15l833t2896r1136b2915],
2	.	.	O	.	_	0	SENT_265	[p15l833t2896r1136b2915],

1	SMALL-CELL	NN	O	small-cell	nn	2	SENT_266	[p15l833t2896r1136b2915],
2	LUNG	NN	O	lung	_	0	SENT_266	[p15l1150t2896r1241b2915],
3	CANCER	NNP	O	CANCER	dep	2	SENT_266	[p15l1255t2896r1389b2915],

1	Percent	NN	O	percent	_	0	SENT_267	[p16l296t619r317b715],
2	Change	NNP	O	Change	dep	1	SENT_267	[p16l294t514r325b611],
3	from	IN	O	from	_	0	SENT_267	[p16l293t446r317b506],
4	Baseline	NNP	O	Baseline	prep_from	2	SENT_267	[p16l294t328r317b434],

1	4	CD	NUMBER	4	num	2	SENT_268	[p16l432t924r446b944],
2	19	CD	DATE	19	dep	7	SENT_268	[p16l479t924r505b944],
3	21	CD	DATE	21	num	4	SENT_268	[p16l530t924r556b944],
4	23	CD	DATE	23	dep	2	SENT_268	[p16l582t924r607b944],
5	25	CD	DATE	25	dep	7	SENT_268	[p16l634t924r660b944],
6	27	CD	DATE	27	num	7	SENT_268	[p16l686t924r713b944],
7	29	CD	DATE	29	dep	13	SENT_268	[p16l738t924r765b944],
8	34	CD	DATE	34	number	9	SENT_268	[p16l790t924r817b944],
9	36	CD	DATE	36	dep	7	SENT_268	[p16l842t924r869b944],
10	37	CD	DATE	37	num	11	SENT_268	[p16l894t924r921b944],
11	38	CD	DATE	38	dep	9	SENT_268	[p16l946t924r973b944],
12	42	CD	NUMBER	42	num	13	SENT_268	[p16l998t924r1025b944],
13	43	CD	NUMBER	43	dep	20	SENT_268	[p16l1050t924r1076b944],
14	44	CD	NUMBER	44	num	15	SENT_268	[p16l1102t924r1129b944],
15	45	CD	NUMBER	45	dep	13	SENT_268	[p16l1154t924r1180b944],
16	So	IN	O	so	advmod	18	SENT_268	[p16l1207t924r1234b944],
17	5155	CD	NUMBER	5155	number	18	SENT_268	[p16l1259t924r1336b944],
18	56	CD	NUMBER	56	rcmod	15	SENT_268	[p16l1363t924r1389b944],
19	57	CD	NUMBER	57	num	20	SENT_268	[p16l1415t924r1442b944],
20	58	CD	NUMBER	58	dep	30	SENT_268	[p16l1467t923r1493b944],
21	59	CD	NUMBER	59	number	22	SENT_268	[p16l1519t924r1545b944],
22	61	CD	NUMBER	61	num	24	SENT_268	[p16l1571t924r1597b944],
23	62	CD	NUMBER	62	number	24	SENT_268	[p16l1623t924r1649b944],
24	63	CD	NUMBER	63	dep	20	SENT_268	[p16l1675t924r1700b944],
25	65	CD	NUMBER	65	number	26	SENT_268	[p16l1727t924r1752b944],
26	67	CD	NUMBER	67	num	28	SENT_268	[p16l1779t924r1806b944],
27	68	CD	NUMBER	68	number	28	SENT_268	[p16l1831t924r1857b944],
28	72	CD	NUMBER	72	dep	24	SENT_268	[p16l1884t924r1909b944],
29	75	CD	NUMBER	75	num	30	SENT_268	[p16l1935t922r1960b942],
30	79	CD	NUMBER	79	_	0	SENT_268	[p16l1988t924r2014b944],

1	PatientNo	NN	O	patientno	_	0	SENT_269	[p16l1145t973r1288b996],
2	.	.	O	.	_	0	SENT_269	[p16l1145t973r1288b996],

1	%	NN	O	%	nn	2	SENT_270	[p16l234t1021r393b1050],
2	Response	NN	O	response	dep	8	SENT_270	[p16l234t1021r393b1050],
3	+12	CD	NUMBER	+12	number	4	SENT_270	[p16l417t1021r460b1041],
4	22	CD	NUMBER	22	dep	2	SENT_270	[p16l477t1021r504b1041],
5	26	CD	NUMBER	26	dep	4	SENT_270	[p16l529t1021r556b1041],
6	28	CD	NUMBER	28	dep	8	SENT_270	[p16l581t1021r608b1042],
7	31	CD	NUMBER	31	num	8	SENT_270	[p16l634t1022r659b1041],
8	33	CD	NUMBER	33	dep	14	SENT_270	[p16l686t1022r711b1041],
9	33	CD	NUMBER	33	number	10	SENT_270	[p16l738t1022r763b1041],
10	40	CD	NUMBER	40	dep	8	SENT_270	[p16l789t1021r817b1041],
11	43	CD	NUMBER	43	num	12	SENT_270	[p16l841t1022r867b1041],
12	43	CD	NUMBER	43	dep	10	SENT_270	[p16l893t1022r919b1041],
13	44	CD	NUMBER	44	num	14	SENT_270	[p16l945t1022r973b1041],
14	49	CD	NUMBER	49	dep	26	SENT_270	[p16l998t1022r1024b1041],
15	50	CD	NUMBER	50	number	16	SENT_270	[p16l1050t1021r1077b1041],
16	50	CD	NUMBER	50	num	18	SENT_270	[p16l1102t1021r1129b1041],
17	50	CD	NUMBER	50	number	18	SENT_270	[p16l1155t1021r1181b1041],
18	57	CD	NUMBER	57	dep	14	SENT_270	[p16l1207t1022r1233b1041],
19	57	CD	NUMBER	57	number	20	SENT_270	[p16l1259t1022r1285b1041],
20	64	CD	NUMBER	64	num	22	SENT_270	[p16l1311t1022r1337b1042],
21	65	CD	NUMBER	65	number	22	SENT_270	[p16l1363t1022r1388b1041],
22	67	CD	NUMBER	67	dep	18	SENT_270	[p16l1415t1022r1441b1041],
23	70	CD	NUMBER	70	number	24	SENT_270	[p16l1468t1022r1494b1042],
24	71	CD	NUMBER	71	num	26	SENT_270	[p16l1520t1022r1544b1041],
25	73	CD	NUMBER	73	number	26	SENT_270	[p16l1572t1022r1596b1041],
26	74	CD	NUMBER	74	dep	35	SENT_270	[p16l1624t1022r1649b1041],
27	74	CD	NUMBER	74	number	28	SENT_270	[p16l1676t1022r1701b1042],
28	75	CD	NUMBER	75	dep	31	SENT_270	[p16l1728t1022r1752b1042],
29	76	CD	NUMBER	76	number	30	SENT_270	[p16l1780t1022r1805b1042],
30	78 87 100100	CD	NUMBER	78 87 100100	dep	31	SENT_270	[p16l1929t1022r2021b1042],[p16l1832t1022r1857b1042],
31	Treatment	NN	O	treatment	amod	26	SENT_270	[p16l136t1080r270b1102],
32	Duration	NN	O	duration	prep	26	SENT_270	[p16l280t1078r391b1101],
33	7	CD	NUMBER	7	num	34	SENT_270	[p16l434t1080r445b1099],
34	15	CD	NUMBER	15	dep	32	SENT_270	[p16l479t1080r503b1100],
35	13	CD	NUMBER	13	_	0	SENT_270	[p16l531t1080r555b1100],
36	40	CD	NUMBER	40	number	37	SENT_270	[p16l581t1079r609b1100],
37	20	CD	NUMBER	20	dep	35	SENT_270	[p16l634t1080r661b1100],
38	53	CD	NUMBER	53	num	39	SENT_270	[p16l686t1080r773b1100],
39	+51	NN	NUMBER	+51	dep	37	SENT_270	[p16l686t1080r773b1100],
40	+	CC	O	+	_	0	SENT_270	[p16l686t1080r773b1100],
41	40	CD	NUMBER	40	dep	35	SENT_270	[p16l781t1080r825b1100],
42	+	CC	O	+	_	0	SENT_270	[p16l781t1080r825b1100],
43	15	CD	NUMBER	15	conj_+	37	SENT_270	[p16l835t1080r877b1100],
44	+	CC	O	+	_	0	SENT_270	[p16l835t1080r877b1100],
45	27	CD	NUMBER	27	num	46	SENT_270	[p16l894t1080r921b1099],
46	40	CD	NUMBER	40	conj_+	37	SENT_270	[p16l937t1080r981b1100],
47	+	CC	O	+	_	0	SENT_270	[p16l937t1080r981b1100],
48	40	CD	NUMBER	40	conj_+	46	SENT_270	[p16l990t1080r1033b1100],
49	+	CC	O	+	_	0	SENT_270	[p16l990t1080r1033b1100],
50	21	CD	NUMBER	21	num	51	SENT_270	[p16l1050t1080r1076b1099],
51	12	CD	NUMBER	12	conj_+	41	SENT_270	[p16l1096t1080r1137b1099],
52	+	CC	O	+	_	0	SENT_270	[p16l1096t1080r1137b1099],
53	49	CD	NUMBER	49	conj_+	51	SENT_270	[p16l1146t1080r1189b1100],
54	+	CC	O	+	_	0	SENT_270	[p16l1146t1080r1189b1100],
55	27	CD	NUMBER	27	conj_+	51	SENT_270	[p16l1198t1080r1241b1100],
56	+	CC	O	+	_	0	SENT_270	[p16l1198t1080r1241b1100],
57	16	CD	NUMBER	16	conj_+	51	SENT_270	[p16l1252t1080r1293b1100],
58	+	CC	O	+	_	0	SENT_270	[p16l1252t1080r1293b1100],
59	16	CD	NUMBER	16	conj_+	51	SENT_270	[p16l1304t1080r1345b1100],
60	+	CC	O	+	_	0	SENT_270	[p16l1304t1080r1345b1100],
61	22	CD	NUMBER	22	num	62	SENT_270	[p16l1362t1080r1389b1100],
62	40	CD	NUMBER	40	conj_+	59	SENT_270	[p16l1406t1080r1449b1100],
63	+	CC	O	+	_	0	SENT_270	[p16l1406t1080r1449b1100],
64	53	CD	NUMBER	53	conj_+	59	SENT_270	[p16l1459t1080r1501b1100],
65	+	CC	O	+	_	0	SENT_270	[p16l1459t1080r1501b1100],
66	84	CD	NUMBER	84	conj_+	59	SENT_270	[p16l1511t1080r1553b1100],
67	+	CC	O	+	_	0	SENT_270	[p16l1511t1080r1553b1100],
68	79	CD	NUMBER	79	conj_+	59	SENT_270	[p16l1564t1080r1605b1100],
69	+	CC	O	+	_	0	SENT_270	[p16l1564t1080r1605b1100],
70	31	CD	NUMBER	31	conj_+	64	SENT_270	[p16l1615t1080r1657b1100],
71	+	CC	O	+	_	0	SENT_270	[p16l1615t1080r1657b1100],
72	48	CD	NUMBER	48	conj_+	64	SENT_270	[p16l1666t1080r1709b1100],
73	+	CC	O	+	_	0	SENT_270	[p16l1666t1080r1709b1100],
74	36	CD	NUMBER	36	conj_+	68	SENT_270	[p16l1719t1080r1761b1100],
75	+	CC	O	+	_	0	SENT_270	[p16l1719t1080r1761b1100],
76	39	CD	NUMBER	39	num	77	SENT_270	[p16l1779t1080r1805b1100],
77	59	CD	NUMBER	59	conj_+	68	SENT_270	[p16l1823t1081r1866b1100],
78	+	CC	O	+	_	0	SENT_270	[p16l1823t1081r1866b1100],
79	17	CD	NUMBER	17	conj_+	77	SENT_270	[p16l1876t1081r1918b1100],
80	+	CC	O	+	_	0	SENT_270	[p16l1876t1081r1918b1100],
81	79	CD	NUMBER	79	conj_+	77	SENT_270	[p16l1928t1081r1970b1100],
82	+	CC	O	+	_	0	SENT_270	[p16l1928t1081r1970b1100],
83	57	CD	NUMBER	57	conj_+	81	SENT_270	[p16l1979t1081r2022b1100],
84	+	CC	O	+	cc	83	SENT_270	[p16l1979t1081r2022b1100],

1	(	NN	O	(	_	0	SENT_271	[p16l340t1113r391b1144],
2	Wk	NN	DURATION	wk	nn	3	SENT_271	[p16l340t1113r391b1144],
3	)	NN	O	)	dep	1	SENT_271	[p16l340t1113r391b1144],

1	Smoking	NN	O	smoking	nn	3	SENT_272	[p16l160t1172r2007b1203],
2	(	NN	O	(	nn	3	SENT_272	[p16l160t1172r2007b1203],
3	pack-yr	NN	O	pack-yr	_	0	SENT_272	[p16l160t1172r2007b1203],
4	)	CD	NUMBER	)	num	5	SENT_272	[p16l160t1172r2007b1203],
5	000O50010950530690035300000510000	NN	O	000o50010950530690035300000510000	dep	3	SENT_272	[p16l160t1172r2007b1203],

1	ALKFISH	NNP	O	ALKFISH	_	0	SENT_273	[p16l266t1232r391b1254],
2	EML4-ALK	NN	O	eml4-alk	nn	5	SENT_273	[p16l259t1291r395b1312],
3	6	CD	NUMBER	6	num	5	SENT_273	[p16l433t1290r445b1310],
4	Ul3U	NN	O	ul3u	nn	5	SENT_273	[p16l483t1290r602b1310],
5	Ul313l3U13U13U	NN	O	ul313l3u13u13u	dep	1	SENT_273	[p16l639t1290r1071b1310],
6	U1362013U	NN	O	u1362013u	nn	7	SENT_273	[p16l1108t1290r1383b1310],
7	U13136b61313	NN	O	u13136b61313	dep	5	SENT_273	[p16l1420t1289r1752b1310],
8	61313	CD	NUMBER	61313	num	9	SENT_273	[p16l1839t1291r1960b1310],
9	Breakpoint	NN	O	breakpoint	dep	1	SENT_273	[p16l255t1324r393b1354],

1	ALKExpression	NN	O	alkexpression	_	0	SENT_274	[p16l191t1383r391b1413],
2	2	CD	NUMBER	2	dep	1	SENT_274	[p16l425t1384r453b1403],
3	+	CC	O	+	_	0	SENT_274	[p16l425t1384r453b1403],
4	2	CD	NUMBER	2	conj_+	2	SENT_274	[p16l480t1384r509b1403],
5	+	CC	O	+	_	0	SENT_274	[p16l480t1384r509b1403],
6	2	CD	NUMBER	2	conj_+	2	SENT_274	[p16l529t1384r557b1404],
7	+	CC	O	+	_	0	SENT_274	[p16l529t1384r557b1404],
8	2	CD	NUMBER	2	conj_+	2	SENT_274	[p16l581t1384r609b1404],
9	+	CC	O	+	_	0	SENT_274	[p16l581t1384r609b1404],
10	1	CD	NUMBER	1	conj_+	4	SENT_274	[p16l634t1384r661b1403],
11	+	CC	O	+	_	0	SENT_274	[p16l634t1384r661b1403],
12	1	CD	NUMBER	1	conj_+	4	SENT_274	[p16l739t1384r765b1403],
13	+	CC	O	+	_	0	SENT_274	[p16l739t1384r765b1403],
14	1	CD	NUMBER	1	conj_+	12	SENT_274	[p16l791t1384r817b1404],
15	+	CC	O	+	_	0	SENT_274	[p16l791t1384r817b1404],
16	2	CD	NUMBER	2	conj_+	12	SENT_274	[p16l893t1384r921b1404],
17	+	CC	O	+	_	0	SENT_274	[p16l893t1384r921b1404],
18	2	CD	NUMBER	2	conj_+	12	SENT_274	[p16l945t1384r974b1404],
19	+	CC	O	+	_	0	SENT_274	[p16l945t1384r974b1404],
20	3	CD	NUMBER	3	conj_+	12	SENT_274	[p16l998t1384r1025b1404],
21	+	CC	O	+	_	0	SENT_274	[p16l998t1384r1025b1404],
22	1	CD	NUMBER	1	conj_+	20	SENT_274	[p16l1051t1384r1078b1404],
23	+	CC	O	+	_	0	SENT_274	[p16l1051t1384r1078b1404],
24	2	CD	NUMBER	2	conj_+	16	SENT_274	[p16l1153t1384r1182b1404],
25	+	CC	O	+	_	0	SENT_274	[p16l1153t1384r1182b1404],
26	3	CD	NUMBER	3	conj_+	20	SENT_274	[p16l1206t1384r1234b1404],
27	+	CC	O	+	_	0	SENT_274	[p16l1206t1384r1234b1404],
28	3	CD	NUMBER	3	conj_+	20	SENT_274	[p16l1258t1384r1286b1404],
29	+	CC	O	+	_	0	SENT_274	[p16l1258t1384r1286b1404],
30	1	CD	NUMBER	1	conj_+	28	SENT_274	[p16l1311t1384r1338b1404],
31	+	CC	O	+	_	0	SENT_274	[p16l1311t1384r1338b1404],
32	2	CD	NUMBER	2	conj_+	28	SENT_274	[p16l1466t1384r1494b1404],
33	+	CC	O	+	_	0	SENT_274	[p16l1466t1384r1494b1404],
34	2	CD	NUMBER	2	conj_+	28	SENT_274	[p16l1518t1385r1546b1404],
35	+	CC	O	+	_	0	SENT_274	[p16l1518t1385r1546b1404],
36	2	CD	NUMBER	2	conj_+	28	SENT_274	[p16l1570t1385r1598b1404],
37	+	CC	O	+	_	0	SENT_274	[p16l1570t1385r1598b1404],
38	3	CD	NUMBER	3	conj_+	36	SENT_274	[p16l1622t1384r1650b1404],
39	+	CC	O	+	_	0	SENT_274	[p16l1622t1384r1650b1404],
40	1	CD	NUMBER	1	conj_+	32	SENT_274	[p16l1676t1385r1702b1404],
41	+	CC	O	+	_	0	SENT_274	[p16l1676t1385r1702b1404],
42	2	CD	NUMBER	2	conj_+	36	SENT_274	[p16l1726t1385r1754b1404],
43	+	CC	O	+	_	0	SENT_274	[p16l1726t1385r1754b1404],
44	2	CD	NUMBER	2	conj_+	36	SENT_274	[p16l1778t1385r1806b1404],
45	+	CC	O	+	_	0	SENT_274	[p16l1778t1385r1806b1404],
46	2	CD	NUMBER	2	conj_+	44	SENT_274	[p16l1830t1385r1858b1404],
47	+	CC	O	+	_	0	SENT_274	[p16l1830t1385r1858b1404],
48	2	CD	NUMBER	2	conj_+	44	SENT_274	[p16l1934t1385r1962b1404],
49	+	CC	O	+	cc	48	SENT_274	[p16l1934t1385r1962b1404],
50	+	CC	O	+	rcmod	48	SENT_274	[p16l2000t1390r2015b1404],

1	Figure	NNP	O	Figure	_	0	SENT_275	[p16l122t1485r206b1517],
2	3	CD	NUMBER	3	dep	1	SENT_275	[p16l217t1487r239b1510],
3	.	.	O	.	_	0	SENT_275	[p16l217t1487r239b1510],

1	Best	JJS	O	best	_	0	SENT_276	[p16l252t1487r312b1510],
2	Response	NN	O	response	amod	1	SENT_276	[p16l324t1487r457b1517],
3	to	TO	O	to	_	0	SENT_276	[p16l466t1489r493b1510],
4	Crizotinib	NNP	O	Crizotinib	prep_to	2	SENT_276	[p16l503t1485r636b1510],
5	in	IN	O	in	_	0	SENT_276	[p16l648t1485r671b1509],
6	31	CD	NUMBER	31	num	7	SENT_276	[p16l683t1487r712b1510],
7	Patients	NNS	O	patient	prep_in	4	SENT_276	[p16l726t1485r836b1510],
8	with	IN	O	with	_	0	SENT_276	[p16l846t1485r905b1510],
9	ALK-Positive	JJ	O	alk-positive	amod	10	SENT_276	[p16l915t1485r1090b1510],
10	Tumors	NNS	O	tumor	prep_with	2	SENT_276	[p16l1099t1487r1213b1515],
11	,	,	O	,	_	0	SENT_276	[p16l1099t1487r1213b1515],
12	as	IN	O	as	mark	13	SENT_276	[p16l1224t1493r1253b1510],
13	Correlated	VBN	O	correlate	dep	10	SENT_276	[p16l1264t1485r1407b1510],
14	with	IN	O	with	_	0	SENT_276	[p16l1418t1485r1477b1510],
15	Clinicopathological	JJ	O	clinicopathological	amod	16	SENT_276	[p16l1488t1485r1753b1517],
16	Characteristics	NNS	O	characteristic	prep_with	13	SENT_276	[p16l1764t1485r1980b1510],
17	.	.	O	.	_	0	SENT_276	[p16l1764t1485r1980b1510],

1	Percent	NN	O	percent	nn	3	SENT_277	[p16l122t1537r224b1560],
2	tumor	NN	O	tumor	nn	3	SENT_277	[p16l234t1539r321b1560],
3	response	NN	O	response	nsubjpass	16	SENT_277	[p16l333t1543r465b1567],
4	,	,	O	,	_	0	SENT_277	[p16l333t1543r465b1567],
5	treatment	NN	O	treatment	nn	6	SENT_277	[p16l476t1539r614b1560],
6	duration	NN	O	duration	appos	3	SENT_277	[p16l625t1535r749b1564],
7	,	,	O	,	_	0	SENT_277	[p16l625t1535r749b1564],
8	smoking	NN	O	smoking	nn	9	SENT_277	[p16l763t1535r881b1568],
9	history	NN	O	history	appos	3	SENT_277	[p16l893t1535r992b1568],
10	,	,	O	,	_	0	SENT_277	[p16l893t1535r992b1568],
11	and	CC	O	and	_	0	SENT_277	[p16l1006t1535r1054b1560],
12	selected	VBN	O	select	amod	14	SENT_277	[p16l1067t1535r1180b1560],
13	tumor	NN	O	tumor	nn	14	SENT_277	[p16l1192t1539r1278b1560],
14	characteristics	NNS	O	characteristic	conj_and	6	SENT_277	[p16l1289t1535r1490b1560],
15	are	VBP	O	be	auxpass	16	SENT_277	[p16l1503t1543r1543b1560],
16	listed	VBN	O	list	_	0	SENT_277	[p16l1556t1535r1628b1560],
17	in	IN	O	in	_	0	SENT_277	[p16l1641t1537r1663b1559],
18	the	DT	O	the	det	19	SENT_277	[p16l1675t1535r1718b1560],
19	table	NN	O	table	prep_in	16	SENT_277	[p16l1729t1535r1797b1560],
20	below	IN	O	below	_	0	SENT_277	[p16l1809t1535r1890b1560],
21	the	DT	O	the	det	22	SENT_277	[p16l1899t1535r1943b1560],
22	graph	NN	O	graph	prep_below	16	SENT_277	[p16l1954t1535r2040b1568],
23	,	,	O	,	_	0	SENT_277	[p16l1954t1535r2040b1568],
24	with	IN	O	with	_	0	SENT_277	[p16l119t1576r176b1601],
25	each	DT	O	each	det	27	SENT_277	[p16l189t1576r251b1601],
26	table	NN	O	table	nn	27	SENT_277	[p16l263t1576r330b1601],
27	entry	NN	O	entry	prep_with	16	SENT_277	[p16l342t1581r412b1609],
28	corresponding	VBG	O	correspond	partmod	27	SENT_277	[p16l422t1576r625b1609],
29	to	TO	O	to	_	0	SENT_277	[p16l635t1581r661b1601],
30	a	DT	O	a	det	31	SENT_277	[p16l673t1585r686b1601],
31	patient	NN	O	patient	prep_to	28	SENT_277	[p16l699t1579r795b1609],
32	in	IN	O	in	_	0	SENT_277	[p16l807t1579r828b1601],
33	the	DT	O	the	det	34	SENT_277	[p16l840t1576r884b1601],
34	graph	NN	O	graph	prep_in	31	SENT_277	[p16l895t1576r973b1609],
35	above	IN	O	above	prep	28	SENT_277	[p16l986t1576r1074b1601],
36	.	.	O	.	_	0	SENT_277	[p16l986t1576r1074b1601],

1	Patients	NNS	O	patient	nsubjpass	3	SENT_278	[p16l1088t1579r1198b1601],
2	are	VBP	O	be	auxpass	3	SENT_278	[p16l1210t1585r1251b1601],
3	listed	VBN	O	list	_	0	SENT_278	[p16l1263t1576r1335b1601],
4	in	IN	O	in	_	0	SENT_278	[p16l1349t1579r1370b1601],
5	order	NN	O	order	nn	8	SENT_278	[p16l1383t1576r1457b1601],
6	ofincreasing	NN	O	ofincreasing	nn	8	SENT_278	[p16l1468t1576r1646b1609],
7	percen	NN	O	percen	nn	8	SENT_278	[p16l1659t1585r1749b1609],
8	response	NN	O	response	prep_in	3	SENT_278	[p16l1823t1585r1948b1609],
9	to	TO	O	to	_	0	SENT_278	[p16l1958t1581r1985b1601],
10	crizotinib	NN	O	crizotinib	prep_to	3	SENT_278	[p16l120t1618r256b1648],
11	,	,	O	,	_	0	SENT_278	[p16l120t1618r256b1648],
12	with	IN	O	with	_	0	SENT_278	[p16l268t1618r325b1643],
13	listed	VBN	O	list	prepc_with	3	SENT_278	[p16l339t1618r411b1643],
14	'	''	O	'	_	0	SENT_278	[p16l470t1620r473b1624],
15	nt	NNS	O	nt	nn	16	SENT_278	[p16l495t1623r520b1643],
16	numbers	NNS	O	number	dobj	13	SENT_278	[p16l532t1618r654b1643],
17	correspondi	NN	O	correspondus	nn	18	SENT_278	[p16l666t1618r831b1651],
18	o	NN	O	o	npadvmod	13	SENT_278	[p16l890t1627r905b1643],
19	those	DT	O	those	dep	18	SENT_278	[p16l916t1618r992b1643],
20	in	IN	O	in	_	0	SENT_278	[p16l1004t1620r1026b1643],
21	Fi	NNP	O	Fi	nn	22	SENT_278	[p16l1041t1620r1061b1643],
22	2A	NN	O	2a	prep_in	13	SENT_278	[p16l1137t1620r1181b1643],
23	.	.	O	.	_	0	SENT_278	[p16l1137t1620r1181b1643],

1	Smoking	NN	O	smoking	nn	2	SENT_279	[p16l1193t1618r1315b1651],
2	history	NN	O	history	nsubjpass	4	SENT_279	[p16l1327t1618r1421b1651],
3	is	VBZ	O	be	auxpass	4	SENT_279	[p16l1433t1620r1452b1643],
4	reported	VBN	O	report	_	0	SENT_279	[p16l1465t1618r1582b1651],
5	i	FW	O	i	nn	6	SENT_279	[p16l1596t1620r1600b1643],
6	ck-yea	FW	O	ck-yea	dobj	4	SENT_279	[p16l1665t1618r1748b1651],
7	.	.	O	.	_	0	SENT_279	[p16l1778t1639r1783b1643],

1	he	PRP	O	he	_	0	SENT_280	[p16l1815t1618r1845b1643],
2	EML4-ALK	NN	O	eml4-alk	dep	1	SENT_280	[p16l1858t1620r2005b1643],

1	e	SYM	O	e	dep	3	SENT_281	[p16l492t1668r505b1685],
2	EML4	NN	O	eml4	nn	3	SENT_281	[p16l518t1662r595b1684],
3	exon	NN	O	exon	_	0	SENT_281	[p16l605t1668r668b1685],
4	that	WDT	O	that	nsubj	7	SENT_281	[p16l679t1660r734b1685],
5	is	VBZ	O	be	cop	7	SENT_281	[p16l746t1662r765b1685],
6	fuse	NN	O	fuse	nn	7	SENT_281	[p16l776t1659r834b1685],
7	genotype	NN	O	genotype	rcmod	3	SENT_281	[p16l120t1664r248b1693],
8	is	VBZ	O	be	auxpass	9	SENT_281	[p16l260t1662r279b1685],
9	reported	VBN	O	report	rcmod	7	SENT_281	[p16l293t1660r410b1692],
10	a	DT	O	a	dobj	9	SENT_281	[p16l423t1668r436b1685],
11	ALK	NNP	O	ALK	dep	17	SENT_281	[p16l899t1661r962b1689],
12	,	,	O	,	_	0	SENT_281	[p16l899t1661r962b1689],
13	as	IN	O	as	_	0	SENT_281	[p16l976t1668r1003b1685],
14	ass	NN	O	ass	prep_as	11	SENT_281	[p16l1016t1668r1058b1685],
15	by	IN	O	by	_	0	SENT_281	[p16l1136t1660r1164b1692],
16	nucleotide	NN	O	nucleotide	prep_by	14	SENT_281	[p16l1176t1660r1321b1685],
17	se	FW	O	se	dep	10	SENT_281	[p16l1332t1668r1360b1685],
18	ncing	NN	O	ncing	dep	17	SENT_281	[p16l1417t1662r1491b1693],
19	of	IN	O	of	_	0	SENT_281	[p16l1502t1659r1532b1685],
20	RT-P	NN	O	rt-p	nn	21	SENT_281	[p16l1541t1662r1602b1684],
21	products	NNS	O	product	prep_of	18	SENT_281	[p16l1655t1660r1785b1692],
22	.	.	O	.	_	0	SENT_281	[p16l1655t1660r1785b1692],

1	U	NNP	O	U	nsubj	2	SENT_282	[p16l1800t1662r1817b1685],
2	denotes	VBZ	O	denote	_	0	SENT_282	[p16l1830t1660r1940b1685],
3	undetermined	JJ	O	undetermined	amod	9	SENT_282	[p16l1953t1660r2031b1685, p16l119t1701r244b1726],
4	for	IN	O	for	_	0	SENT_282	[p16l257t1701r295b1726],
5	patients	NNS	O	patient	prep_for	3	SENT_282	[p16l307t1704r417b1734],
6	for	IN	O	for	_	0	SENT_282	[p16l428t1701r467b1726],
7	whom	WP	O	whom	prep_for	5	SENT_282	[p16l476t1701r561b1726],
8	RT-PCR	NN	O	rt-pcr	nn	9	SENT_282	[p16l576t1703r677b1726],
9	assays	NNS	O	assay	dobj	2	SENT_282	[p16l689t1710r776b1734],
10	using	VBG	O	use	xcomp	2	SENT_282	[p16l789t1704r863b1734],
11	primers	NNS	O	primer	dobj	10	SENT_282	[p16l875t1704r981b1734],
12	to	TO	O	to	_	0	SENT_282	[p16l992t1706r1019b1726],
13	ALK	NNP	O	ALK	nn	14	SENT_282	[p16l1028t1703r1087b1726],
14	exon	NN	O	exon	prep_to	10	SENT_282	[p16l1095t1710r1158b1726],
15	20	CD	NUMBER	20	num	19	SENT_282	[p16l1170t1703r1202b1726],
16	alon	NN	O	alon	nn	19	SENT_282	[p16l1213t1701r1270b1726],
17	ith	NN	O	ith	nn	19	SENT_282	[p16l1324t1701r1356b1726],
18	L4	NN	O	l4	nn	19	SENT_282	[p16l1417t1704r1447b1726],
19	exons	NNS	O	exon	dep	14	SENT_282	[p16l1458t1710r1536b1726],
20	6	CD	NUMBER	6	tmod	10	SENT_282	[p16l1549t1703r1570b1731],
21	,	,	O	,	_	0	SENT_282	[p16l1549t1703r1570b1731],
22	13	CD	NUMBER	13	appos	20	SENT_282	[p16l1585t1703r1621b1731],
23	,	,	O	,	_	0	SENT_282	[p16l1585t1703r1621b1731],
24	and	CC	O	and	_	0	SENT_282	[p16l1634t1701r1682b1726],
25	roduced	VBD	O	roduce	conj_and	2	SENT_282	[p16l1757t1701r1868b1726],
26	no	DT	O	no	det	27	SENT_282	[p16l1882t1710r1915b1726],
27	product	NN	O	product	dobj	25	SENT_282	[p16l1928t1701r2043b1734],
28	.	.	O	.	_	0	SENT_282	[p16l1928t1701r2043b1734],

1	Blank	NNP	O	Blank	nn	2	SENT_283	[p16l122t1743r196b1768],
2	fields	NNS	O	field	nsubj	3	SENT_283	[p16l206t1743r281b1768],
3	indicate	VBP	O	indicate	_	0	SENT_283	[p16l294t1743r402b1768],
4	that	IN	O	that	complm	10	SENT_283	[p16l413t1743r467b1768],
5	adequate	JJ	O	adequate	amod	7	SENT_283	[p16l478t1743r605b1776],
6	tumor	NN	O	tumor	nn	7	SENT_283	[p16l615t1748r702b1768],
7	samples	NNS	O	sample	nsubj	10	SENT_283	[p16l713t1743r826b1776],
8	were	VBD	O	be	cop	10	SENT_283	[p16l837t1752r902b1768],
9	not	RB	O	not	neg	10	SENT_283	[p16l915t1748r959b1768],
10	available	JJ	O	available	ccomp	3	SENT_283	[p16l970t1743r1088b1768],
11	for	IN	O	for	_	0	SENT_283	[p16l1099t1743r1138b1768],
12	analysis	NN	O	analysis	prep_for	10	SENT_283	[p16l1149t1743r1264b1776],
13	.	.	O	.	_	0	SENT_283	[p16l1149t1743r1264b1776],

1	expression	NN	O	expression	nsubjpass	3	SENT_284	[p16l1342t1745r1488b1776],
2	is	VBZ	O	be	auxpass	3	SENT_284	[p16l1502t1745r1521b1768],
3	reported	VBN	O	report	_	0	SENT_284	[p16l1535t1743r1652b1776],
4	as	IN	O	as	prep	3	SENT_284	[p16l1665t1752r1693b1768],
5	,	,	O	,	_	0	SENT_284	[p16l1723t1764r1727b1773],
6	+	CC	O	+	_	0	SENT_284	[p16l1755t1751r1777b1773],
7	,	,	O	,	_	0	SENT_284	[p16l1755t1751r1777b1773],
8	2	CD	NUMBER	2	conj_+	3	SENT_284	[p16l1790t1745r1828b1773],
9	+	CC	O	+	_	0	SENT_284	[p16l1790t1745r1828b1773],
10	,	,	O	,	_	0	SENT_284	[p16l1790t1745r1828b1773],
11	or	CC	O	or	_	0	SENT_284	[p16l1841t1752r1869b1768],
12	3	CD	NUMBER	3	conj_+	3	SENT_284	[p16l1880t1745r1918b1773],
13	+	CC	O	+	cc	12	SENT_284	[p16l1880t1745r1918b1773],
14	,	,	O	,	_	0	SENT_284	[p16l1880t1745r1918b1773],
15	per	IN	O	per	_	0	SENT_284	[p16l1932t1752r1976b1776],
16	convention	NN	O	convention	prep_per	8	SENT_284	[p16l1986t1752r2045b1768, p16l119t1787r221b1810],
17	for	IN	O	for	_	0	SENT_284	[p16l233t1784r272b1810],
18	immunohistochemical	JJ	O	immunohistochemical	amod	19	SENT_284	[p16l284t1785r595b1810],
19	analysis	NN	O	analysis	prep_for	3	SENT_284	[p16l608t1785r724b1817],
20	.	.	O	.	_	0	SENT_284	[p16l608t1785r724b1817],

1	that	WDT	O	that	nsubj	2	SENT_285	[p16l11t2044r180b2123],
2	had	VBD	O	have	_	0	SENT_285	[p16l206t2044r361b2124],
3	sufficient	JJ	O	sufficient	amod	4	SENT_285	[p16l393t2043r795b2124],
4	tissue	NN	O	tissue	dobj	2	SENT_285	[p16l822t2045r1063b2124],
5	available	JJ	O	available	amod	7	SENT_285	[p16l1093t2044r1457b2124],
6	(	NN	O	(	nn	7	SENT_285	[p16l1493t2045r1668b2146],
7	Fig	NN	O	fig	dep	4	SENT_285	[p16l1493t2045r1668b2146],
8	.	.	O	.	_	0	SENT_285	[p16l1493t2045r1668b2146],

1	1D	NN	O	1d	_	0	SENT_286	[p16l1707t2050r1825b2123],
2	and	CC	O	and	_	0	SENT_286	[p16l1856t2044r2013b2124],
3	3	CD	NUMBER	3	num	4	SENT_286	[p16l2044t2051r2143b2136],
4	)	NN	O	)	conj_and	1	SENT_286	[p16l2044t2051r2143b2136],
5	.	.	O	.	_	0	SENT_286	[p16l2044t2051r2143b2136],

1	FISH	NN	O	fish	nsubj	17	SENT_287	[p16l8t2174r611b2274],
2	—	CD	NUMBER	—	num	4	SENT_287	[p16l8t2174r611b2274],
3	negative	JJ	O	negative	amod	4	SENT_287	[p16l8t2174r611b2274],
4	samples	NNS	O	sample	nsubj	11	SENT_287	[p16l658t2173r1005b2273],
5	and	CC	O	and	_	0	SENT_287	[p16l1053t2173r1212b2252],
6	normal	JJ	O	normal	amod	8	SENT_287	[p16l1258t2173r1574b2252],
7	lung	NN	O	lung	nn	8	SENT_287	[p16l1618t2173r1813b2274],
8	tissues	NNS	O	tissue	conj_and	4	SENT_287	[p16l1856t2174r2147b2252],
9	did	VBD	O	do	aux	11	SENT_287	[p16l11t2301r146b2380],
10	not	RB	O	not	neg	11	SENT_287	[p16l181t2318r324b2380],
11	express	VB	O	express	rcmod	1	SENT_287	[p16l355t2327r674b2401],
12	ALK	NN	O	alk	nn	13	SENT_287	[p16l707t2309r900b2382],
13	protein	NN	O	protein	dobj	11	SENT_287	[p16l930t2302r1243b2401],
14	(	CD	NUMBER	(	num	15	SENT_287	[p16l1283t2301r1493b2392],
15	data	NNS	O	datum	npadvmod	16	SENT_287	[p16l1283t2301r1493b2392],
16	not	RB	O	not	neg	17	SENT_287	[p16l1526t2318r1670b2380],
17	shown	VBN	O	show	_	0	SENT_287	[p16l1702t2301r2036b2392],
18	)	NN	O	)	dobj	17	SENT_287	[p16l1702t2301r2036b2392],
19	.	.	O	.	_	0	SENT_287	[p16l1702t2301r2036b2392],

1	Because	IN	O	because	mark	4	SENT_288	[p16l138t2436r478b2509],
2	Crizotinib	NNP	O	Crizotinib	nsubj	4	SENT_288	[p16l516t2430r930b2509],
3	also	RB	O	also	advmod	4	SENT_288	[p16l967t2430r1137b2509],
4	inhibits	VBZ	O	inhibit	advcl	18	SENT_288	[p16l1174t2430r1499b2509],
5	the	DT	O	the	det	8	SENT_288	[p16l1539t2430r1670b2508],
6	MET	NN	O	met	nn	8	SENT_288	[p16l1705t2436r1910b2508],
7	tyrosine	NN	O	tyrosine	nn	8	SENT_288	[p16l1945t2447r2147b2530, p16l11t2559r181b2636],
8	kinase	NN	O	kinase	dobj	4	SENT_288	[p16l220t2558r524b2654],
9	,	,	O	,	_	0	SENT_288	[p16l220t2558r524b2654],
10	tumors	NNS	O	tumor	nsubjpass	18	SENT_288	[p16l568t2575r878b2638],
11	from	IN	O	from	_	0	SENT_288	[p16l919t2557r1130b2637],
12	33	CD	NUMBER	33	num	13	SENT_288	[p16l1170t2564r1264b2637],
13	patients	NNS	O	patient	prep_from	10	SENT_288	[p16l1305t2559r1649b2658],
14	with	IN	O	with	_	0	SENT_288	[p16l1685t2558r1882b2638],
15	available	JJ	O	available	amod	16	SENT_288	[p16l1919t2558r2147b2638, p16l9t2686r178b2765],
16	tissue	NN	O	tissue	prep_with	13	SENT_288	[p16l215t2687r457b2765],
17	were	VBD	O	be	auxpass	18	SENT_288	[p16l489t2712r690b2766],
18	tested	VBN	O	test	_	0	SENT_288	[p16l727t2686r977b2765],
19	for	IN	O	for	_	0	SENT_288	[p16l1013t2685r1135b2765],
20	MET	NN	O	met	nn	21	SENT_288	[p16l1168t2693r1363b2765],
21	amplification	NN	O	amplification	prep_for	18	SENT_288	[p16l1389t2685r1987b2786],
22	.	.	O	.	_	0	SENT_288	[p16l1389t2685r1987b2786],

1	All	DT	O	all	det	2	SENT_289	[p16l2025t2686r2149b2764],
2	samples	NNS	O	sample	nsubj	4	SENT_289	[p16l11t2815r352b2915],
3	were	VBD	O	be	cop	4	SENT_289	[p16l415t2841r616b2894],
4	negative	JJ	O	negative	_	0	SENT_289	[p16l682t2816r1052b2916],
5	,	,	O	,	_	0	SENT_289	[p16l682t2816r1052b2916],
6	arguing	VBG	O	argue	xcomp	4	SENT_289	[p16l1123t2816r1462b2916],
7	against	IN	O	against	_	0	SENT_289	[p16l1524t2816r1836b2916],
8	crizotinib	JJ	O	crizotinib	poss	12	SENT_289	[p16l1897t2816r2147b2894, p16l11t2943r277b3022],
9	’s	POS	O	’s	_	0	SENT_289	[p16l1897t2816r2147b2894, p16l11t2943r277b3022],
10	MET	NN	O	met	nn	12	SENT_289	[p16l320t2949r528b3022],
11	inhibitory	JJ	O	inhibitory	amod	12	SENT_289	[p16l569t2943r1004b3043],
12	activity	NN	O	activity	prep_against	6	SENT_289	[p16l1043t2944r1355b3043],
13	as	IN	O	as	_	0	SENT_289	[p16l1394t2969r1480b3021],
14	a	DT	O	a	det	15	SENT_289	[p16l1525t2969r1570b3021],
15	determinant	NN	O	determinant	prep_as	12	SENT_289	[p16l1613t2943r2153b3022],
16	of	IN	O	of	_	0	SENT_289	[p16l11t3070r111b3150],
17	response	NN	O	response	prep_of	15	SENT_289	[p16l136t3097r519b3171],
18	in	IN	O	in	_	0	SENT_289	[p16l562t3072r647b3149],
19	these	DT	O	these	det	20	SENT_289	[p16l690t3071r916b3149],
20	patients	NNS	O	patient	prep_in	6	SENT_289	[p16l957t3072r1326b3171],
21	.	.	O	.	_	0	SENT_289	[p16l957t3072r1326b3171],

1	In	IN	O	in	_	0	SENT_290	[p16l1374t3079r1463b3149],
2	addition	NN	O	addition	prep_in	20	SENT_290	[p16l1507t3071r1889b3167],
3	,	,	O	,	_	0	SENT_290	[p16l1507t3071r1889b3167],
4	none	NN	O	none	nsubj	20	SENT_290	[p16l1938t3097r2148b3150],
5	of	IN	O	of	_	0	SENT_290	[p16l11t3199r111b3280],
6	the	DT	O	the	det	7	SENT_290	[p16l147t3200r281b3279],
7	patients	NNS	O	patient	prep_of	4	SENT_290	[p16l335t3201r679b3301],
8	with	IN	O	with	_	0	SENT_290	[p16l731t3200r928b3280],
9	ALK	NN	O	alk	nn	10	SENT_290	[p16l975t3207r1151b3279],
10	rearrangement	NN	O	rearrangement	prep_with	7	SENT_290	[p16l1197t3217r1844b3302],
11	had	VBD	O	have	aux	20	SENT_290	[p16l1894t3200r2052b3280],
12	a	DT	O	a	det	14	SENT_290	[p16l2105t3227r2150b3279],
13	concurrent	JJ	O	concurrent	amod	14	SENT_290	[p16l11t3346r485b3409],
14	mutation	NN	O	mutation	dobj	20	SENT_290	[p16l528t3330r924b3408],
15	in	IN	O	in	_	0	SENT_290	[p16l972t3330r1056b3407],
16	EGFR	NN	ORGANIZATION	egfr	prep_in	20	SENT_290	[p16l1102t3335r1316b3409],
17	(	CD	NUMBER	(	num	18	SENT_290	[p16l1363t3329r1572b3420],
18	data	NNS	O	datum	npadvmod	19	SENT_290	[p16l1363t3329r1572b3420],
19	not	RB	O	not	neg	20	SENT_290	[p16l1620t3346r1763b3408],
20	shown	VBN	O	show	_	0	SENT_290	[p16l1808t3329r2143b3420],
21	)	NN	O	)	dobj	20	SENT_290	[p16l1808t3329r2143b3420],
22	.	.	O	.	_	0	SENT_290	[p16l1808t3329r2143b3420],

1	This	DT	O	this	det	2	SENT_291	[p16l7t3458r195b3537],
2	finding	NN	O	finding	nsubj	4	SENT_291	[p16l259t3457r586b3560],
3	was	VBD	O	be	cop	4	SENT_291	[p16l640t3485r804b3538],
4	noteworthy	JJ	O	noteworthy	_	0	SENT_291	[p16l869t3458r1380b3559],
5	,	,	O	,	_	0	SENT_291	[p16l869t3458r1380b3559],
6	since	IN	O	since	mark	9	SENT_291	[p16l1450t3459r1666b3537],
7	these	DT	O	these	det	8	SENT_291	[p16l1729t3458r1954b3537],
8	patients	NNS	O	patient	nsubj	9	SENT_291	[p16l2015t3484r2147b3559, p16l11t3587r248b3664],
9	shared	VBD	O	share	advcl	4	SENT_291	[p16l305t3586r592b3665],
10	several	JJ	O	several	amod	13	SENT_291	[p16l646t3586r940b3666],
11	key	JJ	O	key	amod	13	SENT_291	[p16l992t3586r1138b3686],
12	clinical	JJ	O	clinical	amod	13	SENT_291	[p16l1187t3586r1503b3664],
13	features	NNS	O	feature	nsubj	19	SENT_291	[p16l1555t3585r1901b3666],
14	with	IN	O	with	_	0	SENT_291	[p16l1951t3586r2148b3666],
15	patients	NNS	O	patient	prep_with	13	SENT_291	[p17l6t23r351b124],
16	with	IN	O	with	_	0	SENT_291	[p17l400t23r597b103],
17	EGFR	NN	ORGANIZATION	egfr	nn	18	SENT_291	[p17l648t30r862b103],
18	mutations	NNS	O	mutation	prep_with	15	SENT_291	[p17l908t23r1346b103],
19	(	VBP	O	(	ccomp	9	SENT_291	[p17l1405t22r2152b115],
20	adenocarcinoma	NN	O	adenocarcinoma	nn	21	SENT_291	[p17l1405t22r2152b115],
21	histology	NN	O	histology	dobj	19	SENT_291	[p17l7t153r414b254],
22	and	CC	O	and	_	0	SENT_291	[p17l449t153r608b232],
23	nonsmoking	JJ	O	nonsmoking	amod	25	SENT_291	[p17l648t153r1200b254],
24	history	NN	O	history	nn	25	SENT_291	[p17l1236t153r1591b254],
25	)	NN	O	)	dobj	19	SENT_291	[p17l1236t153r1591b254],
26	.	.	O	.	_	0	SENT_291	[p17l1236t153r1591b254],

1	SAFETY	NN	O	safety	nsubjpass	24	SENT_292	[p17l8t431r295b481],
2	AND	CC	O	and	_	0	SENT_292	[p17l325t431r496b481],
3	ADVERSE	JJ	O	adverse	amod	4	SENT_292	[p17l529t431r883b482],
4	EVENTS	NNS	O	event	nsubjpass	24	SENT_292	[p17l922t431r1218b482],
5	Safety	NN	O	safety	nn	6	SENT_292	[p17l10t532r272b634],
6	data	NNS	O	datum	dep	4	SENT_292	[p17l320t533r504b612],
7	from	IN	O	from	_	0	SENT_292	[p17l554t532r766b612],
8	82	CD	NUMBER	82	num	9	SENT_292	[p17l818t538r916b612],
9	patients	NNS	O	patient	prep_from	1	SENT_292	[p17l967t533r1312b634],
10	who	WP	O	who	nsubjpass	12	SENT_292	[p17l1360t533r1545b613],
11	were	VBD	O	be	auxpass	12	SENT_292	[p17l1593t559r1796b613],
12	treated	VBN	O	treat	rcmod	9	SENT_292	[p17l1848t532r2149b612],
13	primarily	RB	O	primarily	advmod	12	SENT_292	[p17l6t662r415b764],
14	with	IN	O	with	_	0	SENT_292	[p17l446t663r643b743],
15	250	CD	NUMBER	250	num	16	SENT_292	[p17l681t668r834b742],
16	mg	NN	O	mg	prep_with	12	SENT_292	[p17l874t689r1014b764],
17	twice	RB	O	twice	advmod	18	SENT_292	[p17l1050t663r1279b743],
18	daily	RB	SET	daily	advmod	1	SENT_292	[p17l1319t663r1528b764],
19	in	IN	O	in	_	0	SENT_292	[p17l1563t663r1646b741],
20	the	DT	O	the	det	22	SENT_292	[p17l1685t663r1820b742],
21	expansion	NN	O	expansion	nn	22	SENT_292	[p17l1860t688r2148b764, p17l9t793r186b872],
22	cohort	NN	O	cohort	prep_in	18	SENT_292	[p17l217t793r501b872],
23	are	VBP	O	be	auxpass	24	SENT_292	[p17l524t819r654b872],
24	shown	VBN	O	show	_	0	SENT_292	[p17l686t793r970b873],
25	in	IN	O	in	_	0	SENT_292	[p17l999t793r1083b871],
26	Table	NNP	O	Table	prep_in	24	SENT_292	[p17l1110t793r1346b872],
27	2	CD	NUMBER	2	num	26	SENT_292	[p17l1378t798r1450b872],
28	.	.	O	.	_	0	SENT_292	[p17l1378t798r1450b872],

1	Grade	NNP	O	Grade	nn	3	SENT_293	[p17l1486t793r1743b872],
2	1	CD	NUMBER	1	num	3	SENT_293	[p17l1776t798r1821b871],
3	nausea	NN	O	nausea	nsubj	6	SENT_293	[p17l1852t818r2151b873],
4	and	CC	O	and	_	0	SENT_293	[p17l7t923r166b1002],
5	diarrhea	NN	O	diarrhea	conj_and	3	SENT_293	[p17l207t923r572b1002],
6	were	VBD	O	be	_	0	SENT_293	[p17l607t949r810b1003],
7	the	DT	O	the	det	12	SENT_293	[p17l852t923r985b1002],
8	most	RBS	O	most	advmod	10	SENT_293	[p17l1026t939r1244b1002],
9	commonly	RB	O	commonly	advmod	10	SENT_293	[p17l1280t923r1744b1024],
10	reported	VBN	O	report	amod	12	SENT_293	[p17l1780t922r2149b1024],
11	side	JJ	O	side	amod	12	SENT_293	[p17l9t1053r171b1132],
12	effects	NNS	O	effect	dep	6	SENT_293	[p17l205t1052r506b1132],
13	.	.	O	.	_	0	SENT_293	[p17l205t1052r506b1132],

1	Mild	JJ	O	mild	amod	3	SENT_294	[p17l542t1053r740b1132],
2	visual	JJ	O	visual	amod	3	SENT_294	[p17l768t1053r1016b1133],
3	disturbances	NNS	O	disturbance	nsubjpass	5	SENT_294	[p17l1050t1052r1593b1133],
4	were	VBD	O	be	auxpass	5	SENT_294	[p17l1623t1079r1824b1133],
5	reported	VBN	O	report	_	0	SENT_294	[p17l1857t1069r2148b1154, p17l8t1182r105b1262],
6	by	IN	O	by	_	0	SENT_294	[p17l145t1183r243b1284],
7	34	CD	NUMBER	34	num	8	SENT_294	[p17l278t1188r380b1262],
8	patients	NNS	O	patient	agent	5	SENT_294	[p17l416t1183r761b1284],
9	(	IN	O	(	_	0	SENT_294	[p17l807t1188r1057b1275],
10	41	CD	NUMBER	41	number	11	SENT_294	[p17l807t1188r1057b1275],
11	°	CD	NUMBER	°	prep_(	5	SENT_294	[p17l807t1188r1057b1275],
12	/	:	O	/	punct	14	SENT_294	[p17l807t1188r1057b1275],
13	o	NN	O	o	nn	14	SENT_294	[p17l807t1188r1057b1275],
14	)	NN	O	)	dep	11	SENT_294	[p17l807t1188r1057b1275],
15	.	.	O	.	_	0	SENT_294	[p17l807t1188r1057b1275],

1	These	DT	O	these	det	2	SENT_295	[p17l1098t1183r1352b1262],
2	events	NNS	O	event	nsubjpass	6	SENT_295	[p17l1391t1199r1657b1263],
3	were	VBD	O	be	auxpass	6	SENT_295	[p17l1693t1209r1897b1263],
4	most	RBS	O	most	advmod	5	SENT_295	[p17l1936t1199r2154b1262],
5	frequently	RB	O	frequently	advmod	6	SENT_295	[p17l7t1312r451b1414],
6	described	VBN	O	describe	_	0	SENT_295	[p17l494t1312r908b1392],
7	as	IN	O	as	mark	8	SENT_295	[p17l955t1339r1041b1392],
8	trails	VBZ	O	trail	advcl	6	SENT_295	[p17l1090t1313r1311b1392],
9	of	IN	O	of	_	0	SENT_295	[p17l1361t1312r1462b1392],
10	light	NN	O	light	prep_of	8	SENT_295	[p17l1489t1313r1692b1414],
11	following	VBG	O	follow	_	0	SENT_295	[p17l1733t1312r2153b1414],
12	objects	NNS	O	object	prep_following	10	SENT_295	[p17l8t1443r307b1543],
13	moving	VBG	O	move	partmod	12	SENT_295	[p17l351t1443r679b1543],
14	relative	JJ	O	relative	advmod	13	SENT_295	[p17l718t1443r1029b1521],
15	to	TO	O	to	_	0	SENT_295	[p17l1072t1459r1154b1521],
16	the	DT	O	the	det	17	SENT_295	[p17l1197t1443r1331b1521],
17	observer	NN	O	observer	prep_to	14	SENT_295	[p17l1374t1443r1761b1538],
18	,	,	O	,	_	0	SENT_295	[p17l1374t1443r1761b1538],
19	particularly	RB	O	particularly	advmod	20	SENT_295	[p17l1806t1443r2148b1543, p17l6t1572r197b1673],
20	noticed	VBN	O	notice	partmod	17	SENT_295	[p17l228t1572r549b1651],
21	during	IN	O	during	_	0	SENT_295	[p17l586t1572r877b1673],
22	changes	NNS	O	change	prep_during	20	SENT_295	[p17l911t1572r1261b1673],
23	in	IN	O	in	_	0	SENT_295	[p17l1299t1572r1383b1650],
24	ambient	JJ	O	ambient	amod	25	SENT_295	[p17l1418t1571r1775b1651],
25	lighting	NN	O	lighting	prep_in	22	SENT_295	[p17l1805t1571r2153b1673],

1	N	NN	O	n	nn	3	SENT_296	[p17l546t1759r559b1774],
2	ENGLJ	NN	O	englj	nn	3	SENT_296	[p17l574t1759r652b1781],
3	MED	NN	O	med	_	0	SENT_296	[p17l667t1759r719b1774],
4	3	CD	NUMBER	3	num	6	SENT_296	[p17l759t1753r806b1781],
5	;	:	O	;	_	0	SENT_296	[p17l759t1753r806b1781],
6	18	CD	NUMBER	18	dep	3	SENT_296	[p17l759t1753r806b1781],
7	NEjM	NNP	O	NEjM	nn	10	SENT_296	[p17l841t1759r965b1781],
8	,	,	O	,	_	0	SENT_296	[p17l841t1759r965b1781],
9	ORG	NNP	O	ORG	appos	10	SENT_296	[p17l841t1759r965b1781],
10	OCTOBER	NNP	DATE	OCTOBER	dep	3	SENT_296	[p17l1000t1759r1112b1775],
11	28,2010	CD	DATE	28,2010	number	12	SENT_296	[p17l1123t1753r1229b1779],
12	1599	CD	DATE	1599	dep	10	SENT_296	[p17l1940t1748r2016b1772],

1	e	LS	O	e	dep	4	SENT_297	[p17l739t1800r753b1816],
2	New	NNP	O	New	nn	4	SENT_297	[p17l762t1793r824b1816],
3	England	NNP	O	England	nn	4	SENT_297	[p17l833t1792r944b1823],
4	Joumal	NNP	O	Joumal	_	0	SENT_297	[p17l953t1792r1050b1816],
5	of	IN	O	of	prep	4	SENT_297	[p17l1060t1792r1089b1816],
6	Medicine	NNP	O	Medicine	dep	4	SENT_297	[p17l1095t1792r1220b1816],

1	The	DT	O	the	det	4	SENT_298	[p17l673t1980r718b2001],
2	NEW	NNP	O	NEW	nn	4	SENT_298	[p17l737t1982r822b2001],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_298	[p17l841t1982r1029b2001],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_298	[p17l1048t1982r1227b2008],
5	of	IN	O	of	_	0	SENT_298	[p17l1247t1980r1275b2007],
6	MEDICINE	NNP	O	MEDICINE	prep_of	4	SENT_298	[p17l1287t1982r1486b2001],

1	Table	NNP	O	Table	_	0	SENT_299	[p18l59t132r201b180],
2	2	CD	NUMBER	2	dep	1	SENT_299	[p18l218t136r262b180],
3	.	.	O	.	_	0	SENT_299	[p18l218t136r262b180],

1	Adverse	JJ	O	adverse	amod	2	SENT_300	[p18l280t132r492b180],
2	Events	NNS	O	event	_	0	SENT_300	[p18l512t136r683b180],
3	in	IN	O	in	_	0	SENT_300	[p18l703t133r747b179],
4	the	DT	O	the	det	6	SENT_300	[p18l766t132r850b180],
5	82	CD	NUMBER	82	num	6	SENT_300	[p18l867t135r928b180],
6	Patients	NNS	O	patient	prep_in	2	SENT_300	[p18l950t133r1207b180],
7	.	.	O	.	_	0	SENT_300	[p18l950t133r1207b180],

1	*	NN	O	*	_	0	SENT_301	[p18l950t133r1207b180],

1	Adverse	JJ	O	adverse	amod	5	SENT_302	[p18l59t276r270b325],
2	Event	NN	O	event	nn	5	SENT_302	[p18l294t281r438b325],
3	Grade	NNP	O	Grade	nn	5	SENT_302	[p18l709t276r868b325],
4	1	CD	NUMBER	1	num	5	SENT_302	[p18l891t281r914b324],
5	Grade	NNP	O	Grade	dep	12	SENT_302	[p18l998t276r1157b325],
6	2	CD	NUMBER	2	num	9	SENT_302	[p18l1176t281r1206b324],
7	Grade	NNP	O	Grade	nn	9	SENT_302	[p18l1287t276r1446b325],
8	3	CD	NUMBER	3	num	9	SENT_302	[p18l1467t281r1492b325],
9	Grade	NNP	O	Grade	dep	5	SENT_302	[p18l1576t276r1735b325],
10	4	CD	NUMBER	4	dep	12	SENT_302	[p18l1754t281r1785b324],
11	Total	JJ	O	total	amod	12	SENT_302	[p18l1917t276r2046b325],
12	no.	NN	O	no.	dep	16	SENT_302	[p18l1171t405r1242b436],
13	of	IN	O	of	_	0	SENT_302	[p18l1266t387r1324b452],
14	patients	NNS	O	patient	prep_of	12	SENT_302	[p18l1325t390r1525b451],
15	(	CD	PERCENT	(	num	16	SENT_302	[p18l1548t390r1635b451],
16	%	NN	PERCENT	%	dep	17	SENT_302	[p18l1548t390r1635b451],
17	)	CD	NUMBER	)	_	0	SENT_302	[p18l1548t390r1635b451],

1	Any	DT	O	any	det	5	SENT_303	[p18l58t503r159b562],
2	adverse	JJ	O	adverse	amod	5	SENT_303	[p18l176t499r378b547],
3	event	NN	O	event	nn	5	SENT_303	[p18l395t504r572b563],
4	'	''	O	'	_	0	SENT_303	[p18l395t504r572b563],
5	j'	NN	O	j'	_	0	SENT_303	[p18l395t504r572b563],
6	Nausea	NN	O	nausea	nn	7	SENT_303	[p18l65t614r259b658],
7	Diarrhea	NN	O	diarrhea	dep	5	SENT_303	[p18l65t721r286b769],

1	/	:	O	/	punct	2	SENT_304	[p18l1102t614r1116b895],
2	xrx	NN	O	xrx	_	0	SENT_304	[p18l1102t614r1116b895],
3	/	:	O	/	punct	2	SENT_304	[p18l1102t614r1116b895],
4	-	:	O	-	_	0	SENT_304	[p18l1102t614r1116b895],
5	s	NNS	O	s	dep	12	SENT_304	[p18l1102t614r1116b895],
6	l	NN	O	l	prep	5	SENT_304	[p18l1123t614r1145b880],
7	—	NN	O	—	dep	6	SENT_304	[p18l1123t614r1145b880],
8	'	''	O	'	_	0	SENT_304	[p18l1123t614r1145b880],
9	l	NN	O	l	dep	12	SENT_304	[p18l1123t614r1145b880],
10	—	NN	O	—	nn	12	SENT_304	[p18l1123t614r1145b880],
11	'	''	O	'	_	0	SENT_304	[p18l1123t614r1145b880],
12	l	NN	O	l	dep	16	SENT_304	[p18l1123t614r1145b880],
13	—	NN	O	—	nn	15	SENT_304	[p18l1123t614r1145b880],
14	'	''	O	'	_	0	SENT_304	[p18l1123t614r1145b880],
15	‘	NN	O	‘	dep	12	SENT_304	[p18l1151t614r1165b895],
16	xxx	NN	O	xxx	dep	2	SENT_304	[p18l1151t614r1165b895],
17	;	:	O	;	_	0	SENT_304	[p18l1151t614r1165b895],

1	Vomiting	VBG	O	vomit	_	0	SENT_305	[p18l59t837r303b896],
2	Visual	JJ	O	visual	amod	3	SENT_305	[p18l59t943r216b991],
3	disturbance	NN	O	disturbance	dobj	1	SENT_305	[p18l239t943r548b991],
4	Constipation	NNP	O	Constipation	nn	7	SENT_305	[p18l62t1058r396b1117],
5	Peripheral	JJ	O	peripheral	amod	7	SENT_305	[p18l66t1165r324b1228],
6	edema	NN	O	edema	nn	7	SENT_305	[p18l346t1165r521b1213],
7	Dizziness	NNP	O	Dizziness	dep	3	SENT_305	[p18l66t1281r314b1324],
8	Decreased	VBD	O	decrease	dep	1	SENT_305	[p18l66t1387r334b1435],
9	appetite	NN	O	appetite	nn	10	SENT_305	[p18l357t1392r568b1450],
10	ll	NN	O	ll	dobj	8	SENT_305	[p18l724t1392r778b1435],
11	(	CD	NUMBER	(	num	10	SENT_305	[p18l805t1391r901b1451],
12	13	CD	NUMBER	13	num	14	SENT_305	[p18l805t1391r901b1451],
13	)	CD	NUMBER	)	num	14	SENT_305	[p18l805t1391r901b1451],
14	Fatigue	NN	O	fatigue	nsubj	1	SENT_305	[p18l66t1502r254b1562],
15	8	CD	NUMBER	8	num	16	SENT_305	[p18l753t1501r780b1547],
16	(	NN	O	(	dep	14	SENT_305	[p18l805t1501r901b1561],
17	10	CD	NUMBER	10	num	18	SENT_305	[p18l805t1501r901b1561],
18	)	NN	O	)	dep	16	SENT_305	[p18l805t1501r901b1561],

1	#	#	MONEY	#	dep	2	SENT_306	[p18l1102t1058r1116b1117],
2	1	CD	MONEY	1	_	0	SENT_306	[p18l1102t1058r1116b1117],
3	I	PRP	O	I	nsubj	4	SENT_306	[p18l1120t1058r1146b1102],
4	\	VBP	O	\	rcmod	2	SENT_306	[p18l1120t1058r1146b1102],
5	.	.	O	.	_	0	SENT_306	[p18l1120t1058r1146b1102],
6	)	SYM	O	)	dep	2	SENT_306	[p18l1120t1058r1146b1102],

1	§	NN	O	§	_	0	SENT_307	[p18l1151t1058r1165b1117],
2	/	:	O	/	punct	1	SENT_307	[p18l1151t1058r1165b1117],

1	OOCDOOOOOO	NNP	O	OOCDOOOOOO	nn	2	SENT_308	[p18l1321t613r1350b1546],
2	OOOOOOOOO	NNP	O	OOOOOOOOO	_	0	SENT_308	[p18l1618t613r1647b1546],

1	1	CD	NUMBER	1	_	0	SENT_309	[p18l1053t614r1074b657],
2	1	CD	NUMBER	1	number	3	SENT_309	[p18l1053t725r1074b769],
3	1	CD	NUMBER	1	dep	1	SENT_309	[p18l1053t837r1074b880],
4	o	NN	O	o	nn	7	SENT_309	[p18l1048t946r1077b991],
5	2	CD	NUMBER	2	num	7	SENT_309	[p18l1050t1058r1076b1102],
6	O	NN	O	o	nn	7	SENT_309	[p18l1048t1168r1077b1214],
7	O	NN	O	o	dep	3	SENT_309	[p18l1048t1279r1077b1324],
8	O	NN	O	o	nn	9	SENT_309	[p18l1048t1390r1077b1435],
9	o	NN	O	o	dep	1	SENT_309	[p18l1048t1501r1077b1546],

1	Grade	NNP	O	Grade	_	0	SENT_310	[p18l61t1609r220b1657],
2	3	CD	NUMBER	3	num	1	SENT_310	[p18l238t1613r263b1657],
3	or	CC	O	or	_	0	SENT_310	[p18l284t1625r338b1657],
4	4	CD	NUMBER	4	num	6	SENT_310	[p18l353t1613r384b1657],
5	adverse	JJ	O	adverse	amod	6	SENT_310	[p18l401t1609r603b1657],
6	events	NNS	O	event	conj_or	1	SENT_310	[p18l156t1686r362b1745],
7	:	:	O	:	_	0	SENT_310	[p18l156t1686r362b1745],
8	§	CD	NUMBER	§	dep	1	SENT_310	[p18l156t1686r362b1745],
9	:	:	O	:	_	0	SENT_310	[p18l156t1686r362b1745],

1	ALT	NNP	O	ALT	nn	3	SENT_311	[p18l60t1796r163b1840],
2	elevation	NN	O	elevation	nn	3	SENT_311	[p18l181t1792r413b1841],
3	AST	NNP	ORGANIZATION	AST	_	0	SENT_311	[p18l60t1907r166b1952],
4	elevation	NN	O	elevation	dep	3	SENT_311	[p18l183t1903r416b1952],
5	Lymphopenia	NNP	O	Lymphopenia	nn	9	SENT_311	[p18l66t2014r418b2078],
6	Hypophosphatemia	NNP	O	Hypophosphatemia	nn	9	SENT_311	[p18l66t2125r583b2189],
7	Neutropenia	NNP	O	Neutropenia	nn	9	SENT_311	[p18l66t2241r392b2299],
8	Hypoxia	NN	O	hypoxium	nn	9	SENT_311	[p18l66t2352r273b2411],
9	Pneumonitis	NN	O	pneumonitis	dep	3	SENT_311	[p18l66t2463r395b2507],

1	©	NN	O	©	_	0	SENT_312	[p18l1618t1797r1647b2618],
2	©	CD	NUMBER	©	number	3	SENT_312	[p18l1618t1797r1647b2618],
3	©	CD	NUMBER	©	dep	1	SENT_312	[p18l1618t1797r1647b2618],
4	$	$	MONEY	$	dep	6	SENT_312	[p18l1618t1797r1647b2618],
5	©	CD	MONEY	©	num	6	SENT_312	[p18l1618t1797r1647b2618],
6	C	NN	O	c	dep	3	SENT_312	[p18l1618t1797r1647b2618],
7	>	JJR	O	>	dep	1	SENT_312	[p18l1618t1797r1647b2618],
8	©	CD	NUMBER	©	num	9	SENT_312	[p18l1618t1797r1647b2618],
9	|	NN	O	|	dep	7	SENT_312	[p18l1618t1797r1647b2618],
10	.	.	O	.	_	0	SENT_312	[p18l1618t1797r1647b2618],

1	—	NN	O	—	_	0	SENT_313	[p18l1618t1797r1647b2618],
2	.	.	O	.	_	0	SENT_313	[p18l1618t1797r1647b2618],
3	'	''	O	'	_	0	SENT_313	[p18l1618t1797r1647b2618],

1	Pulmonary	JJ	O	pulmonary	amod	2	SENT_314	[p18l66t2569r346b2633],
2	embolism	NN	O	embolism	_	0	SENT_314	[p18l364t2569r624b2618],

1	*	NN	O	*	nn	2	SENT_315	[p18l10t2737r39b2765],
2	ALT	NN	O	alt	nsubj	3	SENT_315	[p18l57t2736r161b2781],
3	denotes	VBZ	O	denote	_	0	SENT_315	[p18l181t2733r388b2781],
4	alanine	NN	O	alanine	nn	5	SENT_315	[p18l412t2733r599b2781],
5	aminotransferase	NN	O	aminotransferase	dobj	3	SENT_315	[p18l622t2732r1096b2790],
6	,	,	O	,	_	0	SENT_315	[p18l622t2732r1096b2790],
7	and	CC	O	and	_	0	SENT_315	[p18l1121t2733r1213b2781],
8	AST	NNP	O	AST	nsubj	9	SENT_315	[p18l1236t2736r1343b2781],
9	aspartate	VBP	O	aspartate	conj_and	3	SENT_315	[p18l1364t2742r1605b2796],
10	aminotransferase	NN	O	aminotransferase	dobj	9	SENT_315	[p18l1628t2732r2102b2781],
11	.	.	O	.	_	0	SENT_315	[p18l1628t2732r2102b2781],

1	1	CD	NUMBER	1	dep	6	SENT_316	[p18l12t2810r42b2869],
2	'	''	O	'	_	0	SENT_316	[p18l12t2810r42b2869],
3	These	DT	O	these	det	5	SENT_316	[p18l57t2806r212b2854],
4	adverse	JJ	O	adverse	amod	5	SENT_316	[p18l235t2806r435b2854],
5	events	NNS	O	event	nsubj	6	SENT_316	[p18l457t2815r623b2854],
6	occurred	VBD	O	occur	_	0	SENT_316	[p18l647t2806r873b2854],
7	in	IN	O	in	_	0	SENT_316	[p18l901t2810r942b2854],
8	at	IN	O	at	quantmod	10	SENT_316	[p18l968t2815r1014b2854],
9	least	JJS	O	least	mwe	8	SENT_316	[p18l1037t2806r1156b2854],
10	10	CD	PERCENT	10	num	11	SENT_316	[p18l1181t2808r1292b2856],
11	%	NN	PERCENT	%	prep_in	6	SENT_316	[p18l1181t2808r1292b2856],
12	ofthe	NN	O	ofthe	dep	11	SENT_316	[p18l1314t2805r1464b2854],
13	82	CD	NUMBER	82	num	14	SENT_316	[p18l1486t2809r1544b2855],
14	patients	NNS	O	patient	dep	12	SENT_316	[p18l1570t2810r1792b2869],
15	.	.	O	.	_	0	SENT_316	[p18l1570t2810r1792b2869],

1	The	DT	O	the	det	3	SENT_317	[p18l1814t2806r1911b2854],
2	adverse	JJ	O	adverse	amod	3	SENT_317	[p18l1934t2806r2133b2854],
3	events	NNS	O	event	nsubjpass	16	SENT_317	[p18l59t2887r225b2926],
4	that	WDT	O	that	nsubj	5	SENT_317	[p18l247t2878r350b2926],
5	occurred	VBD	O	occur	rcmod	3	SENT_317	[p18l371t2878r598b2926],
6	in	IN	O	in	_	0	SENT_317	[p18l625t2882r666b2926],
7	two	CD	NUMBER	two	num	8	SENT_317	[p18l690t2887r783b2926],
8	patients	NNS	O	patient	prep_in	5	SENT_317	[p18l809t2882r1015b2941],
9	who	WP	O	who	nsubj	10	SENT_317	[p18l1037t2878r1145b2926],
10	received	VBD	O	receive	rcmod	8	SENT_317	[p18l1170t2878r1380b2926],
11	crizotinib	NN	O	crizotinib	dobj	10	SENT_317	[p18l1405t2878r1650b2926],
12	during	IN	O	during	_	0	SENT_317	[p18l1673t2878r1844b2942],
13	dose	NN	O	dose	nn	14	SENT_317	[p18l1865t2878r1988b2926],
14	escalation	NN	O	escalation	prep_during	10	SENT_317	[p18l2010t2895r2141b2926, p18l62t2950r202b2998],
15	are	VBP	O	be	auxpass	16	SENT_317	[p18l228t2967r305b2998],
16	included	VBN	O	include	_	0	SENT_317	[p18l329t2950r566b2998],
17	.	.	O	.	_	0	SENT_317	[p18l329t2950r566b2998],

1	The	DT	O	the	det	3	SENT_318	[p18l588t2950r685b2998],
2	remaining	VBG	O	remain	amod	3	SENT_318	[p18l710t2954r974b3014],
3	patients	NNS	O	patient	nsubj	4	SENT_318	[p18l998t2954r1204b3013],
4	started	VBD	O	start	_	0	SENT_318	[p18l1229t2950r1406b2998],
5	treatment	NN	O	treatment	dobj	4	SENT_318	[p18l1429t2959r1689b2998],
6	at	IN	O	at	_	0	SENT_318	[p18l1711t2959r1756b2998],
7	250	CD	NUMBER	250	num	8	SENT_318	[p18l1778t2953r1870b2998],
8	mg	NN	O	mg	prep_at	4	SENT_318	[p18l1895t2967r1975b3014],
9	of	IN	O	of	_	0	SENT_318	[p18l1997t2949r2054b2998],
10	crizotinib	NN	O	crizotinib	prep_of	8	SENT_318	[p18l59t3022r304b3070],
11	twice	RB	O	twice	advmod	12	SENT_318	[p18l325t3026r460b3070],
12	daily	RB	SET	daily	advmod	4	SENT_318	[p18l482t3022r613b3085],
13	.	.	O	.	_	0	SENT_318	[p18l482t3022r613b3085],

1	Ii	NN	O	ii	_	0	SENT_319	[p18l12t3098r42b3157],
2	:	:	O	:	_	0	SENT_319	[p18l12t3098r42b3157],
3	These	DT	O	these	det	4	SENT_319	[p18l57t3094r212b3142],
4	grade	NN	O	grade	dep	1	SENT_319	[p18l235t3094r380b3158],
5	3	CD	NUMBER	3	num	9	SENT_319	[p18l403t3098r426b3142],
6	or	CC	O	or	_	0	SENT_319	[p18l451t3111r505b3142],
7	4	CD	NUMBER	4	num	9	SENT_319	[p18l524t3098r552b3142],
8	adverse	JJ	O	adverse	amod	9	SENT_319	[p18l575t3094r775b3142],
9	events	NNS	O	event	nsubjpass	11	SENT_319	[p18l797t3103r963b3142],
10	were	VBD	O	be	auxpass	11	SENT_319	[p18l985t3111r1107b3142],
11	evaluated	VBN	O	evaluate	rcmod	4	SENT_319	[p18l1129t3094r1377b3142],
12	in	IN	O	in	_	0	SENT_319	[p18l1404t3098r1445b3142],
13	82	CD	NUMBER	82	num	14	SENT_319	[p18l1471t3097r1529b3143],
14	patients	NNS	O	patient	prep_in	11	SENT_319	[p18l1555t3098r1776b3157],
15	;	:	O	;	_	0	SENT_319	[p18l1555t3098r1776b3157],
16	laboratory	NN	O	laboratory	nn	17	SENT_319	[p18l1803t3094r2065b3157],
17	data	NNS	O	datum	nsubj	21	SENT_319	[p18l59t3166r169b3214],
18	were	VBD	O	be	cop	21	SENT_319	[p18l190t3183r313b3214],
19	not	RB	O	not	neg	21	SENT_319	[p18l337t3175r420b3214],
20	always	RB	O	always	advmod	21	SENT_319	[p18l442t3166r609b3229],
21	available	JJ	O	available	parataxis	11	SENT_319	[p18l634t3166r860b3214],
22	for	IN	O	for	_	0	SENT_319	[p18l880t3165r953b3214],
23	all	DT	O	all	det	25	SENT_319	[p18l974t3166r1027b3214],
24	82	CD	NUMBER	82	num	25	SENT_319	[p18l1053t3169r1111b3215],
25	patients	NNS	O	patient	prep_for	21	SENT_319	[p18l1137t3170r1358b3229],
26	.	.	O	.	_	0	SENT_319	[p18l1137t3170r1358b3229],

1	from	IN	O	from	advmod	2	SENT_320	[p18l564t3433r721b3493],
2	dark	JJ	O	dark	_	0	SENT_320	[p18l750t3434r897b3493],
3	to	TO	O	to	_	0	SENT_320	[p18l924t3446r984b3493],
4	light	NN	O	light	prep_to	2	SENT_320	[p18l1014t3434r1180b3509],
5	,	,	O	,	_	0	SENT_320	[p18l1014t3434r1180b3509],
6	often	RB	O	often	advmod	7	SENT_320	[p18l1214t3433r1380b3493],
7	improving	VBG	O	improve	dep	2	SENT_320	[p18l1409t3435r1744b3509],
8	with	IN	O	with	_	0	SENT_320	[p18l1768t3434r1913b3493],
9	length	NN	O	length	prep_with	7	SENT_320	[p18l1942t3434r2148b3509],
10	of	IN	O	of	_	0	SENT_320	[p18l564t3528r639b3588],
11	time	NN	O	time	prep_of	9	SENT_320	[p18l650t3530r794b3587],
12	receiving	VBG	O	receive	xcomp	7	SENT_320	[p18l819t3530r1111b3604],
13	therapy	NN	O	therapy	dobj	12	SENT_320	[p18l1133t3529r1383b3603],
14	.	.	O	.	_	0	SENT_320	[p18l1133t3529r1383b3603],

1	No	DT	O	no	det	2	SENT_321	[p18l1410t3534r1504b3588],
2	abnormalities	NNS	O	abnormality	nsubjpass	4	SENT_321	[p18l1529t3529r1974b3588],
3	were	VBD	O	be	auxpass	4	SENT_321	[p18l1998t3548r2148b3588],
4	found	VBN	O	find	_	0	SENT_321	[p18l564t3623r752b3683],
5	in	IN	O	in	_	0	SENT_321	[p18l781t3625r843b3681],
6	three	CD	NUMBER	three	prep_in	4	SENT_321	[p18l873t3624r1038b3682],
7	of	IN	O	of	_	0	SENT_321	[p18l1068t3623r1143b3683],
8	these	DT	O	these	det	9	SENT_321	[p18l1159t3624r1326b3682],
9	patients	NNS	O	patient	prep_of	6	SENT_321	[p18l1354t3625r1610b3698],
10	who	WP	O	who	nsubj	11	SENT_321	[p18l1638t3624r1774b3683],
11	underwent	VBD	O	undergo	rcmod	9	SENT_321	[p18l1805t3624r2152b3683],
12	detailed	JJ	O	detailed	amod	14	SENT_321	[p19l564t17r819b76],
13	ophthalmologic	JJ	O	ophthalmologic	amod	14	SENT_321	[p19l850t17r1362b92],
14	examination	NN	O	examination	dobj	11	SENT_321	[p19l1393t18r1814b76],
15	.	.	O	.	_	0	SENT_321	[p19l1393t18r1814b76],

1	Increases	NNS	O	increase	nsubj	9	SENT_322	[p19l1848t23r2146b75],
2	in	IN	O	in	_	0	SENT_322	[p19l563t113r625b170],
3	levels	NNS	O	level	prep_in	1	SENT_322	[p19l649t112r821b171],
4	of	IN	O	of	_	0	SENT_322	[p19l848t111r922b171],
5	hepatic	JJ	O	hepatic	amod	6	SENT_322	[p19l933t112r1165b186],
6	transaminases	NNS	O	transaminase	prep_of	3	SENT_322	[p19l1189t113r1659b170],
7	were	VBD	O	be	cop	9	SENT_322	[p19l1682t131r1832b171],
8	generally	RB	O	generally	advmod	9	SENT_322	[p19l1857t112r2151b187],
9	grade	NN	O	grade	_	0	SENT_322	[p19l563t207r742b282],
10	1	CD	NUMBER	1	dep	9	SENT_322	[p19l773t211r806b265],
11	or	CC	O	or	_	0	SENT_322	[p19l835t226r902b266],
12	2	CD	NUMBER	2	conj_or	10	SENT_322	[p19l928t211r981b278],
13	;	:	O	;	_	0	SENT_322	[p19l928t211r981b278],
14	however	RB	O	however	advmod	32	SENT_322	[p19l1012t207r1292b278],
15	,	,	O	,	_	0	SENT_322	[p19l1012t207r1292b278],
16	grade	NN	O	grade	dep	24	SENT_322	[p19l1325t207r1503b282],
17	3	CD	NUMBER	3	num	18	SENT_322	[p19l1533t211r1565b266],
18	elevations	NNS	O	elevation	dep	16	SENT_322	[p19l1597t207r1913b266],
19	in	IN	O	in	_	0	SENT_322	[p19l1943t208r2005b265],
20	alanine	NN	O	alanine	prep_in	18	SENT_322	[p19l2033t207r2147b265, p19l564t303r700b360],
21	aminotransferase	NN	O	aminotransferase	dep	24	SENT_322	[p19l719t301r1268b361],
22	(	CD	NUMBER	(	num	21	SENT_322	[p19l1290t307r1457b370],
23	ALT	NN	O	alt	nn	24	SENT_322	[p19l1290t307r1457b370],
24	)	NN	O	)	dep	27	SENT_322	[p19l1290t307r1457b370],
25	and	CC	O	and	_	0	SENT_322	[p19l1480t302r1595b361],
26	aspartate	NN	O	aspartate	dep	27	SENT_322	[p19l1614t314r1900b376],
27	aminotransferase	NN	O	aminotransferase	dep	32	SENT_322	[p19l1919t303r2147b361, p19l564t396r911b455],
28	(	CD	NUMBER	(	num	27	SENT_322	[p19l936t401r1105b465],
29	AST	NNP	O	AST	nsubjpass	32	SENT_322	[p19l936t401r1105b465],
30	)	CD	NUMBER	)	num	29	SENT_322	[p19l936t401r1105b465],
31	were	VBD	O	be	auxpass	32	SENT_322	[p19l1127t416r1275b456],
32	observed	VBN	O	observe	dep	9	SENT_322	[p19l1296t397r1575b456],
33	in	IN	O	in	_	0	SENT_322	[p19l1595t398r1657b454],
34	4	CD	NUMBER	4	num	35	SENT_322	[p19l1676t402r1714b455],
35	patients	NNS	O	patient	prep_in	32	SENT_322	[p19l1733t398r1983b471],
36	(	IN	O	(	_	0	SENT_322	[p19l2009t401r2144b465],
37	5	CD	NUMBER	5	number	38	SENT_322	[p19l2009t401r2144b465],
38	°	CD	NUMBER	°	prep_(	35	SENT_322	[p19l2009t401r2144b465],
39	/	:	O	/	punct	41	SENT_322	[p19l2009t401r2144b465],
40	o	NN	O	o	nn	41	SENT_322	[p19l2009t401r2144b465],
41	)	NN	O	)	dep	38	SENT_322	[p19l2009t401r2144b465],
42	and	CC	O	and	_	0	SENT_322	[p19l563t492r681b551],
43	5	CD	NUMBER	5	num	44	SENT_322	[p19l704t498r736b551],
44	patients	NNS	O	patient	dep	38	SENT_322	[p19l760t493r1015b566],
45	(	CD	PERCENT	(	number	46	SENT_322	[p19l1042t496r1195b563],
46	6	CD	PERCENT	6	num	47	SENT_322	[p19l1042t496r1195b563],
47	%	NN	PERCENT	%	dep	44	SENT_322	[p19l1042t496r1195b563],
48	)	CD	NUMBER	)	dep	41	SENT_322	[p19l1042t496r1195b563],
49	,	,	O	,	_	0	SENT_322	[p19l1042t496r1195b563],
50	respectively	RB	O	respectively	dep	41	SENT_322	[p19l1221t492r1605b566],
51	,	,	O	,	_	0	SENT_322	[p19l1221t492r1605b566],
52	usually	RB	O	usually	advmod	32	SENT_322	[p19l1632t492r1861b566],
53	with	IN	O	with	_	0	SENT_322	[p19l1876t492r2022b551],
54	onset	NN	O	onset	prep_with	32	SENT_322	[p19l2045t511r2147b551, p19l565t599r654b645],
55	during	IN	O	during	_	0	SENT_322	[p19l679t587r894b662],
56	cycle	NN	O	cycle	prep_during	32	SENT_322	[p19l920t587r1072b661],
57	2	CD	NUMBER	2	num	56	SENT_322	[p19l1100t591r1153b658],
58	;	:	O	;	_	0	SENT_322	[p19l1100t591r1153b658],
59	1	CD	NUMBER	1	num	60	SENT_322	[p19l1186t591r1219b645],
60	patient	NN	O	patient	nsubj	61	SENT_322	[p19l1246t588r1472b661],
61	had	VBD	O	have	parataxis	9	SENT_322	[p19l1496t587r1613b646],
62	a	DT	O	a	det	65	SENT_322	[p19l1640t606r1673b645],
63	grade	NN	O	grade	nn	65	SENT_322	[p19l1699t587r1878b662],
64	4	CD	NUMBER	4	num	65	SENT_322	[p19l1904t592r1942b645],
65	elevation	NN	O	elevation	dobj	61	SENT_322	[p19l1970t587r2147b646, p19l564t684r688b742],
66	in	IN	O	in	_	0	SENT_322	[p19l710t684r771b741],
67	ALT	NNP	O	ALT	prep_in	65	SENT_322	[p19l791t688r933b742],
68	.	.	O	.	_	0	SENT_322	[p19l791t688r933b742],

1	These	DT	O	these	det	2	SENT_323	[p19l957t683r1141b742],
2	increases	NNS	O	increase	nsubj	3	SENT_323	[p19l1163t684r1451b742],
3	reversed	VBD	O	reverse	_	0	SENT_323	[p19l1475t683r1734b742],
4	on	IN	O	on	_	0	SENT_323	[p19l1757t702r1835b742],
5	cessation	NN	O	cessation	prep_on	3	SENT_323	[p19l1858t684r2148b742],
6	of	IN	O	of	_	0	SENT_323	[p19l564t777r639b837],
7	crizotinib	NN	O	crizotinib	prep_of	5	SENT_323	[p19l661t778r991b849],
8	,	,	O	,	_	0	SENT_323	[p19l661t778r991b849],
9	and	CC	O	and	_	0	SENT_323	[p19l1031t778r1149b837],
10	4	CD	TIME	4	nsubj	19	SENT_323	[p19l1183t783r1220b837],
11	of	IN	TIME	of	_	0	SENT_323	[p19l1256t777r1330b837],
12	5	CD	TIME	5	num	13	SENT_323	[p19l1354t784r1386b837],
13	patients	NNS	O	patient	prep_of	10	SENT_323	[p19l1423t779r1677b852],
14	with	IN	O	with	_	0	SENT_323	[p19l1711t778r1857b837],
15	elevated	JJ	O	elevated	amod	17	SENT_323	[p19l1893t778r2148b837],
16	transaminase	NN	O	transaminase	nn	17	SENT_323	[p19l564t875r1002b932],
17	levels	NNS	O	level	prep_with	13	SENT_323	[p19l1041t874r1213b933],
18	were	VBD	O	be	cop	19	SENT_323	[p19l1250t893r1401b933],
19	able	JJ	O	able	conj_and	3	SENT_323	[p19l1440t874r1567b933],
20	to	TO	O	to	aux	21	SENT_323	[p19l1607t886r1668b933],
21	resume	VB	O	resume	xcomp	19	SENT_323	[p19l1708t893r1941b933],
22	treatment	NN	O	treatment	dobj	21	SENT_323	[p19l1981t886r2147b932, p19l563t982r729b1029],
23	at	IN	O	at	_	0	SENT_323	[p19l749t982r808b1028],
24	a	DT	O	a	det	26	SENT_323	[p19l828t990r862b1028],
25	lower	JJR	O	lower	amod	26	SENT_323	[p19l884t970r1062b1029],
26	dose	NN	O	dose	prep_at	21	SENT_323	[p19l1085t970r1230b1029],
27	without	IN	O	without	_	0	SENT_323	[p19l1251t970r1505b1029],
28	recurrence	NN	O	recurrence	prep_without	21	SENT_323	[p19l1526t989r1866b1029],
29	of	IN	O	of	_	0	SENT_323	[p19l1891t969r1966b1029],
30	doselimiting	VBG	O	doselimit	prepc_of	28	SENT_323	[p19l1977t970r2147b1029, p19l563t1065r826b1140],
31	toxic	JJ	O	toxic	amod	32	SENT_323	[p19l857t1066r1011b1124],
32	effects	NNS	O	effect	dobj	30	SENT_323	[p19l1044t1064r1272b1124],
33	.	.	O	.	_	0	SENT_323	[p19l1044t1064r1272b1124],

1	One	CD	NUMBER	one	num	2	SENT_324	[p19l1309t1069r1438b1124],
2	patient	NN	O	patient	_	0	SENT_324	[p19l1470t1066r1696b1139],
3	with	IN	O	with	_	0	SENT_324	[p19l1722t1065r1867b1124],
4	grade	NN	O	grade	nn	6	SENT_324	[p19l1900t1065r2079b1140],
5	3	CD	NUMBER	3	num	6	SENT_324	[p19l2113t1069r2145b1124],
6	ALT	NN	O	alt	prep_with	2	SENT_324	[p19l561t1166r692b1219],
7	discontinued	VBN	O	discontinue	partmod	2	SENT_324	[p19l713t1161r1118b1220],
8	crizotinib	NN	O	crizotinib	dobj	7	SENT_324	[p19l1141t1161r1444b1220],
9	because	IN	O	because	_	0	SENT_324	[p19l1468t1161r1713b1220],
10	of	IN	O	of	_	0	SENT_324	[p19l1736t1160r1810b1220],
11	recurrence	NN	O	recurrence	prep_because_of	7	SENT_324	[p19l1819t1180r2148b1220],
12	of	IN	O	of	_	0	SENT_324	[p19l564t1255r639b1315],
13	grade	NN	O	grade	nn	15	SENT_324	[p19l650t1256r829b1331],
14	3	CD	NUMBER	3	num	15	SENT_324	[p19l855t1260r888b1315],
15	ALT	NN	O	alt	prep_of	11	SENT_324	[p19l914t1261r1058b1327],
16	,	,	O	,	_	0	SENT_324	[p19l914t1261r1058b1327],
17	despite	IN	O	despite	_	0	SENT_324	[p19l1089t1256r1313b1330],
18	dose	NN	O	dose	nn	19	SENT_324	[p19l1339t1256r1484b1315],
19	reduction	NN	O	reduction	prep_despite	7	SENT_324	[p19l1510t1256r1833b1315],
20	.	.	O	.	_	0	SENT_324	[p19l1510t1256r1833b1315],

1	DURATION	NN	O	duration	_	0	SENT_325	[p19l17t1524r429b1574],
2	OF	IN	O	of	_	0	SENT_325	[p19l470t1524r573b1574],
3	TREATMENT	NN	O	treatment	prep_of	1	SENT_325	[p19l603t1525r1073b1573],

1	Of	IN	O	of	_	0	SENT_326	[p19l12t1631r133b1710],
2	the	DT	O	the	det	4	SENT_326	[p19l148t1632r281b1710],
3	82	CD	NUMBER	82	num	4	SENT_326	[p19l315t1637r413b1710],
4	patients	NNS	O	patient	prep_of	11	SENT_326	[p19l446t1632r811b1732],
5	,	,	O	,	_	0	SENT_326	[p19l446t1632r811b1732],
6	63	CD	PERCENT	63	number	7	SENT_326	[p19l851t1637r946b1710],
7	(	CD	PERCENT	(	nsubj	11	SENT_326	[p19l987t1637r1228b1723],
8	77	CD	PERCENT	77	num	9	SENT_326	[p19l987t1637r1228b1723],
9	%	NN	PERCENT	%	dep	7	SENT_326	[p19l987t1637r1228b1723],
10	)	CD	NUMBER	)	dep	7	SENT_326	[p19l987t1637r1228b1723],
11	continued	VBD	O	continue	_	0	SENT_326	[p19l1267t1632r1696b1711],
12	to	TO	O	to	aux	13	SENT_326	[p19l1730t1648r1811b1710],
13	receive	VB	O	receive	xcomp	11	SENT_326	[p19l1846t1632r2135b1711],
14	crizotinib	NN	O	crizotinib	dobj	13	SENT_326	[p19l13t1760r433b1838],
15	after	IN	O	after	_	0	SENT_326	[p19l463t1759r664b1838],
16	the	DT	O	the	det	18	SENT_326	[p19l691t1760r824b1838],
17	data	NNS	O	datum	nn	18	SENT_326	[p19l854t1759r1037b1838],
18	cutoff	NN	O	cutoff	prep_after	13	SENT_326	[p19l1065t1759r1336b1839],
19	for	IN	O	for	_	0	SENT_326	[p19l1347t1759r1470b1838],
20	this	DT	O	this	det	23	SENT_326	[p19l1496t1760r1656b1838],
21	study	NN	O	study	nn	23	SENT_326	[p19l1688t1760r1918b1860],
22	(	CD	NUMBER	(	num	23	SENT_326	[p19l1948t1760r2130b1860],
23	Fig	NN	O	fig	prep_for	18	SENT_326	[p19l1948t1760r2130b1860],
24	.	.	O	.	_	0	SENT_326	[p19l1948t1760r2130b1860],

1	4A	NN	O	4a	_	0	SENT_327	[p19l11t1894r177b1980],
2	)	NN	O	)	dep	1	SENT_327	[p19l11t1894r177b1980],
3	.	.	O	.	_	0	SENT_327	[p19l11t1894r177b1980],

1	The	DT	O	the	det	3	SENT_328	[p19l237t1889r397b1967],
2	mean	NN	O	mean	nn	3	SENT_328	[p19l455t1914r693b1967],
3	duration	NN	O	duration	nsubj	8	SENT_328	[p19l751t1889r1117b1968],
4	of	IN	O	of	_	0	SENT_328	[p19l1175t1888r1275b1967],
5	treatment	NN	O	treatment	prep_of	3	SENT_328	[p19l1315t1905r1739b1967],
6	was	VBD	O	be	cop	8	SENT_328	[p19l1786t1915r1949b1968],
7	6.4	CD	DURATION	6.4	num	8	SENT_328	[p19l2010t1894r2135b1967],
8	months	NNS	NUMBER	month	_	0	SENT_328	[p19l12t2017r364b2112],
9	,	,	O	,	_	0	SENT_328	[p19l12t2017r364b2112],
10	with	IN	O	with	_	0	SENT_328	[p19l408t2017r604b2096],
11	follow-up	JJ	O	follow-up	amod	12	SENT_328	[p19l647t2016r1055b2117],
12	ongoing	JJ	O	ongoing	prep_with	8	SENT_328	[p19l1100t2017r1476b2117],
13	.	.	O	.	_	0	SENT_328	[p19l1100t2017r1476b2117],

1	This	DT	O	this	det	2	SENT_329	[p19l1521t2017r1708b2095],
2	trial	NN	O	trial	nsubjpass	5	SENT_329	[p19l1754t2017r1932b2095],
3	was	VBD	O	be	auxpass	5	SENT_329	[p19l1970t2043r2133b2096],
4	not	RB	O	not	neg	5	SENT_329	[p19l12t2161r155b2223],
5	designed	VBN	O	design	_	0	SENT_329	[p19l181t2144r563b2245],
6	to	TO	O	to	aux	7	SENT_329	[p19l594t2161r676b2223],
7	address	VB	O	address	xcomp	5	SENT_329	[p19l707t2144r1032b2223],
8	progression-free	JJ	O	progression-free	amod	9	SENT_329	[p19l1063t2144r1771b2245],
9	survival	NN	O	survival	dobj	7	SENT_329	[p19l1804t2145r2135b2224],
10	as	IN	O	as	_	0	SENT_329	[p19l11t2299r97b2351],
11	an	DT	O	a	det	13	SENT_329	[p19l143t2298r246b2351],
12	end	NN	O	end	nn	13	SENT_329	[p19l291t2273r444b2351],
13	point	NN	O	point	prep_as	7	SENT_329	[p19l486t2273r738b2373],
14	;	:	O	;	_	0	SENT_329	[p19l486t2273r738b2373],
15	the	DT	O	the	det	16	SENT_329	[p19l786t2273r918b2351],
16	responses	NNS	O	response	nsubj	24	SENT_329	[p19l963t2298r1387b2373],
17	seen	VBN	O	see	partmod	16	SENT_329	[p19l1434t2298r1623b2351],
18	in	IN	O	in	_	0	SENT_329	[p19l1666t2273r1749b2350],
19	patients	NNS	O	patient	prep_in	17	SENT_329	[p19l1792t2273r2134b2373],
20	with	IN	O	with	_	0	SENT_329	[p19l7t2401r203b2479],
21	ALK	NN	O	alk	nn	22	SENT_329	[p19l251t2406r426b2478],
22	rearrangement	NN	O	rearrangement	prep_with	19	SENT_329	[p19l472t2416r1113b2500],
23	were	VBD	O	be	cop	24	SENT_329	[p19l1159t2426r1361b2479],
24	unanticipated	JJ	O	unanticipated	parataxis	5	SENT_329	[p19l1415t2401r2007b2500],
25	at	IN	O	at	_	0	SENT_329	[p19l2061t2416r2140b2478],
26	the	DT	O	the	det	27	SENT_329	[p19l12t2529r145b2607],
27	time	NN	O	time	prep_at	24	SENT_329	[p19l181t2529r374b2607],
28	the	DT	O	the	det	29	SENT_329	[p19l410t2528r542b2607],
29	protocol	NN	O	protocol	nsubjpass	31	SENT_329	[p19l576t2529r937b2629],
30	was	VBD	O	be	auxpass	31	SENT_329	[p19l967t2555r1129b2608],
31	Written	VBN	O	write	rcmod	27	SENT_329	[p19l1162t2529r1499b2624],
32	,	,	O	,	_	0	SENT_329	[p19l1162t2529r1499b2624],
33	and	CC	O	and	_	0	SENT_329	[p19l1539t2529r1696b2607],
34	no	DT	O	no	det	38	SENT_329	[p19l1731t2554r1837b2607],
35	statistically	RB	O	statistically	advmod	36	SENT_329	[p19l1874t2529r2134b2607, p19l12t2657r274b2757],
36	predetermined	JJ	O	predetermined	amod	38	SENT_329	[p19l321t2657r958b2757],
37	enrollment	NN	O	enrollment	nn	38	SENT_329	[p19l1011t2656r1489b2735],
38	goal	NN	O	goal	nsubjpass	43	SENT_329	[p19l1536t2657r1720b2757],
39	for	IN	O	for	_	0	SENT_329	[p19l1773t2656r1896b2735],
40	ALKpositive	JJ	O	alkpositive	amod	41	SENT_329	[p19l1940t2662r2134b2735, p19l11t2785r341b2885],
41	patients	NNS	O	patient	prep_for	38	SENT_329	[p19l390t2785r732b2885],
42	was	VBD	O	be	auxpass	43	SENT_329	[p19l780t2811r943b2864],
43	established	VBN	O	establish	conj_and	24	SENT_329	[p19l997t2784r1503b2863],
44	.	.	O	.	_	0	SENT_329	[p19l997t2784r1503b2863],

1	Furthermore	RB	O	furthermore	advmod	7	SENT_330	[p19l1557t2785r2129b2880],
2	,	,	O	,	_	0	SENT_330	[p19l1557t2785r2129b2880],
3	ALK-positive	JJ	O	alk-positive	amod	4	SENT_330	[p19l6t2913r533b3013],
4	patients	NNS	O	patient	nsubj	7	SENT_330	[p19l582t2913r923b3013],
5	receiving	VBG	O	receive	partmod	4	SENT_330	[p19l976t2913r1366b3013],
6	crizotinib	NN	O	crizotinib	dobj	5	SENT_330	[p19l1414t2913r1834b2991],
7	had	VBD	O	have	_	0	SENT_330	[p19l1886t2913r2042b2991],
8	a	DT	O	a	det	10	SENT_330	[p19l2092t2939r2137b2991],
9	heterogeneous	JJ	O	heterogeneous	amod	10	SENT_330	[p19l12t3041r625b3141],
10	history	NN	O	history	dobj	7	SENT_330	[p19l661t3041r959b3141],
11	of	IN	O	of	_	0	SENT_330	[p19l989t3040r1088b3119],
12	previous	JJ	O	previous	amod	13	SENT_330	[p19l1102t3041r1456b3141],
13	treatments	NNS	O	treatment	prep_of	10	SENT_330	[p19l1493t3057r1970b3119],
14	.	.	O	.	_	0	SENT_330	[p19l1493t3057r1970b3119],

1	On	IN	O	on	_	0	SENT_331	[p19l2010t3046r2135b3119],
2	the	DT	O	the	det	3	SENT_331	[p19l12t3168r145b3245],
3	basis	NN	O	basis	prep_on	38	SENT_331	[p19l178t3168r389b3246],
4	of	IN	O	of	_	0	SENT_331	[p19l424t3167r524b3246],
5	these	DT	O	these	det	6	SENT_331	[p19l538t3168r761b3245],
6	limitations	NNS	O	limitation	prep_of	3	SENT_331	[p19l793t3168r1289b3262],
7	,	,	O	,	_	0	SENT_331	[p19l793t3168r1289b3262],
8	and	CC	O	and	_	0	SENT_331	[p19l1326t3167r1484b3246],
9	with	IN	O	with	conj_and	3	SENT_331	[p19l1511t3168r1706b3247],
10	a	DT	O	a	det	12	SENT_331	[p19l1737t3194r1782b3245],
11	median	JJ	O	median	amod	12	SENT_331	[p19l1812t3167r2135b3246],
12	follow-up	NN	O	follow-up	pobj	9	SENT_331	[p19l12t3295r429b3396],
13	for	IN	O	for	mark	19	SENT_331	[p19l492t3295r617b3374],
14	progression-free	JJ	O	progression-free	amod	15	SENT_331	[p19l674t3295r1398b3396],
15	survival	NN	O	survival	nsubj	19	SENT_331	[p19l1461t3295r1801b3375],
16	of	IN	O	of	_	0	SENT_331	[p19l1863t3295r1964b3374],
17	6.4	CD	DURATION	6.4	num	18	SENT_331	[p19l2007t3301r2135b3374],
18	months	NNS	NUMBER	month	prep_of	15	SENT_331	[p19l12t3423r344b3502],
19	(	VBP	O	(	dep	12	SENT_331	[p19l397t3429r611b3515],
20	95	CD	PERCENT	95	number	21	SENT_331	[p19l397t3429r611b3515],
21	%	NN	PERCENT	%	amod	22	SENT_331	[p19l397t3429r611b3515],
22	CI	NN	O	ci	dobj	19	SENT_331	[p19l655t3429r772b3519],
23	,	,	O	,	_	0	SENT_331	[p19l655t3429r772b3519],
24	5.5	CD	NUMBER	5.5	dep	12	SENT_331	[p19l825t3431r947b3502],
25	to	TO	O	to	_	0	SENT_331	[p19l996t3440r1078b3502],
26	7.2	CD	NUMBER	7.2	number	27	SENT_331	[p19l1126t3429r1297b3519],
27	)	CD	NUMBER	)	prep_to	24	SENT_331	[p19l1126t3429r1297b3519],
28	,	,	O	,	_	0	SENT_331	[p19l1126t3429r1297b3519],
29	the	DT	O	the	det	30	SENT_331	[p19l1348t3424r1483b3502],
30	probability	NN	O	probability	nsubjpass	38	SENT_331	[p19l1527t3423r2011b3524],
31	of	IN	O	of	_	0	SENT_331	[p19l2052t3423r2153b3502],
32	progression-free	JJ	O	progression-free	amod	33	SENT_331	[p19l11t3551r722b3652],
33	survival	NN	O	survival	prep_of	30	SENT_331	[p19l772t3551r1104b3631],
34	at	IN	O	at	_	0	SENT_331	[p19l1150t3568r1229b3630],
35	6	CD	DURATION	6	num	36	SENT_331	[p19l1273t3557r1320b3630],
36	months	NNS	NUMBER	month	prep_at	33	SENT_331	[p19l1368t3552r1695b3630],
37	was	VBD	O	be	auxpass	38	SENT_331	[p19l1741t3578r1903b3631],
38	estimated	VBN	O	estimate	_	0	SENT_331	[p19l1954t3552r2134b3630, p19l12t3680r278b3758],
39	at	IN	O	at	_	0	SENT_331	[p19l313t3696r392b3758],
40	720/0	CD	PERCENT	720/0	num	44	SENT_331	[p19l423t3685r606b3759],
41	(	CD	PERCENT	(	number	42	SENT_331	[p19l646t3685r857b3771],
42	95	CD	PERCENT	95	dep	43	SENT_331	[p19l646t3685r857b3771],
43	%	NN	PERCENT	%	dep	44	SENT_331	[p19l646t3685r857b3771],
44	CI	NN	O	ci	prep_at	38	SENT_331	[p19l891t3685r1006b3775],
45	,	,	O	,	_	0	SENT_331	[p19l891t3685r1006b3775],
46	61	CD	NUMBER	61	number	49	SENT_331	[p19l1047t3685r1142b3758],
47	to	TO	O	to	dep	49	SENT_331	[p19l1178t3696r1259b3758],
48	83	CD	NUMBER	83	number	49	SENT_331	[p19l1296t3685r1419b3771],
49	)	CD	NUMBER	)	appos	44	SENT_331	[p19l1296t3685r1419b3771],
50	(	CD	NUMBER	(	num	51	SENT_331	[p19l1464t3680r1647b3780],
51	Fig	NN	O	fig	dep	49	SENT_331	[p19l1464t3680r1647b3780],
52	.	.	O	.	_	0	SENT_331	[p19l1464t3680r1647b3780],

1	4B	NN	O	4b	_	0	SENT_332	[p19l1687t3685r1849b3771],
2	)	NN	O	)	dep	1	SENT_332	[p19l1687t3685r1849b3771],
3	.	.	O	.	_	0	SENT_332	[p19l1687t3685r1849b3771],

1	DISCUSSION	NN	O	discussion	_	0	SENT_333	[p20l735t181r1413b240],

1	Our	PRP$	O	we	poss	2	SENT_334	[p20l12t440r179b514],
2	results	NNS	O	result	nsubj	3	SENT_334	[p20l206t434r489b514],
3	show	VBP	O	show	_	0	SENT_334	[p20l523t434r748b514],
4	that	IN	O	that	complm	11	SENT_334	[p20l775t435r947b513],
5	a	DT	O	a	det	7	SENT_334	[p20l971t461r1016b513],
6	targeted	VBN	O	target	amod	7	SENT_334	[p20l1045t434r1400b535],
7	inhibitor	NN	O	inhibitor	nsubj	11	SENT_334	[p20l1429t435r1811b513],
8	of	IN	O	of	_	0	SENT_334	[p20l1839t434r1939b513],
9	ALK	NNP	O	ALK	prep_of	7	SENT_334	[p20l1947t442r2139b516],
10	is	VBZ	O	be	cop	11	SENT_334	[p20l11t563r77b641],
11	effective	JJ	O	effective	ccomp	3	SENT_334	[p20l112t562r470b642],
12	against	IN	O	against	_	0	SENT_334	[p20l502t563r818b663],
13	advanced	JJ	O	advanced	amod	20	SENT_334	[p20l844t562r1240b642],
14	non	JJ	O	non	amod	20	SENT_334	[p20l1272t562r1914b641],
15	—	NN	O	—	nn	20	SENT_334	[p20l1272t562r1914b641],
16	small	JJ	O	small	amod	20	SENT_334	[p20l1272t562r1914b641],
17	—	NN	O	—	nn	20	SENT_334	[p20l1272t562r1914b641],
18	cell	NN	O	cell	nn	20	SENT_334	[p20l1272t562r1914b641],
19	lung	NN	O	lung	nn	20	SENT_334	[p20l1945t562r2139b663],
20	cancers	NNS	O	cancer	prep_against	11	SENT_334	[p20l13t716r334b769],
21	carrying	VBG	O	carry	partmod	20	SENT_334	[p20l372t691r735b791],
22	activated	VBN	O	activate	amod	24	SENT_334	[p20l768t691r1146b770],
23	ALK	NN	O	alk	nn	24	SENT_334	[p20l1178t698r1370b772],
24	kinase	NN	O	kinase	dep	21	SENT_334	[p20l1402t691r1704b770],
25	.	.	O	.	_	0	SENT_334	[p20l1402t691r1704b770],

1	In	IN	O	in	_	0	SENT_335	[p20l1744t698r1833b768],
2	82	CD	NUMBER	82	num	3	SENT_335	[p20l1869t696r1967b769],
3	patients	NNS	O	patient	prep_in	16	SENT_335	[p20l2003t717r2134b791, p20l12t819r273b914],
4	,	,	O	,	_	0	SENT_335	[p20l2003t717r2134b791, p20l12t819r273b914],
5	the	DT	O	the	det	6	SENT_335	[p20l316t819r449b897],
6	majority	NN	O	majority	appos	3	SENT_335	[p20l485t819r846b919],
7	of	IN	O	of	_	0	SENT_335	[p20l878t818r979b897],
8	whom	WP	O	whom	nsubj	10	SENT_335	[p20l992t818r1263b898],
9	had	VBD	O	have	aux	10	SENT_335	[p20l1299t819r1456b897],
10	received	VBN	O	receive	prepc_of	6	SENT_335	[p20l1492t818r1837b898],
11	multiple	JJ	O	multiple	amod	13	SENT_335	[p20l1874t818r2134b898, p20l11t947r138b1047],
12	previous	JJ	O	previous	amod	13	SENT_335	[p20l186t947r556b1047],
13	therapies	NNS	O	therapy	dobj	10	SENT_335	[p20l608t946r1032b1047],
14	,	,	O	,	_	0	SENT_335	[p20l608t946r1032b1047],
15	we	PRP	O	we	nsubj	16	SENT_335	[p20l1083t973r1201b1026],
16	observed	VBD	O	observe	_	0	SENT_335	[p20l1252t947r1641b1026],
17	an	DT	O	a	det	20	SENT_335	[p20l1690t972r1793b1025],
18	overall	JJ	O	overall	amod	20	SENT_335	[p20l1844t946r2135b1026],
19	response	NN	O	response	nn	20	SENT_335	[p20l12t1100r395b1175],
20	rate	NN	O	rate	dobj	16	SENT_335	[p20l460t1091r619b1153],
21	of	IN	O	of	_	0	SENT_335	[p20l685t1074r785b1153],
22	57	CD	PERCENT	57	num	23	SENT_335	[p20l833t1080r1016b1154],
23	%	NN	PERCENT	%	prep_of	20	SENT_335	[p20l833t1080r1016b1154],
24	(	CD	NUMBER	(	nsubj	25	SENT_335	[p20l1086t1074r1564b1166],
25	confirmed	VBD	O	confirm	rcmod	23	SENT_335	[p20l1086t1074r1564b1166],
26	partial	JJ	O	partial	amod	30	SENT_335	[p20l1627t1075r1914b1175],
27	and	CC	O	and	_	0	SENT_335	[p20l1977t1075r2135b1153],
28	complete	JJ	O	complete	conj_and	26	SENT_335	[p20l13t1202r401b1303],
29	responses	NNS	O	response	nn	30	SENT_335	[p20l441t1210r890b1303],
30	)	NN	O	)	dobj	25	SENT_335	[p20l441t1210r890b1303],
31	and	CC	O	and	_	0	SENT_335	[p20l935t1203r1093b1281],
32	a	DT	O	a	det	33	SENT_335	[p20l1131t1229r1176b1281],
33	rate	NN	O	rate	prep_of	20	SENT_335	[p20l1214t1219r1374b1281],
34	of	IN	O	of	_	0	SENT_335	[p20l1414t1202r1514b1281],
35	stable	JJ	O	stable	amod	36	SENT_335	[p20l1537t1203r1784b1281],
36	disease	NN	O	disease	prep_of	33	SENT_335	[p20l1824t1203r2135b1281],
37	of	IN	O	of	_	0	SENT_335	[p20l13t1330r113b1409],
38	33	CD	PERCENT	33	number	39	SENT_335	[p20l135t1336r317b1409],
39	%	NN	PERCENT	%	amod	42	SENT_335	[p20l135t1336r317b1409],
40	(	CD	NUMBER	(	npadvmod	41	SENT_335	[p20l361t1331r635b1422],
41	stable	JJ	O	stable	amod	42	SENT_335	[p20l361t1331r635b1422],
42	disease	NN	O	disease	prep_of	36	SENT_335	[p20l676t1330r986b1409],
43	plus	CC	O	plus	_	0	SENT_335	[p20l1025t1331r1200b1431],
44	unconfirmed	JJ	O	unconfirmed	amod	46	SENT_335	[p20l1242t1330r1810b1410],
45	partial	JJ	O	partial	amod	46	SENT_335	[p20l1848t1331r2135b1431],
46	responses	NNS	O	response	conj_and	23	SENT_335	[p20l12t1467r487b1560],
47	)	NN	O	)	dep	46	SENT_335	[p20l12t1467r487b1560],
48	.	.	O	.	_	0	SENT_335	[p20l12t1467r487b1560],

1	The	DT	O	the	det	3	SENT_336	[p20l540t1460r700b1538],
2	response	NN	O	response	nn	3	SENT_336	[p20l752t1485r1133b1560],
3	rate	NN	O	rate	nsubj	5	SENT_336	[p20l1184t1476r1344b1538],
4	is	VBZ	O	be	cop	5	SENT_336	[p20l1394t1460r1460b1538],
5	impressive	JJ	O	impressive	_	0	SENT_336	[p20l1513t1460r1991b1560],
6	,	,	O	,	_	0	SENT_336	[p20l1513t1460r1991b1560],
7	as	IN	O	as	mark	21	SENT_336	[p20l2047t1486r2132b1538],
8	compared	VBN	O	compare	_	0	SENT_336	[p20l13t1588r440b1688],
9	with	IN	O	with	prepc_compared_with	21	SENT_336	[p20l488t1587r684b1667],
10	the	DT	O	the	det	15	SENT_336	[p20l737t1588r870b1666],
11	approximate	JJ	O	approximate	amod	15	SENT_336	[p20l923t1588r1463b1688],
12	10	CD	PERCENT	10	number	13	SENT_336	[p20l1520t1593r1701b1666],
13	%	NN	PERCENT	%	amod	15	SENT_336	[p20l1520t1593r1701b1666],
14	response	NN	O	response	nn	15	SENT_336	[p20l1754t1613r2135b1688],
15	rate	NN	O	rate	pobj	21	SENT_336	[p20l12t1732r172b1794],
16	in	IN	O	in	_	0	SENT_336	[p20l215t1716r298b1793],
17	such	JJ	O	such	amod	18	SENT_336	[p20l342t1716r535b1795],
18	cancers	NNS	O	cancer	prep_in	15	SENT_336	[p20l579t1741r899b1794],
19	that	WDT	O	that	nsubjpass	21	SENT_336	[p20l945t1716r1117b1794],
20	were	VBD	O	be	auxpass	21	SENT_336	[p20l1151t1742r1353b1795],
21	treated	VBN	O	treat	advcl	5	SENT_336	[p20l1396t1715r1694b1794],
22	with	IN	O	with	_	0	SENT_336	[p20l1732t1715r1927b1795],
23	second	JJ	ORDINAL	second	amod	26	SENT_336	[p20l1972t1742r2134b1794, p20l13t1843r367b1922],
24	—	NN	O	—	nn	26	SENT_336	[p20l1972t1742r2134b1794, p20l13t1843r367b1922],
25	line	NN	O	line	nn	26	SENT_336	[p20l1972t1742r2134b1794, p20l13t1843r367b1922],
26	chemotherapy	NN	O	chemotherapy	prep_with	21	SENT_336	[p20l412t1844r1116b1944],
27	.	.	O	.	_	0	SENT_336	[p20l412t1844r1116b1944],

1	”	NN	O	”	_	0	SENT_337	[p20l412t1844r1116b1944],
2	The	DT	O	the	det	3	SENT_337	[p20l1157t1844r1317b1922],
3	rate	NN	O	rate	nsubj	10	SENT_337	[p20l1362t1860r1521b1922],
4	and	CC	O	and	_	0	SENT_337	[p20l1564t1844r1722b1922],
5	speed	NN	O	speed	nsubj	10	SENT_337	[p20l1767t1843r2010b1944],
6	of	IN	O	of	_	0	SENT_337	[p20l2054t1843r2153b1922],
7	clinical	JJ	O	clinical	amod	8	SENT_337	[p20l13t1972r326b2050],
8	response	NN	O	response	prep_of	3	SENT_337	[p20l359t1997r740b2072],
9	were	VBD	O	be	cop	10	SENT_337	[p20l769t1998r971b2051],
10	similar	JJ	O	similar	rcmod	1	SENT_337	[p20l1006t1972r1312b2050],
11	to	TO	O	to	_	0	SENT_337	[p20l1343t1988r1424b2050],
12	those	DT	O	those	prep_to	10	SENT_337	[p20l1460t1972r1691b2050],
13	shown	VBN	O	show	partmod	12	SENT_337	[p20l1726t1972r2008b2051],
14	by	IN	O	by	_	0	SENT_337	[p20l2042t1972r2139b2072],
15	EGFR	NN	ORGANIZATION	egfr	nn	18	SENT_337	[p20l11t2105r267b2183],
16	tyrosine	NN	O	tyrosine	nn	18	SENT_337	[p20l297t2100r643b2200],
17	kinase	NN	O	kinase	nn	18	SENT_337	[p20l683t2100r962b2179],
18	inhibitors	NNS	O	inhibitor	agent	13	SENT_337	[p20l1002t2100r1424b2178],
19	in	IN	O	in	_	0	SENT_337	[p20l1466t2100r1549b2177],
20	EGFR	NN	ORGANIZATION	egfr	prep_in	13	SENT_337	[p20l1588t2106r2140b2179],
21	—	CD	NUMBER	—	num	29	SENT_337	[p20l1588t2106r2140b2179],
22	mutant	JJ	O	mutant	amod	29	SENT_337	[p20l1588t2106r2140b2179],
23	non	JJ	O	non	amod	29	SENT_337	[p20l12t2227r655b2306],
24	—	NN	O	—	nn	29	SENT_337	[p20l12t2227r655b2306],
25	small	JJ	O	small	amod	29	SENT_337	[p20l12t2227r655b2306],
26	—	NN	O	—	nn	29	SENT_337	[p20l12t2227r655b2306],
27	cell	NN	O	cell	nn	29	SENT_337	[p20l12t2227r655b2306],
28	lung	NN	O	lung	nn	29	SENT_337	[p20l687t2228r881b2328],
29	cancers	NNS	O	cancer	dep	20	SENT_337	[p20l913t2231r1436b2323],
30	,23	CD	NUMBER	,23	number	31	SENT_337	[p20l913t2231r1436b2323],
31	‘	CD	NUMBER	‘	dep	1	SENT_337	[p20l913t2231r1436b2323],
32	26	CD	NUMBER	26	dep	31	SENT_337	[p20l913t2231r1436b2323],
33	which	WDT	O	which	nsubj	34	SENT_337	[p20l1468t2228r1730b2307],
34	suggests	VBZ	O	suggest	rcmod	31	SENT_337	[p20l1766t2244r2133b2328],
35	that	IN	O	that	complm	40	SENT_337	[p20l12t2356r185b2434],
36	ALK	NNP	O	ALK	dep	38	SENT_337	[p20l211t2356r738b2456],
37	—	CD	NUMBER	—	num	36	SENT_337	[p20l211t2356r738b2456],
38	positive	JJ	O	positive	amod	39	SENT_337	[p20l211t2356r738b2456],
39	tumors	NNS	O	tumor	nsubj	40	SENT_337	[p20l776t2372r1084b2435],
40	constitute	VBP	O	constitute	ccomp	34	SENT_337	[p20l1124t2356r1551b2435],
41	a	DT	DURATION	a	det	45	SENT_337	[p20l1588t2382r1633b2434],
42	second	JJ	DURATION	second	amod	45	SENT_337	[p20l1670t2356r1967b2434],
43	genetically	RB	O	genetically	advmod	44	SENT_337	[p20l2004t2382r2134b2456, p20l12t2484r378b2584],
44	defined	VBN	O	define	amod	45	SENT_337	[p20l431t2483r757b2562],
45	subgroup	NN	O	subgroup	dobj	40	SENT_337	[p20l816t2483r1220b2584],
46	of	IN	O	of	_	0	SENT_337	[p20l1279t2483r1379b2562],
47	oncogene	NN	O	oncogene	nn	48	SENT_337	[p20l1419t2484r2135b2584],
48	—	NN	O	—	prep_of	45	SENT_337	[p20l1419t2484r2135b2584],
49	driven	VBN	O	drive	partmod	48	SENT_337	[p20l1419t2484r2135b2584],
50	lung	NN	O	lung	nn	51	SENT_337	[p20l11t2611r205b2712],
51	cancer	NN	O	cancer	dobj	49	SENT_337	[p20l236t2637r516b2690],
52	that	WDT	O	that	nsubj	55	SENT_337	[p20l548t2612r720b2690],
53	is	VBZ	O	be	cop	55	SENT_337	[p20l748t2612r814b2690],
54	highly	RB	O	highly	advmod	55	SENT_337	[p20l850t2612r1122b2712],
55	susceptible	JJ	O	susceptible	rcmod	51	SENT_337	[p20l1153t2611r1628b2712],
56	to	TO	O	to	_	0	SENT_337	[p20l1663t2628r1744b2690],
57	targeted	VBN	O	target	amod	58	SENT_337	[p20l1780t2612r2135b2712],
58	therapy	NN	O	therapy	prep_to	55	SENT_337	[p20l12t2740r347b2840],
59	.	.	O	.	_	0	SENT_337	[p20l12t2740r347b2840],

1	It	PRP	O	it	nsubj	3	SENT_338	[p20l416t2747r481b2818],
2	is	VBZ	O	be	cop	3	SENT_338	[p20l540t2740r605b2818],
3	notable	JJ	O	notable	_	0	SENT_338	[p20l672t2740r989b2818],
4	that	IN	O	that	complm	54	SENT_338	[p20l1055t2740r1227b2818],
5	patients	NNS	O	patient	nsubj	54	SENT_338	[p20l1285t2740r1626b2840],
6	who	WP	O	who	nsubjpass	8	SENT_338	[p20l1688t2740r1872b2819],
7	were	VBD	O	be	auxpass	8	SENT_338	[p20l1933t2766r2135b2819],
8	treated	VBN	O	treat	rcmod	5	SENT_338	[p20l12t2867r311b2946],
9	with	IN	O	with	_	0	SENT_338	[p20l348t2868r543b2947],
10	therapeutic	JJ	O	therapeutic	amod	11	SENT_338	[p20l584t2868r1070b2968],
11	doses	NNS	O	dose	prep_with	8	SENT_338	[p20l1111t2868r1348b2946],
12	of	IN	O	of	_	0	SENT_338	[p20l1392t2867r1491b2946],
13	crizotinib	NN	O	crizotinib	prep_of	11	SENT_338	[p20l1515t2867r1935b2946],
14	and	CC	O	and	_	0	SENT_338	[p20l1977t2867r2135b2946],
15	whose	WP$	O	whose	poss	16	SENT_338	[p20l7t2996r282b3075],
16	tumors	NNS	O	tumor	nsubj	20	SENT_338	[p20l332t3012r640b3075],
17	did	VBD	O	do	aux	20	SENT_338	[p20l691t2995r826b3074],
18	not	RB	O	not	neg	20	SENT_338	[p20l875t3012r1018b3074],
19	have	VB	O	have	aux	20	SENT_338	[p20l1062t2995r1251b3075],
20	known	VBN	O	know	rcmod	5	SENT_338	[p20l1301t2996r1598b3075],
21	ALK	NN	O	alk	nn	22	SENT_338	[p20l1641t3001r1815b3074],
22	abnormalities	NNS	O	abnormality	nsubj	23	SENT_338	[p20l1856t2996r2134b3074, p20l12t3123r355b3202],
23	(	VBP	O	(	ccomp	20	SENT_338	[p20l393t3124r832b3224],
24	including	VBG	O	include	_	0	SENT_338	[p20l393t3124r832b3224],
25	two	CD	NUMBER	two	num	26	SENT_338	[p20l860t3140r1017b3203],
26	patients	NNS	O	patient	prep_including	42	SENT_338	[p20l1048t3124r1389b3224],
27	with	IN	O	with	_	0	SENT_338	[p20l1419t3124r1614b3203],
28	non	JJ	O	non	amod	29	SENT_338	[p20l1645t3123r2134b3202, p20l13t3252r158b3330],
29	—	NN	O	—	prep_with	26	SENT_338	[p20l1645t3123r2134b3202, p20l13t3252r158b3330],
30	smallcell	NN	O	smallcell	nn	32	SENT_338	[p20l1645t3123r2134b3202, p20l13t3252r158b3330],
31	lung	NN	O	lung	nn	32	SENT_338	[p20l207t3251r401b3352],
32	cancer	NN	O	cancer	nsubj	42	SENT_338	[p20l448t3277r729b3330],
33	who	WP	O	who	nsubjpass	35	SENT_338	[p20l772t3252r955b3331],
34	were	VBD	O	be	auxpass	35	SENT_338	[p20l1002t3278r1204b3331],
35	treated	VBN	O	treat	rcmod	32	SENT_338	[p20l1255t3252r1553b3330],
36	during	IN	O	during	_	0	SENT_338	[p20l1604t3252r1893b3352],
37	dose	NN	O	dose	nn	39	SENT_338	[p20l1940t3252r2134b3330],
38	escalation	NN	O	escalation	nn	39	SENT_338	[p20l13t3379r472b3471],
39	)	NN	O	)	prep_during	35	SENT_338	[p20l13t3379r472b3471],
40	did	VBD	O	do	aux	42	SENT_338	[p20l513t3380r647b3458],
41	not	RB	O	not	neg	42	SENT_338	[p20l681t3396r823b3458],
42	have	VB	O	have	ccomp	23	SENT_338	[p20l852t3380r1042b3459],
43	a	DT	O	a	det	44	SENT_338	[p20l1076t3406r1121b3458],
44	response	NN	O	response	dobj	42	SENT_338	[p20l1153t3405r1534b3480],
45	to	TO	O	to	_	0	SENT_338	[p20l1568t3396r1650b3458],
46	treatment	NN	O	treatment	prep_to	42	SENT_338	[p20l1686t3396r2130b3475],
47	,	,	O	,	_	0	SENT_338	[p20l1686t3396r2130b3475],
48	which	WDT	O	which	nsubj	50	SENT_338	[p20l7t3507r275b3587],
49	was	VBD	O	be	cop	50	SENT_338	[p20l337t3534r502b3587],
50	consistent	JJ	O	consistent	rcmod	46	SENT_338	[p20l571t3508r1020b3586],
51	with	IN	O	with	_	0	SENT_338	[p20l1077t3508r1276b3587],
52	preclinical	JJ	O	preclinical	amod	53	SENT_338	[p20l1340t3508r1807b3608],
53	data	NNS	O	datum	prep_with	50	SENT_338	[p20l1874t3507r2135b3586],
54	”	VBP	O	”	ccomp	3	SENT_338	[p20l1874t3507r2135b3586],
55	(	CD	NUMBER	(	num	56	SENT_338	[p20l17t3637r225b3728],
56	data	NNS	O	datum	npadvmod	57	SENT_338	[p20l17t3637r225b3728],
57	not	RB	O	not	neg	54	SENT_338	[p20l259t3653r401b3715],
58	shown	VBN	O	show	dep	54	SENT_338	[p20l432t3637r765b3728],
59	)	NN	O	)	dobj	58	SENT_338	[p20l432t3637r765b3728],
60	.	.	O	.	_	0	SENT_338	[p20l432t3637r765b3728],

1	The	DT	O	the	det	2	SENT_339	[p21l137t25r299b104],
2	beneﬁt	NN	O	beneﬁt	nsubj	37	SENT_339	[p21l340t25r645b104],
3	that	IN	O	that	complm	5	SENT_339	[p21l680t25r853b104],
4	we	PRP	O	we	nsubj	5	SENT_339	[p21l883t52r1001b105],
5	observed	VBD	O	observe	dep	2	SENT_339	[p21l1042t25r1423b105],
6	from	IN	O	from	_	0	SENT_339	[p21l1462t25r1673b104],
7	crizotinib	NN	O	crizotinib	nn	8	SENT_339	[p21l1714t25r2134b104],
8	therapy	NN	O	therapy	prep_from	5	SENT_339	[p21l12t154r341b253],
9	in	IN	O	in	_	0	SENT_339	[p21l393t154r477b230],
10	ALK	NNP	O	ALK	prep_in	8	SENT_339	[p21l527t154r1065b253],
11	—	CD	NUMBER	—	num	10	SENT_339	[p21l527t154r1065b253],
12	positive	JJ	O	positive	amod	13	SENT_339	[p21l527t154r1065b253],
13	patients	NNS	O	patient	nsubj	15	SENT_339	[p21l1121t154r1469b253],
14	is	VBZ	O	be	cop	15	SENT_339	[p21l1528t154r1596b231],
15	promising	JJ	O	promising	rcmod	8	SENT_339	[p21l1653t154r2130b253],
16	,	,	O	,	_	0	SENT_339	[p21l1653t154r2130b253],
17	with	IN	O	with	_	0	SENT_339	[p21l7t281r206b361],
18	an	DT	O	a	det	21	SENT_339	[p21l257t307r360b360],
19	estimated	VBN	O	estimate	amod	21	SENT_339	[p21l411t281r833b360],
20	6-month	JJ	DURATION	6-month	amod	21	SENT_339	[p21l883t281r1255b360],
21	probability	NN	O	probability	prep_with	15	SENT_339	[p21l1304t281r1778b382],
22	of	IN	O	of	_	0	SENT_339	[p21l1825t281r1925b360],
23	progression	NN	O	progression	npadvmod	25	SENT_339	[p21l1955t307r2134b382, p21l12t409r571b510],
24	—	CD	NUMBER	—	num	23	SENT_339	[p21l1955t307r2134b382, p21l12t409r571b510],
25	free	JJ	O	free	amod	26	SENT_339	[p21l1955t307r2134b382, p21l12t409r571b510],
26	survival	NN	O	survival	prep_of	21	SENT_339	[p21l608t409r940b489],
27	of	IN	O	of	_	0	SENT_339	[p21l975t409r1075b488],
28	72	CD	NUMBER	72	number	29	SENT_339	[p21l1092t415r1300b505],
29	°	CD	NUMBER	°	prep_of	5	SENT_339	[p21l1092t415r1300b505],
30	/	:	O	/	punct	31	SENT_339	[p21l1092t415r1300b505],
31	o	NN	O	o	dep	29	SENT_339	[p21l1092t415r1300b505],
32	;	:	O	;	_	0	SENT_339	[p21l1092t415r1300b505],
33	follow	VB	O	follow	dep	5	SENT_339	[p21l1339t409r1748b510],
34	—	CD	NUMBER	—	dobj	33	SENT_339	[p21l1339t409r1748b510],
35	up	RP	O	up	prt	33	SENT_339	[p21l1339t409r1748b510],
36	is	VBZ	O	be	cop	37	SENT_339	[p21l1783t410r1849b488],
37	ongoing	JJ	O	ongoing	_	0	SENT_339	[p21l1886t435r2134b510, p21l11t538r170b638],
38	.	.	O	.	_	0	SENT_339	[p21l1886t435r2134b510, p21l11t538r170b638],

1	Since	IN	O	since	_	0	SENT_340	[p21l216t538r438b616],
2	more	JJR	O	more	mwe	3	SENT_340	[p21l477t563r696b616],
3	than	IN	O	than	quantmod	5	SENT_340	[p21l735t538r931b616],
4	90	CD	NUMBER	90	number	5	SENT_340	[p21l971t543r1160b616],
5	°	CD	NUMBER	°	pobj	1	SENT_340	[p21l971t543r1160b616],
6	/	:	O	/	punct	7	SENT_340	[p21l971t543r1160b616],
7	o	NN	O	o	dep	5	SENT_340	[p21l971t543r1160b616],
8	of	IN	O	of	_	0	SENT_340	[p21l1198t537r1298b616],
9	the	DT	O	the	det	10	SENT_340	[p21l1318t538r1451b616],
10	patients	NNS	O	patient	prep_of	7	SENT_340	[p21l1488t538r1830b638],
11	in	IN	O	in	_	0	SENT_340	[p21l1870t538r1953b615],
12	our	PRP$	O	we	prep_in	5	SENT_340	[p21l1993t563r2138b617],

1	1700	CD	DATE	1700	num	4	SENT_341	[p21l149t713r225b735],
2	N	NN	O	n	nn	4	SENT_341	[p21l938t723r951b738],
3	ENGLJ	NN	O	englj	nn	4	SENT_341	[p21l966t723r1044b745],
4	MED	NN	O	med	_	0	SENT_341	[p21l1059t723r1110b738],
5	363	CD	NUMBER	363	dep	4	SENT_341	[p21l1121t717r1197b745],
6	;	:	O	;	_	0	SENT_341	[p21l1121t717r1197b745],
7	18	CD	NUMBER	18	num	9	SENT_341	[p21l1121t717r1197b745],
8	NEJM.ORG	NN	O	nejm.org	nn	9	SENT_341	[p21l1232t723r1356b745],
9	OCTOBER	NN	DATE	october	dep	5	SENT_341	[p21l1392t723r1504b739],
10	28,2010	CD	DATE	28,2010	dep	9	SENT_341	[p21l1514t717r1621b743],

1	The	DT	O	the	det	4	SENT_342	[p21l935t756r986b780],
2	New	NNP	O	New	nn	4	SENT_342	[p21l995t757r1057b780],
3	England	NNP	O	England	nn	4	SENT_342	[p21l1066t756r1177b787],
4	Joumal	NNP	O	Joumal	_	0	SENT_342	[p21l1186t756r1283b780],
5	of	IN	O	of	_	0	SENT_342	[p21l1293t756r1322b780],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_342	[p21l1329t756r1454b780],

1	ALK	NNP	O	ALK	nn	2	SENT_343	[p21l485t881r549b900],
2	INHIBITION	NNP	O	INHIBITION	_	0	SENT_343	[p21l562t881r765b900],
3	IN	IN	O	in	_	0	SENT_343	[p21l781t881r818b900],
4	NON	NNP	O	NON	prep_in	2	SENT_343	[p21l834t881r1136b900],
5	.	.	O	.	_	0	SENT_343	[p21l834t881r1136b900],

1	—	NN	O	—	_	0	SENT_344	[p21l834t881r1136b900],
2	.	.	O	.	_	0	SENT_344	[p21l834t881r1136b900],

1	SMALL-CELL	NN	O	small-cell	nn	2	SENT_345	[p21l834t881r1136b900],
2	LUNG	NN	O	lung	_	0	SENT_345	[p21l1150t881r1242b900],
3	CANCER	NNP	O	CANCER	dep	2	SENT_345	[p21l1256t881r1390b900],

1	A	DT	O	a	det	2	SENT_346	[p21l114t1006r136b1031],
2	Duration	NN	O	duration	_	0	SENT_346	[p21l160t1009r271b1032],
3	of	IN	O	of	_	0	SENT_346	[p21l281t1008r311b1032],
4	Treatment	NN	O	treatment	nn	6	SENT_346	[p21l314t1010r448b1032],
5	VI	NNP	O	VI	nn	6	SENT_346	[p21l456t1678r472b1690],
6	o	NN	O	o	prep_of	2	SENT_346	[p21l452t1691r472b1701, p21l456t1702r471b1716],
7	=	JJ	O	=	amod	6	SENT_346	[p21l452t1691r472b1701, p21l456t1702r471b1716],
8	.1	CD	NUMBER	.1	tmod	7	SENT_346	[p21l449t1718r472b1738],
9	’	SYM	O	’	dep	2	SENT_346	[p21l449t1718r472b1738],
10	-	:	O	-	_	0	SENT_346	[p21l452t1740r472b1750],
11	H	NN	O	h	dep	2	SENT_346	[p21l452t1740r472b1750],
12	I	PRP	O	I	dep	11	SENT_346	[p21l456t1750r472b1764],
13	!	.	O	!	_	0	SENT_346	[p21l456t1750r472b1764],

1	D.	NNP	O	D.	_	0	SENT_347	[p21l450t1764r471b1779],

1	30	CD	NUMBER	30	_	0	SENT_348	[p21l872t2423r899b2444],
2	40	CD	NUMBER	40	dep	1	SENT_348	[p21l995t2423r1023b2444],
3	50	CD	NUMBER	50	number	4	SENT_348	[p21l1120t2423r1148b2444],
4	60	CD	NUMBER	60	num	9	SENT_348	[p21l1245t2423r1272b2444],
5	Treatment	NN	O	treatment	nn	9	SENT_348	[p21l911t2474r1045b2496],
6	Duration	NN	O	duration	nn	9	SENT_348	[p21l1055t2473r1166b2496],
7	(	CD	NUMBER	(	num	9	SENT_348	[p21l1178t2472r1229b2503],
8	wk	NN	DURATION	wk	nn	9	SENT_348	[p21l1178t2472r1229b2503],
9	)	NN	O	)	dep	2	SENT_348	[p21l1178t2472r1229b2503],

1	B	NN	O	b	_	0	SENT_349	[p21l117t2554r135b2579],
2	Progression-free	JJ	O	progression-free	amod	3	SENT_349	[p21l160t2556r368b2587],
3	Survival	NN	O	survival	dep	1	SENT_349	[p21l377t2556r478b2580],

1	Probability	NN	O	probability	_	0	SENT_350	[p21l509t2911r540b3046],
2	of	IN	O	of	_	0	SENT_350	[p21l508t2873r532b2902],
3	Progression-free	JJ	O	progression-free	prep_of	1	SENT_350	[p21l508t2659r540b2867],

1	Figure	NNP	O	Figure	_	0	SENT_351	[p21l123t3293r207b3325],
2	4	CD	NUMBER	4	dep	1	SENT_351	[p21l217t3294r241b3317],
3	.	.	O	.	_	0	SENT_351	[p21l217t3294r241b3317],

1	Duration	NN	O	duration	_	0	SENT_352	[p21l254t3293r374b3317],
2	of	IN	O	of	_	0	SENT_352	[p21l386t3292r417b3317],
3	Treatment	NN	O	treatment	amod	7	SENT_352	[p21l421t3294r564b3317],
4	and	CC	O	and	_	0	SENT_352	[p21l574t3292r623b3317],
5	Estimated	VBN	O	estimate	amod	7	SENT_352	[p21l637t3292r773b3317],
6	Progression-free	JJ	O	progression-free	amod	7	SENT_352	[p21l787t3292r1014b3325],
7	Survival	NN	O	survival	prep_of	1	SENT_352	[p21l1024t3292r1142b3317],
8	.	.	O	.	_	0	SENT_352	[p21l1024t3292r1142b3317],

1	Panel	NN	O	panel	nn	2	SENT_353	[p21l123t3342r193b3367],
2	A	NN	O	a	nsubj	3	SENT_353	[p21l205t3344r224b3367],
3	shows	VBZ	O	show	_	0	SENT_353	[p21l234t3342r319b3367],
4	the	DT	O	the	det	6	SENT_353	[p21l329t3342r372b3367],
5	duration	NN	O	duration	nn	6	SENT_353	[p21l382t3342r496b3367],
6	oftreatment	NN	O	oftreatment	dobj	3	SENT_353	[p21l508t3342r677b3367],
7	for	IN	O	for	_	0	SENT_353	[p21l687t3342r725b3367],
8	the	DT	O	the	det	10	SENT_353	[p21l734t3342r776b3367],
9	82	CD	NUMBER	82	num	10	SENT_353	[p21l787t3344r817b3367],
10	patients	NNS	O	patient	prep_for	6	SENT_353	[p21l830t3344r945b3375],
11	,	,	O	,	_	0	SENT_353	[p21l830t3344r945b3375],
12	with	IN	O	with	_	0	SENT_353	[p21l956t3342r1013b3367],
13	blue	JJ	O	blue	amod	14	SENT_353	[p21l1026t3342r1082b3367],
14	bars	NNS	O	bar	prep_with	3	SENT_353	[p21l1094t3342r1149b3367],
15	indicating	VBG	O	indicate	partmod	14	SENT_353	[p21l1161t3342r1295b3375],
16	patients	NNS	O	patient	dobj	15	SENT_353	[p21l1306t3344r1414b3375],
17	who	WP	O	who	nsubj	19	SENT_353	[p21l1424t3342r1481b3367],
18	were	VBD	O	be	aux	19	SENT_353	[p21l1491t3351r1555b3367],
19	continuing	VBG	O	continue	rcmod	16	SENT_353	[p21l1565t3344r1711b3375],
20	to	TO	O	to	aux	21	SENT_353	[p21l1720t3347r1746b3367],
21	receive	VB	O	receive	xcomp	19	SENT_353	[p21l122t3386r213b3409],
22	crizotinib	NN	O	crizotinib	dobj	21	SENT_353	[p21l223t3384r344b3409],
23	by	IN	O	by	_	0	SENT_353	[p21l356t3384r383b3417],
24	data	NNS	O	datum	nn	25	SENT_353	[p21l392t3384r448b3409],
25	cutoff	NN	O	cutoff	prep_by	21	SENT_353	[p21l459t3383r541b3409],
26	.	.	O	.	_	0	SENT_353	[p21l459t3383r541b3409],

1	Red	NNP	O	Red	nn	2	SENT_354	[p21l554t3384r600b3409],
2	bars	NNS	O	bar	nsubj	3	SENT_354	[p21l613t3384r667b3409],
3	indicate	VBP	O	indicate	_	0	SENT_354	[p21l678t3384r780b3409],
4	19	CD	NUMBER	19	num	5	SENT_354	[p21l792t3386r819b3409],
5	patients	NNS	O	patient	dobj	3	SENT_354	[p21l831t3386r935b3417],
6	who	WP	O	who	nsubj	7	SENT_354	[p21l945t3384r1001b3409],
7	discontinued	VBD	O	discontinue	rcmod	5	SENT_354	[p21l1010t3384r1181b3409],
8	treatment	NN	O	treatment	iobj	7	SENT_354	[p21l1191t3388r1322b3409],
9	(	CD	NUMBER	(	number	10	SENT_354	[p21l1334t3386r1371b3417],
10	13	CD	NUMBER	13	dobj	7	SENT_354	[p21l1334t3386r1371b3417],
11	because	IN	O	because	_	0	SENT_354	[p21l1384t3384r1491b3409],
12	ofdisease	NN	O	ofdisease	nn	13	SENT_354	[p21l1501t3383r1632b3409],
13	progression	NN	O	progression	prep_because	7	SENT_354	[p21l1643t3392r1750b3417, p21l122t3428r184b3455],
14	,	,	O	,	_	0	SENT_354	[p21l1643t3392r1750b3417, p21l122t3428r184b3455],
15	1	CD	NUMBER	1	appos	13	SENT_354	[p21l197t3428r209b3450],
16	because	IN	O	because	_	0	SENT_354	[p21l222t3425r330b3451],
17	of	IN	O	of	_	0	SENT_354	[p21l341t3425r370b3451],
18	crizotinib-related	JJ	O	crizotinib-related	amod	20	SENT_354	[p21l376t3425r603b3451],
19	adverse	JJ	O	adverse	amod	20	SENT_354	[p21l615t3425r718b3451],
20	events	NNS	O	event	prep_because_of	7	SENT_354	[p21l729t3430r823b3455],
21	,	,	O	,	_	0	SENT_354	[p21l729t3430r823b3455],
22	1	CD	NUMBER	1	appos	20	SENT_354	[p21l836t3428r847b3450],
23	because	IN	O	because	prep	7	SENT_354	[p21l860t3425r969b3451],
24	of	IN	O	of	pcomp	23	SENT_354	[p21l979t3425r1009b3451],
25	unrelated	JJ	O	unrelated	amod	27	SENT_354	[p21l1016t3425r1140b3451],
26	adverse	JJ	O	adverse	amod	27	SENT_354	[p21l1152t3425r1255b3451],
27	events	NNS	O	event	pobj	24	SENT_354	[p21l1266t3430r1360b3455],
28	,	,	O	,	_	0	SENT_354	[p21l1266t3430r1360b3455],
29	2	CD	NUMBER	2	dep	7	SENT_354	[p21l1371t3428r1385b3450],
30	because	IN	O	because	_	0	SENT_354	[p21l1398t3425r1506b3451],
31	of	IN	O	of	prepc_because_of	29	SENT_354	[p21l1516t3425r1546b3451],
32	death	NN	O	death	pobj	29	SENT_354	[p21l1552t3425r1625b3451],
33	from	IN	O	from	_	0	SENT_354	[p21l1636t3425r1700b3451],
34	unrelated	JJ	O	unrelated	amod	35	SENT_354	[p21l1713t3434r1755b3451, p21l122t3467r211b3492],
35	causes	NNS	O	cause	prep_from	32	SENT_354	[p21l222t3476r319b3497],
36	,	,	O	,	_	0	SENT_354	[p21l222t3476r319b3497],
37	and	CC	O	and	_	0	SENT_354	[p21l330t3467r378b3492],
38	2	CD	NUMBER	2	dobj	3	SENT_354	[p21l389t3469r403b3492],
39	because	IN	O	because	mark	43	SENT_354	[p21l415t3467r522b3492],
40	of	IN	O	of	_	0	SENT_354	[p21l532t3467r561b3492],
41	other	JJ	O	other	amod	42	SENT_354	[p21l567t3467r637b3492],
42	reasons	NNS	O	reason	prep_of	43	SENT_354	[p21l648t3469r766b3500],
43	)	VBP	O	)	dep	38	SENT_354	[p21l648t3469r766b3500],
44	.	.	O	.	_	0	SENT_354	[p21l648t3469r766b3500],

1	Panel	NN	O	panel	nn	2	SENT_355	[p21l779t3467r848b3492],
2	B	NN	O	b	nsubj	3	SENT_355	[p21l862t3469r876b3492],
3	shows	VBZ	O	show	_	0	SENT_355	[p21l888t3467r971b3492],
4	a	DT	O	a	det	6	SENT_355	[p21l982t3476r994b3492],
5	Kaplan-Meier	NNP	O	Kaplan-Meier	nn	6	SENT_355	[p21l1007t3467r1194b3500],
6	curve	NN	O	curve	nsubj	7	SENT_355	[p21l1203t3476r1275b3492],
7	ofestimated	VBD	O	ofestimate	conj_and	7	SENT_355	[p21l1285t3467r1450b3492],
8	progression-free	JJ	O	progression-free	amod	9	SENT_355	[p21l1463t3467r1679b3500],
9	survival	NN	O	survival	dobj	7	SENT_355	[p21l1690t3476r1738b3492, p21l120t3509r186b3538],
10	,	,	O	,	_	0	SENT_355	[p21l1690t3476r1738b3492, p21l120t3509r186b3538],
11	with	IN	O	with	_	0	SENT_355	[p21l196t3509r251b3534],
12	the	DT	O	the	det	14	SENT_355	[p21l261t3509r304b3534],
13	lighter	JJR	O	lighter	amod	14	SENT_355	[p21l315t3509r398b3542],
14	curves	NNS	O	curve	prep_with	7	SENT_355	[p21l407t3518r493b3534],
15	above	IN	O	above	_	0	SENT_355	[p21l504t3509r581b3534],
16	and	CC	O	and	_	0	SENT_355	[p21l592t3509r639b3534],
17	below	IN	O	below	_	0	SENT_355	[p21l652t3509r730b3534],
18	the	DT	O	the	det	19	SENT_355	[p21l738t3509r780b3534],
19	Kaplan	NNP	LOCATION	Kaplan	prep_below	7	SENT_355	[p21l792t3509r978b3542],
20	.	.	O	.	_	0	SENT_355	[p21l792t3509r978b3542],

1	—	NN	O	—	_	0	SENT_356	[p21l792t3509r978b3542],
2	.	.	O	.	_	0	SENT_356	[p21l792t3509r978b3542],

1	Meier	NNP	PERSON	Meier	nsubj	2	SENT_357	[p21l792t3509r978b3542],
2	curve	NN	O	curve	_	0	SENT_357	[p21l988t3518r1059b3534],
3	representing	VBG	O	represent	xcomp	2	SENT_357	[p21l1071t3511r1238b3542],
4	95	CD	PERCENT	95	number	5	SENT_357	[p21l1247t3510r1305b3535],
5	%	NN	PERCENT	%	amod	6	SENT_357	[p21l1247t3510r1305b3535],
6	Ha	NN	O	ha	dobj	3	SENT_357	[p21l1317t3509r1490b3534],
7	|	CD	NUMBER	|	num	8	SENT_357	[p21l1317t3509r1490b3534],
8	|	NN	O	|	dep	6	SENT_357	[p21l1317t3509r1490b3534],
9	.	.	O	.	_	0	SENT_357	[p21l1317t3509r1490b3534],

1	—	NN	O	—	_	0	SENT_358	[p21l1317t3509r1490b3534],
2	.	.	O	.	_	0	SENT_358	[p21l1317t3509r1490b3534],

1	Wel	NNP	O	Wel	nn	2	SENT_359	[p21l1317t3509r1490b3534],
2	|	NNP	O	|	_	0	SENT_359	[p21l1317t3509r1490b3534],
3	ner	NN	O	ner	nn	5	SENT_359	[p21l1317t3509r1490b3534],
4	confidence	NN	O	confidence	nn	5	SENT_359	[p21l1499t3508r1645b3534],
5	limits	NNS	O	limit	dep	2	SENT_359	[p21l1657t3509r1736b3534],
6	.	.	O	.	_	0	SENT_359	[p21l1657t3509r1736b3534],

1	N	NN	O	n	nn	3	SENT_360	[p21l597t3662r610b3677],
2	ENGLJ	NN	O	englj	nn	3	SENT_360	[p21l625t3662r703b3684],
3	MED	NN	O	med	_	0	SENT_360	[p21l718t3662r770b3677],
4	363	CD	NUMBER	363	dep	3	SENT_360	[p21l780t3656r856b3684],
5	;	:	O	;	_	0	SENT_360	[p21l780t3656r856b3684],
6	18	CD	NUMBER	18	num	8	SENT_360	[p21l780t3656r856b3684],
7	NEJM.ORG	NN	O	nejm.org	nn	8	SENT_360	[p21l892t3662r1016b3684],
8	OCTOBER	NN	DATE	october	dep	4	SENT_360	[p21l1051t3662r1163b3678],
9	28	CD	DATE	28	dep	8	SENT_360	[p21l1173t3656r1208b3682],
10	,	,	DATE	,	_	0	SENT_360	[p21l1173t3656r1208b3682],
11	2010	CD	DATE	2010	num	12	SENT_360	[p21l1220t3662r1280b3678],
12	1701	CD	DATE	1701	appos	9	SENT_360	[p21l1991t3652r2067b3674],

1	The	DT	O	the	det	4	SENT_361	[p21l753t3695r804b3719],
2	New	NNP	O	New	nn	4	SENT_361	[p21l813t3696r875b3719],
3	England	NNP	O	England	nn	4	SENT_361	[p21l884t3695r995b3726],
4	Journal	NNP	O	Journal	_	0	SENT_361	[p21l1003t3695r1101b3719],
5	of	IN	O	of	_	0	SENT_361	[p21l1110t3695r1139b3719],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_361	[p21l1146t3695r1271b3719],

1	The	DT	O	the	det	4	SENT_362	[p22l673t69r718b90],
2	NEW	NNP	O	NEW	nn	4	SENT_362	[p22l737t71r822b90],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_362	[p22l841t71r1029b90],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_362	[p22l1048t71r1227b97],
5	of	IN	O	of	_	0	SENT_362	[p22l1247t69r1275b96],
6	MEDICINE	NNP	O	MEDICINE	prep_of	4	SENT_362	[p22l1287t71r1486b90],

1	study	NN	O	study	nsubj	2	SENT_363	[p22l14t291r243b390],
2	received	VBD	O	receive	dep	13	SENT_363	[p22l273t291r619b370],
3	crizotinib	NN	O	crizotinib	dobj	2	SENT_363	[p22l654t291r1074b369],
4	as	IN	O	as	_	0	SENT_363	[p22l1109t317r1195b369],
5	at	IN	O	at	advmod	9	SENT_363	[p22l1231t308r1310b369],
6	least	JJS	O	least	pobj	5	SENT_363	[p22l1338t291r1537b369],
7	a	DT	O	a	det	9	SENT_363	[p22l1566t317r1611b369],
8	second-line	JJ	O	second-line	amod	9	SENT_363	[p22l1645t291r2135b369],
9	therapy	NN	O	therapy	prep_as	2	SENT_363	[p22l12t419r347b519],
10	,	,	O	,	_	0	SENT_363	[p22l12t419r347b519],
11	our	PRP$	O	we	poss	12	SENT_363	[p22l419t445r565b498],
12	findings	NNS	O	finding	appos	9	SENT_363	[p22l626t418r991b520],
13	compare	VBP	O	compare	_	0	SENT_363	[p22l1059t445r1428b519],
14	favorably	RB	O	favorably	advmod	13	SENT_363	[p22l1493t418r1883b519],
15	with	IN	O	with	_	0	SENT_363	[p22l1940t419r2135b498],
16	those	DT	O	those	prep_with	13	SENT_363	[p22l12t547r244b626],
17	in	IN	O	in	_	0	SENT_363	[p22l286t548r369b625],
18	a	DT	O	a	det	21	SENT_363	[p22l410t573r454b625],
19	meta	NN	O	meta	nn	21	SENT_363	[p22l495t547r1082b647],
20	—	NN	O	—	nn	21	SENT_363	[p22l495t547r1082b647],
21	analysis	NN	O	analysis	prep_in	16	SENT_363	[p22l495t547r1082b647],
22	involving	VBG	O	involve	partmod	21	SENT_363	[p22l1125t547r1522b648],
23	patients	NNS	O	patient	dobj	22	SENT_363	[p22l1559t548r1900b647],
24	with	IN	O	with	_	0	SENT_363	[p22l1940t547r2135b626],
25	such	JJ	O	such	amod	26	SENT_363	[p22l14t676r207b755],
26	tumors	NNS	O	tumor	prep_with	22	SENT_363	[p22l251t693r558b755],
27	who	WP	O	who	nsubjpass	29	SENT_363	[p22l599t676r783b755],
28	were	VBD	O	be	auxpass	29	SENT_363	[p22l822t702r1024b755],
29	treated	VBN	O	treat	rcmod	26	SENT_363	[p22l1068t676r1366b755],
30	with	IN	O	with	_	0	SENT_363	[p22l1405t676r1600b755],
31	second-line	JJ	O	second-line	amod	33	SENT_363	[p22l1644t676r2135b755],
32	multiagent	JJ	O	multiagent	amod	33	SENT_363	[p22l12t804r484b905],
33	chemotherapy	NN	O	chemotherapy	prep_with	29	SENT_363	[p22l527t804r1151b904],
34	,	,	O	,	_	0	SENT_363	[p22l527t804r1151b904],
35	which	WDT	O	which	nsubj	36	SENT_363	[p22l1199t804r1462b883],
36	showed	VBD	O	show	rcmod	33	SENT_363	[p22l1511t804r1834b883],
37	a	DT	O	a	det	39	SENT_363	[p22l1881t830r1926b882],
38	median	JJ	O	median	amod	39	SENT_363	[p22l1972t830r2133b882, p22l13t932r202b1011],
39	duration	NN	O	duration	dep	44	SENT_363	[p22l247t932r613b1011],
40	of	IN	O	of	_	0	SENT_363	[p22l658t931r758b1011],
41	progression	NN	O	progression	prep_of	39	SENT_363	[p22l782t931r1491b1033],
42	—	CD	NUMBER	—	dep	44	SENT_363	[p22l782t931r1491b1033],
43	free	JJ	O	free	amod	44	SENT_363	[p22l782t931r1491b1033],
44	survival	NN	O	survival	dep	56	SENT_363	[p22l1537t932r1869b1011],
45	of	IN	O	of	_	0	SENT_363	[p22l1914t931r2013b1011],
46	14	CD	DURATION	14	num	47	SENT_363	[p22l2043t938r2135b1011],
47	weeks	NNS	NUMBER	week	prep_of	44	SENT_363	[p22l7t1060r269b1139],
48	and	CC	O	and	_	0	SENT_363	[p22l327t1060r485b1139],
49	a	DT	O	a	det	51	SENT_363	[p22l541t1086r586b1138],
50	6-month	JJ	DURATION	6-month	amod	51	SENT_363	[p22l642t1060r1014b1139],
51	rate	NN	O	rate	dep	56	SENT_363	[p22l1071t1077r1231b1138],
52	of	IN	O	of	_	0	SENT_363	[p22l1289t1059r1389b1139],
53	progression	NN	O	progression	prep_of	51	SENT_363	[p22l1426t1059r2135b1161],
54	—	CD	NUMBER	—	num	56	SENT_363	[p22l1426t1059r2135b1161],
55	free	JJ	O	free	amod	56	SENT_363	[p22l1426t1059r2135b1161],
56	survival	NN	O	survival	dep	60	SENT_363	[p22l14t1188r345b1267],
57	of	IN	O	of	_	0	SENT_363	[p22l379t1187r479b1267],
58	27.20	CD	NUMBER	27.20	prep_of	56	SENT_363	[p22l494t1193r949b1267],
59	/	:	O	/	punct	60	SENT_363	[p22l494t1193r949b1267],
60	o.	NN	O	o.	dep	36	SENT_363	[p22l494t1193r949b1267],
61	25	CD	NUMBER	25	number	62	SENT_363	[p22l494t1193r949b1267],
62	’27	CD	NUMBER	’27	nsubj	13	SENT_363	[p22l494t1193r949b1267],
63	Therefore	RB	O	therefore	advmod	73	SENT_363	[p22l980t1187r1420b1284],
64	,	,	O	,	_	0	SENT_363	[p22l980t1187r1420b1284],
65	targeted	VBN	O	target	csubj	73	SENT_363	[p22l1460t1188r1815b1289],
66	inhibition	NN	O	inhibition	dobj	65	SENT_363	[p22l1847t1188r2134b1267, p22l12t1317r182b1395],
67	of	IN	O	of	_	0	SENT_363	[p22l230t1315r330b1395],
68	ALK	NNP	O	ALK	prep_of	66	SENT_363	[p22l356t1324r548b1397],
69	in	IN	O	in	_	0	SENT_363	[p22l591t1317r674b1394],
70	genotyped	JJ	O	genotyped	amod	71	SENT_363	[p22l722t1316r1172b1417],
71	patients	NNS	O	patient	prep_in	65	SENT_363	[p22l1219t1317r1560b1416],
72	may	MD	O	may	aux	73	SENT_363	[p22l1610t1342r1789b1416],
73	lead	VB	O	lead	rcmod	62	SENT_363	[p22l1831t1316r2005b1395],
74	to	TO	O	to	_	0	SENT_363	[p22l2052t1333r2134b1395],
75	improved	VBN	O	improve	amod	76	SENT_363	[p22l11t1444r423b1543],
76	survival	NN	O	survival	prep_to	73	SENT_363	[p22l482t1444r845b1539],
77	,	,	O	,	_	0	SENT_363	[p22l482t1444r845b1539],
78	as	IN	O	as	amod	76	SENT_363	[p22l908t1470r994b1522],
79	compared	VBN	O	compare	_	0	SENT_363	[p22l1055t1444r1488b1543],
80	with	IN	O	with	prepc_compared_with	78	SENT_363	[p22l1541t1444r1740b1523],
81	conventional	JJ	O	conventional	amod	82	SENT_363	[p22l1798t1470r2134b1523, p22l12t1571r267b1650],
82	chemotherapy	NN	O	chemotherapy	pobj	78	SENT_363	[p22l321t1571r945b1671],
83	.	.	O	.	_	0	SENT_363	[p22l321t1571r945b1671],

1	Because	IN	O	because	_	0	SENT_364	[p22l1003t1578r1347b1651],
2	our	PRP$	O	we	poss	3	SENT_364	[p22l1402t1597r1548b1651],
3	discovery	NN	O	discovery	prep_because	11	SENT_364	[p22l1599t1571r2003b1671],
4	of	IN	O	of	_	0	SENT_364	[p22l2053t1570r2154b1650],
5	crizotinib	NN	O	crizotinib	poss	7	SENT_364	[p22l13t1700r496b1778],
6	’s	POS	O	’s	_	0	SENT_364	[p22l13t1700r496b1778],
7	activity	NN	O	activity	prep_of	3	SENT_364	[p22l545t1701r855b1799],
8	in	IN	O	in	_	0	SENT_364	[p22l898t1701r981b1777],
9	this	DT	O	this	prep_in	7	SENT_364	[p22l1029t1700r1189b1778],
10	population	NN	O	population	nsubj	11	SENT_364	[p22l1237t1700r1708b1799],
11	occurred	VBD	O	occur	_	0	SENT_364	[p22l1757t1700r2135b1779],
12	so	RB	O	so	advmod	13	SENT_364	[p22l14t1853r104b1906],
13	proximal	JJ	O	proximal	acomp	11	SENT_364	[p22l148t1827r540b1927],
14	to	TO	O	to	_	0	SENT_364	[p22l585t1844r666b1906],
15	the	DT	O	the	det	16	SENT_364	[p22l713t1827r845b1905],
16	identification	NN	O	identification	prep_to	13	SENT_364	[p22l889t1826r1473b1906],
17	of	IN	O	of	_	0	SENT_364	[p22l1518t1826r1618b1906],
18	EML4	NN	O	eml4	prep_of	16	SENT_364	[p22l1642t1833r2134b1923],
19	.	.	O	.	_	0	SENT_364	[p22l1642t1833r2134b1923],

1	—	NN	O	—	_	0	SENT_365	[p22l1642t1833r2134b1923],
2	.	.	O	.	_	0	SENT_365	[p22l1642t1833r2134b1923],

1	ALK	NNP	O	ALK	nsubj	5	SENT_366	[p22l1642t1833r2134b1923],
2	,8	CD	NUMBER	,8	num	1	SENT_366	[p22l1642t1833r2134b1923],
3	it	PRP	O	it	nsubj	5	SENT_366	[p22l11t1956r71b2033],
4	is	VBZ	O	be	cop	5	SENT_366	[p22l117t1956r183b2033],
5	difficult	JJ	O	difficult	_	0	SENT_366	[p22l237t1954r592b2035],
6	to	TO	O	to	aux	7	SENT_366	[p22l639t1972r721b2034],
7	determine	VB	O	determine	xcomp	5	SENT_366	[p22l774t1955r1212b2034],
8	the	DT	O	the	det	9	SENT_366	[p22l1264t1955r1397b2033],
9	outcome	NN	O	outcome	dobj	7	SENT_366	[p22l1449t1972r1818b2035],
10	of	IN	O	of	_	0	SENT_366	[p22l1870t1954r1971b2034],
11	patients	NNS	O	patient	prep_of	9	SENT_366	[p22l2002t1981r2134b2055, p22l12t2084r249b2161],
12	with	IN	O	with	_	0	SENT_366	[p22l303t2083r498b2163],
13	ALK	NN	O	alk	npadvmod	15	SENT_366	[p22l548t2084r1075b2183],
14	—	CD	NUMBER	—	num	13	SENT_366	[p22l548t2084r1075b2183],
15	positive	JJ	O	positive	amod	16	SENT_366	[p22l548t2084r1075b2183],
16	disease	NN	O	disease	prep_with	11	SENT_366	[p22l1132t2083r1443b2162],
17	after	IN	O	after	_	0	SENT_366	[p22l1499t2082r1701b2161],
18	standard	JJ	O	standard	amod	19	SENT_366	[p22l1756t2083r2135b2162],
19	chemotherapy	NN	O	chemotherapy	prep_after	7	SENT_366	[p22l13t2211r624b2311],
20	in	IN	O	in	_	0	SENT_366	[p22l659t2212r742b2289],
21	the	DT	O	the	det	22	SENT_366	[p22l782t2211r915b2289],
22	absence	NN	O	absence	prep_in	7	SENT_366	[p22l954t2211r1292b2290],
23	of	IN	O	of	_	0	SENT_366	[p22l1332t2210r1433b2290],
24	ALK	NN	O	alk	nn	25	SENT_366	[p22l1451t2219r1642b2292],
25	inhibition	NN	O	inhibition	prep_of	22	SENT_366	[p22l1678t2211r2130b2290],
26	.	.	O	.	_	0	SENT_366	[p22l1678t2211r2130b2290],

1	However	RB	O	however	advmod	20	SENT_367	[p22l11t2347r406b2435],
2	,	,	O	,	_	0	SENT_367	[p22l11t2347r406b2435],
3	preliminary	JJ	O	preliminary	amod	4	SENT_367	[p22l445t2339r960b2439],
4	data	NNS	O	datum	nsubj	20	SENT_367	[p22l991t2339r1174b2418],
5	from	IN	O	from	_	0	SENT_367	[p22l1207t2338r1418b2418],
6	a	DT	O	a	det	8	SENT_367	[p22l1452t2365r1496b2417],
7	small	JJ	O	small	amod	8	SENT_367	[p22l1531t2339r1766b2417],
8	number	NN	O	number	prep_from	4	SENT_367	[p22l1799t2339r2137b2419],
9	of	IN	O	of	_	0	SENT_367	[p22l13t2466r113b2546],
10	patients	NNS	O	patient	prep_of	8	SENT_367	[p22l125t2468r467b2567],
11	who	WP	O	who	nsubjpass	14	SENT_367	[p22l496t2467r680b2547],
12	were	VBD	O	be	auxpass	14	SENT_367	[p22l709t2493r911b2547],
13	retrospectively	RB	O	retrospectively	advmod	14	SENT_367	[p22l943t2467r1572b2567],
14	identified	VBN	O	identify	rcmod	10	SENT_367	[p22l1599t2466r2016b2546],
15	as	IN	O	as	_	0	SENT_367	[p22l2047t2493r2132b2545],
16	having	VBG	O	have	prepc_as	14	SENT_367	[p22l12t2596r303b2697],
17	the	DT	O	the	det	19	SENT_367	[p22l337t2596r471b2674],
18	ALK	NNP	O	ALK	nn	19	SENT_367	[p22l501t2602r676b2674],
19	rearrangement	NN	O	rearrangement	dobj	16	SENT_367	[p22l705t2613r1347b2697],
20	suggest	VBP	O	suggest	_	0	SENT_367	[p22l1381t2613r1709b2697],
21	that	IN	O	that	complm	32	SENT_367	[p22l1741t2596r1914b2674],
22	ALK	NNP	O	ALK	dep	24	SENT_367	[p22l1940t2602r2133b2674],
23	—	CD	NUMBER	—	num	22	SENT_367	[p22l1940t2602r2133b2674],
24	positive	JJ	O	positive	amod	25	SENT_367	[p22l10t2725r342b2823],
25	tumors	NNS	O	tumor	nsubj	32	SENT_367	[p22l388t2741r695b2803],
26	that	WDT	O	that	nsubjpass	28	SENT_367	[p22l743t2724r915b2802],
27	are	VBP	O	be	auxpass	28	SENT_367	[p22l954t2750r1083b2802],
28	treated	VBN	O	treat	rcmod	25	SENT_367	[p22l1130t2724r1428b2802],
29	with	IN	O	with	_	0	SENT_367	[p22l1469t2724r1664b2803],
30	platinumbased	JJ	O	platinumbased	amod	31	SENT_367	[p22l1707t2724r2133b2823, p22l12t2852r253b2930],
31	chemotherapy	NN	O	chemotherapy	prep_with	28	SENT_367	[p22l287t2852r886b2951],
32	have	VBP	O	have	ccomp	20	SENT_367	[p22l916t2852r1103b2931],
33	a	DT	O	a	det	34	SENT_367	[p22l1136t2878r1181b2930],
34	response	NN	O	response	dobj	32	SENT_367	[p22l1213t2878r1587b2951],
35	that	WDT	O	that	nsubj	37	SENT_367	[p22l1621t2852r1790b2930],
36	is	VBZ	O	be	cop	37	SENT_367	[p22l1819t2853r1883b2929],
37	similar	JJ	O	similar	rcmod	34	SENT_367	[p22l1922t2853r2133b2929, p22l11t2980r127b3058],
38	to	TO	O	to	_	0	SENT_367	[p22l168t2997r249b3059],
39	that	DT	O	that	prep_to	37	SENT_367	[p22l295t2980r467b3058],
40	of	IN	O	of	_	0	SENT_367	[p22l506t2979r606b3059],
41	such	JJ	O	such	amod	42	SENT_367	[p22l633t2980r827b3059],
42	tumors	NNS	O	tumor	prep_of	39	SENT_367	[p22l871t2997r1179b3059],
43	without	IN	O	without	_	0	SENT_367	[p22l1220t2980r1559b3059],
44	ALK	NNP	O	ALK	prep_without	37	SENT_367	[p22l1590t2986r1766b3058],
45	or	CC	O	or	_	0	SENT_367	[p22l1801t3006r1890b3059],
46	EGFR	NN	ORGANIZATION	egfr	nn	47	SENT_367	[p22l1929t2987r2141b3060],
47	mutations	NNS	O	mutation	prep_without	37	SENT_367	[p22l12t3109r551b3186],
48	.	.	O	.	_	0	SENT_367	[p22l12t3109r551b3186],

1	”	NN	O	”	_	0	SENT_368	[p22l12t3109r551b3186],

1	Crucial	JJ	O	crucial	nsubj	12	SENT_369	[p22l141t3235r449b3314],
2	to	TO	O	to	_	0	SENT_369	[p22l490t3252r571b3314],
3	the	DT	O	the	det	4	SENT_369	[p22l615t3235r747b3314],
4	identification	NN	O	identification	prep_to	1	SENT_369	[p22l788t3234r1371b3314],
5	of	IN	O	of	_	0	SENT_369	[p22l1413t3234r1513b3314],
6	a	DT	O	a	det	9	SENT_369	[p22l1535t3261r1580b3313],
7	rare	JJ	O	rare	amod	9	SENT_369	[p22l1619t3261r1786b3313],
8	genetic	JJ	O	genetic	amod	9	SENT_369	[p22l1827t3236r2136b3336],
9	subgroup	NN	O	subgroup	prep_of	4	SENT_369	[p22l14t3363r410b3464],
10	was	VBD	O	be	cop	12	SENT_369	[p22l438t3389r598b3442],
11	our	PRP$	O	we	poss	12	SENT_369	[p22l633t3389r776b3442],
12	ability	NN	O	ability	_	0	SENT_369	[p22l804t3363r1068b3463],
13	to	TO	O	to	aux	15	SENT_369	[p22l1095t3380r1175b3442],
14	molecularly	RB	O	molecularly	advmod	15	SENT_369	[p22l1208t3363r1704b3463],
15	prescreen	VB	O	prescreen	infmod	12	SENT_369	[p22l1729t3389r2135b3463],
16	large	JJ	O	large	amod	17	SENT_369	[p22l11t3491r225b3592],
17	numbers	NNS	O	number	dobj	15	SENT_369	[p22l260t3491r638b3570],
18	of	IN	O	of	_	0	SENT_369	[p22l676t3490r776b3570],
19	non	JJ	O	non	amod	25	SENT_369	[p22l793t3491r1435b3570],
20	—	JJ	O	—	amod	25	SENT_369	[p22l793t3491r1435b3570],
21	small	JJ	O	small	amod	25	SENT_369	[p22l793t3491r1435b3570],
22	—	NN	O	—	nn	25	SENT_369	[p22l793t3491r1435b3570],
23	cell	NN	O	cell	nn	25	SENT_369	[p22l793t3491r1435b3570],
24	lung	NN	O	lung	nn	25	SENT_369	[p22l1469t3491r1662b3592],
25	cancers	NNS	O	cancer	prep_of	17	SENT_369	[p22l1695t3517r2015b3569],
26	in	IN	O	in	_	0	SENT_369	[p22l2052t3492r2135b3569],
27	real	JJ	O	real	amod	28	SENT_369	[p22l12t3619r172b3697],
28	time	NN	O	time	prep_in	25	SENT_369	[p22l232t3620r424b3697],
29	and	CC	O	and	_	0	SENT_369	[p22l483t3619r641b3698],
30	incorporate	VB	O	incorporate	conj_and	15	SENT_369	[p22l700t3620r1198b3719],
31	an	DT	O	a	nsubj	33	SENT_369	[p22l1258t3645r1361b3697],
32	expanded	VBN	O	expand	amod	31	SENT_369	[p22l1421t3619r1833b3719],
33	genotype-driven	JJ	O	genotype-driven	xcomp	30	SENT_369	[p22l1892t3645r2134b3720, p23l12t20r512b119],

1	study	NN	O	study	_	0	SENT_370	[p23l568t20r802b119],
2	into	IN	O	into	_	0	SENT_370	[p23l852t21r1024b98],
3	this	DT	O	this	det	6	SENT_370	[p23l1080t20r1243b98],
4	phase	NN	O	phase	nn	6	SENT_370	[p23l1298t20r1552b119],
5	1	CD	NUMBER	1	num	6	SENT_370	[p23l1609t26r1654b97],
6	trial	NN	O	trial	prep_into	1	SENT_370	[p23l1709t20r1915b98],
7	.	.	O	.	_	0	SENT_370	[p23l1709t20r1915b98],

1	The	DT	O	the	det	3	SENT_371	[p23l1972t20r2135b98],
2	ALK	NNP	O	ALK	nn	3	SENT_371	[p23l6t154r183b226],
3	rearrangement	NN	O	rearrangement	nsubj	4	SENT_371	[p23l238t165r892b249],
4	occurred	VBD	O	occur	_	0	SENT_371	[p23l952t148r1338b227],
5	in	IN	O	in	dep	4	SENT_371	[p23l1400t149r1485b226],
6	about	IN	O	about	_	0	SENT_371	[p23l1548t148r1796b227],
7	5	CD	PERCENT	5	num	8	SENT_371	[p23l1857t154r1989b227],
8	%	NN	PERCENT	%	prep_about	4	SENT_371	[p23l1857t154r1989b227],
9	of	IN	O	of	_	0	SENT_371	[p23l2052t147r2153b227],
10	patients	NNS	O	patient	prep_of	8	SENT_371	[p23l11t277r360b376],
11	who	WP	O	who	nsubj	12	SENT_371	[p23l400t276r580b355],
12	underwent	VBD	O	undergo	rcmod	10	SENT_371	[p23l620t276r1077b355],
13	screening	NN	O	screening	dobj	12	SENT_371	[p23l1111t277r1537b377],
14	.	.	O	.	_	0	SENT_371	[p23l1111t277r1537b377],

1	FISH	NN	O	fish	nn	2	SENT_372	[p23l1580t282r1786b355],
2	positivity	NN	O	positivity	nsubjpass	7	SENT_372	[p23l1824t277r2133b376, p23l11t405r117b504],
3	for	IN	O	for	_	0	SENT_372	[p23l146t403r268b483],
4	ALK	NNP	O	ALK	nn	5	SENT_372	[p23l292t410r464b482],
5	rearrangement	NN	O	rearrangement	prep_for	2	SENT_372	[p23l492t421r1134b505],
6	was	VBD	O	be	auxpass	7	SENT_372	[p23l1161t430r1323b483],
7	required	VBN	O	require	_	0	SENT_372	[p23l1362t404r1723b504],
8	for	IN	O	for	_	0	SENT_372	[p23l1759t403r1883b483],
9	entry	NN	O	entry	prep_for	7	SENT_372	[p23l1917t421r2139b504],
10	into	IN	O	into	_	0	SENT_372	[p23l11t533r177b611],
11	the	DT	O	the	det	13	SENT_372	[p23l219t532r349b610],
12	expanded	VBN	O	expand	amod	13	SENT_372	[p23l391t532r793b632],
13	cohort	NN	O	cohort	prep_into	7	SENT_372	[p23l834t532r1129b611],
14	.	.	O	.	_	0	SENT_372	[p23l834t532r1129b611],

1	However	RB	O	however	advmod	11	SENT_373	[p23l1175t540r1560b628],
2	,	,	O	,	_	0	SENT_373	[p23l1175t540r1560b628],
3	the	DT	O	the	det	4	SENT_373	[p23l1607t532r1737b610],
4	findings	NNS	O	finding	nsubj	11	SENT_373	[p23l1778t531r2133b633],
5	that	IN	O	that	_	0	SENT_373	[p23l12t660r188b738],
6	patients	NNS	O	patient	prep_that	4	SENT_373	[p23l232t661r581b760],
7	with	IN	O	with	_	0	SENT_373	[p23l629t660r828b739],
8	the	DT	O	the	det	10	SENT_373	[p23l878t660r1014b738],
9	ALK	NNP	O	ALK	nn	10	SENT_373	[p23l1057t666r1234b738],
10	rearrangement	NN	O	rearrangement	prep_with	6	SENT_373	[p23l1276t677r1931b761],
11	had	VBD	O	have	_	0	SENT_373	[p23l1976t660r2135b739],
12	strong	JJ	O	strong	amod	14	SENT_373	[p23l14t805r296b889],
13	aberrant	JJ	O	aberrant	amod	14	SENT_373	[p23l340t788r714b867],
14	expression	NN	O	expression	dobj	11	SENT_373	[p23l757t789r1223b888],
15	of	IN	O	of	_	0	SENT_373	[p23l1271t787r1372b867],
16	the	DT	O	the	det	18	SENT_373	[p23l1402t788r1536b866],
17	ALK	NN	O	alk	nn	18	SENT_373	[p23l1581t796r1774b869],
18	protein	NN	O	protein	prep_of	14	SENT_373	[p23l1817t789r2135b888],
19	and	CC	O	and	_	0	SENT_373	[p23l11t915r171b994],
20	that	IN	O	that	dep	23	SENT_373	[p23l214t915r389b993],
21	many	JJ	O	many	amod	22	SENT_373	[p23l427t941r669b1015],
22	patients	NNS	O	patient	nsubj	23	SENT_373	[p23l705t916r1054b1015],
23	had	VBD	O	have	conj_and	11	SENT_373	[p23l1099t915r1257b994],
24	positive	JJ	O	positive	amod	25	SENT_373	[p23l1298t916r1636b1015],
25	results	NNS	O	result	dobj	23	SENT_373	[p23l1679t915r1968b995],
26	for	IN	O	for	_	0	SENT_373	[p23l2013t914r2138b994],
27	the	DT	O	the	det	28	SENT_373	[p23l12t1043r145b1121],
28	presence	NN	O	presence	prep_for	25	SENT_373	[p23l180t1069r556b1143],
29	of	IN	O	of	_	0	SENT_373	[p23l593t1042r692b1122],
30	EML4-ALK	NN	O	eml4-alk	prep_of	28	SENT_373	[p23l709t1049r1143b1122],
31	on	IN	O	on	_	0	SENT_373	[p23l1171t1069r1277b1122],
32	RT	NN	O	rt	prep_on	23	SENT_373	[p23l1312t1049r1648b1127],
33	.	.	O	.	_	0	SENT_373	[p23l1312t1049r1648b1127],

1	—	NN	O	—	_	0	SENT_374	[p23l1312t1049r1648b1127],
2	.	.	O	.	_	0	SENT_374	[p23l1312t1049r1648b1127],

1	PCR	NN	O	pcr	nn	2	SENT_375	[p23l1312t1049r1648b1127],
2	assay	NN	O	assay	nsubj	3	SENT_375	[p23l1674t1069r1901b1143],
3	raise	VBP	O	raise	_	0	SENT_375	[p23l1932t1044r2135b1121],
4	the	DT	O	the	det	5	SENT_375	[p23l12t1172r148b1250],
5	possibility	NN	O	possibility	dobj	3	SENT_375	[p23l192t1172r656b1272],
6	that	IN	O	that	complm	12	SENT_375	[p23l696t1172r873b1250],
7	other	JJ	O	other	amod	9	SENT_375	[p23l914t1172r1147b1251],
8	diagnostic	JJ	O	diagnostic	amod	9	SENT_375	[p23l1189t1172r1652b1273],
9	approaches	NNS	O	approach	nsubjpass	12	SENT_375	[p23l1696t1172r2133b1272, p23l13t1326r97b1378],
10	could	MD	O	could	aux	12	SENT_375	[p23l168t1300r406b1379],
11	be	VB	O	be	auxpass	12	SENT_375	[p23l474t1300r571b1379],
12	used	VBN	O	use	ccomp	3	SENT_375	[p23l638t1300r838b1379],
13	to	TO	O	to	aux	14	SENT_375	[p23l905t1317r988b1379],
14	identify	VB	O	identify	xcomp	12	SENT_375	[p23l1055t1299r1396b1400],
15	ALK	NNP	O	ALK	dobj	14	SENT_375	[p23l1451t1300r2135b1401],
16	—	CD	NUMBER	—	num	15	SENT_375	[p23l1451t1300r2135b1401],
17	rearranged	VBN	O	rearrange	partmod	15	SENT_375	[p23l1451t1300r2135b1401],
18	tumors	NNS	O	tumor	dobj	17	SENT_375	[p23l12t1418r351b1480],
19	.	.	O	.	_	0	SENT_375	[p23l12t1418r351b1480],

1	The	DT	O	the	det	2	SENT_376	[p23l137t1529r298b1608],
2	use	NN	O	use	nsubj	7	SENT_376	[p23l336t1555r477b1608],
3	of	IN	O	of	_	0	SENT_376	[p23l515t1528r615b1608],
4	prospective	JJ	O	prospective	amod	6	SENT_376	[p23l633t1530r1122b1629],
5	tumor	NN	O	tumor	nn	6	SENT_376	[p23l1162t1546r1429b1608],
6	genotyping	NN	O	genotyping	prep_of	2	SENT_376	[p23l1464t1530r1954b1630],
7	has	VBZ	O	have	_	0	SENT_376	[p23l1989t1529r2132b1607],
8	the	DT	O	the	det	9	SENT_376	[p23l12t1657r147b1736],
9	potential	JJ	O	potential	dobj	7	SENT_376	[p23l195t1657r592b1757],
10	to	TO	O	to	aux	11	SENT_376	[p23l640t1674r723b1736],
11	streamline	VB	O	streamline	dep	9	SENT_376	[p23l775t1657r1245b1736],
12	drug	NN	O	drug	nn	13	SENT_376	[p23l1295t1657r1501b1758],
13	development	NN	O	development	dobj	11	SENT_376	[p23l1548t1657r2130b1757],
14	.	.	O	.	_	0	SENT_376	[p23l1548t1657r2130b1757],

1	Approximately	RB	O	approximately	quantmod	2	SENT_377	[p23l8t1784r658b1884],
2	2	CD	DURATION	2	num	3	SENT_377	[p23l711t1790r758b1862],
3	years	NNS	NUMBER	year	nsubj	59	SENT_377	[p23l812t1810r1036b1884],
4	after	IN	O	after	_	0	SENT_377	[p23l1095t1783r1301b1862],
5	the	DT	O	the	det	7	SENT_377	[p23l1356t1784r1491b1862],
6	initial	JJ	O	initial	amod	7	SENT_377	[p23l1548t1784r1811b1862],
7	report	NN	O	report	prep_after	3	SENT_377	[p23l1867t1801r2140b1884],
8	describing	VBG	O	describe	partmod	7	SENT_377	[p23l13t1913r464b2014],
9	EML4-ALK	NN	O	eml4-alk	nn	10	SENT_377	[p23l522t1919r956b1992],
10	rearrangement	NN	O	rearrangement	dobj	8	SENT_377	[p23l1011t1919r1714b2014],
11	,8	CD	NUMBER	,8	num	10	SENT_377	[p23l1011t1919r1714b2014],
12	we	PRP	O	we	nsubj	14	SENT_377	[p23l1775t1939r1892b1992],
13	first	RB	ORDINAL	first	advmod	14	SENT_377	[p23l1955t1912r2140b1991],
14	reported	VBD	O	report	parataxis	59	SENT_377	[p23l12t2041r379b2140],
15	that	IN	O	that	complm	18	SENT_377	[p23l414t2041r586b2119],
16	ALK	NN	O	alk	nn	17	SENT_377	[p23l612t2048r803b2121],
17	inhibition	NN	O	inhibition	nsubj	18	SENT_377	[p23l834t2041r1263b2119],
18	shrank	VBD	O	shrink	ccomp	14	SENT_377	[p23l1299t2041r1600b2120],
19	tumors	NNS	O	tumor	dobj	18	SENT_377	[p23l1631t2057r1938b2120],
20	in	IN	O	in	_	0	SENT_377	[p23l1975t2042r2058b2118],
21	a	DT	O	a	det	22	SENT_377	[p23l2092t2067r2136b2118],
22	targeted	VBN	O	target	prep_in	19	SENT_377	[p23l12t2169r368b2270],
23	population	NN	O	population	dep	22	SENT_377	[p23l405t2169r876b2269],
24	of	IN	O	of	_	0	SENT_377	[p23l915t2168r1015b2248],
25	patients	NNS	O	patient	prep_of	23	SENT_377	[p23l1033t2170r1375b2269],
26	with	IN	O	with	_	0	SENT_377	[p23l1411t2169r1606b2248],
27	non	JJ	O	non	amod	33	SENT_377	[p23l1644t2169r2134b2248],
28	—	JJ	O	—	amod	33	SENT_377	[p23l1644t2169r2134b2248],
29	small	JJ	O	small	amod	33	SENT_377	[p23l1644t2169r2134b2248],
30	—	NN	O	—	nn	33	SENT_377	[p23l1644t2169r2134b2248],
31	cell	NN	O	cell	nn	33	SENT_377	[p23l13t2297r158b2375],
32	lung	NN	O	lung	nn	33	SENT_377	[p23l195t2297r389b2398],
33	cancers	NNS	O	cancer	prep_with	25	SENT_377	[p23l425t2302r847b2376],
34	.18	CD	NUMBER	.18	num	22	SENT_377	[p23l425t2302r847b2376],
35	Only	RB	O	only	advmod	37	SENT_377	[p23l888t2297r1092b2397],
36	3	CD	DURATION	3	num	37	SENT_377	[p23l1127t2303r1171b2376],
37	years	NNS	NUMBER	year	npadvmod	18	SENT_377	[p23l1208t2323r1428b2397],
38	after	IN	O	after	_	0	SENT_377	[p23l1468t2296r1670b2375],
39	the	DT	O	the	det	40	SENT_377	[p23l1706t2297r1838b2375],
40	initiation	NN	O	initiation	prep_after	18	SENT_377	[p23l1877t2298r2134b2375, p23l12t2426r182b2504],
41	of	IN	O	of	_	0	SENT_377	[p23l226t2424r326b2504],
42	the	DT	O	the	det	45	SENT_377	[p23l352t2425r485b2504],
43	phase	NN	O	phase	nn	45	SENT_377	[p23l527t2425r776b2525],
44	1	CD	NUMBER	1	num	45	SENT_377	[p23l824t2431r868b2503],
45	trial	NN	O	trial	prep_of	40	SENT_377	[p23l913t2425r1113b2521],
46	,	,	O	,	_	0	SENT_377	[p23l913t2425r1113b2521],
47	a	DT	O	a	det	51	SENT_377	[p23l1162t2451r1206b2503],
48	phase	NN	O	phase	nn	51	SENT_377	[p23l1247t2425r1496b2525],
49	3	CD	NUMBER	3	num	51	SENT_377	[p23l1541t2431r1584b2504],
50	registration	NN	O	registration	nn	51	SENT_377	[p23l1631t2426r2135b2526],
51	trial	NN	O	trial	appos	45	SENT_377	[p23l12t2552r191b2630],
52	of	IN	O	of	_	0	SENT_377	[p23l224t2551r324b2631],
53	crizotinib	NN	O	crizotinib	prep_of	51	SENT_377	[p23l339t2552r761b2631],
54	in	IN	O	in	_	0	SENT_377	[p23l794t2553r878b2630],
55	ALK	NNP	O	ALK	prep_in	18	SENT_377	[p23l904t2553r1433b2652],
56	—	CD	NUMBER	—	num	55	SENT_377	[p23l904t2553r1433b2652],
57	positive	JJ	O	positive	amod	58	SENT_377	[p23l904t2553r1433b2652],
58	patients	NNS	O	patient	nsubj	59	SENT_377	[p23l1464t2553r1807b2652],
59	started	VBD	O	start	_	0	SENT_377	[p23l1843t2552r2143b2631],
60	enrollment	NN	O	enrollment	dobj	59	SENT_377	[p23l12t2681r512b2760],
61	.	.	O	.	_	0	SENT_377	[p23l12t2681r512b2760],

1	In	IN	O	in	_	0	SENT_378	[p23l550t2689r639b2759],
2	contrast	NN	O	contrast	prep_in	5	SENT_378	[p23l673t2698r1047b2777],
3	,	,	O	,	_	0	SENT_378	[p23l673t2698r1047b2777],
4	it	PRP	O	it	nsubj	5	SENT_378	[p23l1086t2682r1145b2759],
5	took	VBD	O	take	_	0	SENT_378	[p23l1174t2681r1370b2761],
6	approximately	RB	O	approximately	quantmod	7	SENT_378	[p23l1398t2681r2016b2781],
7	10	CD	DURATION	10	num	8	SENT_378	[p23l2048t2687r2142b2760],
8	years	NNS	NUMBER	year	tmod	5	SENT_378	[p23l7t2835r228b2909],
9	to	TO	O	to	aux	10	SENT_378	[p23l273t2826r354b2888],
10	advance	VB	O	advance	xcomp	5	SENT_378	[p23l398t2809r739b2889],
11	from	IN	O	from	_	0	SENT_378	[p23l782t2808r993b2888],
12	the	DT	O	the	det	15	SENT_378	[p23l1036t2809r1170b2887],
13	initially	RB	O	initially	advmod	14	SENT_378	[p23l1212t2809r1547b2909],
14	unsuccessful	JJ	O	unsuccessful	amod	15	SENT_378	[p23l1585t2808r2143b2889],
15	trials	NNS	O	trial	prep_from	10	SENT_378	[p23l12t2938r232b3016],
16	of	IN	O	of	_	0	SENT_378	[p23l289t2937r389b3017],
17	EGFR	NN	ORGANIZATION	egfr	nn	18	SENT_378	[p23l423t2944r680b3021],
18	inhibitors	NNS	O	inhibitor	prep_of	15	SENT_378	[p23l723t2938r1146b3017],
19	in	IN	O	in	_	0	SENT_378	[p23l1201t2939r1284b3016],
20	nongenotyped	JJ	O	nongenotyped	amod	21	SENT_378	[p23l1338t2938r1958b3039],
21	patients	NNS	O	patient	prep_in	18	SENT_378	[p23l2010t2964r2142b3038, p23l12t3067r249b3144],
22	to	TO	O	to	_	0	SENT_378	[p23l309t3083r391b3145],
23	a	DT	O	a	det	25	SENT_378	[p23l449t3092r493b3144],
24	randomized	JJ	O	randomized	amod	25	SENT_378	[p23l548t3066r1072b3145],
25	phase	NN	O	phase	prep_to	10	SENT_378	[p23l1127t3066r1377b3166],
26	3	CD	NUMBER	3	num	27	SENT_378	[p23l1435t3072r1479b3145],
27	trial	NN	O	trial	dobj	10	SENT_378	[p23l1540t3066r1718b3144],
28	that	WDT	O	that	nsubj	30	SENT_378	[p23l1775t3066r1948b3144],
29	unequivocally	RB	O	unequivocally	advmod	30	SENT_378	[p23l2000t3092r2142b3145, p23l12t3194r487b3294],
30	showed	VBD	O	show	rcmod	27	SENT_378	[p23l520t3194r838b3274],
31	the	DT	O	the	det	32	SENT_378	[p23l874t3194r1005b3272],
32	effectiveness	NN	O	effectiveness	dobj	30	SENT_378	[p23l1042t3193r1578b3274],
33	of	IN	O	of	_	0	SENT_378	[p23l1617t3193r1717b3273],
34	the	DT	O	the	det	37	SENT_378	[p23l1734t3194r1866b3272],
35	EGFR	NN	ORGANIZATION	egfr	nn	37	SENT_378	[p23l1900t3200r2153b3278],
36	inhibitor	NN	O	inhibitor	nn	37	SENT_378	[p23l11t3323r395b3402],
37	gefitinib	NN	O	gefitinib	prep_of	32	SENT_378	[p23l446t3322r841b3424],
38	,	,	O	,	_	0	SENT_378	[p23l446t3322r841b3424],
39	as	IN	O	as	_	0	SENT_378	[p23l901t3349r986b3401],
40	compared	VBN	O	compare	prepc_as	30	SENT_378	[p23l1043t3323r1472b3423],
41	with	IN	O	with	pcomp	40	SENT_378	[p23l1521t3323r1717b3402],
42	first	JJ	ORDINAL	first	amod	45	SENT_378	[p23l1771t3322r2143b3401],
43	—	NN	O	—	nn	45	SENT_378	[p23l1771t3322r2143b3401],
44	line	NN	O	line	nn	45	SENT_378	[p23l1771t3322r2143b3401],
45	chemotherapy	NN	O	chemotherapy	pobj	41	SENT_378	[p23l12t3451r639b3551],
46	,	,	O	,	_	0	SENT_378	[p23l12t3451r639b3551],
47	in	IN	O	in	_	0	SENT_378	[p23l683t3452r767b3529],
48	EGFR	NN	O	egfr	prep_in	10	SENT_378	[p23l805t3457r1359b3531],
49	—	CD	NUMBER	—	num	51	SENT_378	[p23l805t3457r1359b3531],
50	mutant	JJ	O	mutant	amod	51	SENT_378	[p23l805t3457r1359b3531],
51	tumors	NNS	O	tumor	dep	48	SENT_378	[p23l1394t3457r1805b3530],
52	.25	CD	NUMBER	.25	dep	51	SENT_378	[p23l1394t3457r1805b3530],

1	Prospective	JJ	O	prospective	amod	2	SENT_379	[p23l140t3581r631b3680],
2	genotyping	NN	O	genotyping	nsubj	4	SENT_379	[p23l674t3581r1166b3681],
3	may	MD	O	may	aux	4	SENT_379	[p23l1206t3606r1385b3680],
4	also	RB	O	also	_	0	SENT_379	[p23l1423t3580r1595b3659],
5	more	RBR	O	more	advmod	6	SENT_379	[p23l1640t3606r1859b3659],
6	effectively	RB	O	effectively	advmod	4	SENT_379	[p23l1904t3579r2142b3659, p23l12t3708r237b3808],
7	direct	JJ	O	direct	amod	8	SENT_379	[p23l280t3708r529b3787],
8	patients	NNS	O	patient	dep	6	SENT_379	[p23l569t3709r912b3808],
9	to	TO	O	to	_	0	SENT_379	[p23l961t3725r1043b3787],
10	the	DT	O	the	det	11	SENT_379	[p23l1091t3708r1225b3786],
11	trials	NNS	O	trial	prep_to	4	SENT_379	[p23l1272t3708r1492b3786],
12	that	WDT	O	that	nsubj	15	SENT_379	[p23l1541t3708r1714b3786],
13	are	VBP	O	be	cop	15	SENT_379	[p23l1755t3734r1884b3787],
14	most	RBS	O	most	advmod	15	SENT_379	[p23l1931t3725r2148b3787],
15	likely	JJ	O	likely	rcmod	11	SENT_379	[p24l11t22r249b122],
16	to	TO	O	to	aux	17	SENT_379	[p24l310t39r393b101],
17	provide	VB	O	provide	xcomp	15	SENT_379	[p24l458t22r784b122],
18	benefit	NN	O	benefit	dobj	17	SENT_379	[p24l850t21r1184b101],
19	.	.	O	.	_	0	SENT_379	[p24l850t21r1184b101],

1	In	IN	O	in	_	0	SENT_380	[p24l1254t30r1344b100],
2	the	DT	O	the	det	31	SENT_380	[p24l1410t22r1545b100],
3	randomized	VBN	O	randomize	dep	31	SENT_380	[p24l1610t22r2143b101],
4	phase	NN	O	phase	dobj	3	SENT_380	[p24l11t151r260b251],
5	3	CD	NUMBER	3	num	6	SENT_380	[p24l317t157r361b230],
6	trial	NN	O	trial	nsubj	20	SENT_380	[p24l420t151r598b229],
7	of	IN	O	of	_	0	SENT_380	[p24l653t150r754b230],
8	gefitinib	NN	O	gefitinib	prep_of	6	SENT_380	[p24l790t150r1186b252],
9	,	,	O	,	_	0	SENT_380	[p24l790t150r1186b252],
10	the	DT	O	the	det	11	SENT_380	[p24l1248t151r1381b229],
11	selection	NN	O	selection	appos	8	SENT_380	[p24l1438t151r1818b230],
12	of	IN	O	of	_	0	SENT_380	[p24l1874t150r1974b230],
13	patients	NNS	O	patient	prep_of	11	SENT_380	[p24l2009t177r2142b251, p24l12t280r249b358],
14	on	IN	O	on	_	0	SENT_380	[p24l287t305r393b358],
15	the	DT	O	the	det	16	SENT_380	[p24l428t279r561b357],
16	basis	NN	O	basis	prep_on	13	SENT_380	[p24l596t279r809b358],
17	of	IN	O	of	_	0	SENT_380	[p24l846t278r946b358],
18	clinicopathological	JJ	O	clinicopathological	amod	19	SENT_380	[p24l963t279r1794b380],
19	characteristics	NNS	O	characteristic	prep_of	16	SENT_380	[p24l1829t279r2142b357, p24l12t408r341b486],
20	(	VBP	O	(	rcmod	4	SENT_380	[p24l391t413r581b508],
21	e.g.	FW	O	e.g.	nsubj	28	SENT_380	[p24l391t413r581b508],
22	,	,	O	,	_	0	SENT_380	[p24l391t413r581b508],
23	adenocarcinoma	NN	O	adenocarcinoma	nn	24	SENT_380	[p24l630t407r1333b486],
24	histology	NN	O	histology	conj_and	21	SENT_380	[p24l1375t407r1771b508],
25	and	CC	O	and	_	0	SENT_380	[p24l1809t407r1965b486],
26	ab	NN	O	ab	nn	27	SENT_380	[p24l2008t407r2141b486],
27	—	NN	O	—	nsubj	28	SENT_380	[p24l2008t407r2141b486],
28	sent	VBD	O	send	ccomp	20	SENT_380	[p24l13t552r191b613],
29	or	CC	O	or	_	0	SENT_380	[p24l220t561r309b614],
30	light	JJ	O	light	dep	31	SENT_380	[p24l339t535r541b636],
31	tobacco	NN	O	tobacco	prep_in	35	SENT_380	[p24l570t535r901b614],
32	exposure	NN	O	exposure	nn	33	SENT_380	[p24l937t542r1349b635],
33	)	NN	O	)	nsubj	35	SENT_380	[p24l937t542r1349b635],
34	was	VBD	O	be	cop	35	SENT_380	[p24l1385t561r1547b614],
35	successful	JJ	O	successful	_	0	SENT_380	[p24l1585t534r2026b614],
36	in	IN	O	in	_	0	SENT_380	[p24l2059t536r2143b613],
37	enriching	VBG	O	enrich	prepc_in	35	SENT_380	[p24l12t663r429b764],
38	the	DT	O	the	det	39	SENT_380	[p24l463t663r595b741],
39	group	NN	O	group	dobj	37	SENT_380	[p24l631t689r884b764],
40	for	IN	O	for	_	0	SENT_380	[p24l921t662r1045b742],
41	tumors	NNS	O	tumor	prep_for	37	SENT_380	[p24l1078t680r1386b742],
42	with	IN	O	with	_	0	SENT_380	[p24l1420t663r1616b742],
43	EGFR	NN	ORGANIZATION	egfr	nn	44	SENT_380	[p24l1649t670r1863b743],
44	mutations	NNS	O	mutation	prep_with	41	SENT_380	[p24l1891t680r2142b742, p24l12t792r249b870],
45	.	.	O	.	_	0	SENT_380	[p24l1891t680r2142b742, p24l12t792r249b870],

1	However	RB	O	however	advmod	7	SENT_381	[p24l296t799r692b887],
2	,	,	O	,	_	0	SENT_381	[p24l296t799r692b887],
3	these	DT	O	these	det	4	SENT_381	[p24l739t791r963b869],
4	characteristics	NNS	O	characteristic	nsubj	7	SENT_381	[p24l1006t791r1629b869],
5	alone	RB	O	alone	advmod	7	SENT_381	[p24l1672t791r1903b870],
6	were	VBD	O	be	cop	7	SENT_381	[p24l1940t817r2143b870],
7	inadequate	JJ	O	inadequate	_	0	SENT_381	[p24l12t920r485b1020],
8	to	TO	O	to	aux	9	SENT_381	[p24l522t937r603b999],
9	predict	VB	O	predict	xcomp	7	SENT_381	[p24l640t920r945b1020],
10	which	WDT	O	which	dobj	13	SENT_381	[p24l973t920r1236b999],
11	patients	NNS	O	patient	nsubj	13	SENT_381	[p24l1271t921r1614b1020],
12	would	MD	O	would	aux	13	SENT_381	[p24l1649t920r1915b999],
13	have	VB	O	have	ccomp	9	SENT_381	[p24l1952t920r2143b1000],
14	a	DT	O	a	det	15	SENT_381	[p24l12t1075r56b1127],
15	response	NN	O	response	dobj	13	SENT_381	[p24l91t1075r472b1149],
16	to	TO	O	to	aux	17	SENT_381	[p24l510t1066r591b1128],
17	gefitinib	VB	O	gefitinib	infmod	15	SENT_381	[p24l629t1048r1102b1150],
18	.25	CD	NUMBER	.25	dobj	17	SENT_381	[p24l629t1048r1102b1150],
19	Among	IN	O	among	_	0	SENT_381	[p24l1139t1057r1460b1150],
20	patients	NNS	O	patient	prep_among	39	SENT_381	[p24l1491t1050r1834b1149],
21	with	IN	O	with	_	0	SENT_381	[p24l1868t1049r2064b1128],
22	a	DT	O	a	det	23	SENT_381	[p24l2100t1075r2144b1127],
23	history	NN	O	history	prep_with	20	SENT_381	[p24l12t1177r317b1277],
24	of	IN	O	of	_	0	SENT_381	[p24l374t1176r474b1256],
25	no	DT	O	no	det	26	SENT_381	[p24l516t1203r622b1256],
26	smoking	NN	O	smoking	prep_of	23	SENT_381	[p24l685t1177r1064b1278],
27	or	CC	O	or	_	0	SENT_381	[p24l1122t1203r1211b1256],
28	light	JJ	O	light	amod	29	SENT_381	[p24l1267t1177r1470b1278],
29	smoking	NN	O	smoking	prep_among	39	SENT_381	[p24l1527t1177r1905b1278],
30	who	WP	O	who	nsubj	31	SENT_381	[p24l1957t1177r2142b1256],
31	have	VBP	O	have	rcmod	29	SENT_381	[p24l12t1305r203b1384],
32	adenocarcinoma	NN	O	adenocarcinoma	dobj	31	SENT_381	[p24l245t1305r985b1401],
33	,	,	O	,	_	0	SENT_381	[p24l245t1305r985b1401],
34	the	DT	O	the	det	36	SENT_381	[p24l1035t1305r1168b1384],
35	genetic	JJ	O	genetic	amod	36	SENT_381	[p24l1211t1306r1521b1406],
36	drivers	NNS	O	driver	nsubj	39	SENT_381	[p24l1565t1305r1854b1384],
37	of	IN	O	of	_	0	SENT_381	[p24l1900t1304r2000b1384],
38	tumorigenesis	NN	O	tumorigenesis	prep_of	36	SENT_381	[p24l2026t1322r2142b1384, p24l12t1434r533b1534],
39	include	VBP	O	include	rcmod	18	SENT_381	[p24l574t1433r885b1512],
40	EGFR	NN	ORGANIZATION	egfr	dobj	39	SENT_381	[p24l924t1439r1181b1516],
41	in	IN	O	in	_	0	SENT_381	[p24l1209t1434r1292b1511],
42	50	CD	PERCENT	50	num	43	SENT_381	[p24l1333t1438r1519b1512],
43	%	NN	PERCENT	%	prep_in	39	SENT_381	[p24l1333t1438r1519b1512],
44	and	CC	O	and	_	0	SENT_381	[p24l1557t1433r1715b1512],
45	ALK	NN	O	alk	prep_in	39	SENT_381	[p24l1750t1441r1942b1514],
46	in	IN	O	in	_	0	SENT_381	[p24l1978t1434r2061b1511],
47	a	DT	O	a	det	50	SENT_381	[p24l2100t1459r2144b1511],
48	separate	JJ	O	separate	amod	50	SENT_381	[p24l13t1578r370b1661],
49	20	CD	NUMBER	20	number	50	SENT_381	[p24l408t1566r798b1657],
50	°	CD	NUMBER	°	prep_in	45	SENT_381	[p24l408t1566r798b1657],
51	/	:	O	/	punct	52	SENT_381	[p24l408t1566r798b1657],
52	o	NN	O	o	dep	50	SENT_381	[p24l408t1566r798b1657],
53	,25	CD	NUMBER	,25	num	54	SENT_381	[p24l408t1566r798b1657],
54	’28	CD	NUMBER	’28	dep	52	SENT_381	[p24l408t1566r798b1657],
55	indicating	VBG	O	indicate	xcomp	39	SENT_381	[p24l838t1561r1281b1662],
56	that	IN	O	that	complm	62	SENT_381	[p24l1316t1561r1490b1639],
57	definitive	JJ	O	definitive	amod	60	SENT_381	[p24l1524t1560r1932b1640],
58	molecular	JJ	O	molecular	amod	60	SENT_381	[p24l1970t1587r2142b1640, p24l11t1689r306b1768],
59	genetic	JJ	O	genetic	amod	60	SENT_381	[p24l340t1690r650b1790],
60	categorization	NN	O	categorization	nsubj	62	SENT_381	[p24l687t1690r1306b1790],
61	is	VBZ	O	be	cop	62	SENT_381	[p24l1343t1690r1410b1767],
62	critical	JJ	O	critical	ccomp	55	SENT_381	[p24l1450t1689r1746b1767],
63	to	TO	O	to	aux	64	SENT_381	[p24l1784t1706r1865b1768],
64	guide	VB	O	guide	xcomp	62	SENT_381	[p24l1903t1689r2143b1790],
65	the	DT	O	the	det	66	SENT_381	[p24l12t1817r146b1895],
66	selection	NN	O	selection	dobj	64	SENT_381	[p24l182t1817r561b1896],
67	of	IN	O	of	_	0	SENT_381	[p24l596t1816r696b1896],
68	the	DT	O	the	det	71	SENT_381	[p24l713t1817r845b1895],
69	appropriate	JJ	O	appropriate	dep	70	SENT_381	[p24l879t1818r1376b1917],
70	targeted	VBN	O	target	amod	71	SENT_381	[p24l1411t1817r1767b1918],
71	therapy	NN	O	therapy	prep_of	66	SENT_381	[p24l1802t1817r2138b1917],
72	.	.	O	.	_	0	SENT_381	[p24l1802t1817r2138b1917],

1	This	DT	O	this	det	2	SENT_382	[p24l8t1945r196b2023],
2	concept	NN	O	concept	nsubj	4	SENT_382	[p24l236t1962r573b2045],
3	is	VBZ	O	be	cop	4	SENT_382	[p24l603t1946r669b2023],
4	further	JJ	O	further	_	0	SENT_382	[p24l707t1944r1017b2024],
5	supported	VBN	O	support	partmod	4	SENT_382	[p24l1051t1945r1485b2045],
6	by	IN	O	by	_	0	SENT_382	[p24l1522t1945r1620b2045],
7	the	DT	O	the	det	8	SENT_382	[p24l1652t1945r1784b2023],
8	finding	NN	O	finding	agent	5	SENT_382	[p24l1821t1944r2147b2046],
9	that	IN	O	that	complm	15	SENT_382	[p24l12t2073r189b2151],
10	several	JJ	O	several	amod	11	SENT_382	[p24l241t2073r540b2152],
11	patients	NNS	O	patient	nsubj	22	SENT_382	[p24l595t2074r945b2173],
12	in	IN	O	in	_	0	SENT_382	[p24l1003t2074r1087b2151],
13	our	PRP$	O	we	poss	14	SENT_382	[p24l1144t2099r1292b2152],
14	trial	NN	O	trial	prep_in	11	SENT_382	[p24l1346t2073r1529b2151],
15	had	VBD	O	have	ccomp	5	SENT_382	[p24l1584t2073r1744b2152],
16	a	DT	O	a	det	19	SENT_382	[p24l1799t2099r1844b2151],
17	heavy	JJ	O	heavy	amod	19	SENT_382	[p24l1898t2073r2147b2173],
18	smoking	NN	O	smoking	nn	19	SENT_382	[p24l13t2202r398b2303],
19	history	NN	O	history	dobj	15	SENT_382	[p24l460t2202r771b2302],
20	and	CC	O	and	_	0	SENT_382	[p24l832t2202r992b2281],
21	yet	RB	O	yet	advmod	15	SENT_382	[p24l1052t2219r1179b2302],
22	had	VBD	O	have	ccomp	5	SENT_382	[p24l1239t2202r1398b2281],
23	ALK	NNP	O	ALK	dobj	22	SENT_382	[p24l1456t2202r2143b2303],
24	—	CD	NUMBER	—	num	23	SENT_382	[p24l1456t2202r2143b2303],
25	rearranged	VBN	O	rearrange	partmod	23	SENT_382	[p24l1456t2202r2143b2303],
26	tumors	NNS	O	tumor	dobj	25	SENT_382	[p24l12t2347r321b2409],
27	that	WDT	O	that	nsubj	28	SENT_382	[p24l363t2330r536b2408],
28	responded	VBD	O	respond	rcmod	26	SENT_382	[p24l571t2330r1020b2430],
29	to	TO	O	to	_	0	SENT_382	[p24l1060t2347r1142b2409],
30	crizotinib	NN	O	crizotinib	prep_to	28	SENT_382	[p24l1184t2330r1628b2409],
31	.	.	O	.	_	0	SENT_382	[p24l1184t2330r1628b2409],

1	In	IN	O	in	_	0	SENT_383	[p24l140t2467r229b2537],
2	conclusion	NN	O	conclusion	prep_in	6	SENT_383	[p24l263t2459r749b2555],
3	,	,	O	,	_	0	SENT_383	[p24l263t2459r749b2555],
4	we	PRP	O	we	nsubj	6	SENT_383	[p24l784t2485r902b2538],
5	have	VBP	O	have	aux	6	SENT_383	[p24l935t2459r1126b2538],
6	shown	VBN	O	show	_	0	SENT_383	[p24l1161t2459r1444b2538],
7	the	DT	O	the	det	8	SENT_383	[p24l1478t2459r1611b2537],
8	importance	NN	O	importance	dobj	6	SENT_383	[p24l1644t2460r2143b2559],
9	and	CC	O	and	_	0	SENT_383	[p24l11t2588r172b2667],
10	feasibility	NN	O	feasibility	dobj	6	SENT_383	[p24l217t2587r652b2688],
11	of	IN	O	of	_	0	SENT_383	[p24l693t2587r795b2667],
12	prospective	JJ	O	prospective	amod	13	SENT_383	[p24l820t2589r1322b2688],
13	genotyping	NN	O	genotyping	prep_of	8	SENT_383	[p24l1367t2589r1868b2689],
14	in	IN	O	in	_	0	SENT_383	[p24l1909t2589r1994b2666],
15	an	DT	O	a	det	18	SENT_383	[p24l2039t2614r2143b2666],
16	early	JJ	O	early	amod	18	SENT_383	[p24l12t2715r215b2815],
17	clinical	JJ	O	clinical	amod	18	SENT_383	[p24l240t2715r547b2793],
18	trial	NN	O	trial	prep_in	6	SENT_383	[p24l577t2715r751b2793],
19	and	CC	O	and	_	0	SENT_383	[p24l779t2715r936b2794],
20	have	VBP	O	have	aux	21	SENT_383	[p24l965t2715r1152b2795],
21	found	VBN	O	find	conj_and	6	SENT_383	[p24l1182t2714r1431b2794],
22	that	IN	O	that	complm	35	SENT_383	[p24l1460t2715r1630b2793],
23	non	JJ	O	non	amod	29	SENT_383	[p24l1654t2715r2141b2794],
24	—	JJ	O	—	amod	29	SENT_383	[p24l1654t2715r2141b2794],
25	small	JJ	O	small	amod	29	SENT_383	[p24l1654t2715r2141b2794],
26	—	NN	O	—	nn	29	SENT_383	[p24l1654t2715r2141b2794],
27	cell	NN	O	cell	nn	29	SENT_383	[p24l12t2844r159b2922],
28	lung	NN	O	lung	nn	29	SENT_383	[p24l215t2844r410b2945],
29	cancers	NNS	O	cancer	nsubj	35	SENT_383	[p24l465t2870r787b2922],
30	with	IN	O	with	_	0	SENT_383	[p24l843t2844r1039b2923],
31	ALK	NN	O	alk	nn	32	SENT_383	[p24l1091t2850r1266b2922],
32	rearrangement	NN	O	rearrangement	prep_with	29	SENT_383	[p24l1316t2861r1960b2945],
33	are	VBP	O	be	cop	35	SENT_383	[p24l2013t2870r2143b2923],
34	highly	RB	O	highly	advmod	35	SENT_383	[p24l12t2972r286b3073],
35	sensitive	JJ	O	sensitive	ccomp	21	SENT_383	[p24l323t2973r687b3051],
36	to	TO	O	to	_	0	SENT_383	[p24l728t2989r810b3051],
37	ALK	NN	O	alk	nn	39	SENT_383	[p24l847t2980r1039b3053],
38	kinase	NN	O	kinase	nn	39	SENT_383	[p24l1075t2972r1355b3051],
39	inhibition	NN	O	inhibition	prep_to	35	SENT_383	[p24l1394t2972r1848b3051],
40	.	.	O	.	_	0	SENT_383	[p24l1394t2972r1848b3051],

1	Supported	VBN	O	support	dep	105	SENT_384	[p25l99t31r437b106],
2	by	IN	O	by	dep	105	SENT_384	[p25l467t31r541b106],
3	Pfizer	NNP	ORGANIZATION	Pfizer	dep	105	SENT_384	[p25l565t30r781b102],
4	;	:	O	;	_	0	SENT_384	[p25l565t30r781b102],
5	by	IN	O	by	dep	105	SENT_384	[p25l814t31r888b106],
6	grants	NNS	O	grant	dep	105	SENT_384	[p25l913t44r1122b106],
7	from	IN	O	from	dep	105	SENT_384	[p25l1153t30r1314b90],
8	the	DT	O	the	dep	105	SENT_384	[p25l1343t31r1445b89],
9	Massachusetts	NNP	ORGANIZATION	Massachusetts	dep	105	SENT_384	[p25l1472t31r1954b91],
10	General	NNP	ORGANIZATION	General	dep	105	SENT_384	[p25l1985t35r2143b90, p25l12t116r133b174],
11	Hospital	NNP	ORGANIZATION	Hospital	dep	105	SENT_384	[p25l155t116r437b191],
12	(	CD	NUMBER	(	dep	105	SENT_384	[p25l463t120r685b184],
13	MGH	NNP	ORGANIZATION	MGH	dep	105	SENT_384	[p25l463t120r685b184],
14	)	CD	NUMBER	)	dep	105	SENT_384	[p25l463t120r685b184],
15	Cancer	NNP	O	Cancer	dep	105	SENT_384	[p25l712t120r941b175],
16	Center	NNP	O	Center	dep	105	SENT_384	[p25l962t120r1194b187],
17	,	,	O	,	_	0	SENT_384	[p25l962t120r1194b187],
18	the	DT	O	the	dep	105	SENT_384	[p25l1221t116r1323b174],
19	Aid	NN	O	aid	dep	105	SENT_384	[p25l1342t116r1456b175],
20	for	IN	O	for	dep	105	SENT_384	[p25l1479t115r1574b175],
21	Cancer	NNP	ORGANIZATION	Cancer	dep	105	SENT_384	[p25l1595t120r1824b175],
22	Research	NNP	ORGANIZATION	Research	dep	105	SENT_384	[p25l1843t116r2144b178],
23	Foundation	NNP	ORGANIZATION	Foundation	dep	105	SENT_384	[p25l10t201r409b272],
24	,	,	O	,	_	0	SENT_384	[p25l10t201r409b272],
25	and	CC	O	and	dep	105	SENT_384	[p25l446t201r567b260],
26	from	IN	O	from	dep	105	SENT_384	[p25l601t200r762b260],
27	an	DT	O	a	dep	105	SENT_384	[p25l796t220r875b259],
28	anonymous	JJ	O	anonymous	dep	105	SENT_384	[p25l908t220r1290b276],
29	donor	NN	O	donor	dep	105	SENT_384	[p25l1327t201r1522b260],
30	(	NN	O	(	dep	105	SENT_384	[p25l1557t206r1640b269],
31	to	TO	O	to	dep	105	SENT_384	[p25l1557t206r1640b269],
32	MGH	NNP	ORGANIZATION	MGH	dep	105	SENT_384	[p25l1672t205r1895b272],
33	)	CD	NUMBER	)	dep	105	SENT_384	[p25l1672t205r1895b272],
34	;	:	O	;	_	0	SENT_384	[p25l1672t205r1895b272],
35	grants	NNS	O	grant	dep	105	SENT_384	[p25l1933t214r2143b276],
36	from	IN	O	from	dep	105	SENT_384	[p25l11t284r172b344],
37	the	DT	O	the	dep	105	SENT_384	[p25l200t285r301b344],
38	National	NNP	ORGANIZATION	National	dep	105	SENT_384	[p25l328t285r615b345],
39	Cancer	NNP	ORGANIZATION	Cancer	dep	105	SENT_384	[p25l643t289r872b344],
40	Institute	NNP	ORGANIZATION	Institute	dep	105	SENT_384	[p25l897t286r1177b345],
41	(	NN	O	(	dep	105	SENT_384	[p25l1209t289r1582b357],
42	CA090578	NN	O	ca090578	dep	105	SENT_384	[p25l1209t289r1582b357],
43	,	,	O	,	_	0	SENT_384	[p25l1209t289r1582b357],
44	to	TO	O	to	dep	105	SENT_384	[p25l1614t298r1677b344],
45	MGH	NNP	ORGANIZATION	MGH	dep	105	SENT_384	[p25l1703t289r1899b357],
46	,	,	O	,	_	0	SENT_384	[p25l1703t289r1899b357],
47	DanaFarber	NNP	ORGANIZATION	DanaFarber	dep	105	SENT_384	[p25l1930t290r2145b344, p25l10t370r227b429],
48	Cancer	NNP	ORGANIZATION	Cancer	dep	105	SENT_384	[p25l274t374r507b429],
49	Institute	NNP	ORGANIZATION	Institute	dep	105	SENT_384	[p25l552t371r840b429],
50	[	CD	NUMBER	[	dep	105	SENT_384	[p25l895t374r1134b441],
51	DFCI	NNP	O	DFCI	dep	105	SENT_384	[p25l895t374r1134b441],
52	]	CD	NUMBER	]	dep	105	SENT_384	[p25l895t374r1134b441],
53	,	,	O	,	_	0	SENT_384	[p25l895t374r1134b441],
54	and	CC	O	and	dep	105	SENT_384	[p25l1186t370r1308b428],
55	Beth	NNP	ORGANIZATION	Beth	dep	105	SENT_384	[p25l1355t370r1509b428],
56	Israel	NNP	ORGANIZATION	Israel	dep	105	SENT_384	[p25l1556t370r1740b428],
57	Deaconess	NNP	ORGANIZATION	Deaconess	dep	105	SENT_384	[p25l1787t375r2142b428],
58	Medical	NNP	ORGANIZATION	Medical	dep	105	SENT_384	[p25l8t457r275b516],
59	Center	NNP	ORGANIZATION	Center	dep	105	SENT_384	[p25l303t461r520b516],
60	[	CD	NUMBER	[	dep	105	SENT_384	[p25l553t461r863b526],
61	BIDMC	NNP	ORGANIZATION	BIDMC	dep	105	SENT_384	[p25l553t461r863b526],
62	]	CD	NUMBER	]	dep	105	SENT_384	[p25l553t461r863b526],
63	)	NN	O	)	dep	105	SENT_384	[p25l553t461r863b526],
64	and	CC	O	and	dep	105	SENT_384	[p25l895t457r1015b516],
65	the	DT	O	the	dep	105	SENT_384	[p25l1044t457r1146b516],
66	National	NNP	ORGANIZATION	National	dep	105	SENT_384	[p25l1173t457r1460b517],
67	Institutes	NNPS	ORGANIZATION	Institutes	dep	105	SENT_384	[p25l1487t458r1801b517],
68	of	IN	ORGANIZATION	of	dep	105	SENT_384	[p25l1831t456r1907b516],
69	Health	NNP	ORGANIZATION	Health	dep	105	SENT_384	[p25l1921t457r2144b516],
70	(	CD	NUMBER	(	dep	105	SENT_384	[p25l15t545r516b612],
71	R01CA136851	NN	O	r01ca136851	dep	105	SENT_384	[p25l15t545r516b612],
72	,	,	O	,	_	0	SENT_384	[p25l15t545r516b612],
73	to	TO	O	to	dep	105	SENT_384	[p25l545t553r608b600],
74	DFCI	NNP	ORGANIZATION	DFCI	dep	105	SENT_384	[p25l632t545r843b612],
75	)	CD	NUMBER	)	dep	105	SENT_384	[p25l632t545r843b612],
76	;	:	O	;	_	0	SENT_384	[p25l632t545r843b612],
77	a	DT	O	a	dep	105	SENT_384	[p25l870t560r903b599],
78	Career	NNP	O	Career	dep	105	SENT_384	[p25l927t545r1143b600],
79	Development	NNP	O	Development	dep	105	SENT_384	[p25l1164t541r1602b616],
80	Award	NN	O	award	dep	105	SENT_384	[p25l1619t541r1832b601],
81	from	IN	O	from	dep	105	SENT_384	[p25l1856t540r2017b600],
82	the	DT	O	the	dep	105	SENT_384	[p25l2042t541r2144b599],
83	American	NNP	ORGANIZATION	American	dep	105	SENT_384	[p25l8t627r331b685],
84	Society	NNP	ORGANIZATION	Society	dep	105	SENT_384	[p25l363t627r597b701],
85	of	IN	ORGANIZATION	of	dep	105	SENT_384	[p25l624t625r700b685],
86	Clinical	JJ	ORGANIZATION	clinical	dep	105	SENT_384	[p25l716t626r972b685],
87	Oncology	NN	ORGANIZATION	oncology	dep	105	SENT_384	[p25l1003t626r1320b701],
88	(	CD	NUMBER	(	dep	105	SENT_384	[p25l1350t630r1582b695],
89	ASCO	NNP	ORGANIZATION	ASCO	dep	105	SENT_384	[p25l1350t630r1582b695],
90	)	CD	NUMBER	)	dep	105	SENT_384	[p25l1350t630r1582b695],
91	Cancer	NNP	O	Cancer	dep	105	SENT_384	[p25l1617t630r1846b685],
92	Foundation	NNP	O	Foundation	dep	105	SENT_384	[p25l1873t626r2143b686, p25l11t712r142b771],
93	(	CD	NUMBER	(	dep	105	SENT_384	[p25l174t717r256b780],
94	to	TO	O	to	dep	105	SENT_384	[p25l174t717r256b780],
95	BIDMC	NNP	ORGANIZATION	BIDMC	dep	105	SENT_384	[p25l284t716r565b783],
96	)	CD	NUMBER	)	dep	105	SENT_384	[p25l284t716r565b783],
97	;	:	O	;	_	0	SENT_384	[p25l284t716r565b783],
98	Clinical	JJ	O	clinical	dep	105	SENT_384	[p25l597t712r853b771],
99	Investigator	NNP	O	Investigator	dep	105	SENT_384	[p25l880t712r1276b787],
100	Team	NNP	O	Team	dep	105	SENT_384	[p25l1301t716r1482b770],
101	Leadership	NNP	O	Leadership	dep	105	SENT_384	[p25l1509t712r1871b787],
102	Awards	NNS	O	award	dep	105	SENT_384	[p25l1898t712r2143b772],
103	from	IN	O	from	dep	105	SENT_384	[p25l11t796r172b856],
104	the	DT	O	the	dep	105	SENT_384	[p25l199t797r301b856],
105	NCI	NNP	ORGANIZATION	NCI	_	0	SENT_384	[p25l326t801r688b857],
106	.	.	O	.	_	0	SENT_384	[p25l326t801r688b857],

1	—	NN	O	—	_	0	SENT_385	[p25l326t801r688b857],
2	.	.	O	.	_	0	SENT_385	[p25l326t801r688b857],

1	ASCO	NNP	ORGANIZATION	ASCO	nn	3	SENT_386	[p25l326t801r688b857],
2	Cancer	NNP	ORGANIZATION	Cancer	nn	3	SENT_386	[p25l715t801r945b856],
3	Foundation	NNP	ORGANIZATION	Foundation	_	0	SENT_386	[p25l968t797r1349b857],
4	(	CD	NUMBER	(	num	5	SENT_386	[p25l1378t801r1704b869],
5	CA47179	NN	O	ca47179	dep	3	SENT_386	[p25l1378t801r1704b869],
6	,	,	O	,	_	0	SENT_386	[p25l1378t801r1704b869],
7	to	TO	O	to	_	0	SENT_386	[p25l1735t810r1797b856],
8	Memorial	NNP	MISC	Memorial	nn	11	SENT_386	[p25l1823t797r2144b856],
9	Sloan-Kettering	NNP	MISC	Sloan-Kettering	nn	11	SENT_386	[p25l13t882r532b957],
10	Cancer	NNP	MISC	Cancer	nn	11	SENT_386	[p25l562t886r791b941],
11	Center	NNP	MISC	Center	prep_to	16	SENT_386	[p25l822t886r1056b953],
12	;	:	O	;	_	0	SENT_386	[p25l822t886r1056b953],
13	and	CC	O	and	_	0	SENT_386	[p25l1091t882r1212b941],
14	CAO6516	NNP	O	CAO6516	conj_and	11	SENT_386	[p25l1244t886r1552b953],
15	,	,	O	,	_	0	SENT_386	[p25l1244t886r1552b953],
16	to	TO	O	to	appos	5	SENT_386	[p25l1589t895r1651b941],
17	DFCI	NNP	ORGANIZATION	DFCI	pobj	16	SENT_386	[p25l1684t886r1894b953],
18	)	CD	NUMBER	)	num	17	SENT_386	[p25l1684t886r1894b953],
19	;	:	O	;	_	0	SENT_386	[p25l1684t886r1894b953],
20	a	DT	O	a	det	21	SENT_386	[p25l1930t901r1963b940],
21	John	NNP	PERSON	John	conj_and	16	SENT_386	[p25l1987t882r2144b950],
22	and	CC	O	and	_	0	SENT_386	[p25l11t969r131b1028],
23	Carol	NNP	PERSON	Carol	nn	25	SENT_386	[p25l161t969r337b1028],
24	Barry	NNP	PERSON	Barry	nn	25	SENT_386	[p25l366t974r548b1044],
25	Award	NN	PERSON	award	conj_and	21	SENT_386	[p25l572t969r783b1029],
26	(	CD	NUMBER	(	num	25	SENT_386	[p25l817t974r899b1037],
27	to	TO	O	to	_	0	SENT_386	[p25l817t974r899b1037],
28	Dr.	NNP	O	Dr.	nn	30	SENT_386	[p25l929t974r1026b1028],
29	Kwak	NNP	PERSON	Kwak	nn	30	SENT_386	[p25l1060t969r1283b1040],
30	)	NN	O	)	prep_to	21	SENT_386	[p25l1060t969r1283b1040],
31	;	:	O	;	_	0	SENT_386	[p25l1060t969r1283b1040],
32	and	CC	O	and	_	0	SENT_386	[p25l1315t969r1436b1028],
33	grants	NNS	O	grant	conj_and	16	SENT_386	[p25l1465t981r1675b1044],
34	from	IN	O	from	_	0	SENT_386	[p25l1706t968r1868b1028],
35	the	DT	O	the	det	40	SENT_386	[p25l1898t969r1999b1027],
36	National	NNP	ORGANIZATION	National	nn	40	SENT_386	[p25l2028t974r2143b1028, p25l11t1055r204b1114],
37	Cancer	NNP	ORGANIZATION	Cancer	nn	40	SENT_386	[p25l226t1059r455b1114],
38	Institute	NNP	ORGANIZATION	Institute	nn	40	SENT_386	[p25l475t1055r756b1114],
39	(	NN	O	(	nn	40	SENT_386	[p25l782t1059r1096b1123],
40	CA58187	NN	O	ca58187	prep_from	33	SENT_386	[p25l782t1059r1096b1123],
41	and	CC	O	and	_	0	SENT_386	[p25l1119t1055r1240b1114],
42	CA46934	NN	O	ca46934	prep_from	33	SENT_386	[p25l1263t1059r1573b1126],
43	,	,	O	,	_	0	SENT_386	[p25l1263t1059r1573b1126],
44	to	TO	O	to	dep	5	SENT_386	[p25l1601t1067r1663b1114],
45	the	DT	O	the	det	51	SENT_386	[p25l1688t1055r1789b1113],
46	University	NNP	ORGANIZATION	University	dep	51	SENT_386	[p25l1811t1055r2147b1130],
47	of	IN	ORGANIZATION	of	_	0	SENT_386	[p25l12t1141r88b1201],
48	Colorado	NNP	ORGANIZATION	Colorado	nn	50	SENT_386	[p25l100t1142r398b1201],
49	Cancer	NNP	ORGANIZATION	Cancer	nn	50	SENT_386	[p25l425t1146r655b1201],
50	Center	NNP	ORGANIZATION	Center	prep_of	46	SENT_386	[p25l678t1146r933b1211],
51	)	NN	O	)	dep	5	SENT_386	[p25l678t1146r933b1211],
52	.	.	O	.	_	0	SENT_386	[p25l678t1146r933b1211],

1	Disclosure	NN	O	disclosure	nsubj	2	SENT_387	[p25l96t1229r445b1289],
2	forms	VBZ	O	form	_	0	SENT_387	[p25l478t1228r671b1288],
3	provided	VBN	O	provide	csubj	8	SENT_387	[p25l705t1229r993b1304],
4	by	IN	O	by	_	0	SENT_387	[p25l1026t1229r1100b1304],
5	the	DT	O	the	det	6	SENT_387	[p25l1130t1229r1232b1287],
6	authors	NNS	O	author	prep_by	3	SENT_387	[p25l1264t1229r1512b1289],
7	are	VBP	O	be	cop	8	SENT_387	[p25l1547t1248r1645b1287],
8	available	JJ	O	available	ccomp	2	SENT_387	[p25l1678t1229r1964b1289],
9	with	IN	O	with	_	0	SENT_387	[p25l1995t1229r2144b1289],
10	the	DT	O	the	det	12	SENT_387	[p25l11t1316r113b1374],
11	full	JJ	O	full	amod	12	SENT_387	[p25l139t1315r253b1376],
12	text	NN	O	text	prep_with	8	SENT_387	[p25l279t1328r402b1374],
13	of	IN	O	of	_	0	SENT_387	[p25l424t1315r501b1375],
14	this	DT	O	this	det	15	SENT_387	[p25l512t1316r635b1374],
15	article	NN	O	article	prep_of	12	SENT_387	[p25l661t1316r868b1374],
16	at	IN	O	at	_	0	SENT_387	[p25l893t1329r954b1374],
17	N	NN	O	n	nn	18	SENT_387	[p25l973t1321r1030b1375],
18	EJM.org	NN	O	ejm.org	prep_at	15	SENT_387	[p25l1033t1321r1314b1391],
19	.	.	O	.	_	0	SENT_387	[p25l1033t1321r1314b1391],

1	We	PRP	O	we	nsubj	2	SENT_388	[p25l95t1408r196b1461],
2	thank	VBP	O	thank	_	0	SENT_388	[p25l222t1403r419b1463],
3	the	DT	O	the	det	4	SENT_388	[p25l442t1403r543b1461],
4	patients	NNS	O	patient	dobj	2	SENT_388	[p25l569t1404r831b1478],
5	who	WP	O	who	nsubj	6	SENT_388	[p25l855t1403r995b1463],
6	participated	VBD	O	participate	rcmod	4	SENT_388	[p25l1021t1403r1420b1478],
7	in	IN	O	in	_	0	SENT_388	[p25l1446t1403r1509b1461],
8	this	DT	O	this	det	9	SENT_388	[p25l1535t1403r1658b1461],
9	study	NN	O	study	prep_in	6	SENT_388	[p25l1687t1403r1874b1478],
10	.	.	O	.	_	0	SENT_388	[p25l1687t1403r1874b1478],

1	REFERENCES	NNS	O	reference	_	0	SENT_389	[p25l381t1566r549b1582],
2	1	CD	NUMBER	1	num	1	SENT_389	[p25l380t1598r399b1618],
3	.	.	O	.	_	0	SENT_389	[p25l380t1598r399b1618],

1	Lynch	NNP	PERSON	Lynch	nn	3	SENT_390	[p25l429t1595r504b1625],
2	T	NN	O	t	nn	3	SENT_390	[p25l516t1597r550b1623],
3	]	NN	O	]	_	0	SENT_390	[p25l516t1597r550b1623],
4	,	,	O	,	_	0	SENT_390	[p25l516t1597r550b1623],
5	Bell	NNP	ORGANIZATION	Bell	nn	6	SENT_390	[p25l564t1595r613b1618],
6	DW	NNP	ORGANIZATION	DW	appos	3	SENT_390	[p25l626t1597r677b1623],
7	,	,	O	,	_	0	SENT_390	[p25l626t1597r677b1623],
8	Sordella	NNP	PERSON	Sordella	nn	9	SENT_390	[p25l693t1595r796b1618],
9	R	NNP	PERSON	R	appos	3	SENT_390	[p25l809t1597r835b1623],
10	,	,	O	,	_	0	SENT_390	[p25l809t1597r835b1623],
11	et	FW	O	et	nn	13	SENT_390	[p25l850t1600r873b1618],
12	al.	FW	O	al.	nn	13	SENT_390	[p25l884t1595r914b1618],
13	siveness	NN	O	siveness	appos	3	SENT_390	[p25l955t1595r1057b1619],
14	of	IN	O	of	_	0	SENT_390	[p25l1068t1595r1098b1618],
15	non	JJ	O	non	amod	19	SENT_390	[p25l1103t1595r1295b1618],
16	—	JJ	O	—	amod	19	SENT_390	[p25l1103t1595r1295b1618],
17	small-cell	NN	O	small-cell	nn	19	SENT_390	[p25l1103t1595r1295b1618],
18	lung	NN	O	lung	nn	19	SENT_390	[p25l1305t1595r1362b1625],
19	cancer	NN	O	cancer	prep_of	13	SENT_390	[p25l1372t1603r1456b1618],
20	to	TO	O	to	_	0	SENT_390	[p25l1466t1600r1490b1618],
21	mutations	NNS	O	mutation	prep_to	3	SENT_390	[p25l1529t1595r1661b1619],
22	in	IN	O	in	_	0	SENT_390	[p25l1683t1595r1708b1618],
23	lung	NN	O	lung	nn	24	SENT_390	[p25l1729t1595r1787b1625],
24	cancer	NN	O	cancer	prep_in	21	SENT_390	[p25l1808t1603r1900b1618],
25	:	:	O	:	_	0	SENT_390	[p25l1808t1603r1900b1618],
26	correlation	NN	O	correlation	dep	3	SENT_390	[p25l1922t1595r2065b1618],
27	Activating	VBG	O	activate	partmod	26	SENT_390	[p25l378t1632r510b1662],
28	mutations	NNS	O	mutation	dobj	27	SENT_390	[p25l530t1632r659b1656],
29	in	IN	O	in	_	0	SENT_390	[p25l680t1632r705b1655],
30	the	DT	O	the	det	32	SENT_390	[p25l726t1632r765b1655],
31	epidermal	JJ	O	epidermal	amod	32	SENT_390	[p25l787t1632r915b1662],
32	gefitinib	NN	O	gefitinib	prep_in	28	SENT_390	[p25l954t1632r1072b1662],
33	.	.	O	.	_	0	SENT_390	[p25l954t1632r1072b1662],

1	N	NN	O	n	nsubj	2	SENT_391	[p25l1081t1634r1103b1655],
2	EnglJMed	VBD	O	engljm	_	0	SENT_391	[p25l1111t1632r1247b1662],
3	2004	CD	DATE	2004	dobj	2	SENT_391	[p25l1256t1634r1489b1660],
4	;	:	O	;	_	0	SENT_391	[p25l1256t1634r1489b1660],
5	350:2129	CD	NUMBER	350:2129	num	6	SENT_391	[p25l1256t1634r1489b1660],
6	-39	CD	NUMBER	-39	dep	3	SENT_391	[p25l1256t1634r1489b1660],
7	.	.	O	.	_	0	SENT_391	[p25l1256t1634r1489b1660],

1	with	IN	O	with	_	0	SENT_392	[p25l1528t1632r1587b1656],
2	clinical	JJ	O	clinical	amod	3	SENT_392	[p25l1600t1632r1696b1655],
3	response	NN	O	response	nsubj	9	SENT_392	[p25l1709t1640r1825b1662],
4	to	TO	O	to	_	0	SENT_392	[p25l1838t1637r1863b1655],
5	gefitinib	NN	O	gefitinib	nn	8	SENT_392	[p25l1876t1632r1990b1662],
6	thergrowth	NN	O	thergrowth	nn	8	SENT_392	[p25l2004t1632r2065b1655, p25l379t1669r471b1699],
7	factor	NN	O	factor	nn	8	SENT_392	[p25l481t1669r554b1692],
8	receptor	NN	O	receptor	prep_to	3	SENT_392	[p25l563t1674r667b1699],
9	underlying	VBG	O	underlie	pcomp	1	SENT_392	[p25l676t1669r812b1699],
10	respon	NN	O	respon	dobj	9	SENT_392	[p25l821t1677r915b1699],
11	-	:	O	-	_	0	SENT_392	[p25l821t1677r915b1699],
12	2	CD	NUMBER	2	dep	10	SENT_392	[p25l954t1672r975b1692],
13	.	.	O	.	_	0	SENT_392	[p25l954t1672r975b1692],

1	Paez	NNP	PERSON	Paez	nn	2	SENT_393	[p25l1004t1671r1061b1692],
2	JG	NNP	O	JG	_	0	SENT_393	[p25l1068t1671r1107b1697],
3	,	,	O	,	_	0	SENT_393	[p25l1068t1671r1107b1697],
4	Jéinne	NNP	ORGANIZATION	Jéinne	nn	5	SENT_393	[p25l1116t1671r1189b1696],
5	PA	NN	ORGANIZATION	pa	appos	2	SENT_393	[p25l1198t1671r1238b1697],
6	,	,	O	,	_	0	SENT_393	[p25l1198t1671r1238b1697],
7	Lee	NNP	PERSON	Lee	nn	8	SENT_393	[p25l1249t1671r1292b1692],
8	JC	NNP	PERSON	JC	appos	2	SENT_393	[p25l1299t1671r1335b1697],
9	,	,	O	,	_	0	SENT_393	[p25l1299t1671r1335b1697],
10	et	FW	O	et	nn	11	SENT_393	[p25l1347t1674r1370b1692],
11	al.	FW	O	al.	appos	2	SENT_393	[p25l1378t1669r1407b1692],
12	.	.	O	.	_	0	SENT_393	[p25l1378t1669r1407b1692],

1	EGFR	NN	ORGANIZATION	egfr	_	0	SENT_394	[p25l1418t1671r1493b1694],
2	apy	NN	O	apy	dep	1	SENT_394	[p25l1529t1677r1577b1699],
3	.	.	O	.	_	0	SENT_394	[p25l1529t1677r1577b1699],

1	Science	NNP	O	Science	_	0	SENT_395	[p25l1589t1669r1682b1692],
2	2004	CD	DATE	2004	num	1	SENT_395	[p25l1692t1671r1938b1697],
3	;	:	O	;	_	0	SENT_395	[p25l1692t1671r1938b1697],
4	304:1497	CD	NUMBER	304:1497	number	5	SENT_395	[p25l1692t1671r1938b1697],
5	-500	CD	NUMBER	-500	dep	1	SENT_395	[p25l1692t1671r1938b1697],
6	.	.	O	.	_	0	SENT_395	[p25l1692t1671r1938b1697],

1	N	NN	O	n	nn	3	SENT_396	[p25l882t1784r895b1799],
2	ENGLJ	NN	O	englj	nn	3	SENT_396	[p25l910t1784r988b1806],
3	MED	NN	O	med	_	0	SENT_396	[p25l1003t1784r1055b1799],
4	363	CD	NUMBER	363	num	6	SENT_396	[p25l1065t1778r1141b1806],
5	;	:	O	;	_	0	SENT_396	[p25l1065t1778r1141b1806],
6	18	CD	NUMBER	18	dep	3	SENT_396	[p25l1065t1778r1141b1806],
7	NEJM	NNP	ORGANIZATION	NEJM	dep	3	SENT_396	[p25l1177t1784r1301b1806],
8	,	,	O	,	_	0	SENT_396	[p25l1177t1784r1301b1806],
9	ORG	NNP	O	ORG	nn	10	SENT_396	[p25l1177t1784r1301b1806],
10	OCTOBER	NNP	DATE	OCTOBER	appos	7	SENT_396	[p25l1336t1784r1448b1799],
11	28	CD	DATE	28	num	10	SENT_396	[p25l1458t1778r1493b1804],
12	,	,	DATE	,	_	0	SENT_396	[p25l1458t1778r1493b1804],
13	2010	CD	DATE	2010	num	10	SENT_396	[p25l1505t1784r1565b1800],

1	The	DT	O	the	det	4	SENT_397	[p25l879t1841r930b1865],
2	New	NNP	O	New	nn	4	SENT_397	[p25l939t1842r1001b1865],
3	England	NNP	O	England	nn	4	SENT_397	[p25l1011t1841r1121b1872],
4	Journal	NNP	O	Journal	_	0	SENT_397	[p25l1130t1841r1228b1865],
5	of	IN	O	of	_	0	SENT_397	[p25l1237t1841r1266b1865],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_397	[p25l1273t1841r1398b1865],

1	Downloaded	VBN	O	download	_	0	SENT_398	[p25l321t1882r491b1905],
2	from	IN	O	from	_	0	SENT_398	[p25l500t1882r565b1905],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_398	[p25l573t1882r692b1912],
4	at	IN	O	at	_	0	SENT_398	[p25l702t1886r725b1905],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_398	[p25l734t1882r916b1905],
6	on	IN	O	on	_	0	SENT_398	[p25l926t1889r958b1905],
7	J	NN	O	j	nn	8	SENT_398	[p25l967t1882r979b1905],
8	anuaiy	NN	O	anuaiy	prep_on	5	SENT_398	[p25l981t1889r1069b1912],
9	5	CD	NUMBER	5	num	8	SENT_398	[p25l1079t1882r1102b1909],
10	,	,	O	,	_	0	SENT_398	[p25l1079t1882r1102b1909],
11	2014	CD	DATE	2014	dobj	1	SENT_398	[p25l1113t1882r1185b1905],
12	.	.	O	.	_	0	SENT_398	[p25l1113t1882r1185b1905],

1	For	IN	O	for	_	0	SENT_399	[p25l1195t1882r1242b1905],
2	personal	JJ	O	personal	amod	3	SENT_399	[p25l1250t1882r1362b1912],
3	use	NN	O	use	pobj	1	SENT_399	[p25l1372t1889r1415b1905],
4	only	RB	O	only	advmod	3	SENT_399	[p25l1425t1882r1489b1912],
5	.	.	O	.	_	0	SENT_399	[p25l1425t1882r1489b1912],

1	No	DT	O	no	det	3	SENT_400	[p25l1500t1882r1540b1905],
2	other	JJ	O	other	amod	3	SENT_400	[p25l1550t1882r1618b1905],
3	uses	NNS	O	use	_	0	SENT_400	[p25l1626t1889r1682b1905],
4	without	IN	O	without	_	0	SENT_400	[p25l1692t1882r1794b1905],
5	permission	NN	O	permission	prep_without	3	SENT_400	[p25l1802t1882r1954b1912],
6	.	.	O	.	_	0	SENT_400	[p25l1802t1882r1954b1912],

1	ALK	NNP	O	ALK	nn	2	SENT_401	[p25l627t2029r691b2049],
2	INHIBITION	NNP	O	INHIBITION	_	0	SENT_401	[p25l704t2029r908b2048],
3	IN	IN	O	in	_	0	SENT_401	[p25l923t2029r961b2048],
4	NON	NNP	O	NON	prep_in	2	SENT_401	[p25l977t2029r1279b2048],
5	.	.	O	.	_	0	SENT_401	[p25l977t2029r1279b2048],

1	—	NN	O	—	_	0	SENT_402	[p25l977t2029r1279b2048],
2	.	.	O	.	_	0	SENT_402	[p25l977t2029r1279b2048],

1	SMALL-CELL	NN	O	small-cell	nn	2	SENT_403	[p25l977t2029r1279b2048],
2	LUNG	NN	O	lung	_	0	SENT_403	[p25l1293t2029r1385b2048],
3	CANCER	NNP	O	CANCER	dep	2	SENT_403	[p25l1399t2029r1533b2048],

1	3	LS	NUMBER	3	_	0	SENT_404	[p25l8t2196r45b2234],
2	.	.	O	.	_	0	SENT_404	[p25l8t2196r45b2234],

1	Pao	NNP	O	Pao	nn	2	SENT_405	[p25l102t2195r187b2234],
2	W	NNP	O	W	_	0	SENT_405	[p25l214t2195r273b2244],
3	,	,	O	,	_	0	SENT_405	[p25l214t2195r273b2244],
4	Miller	NNP	PERSON	Miller	nn	5	SENT_405	[p25l303t2191r450b2234],
5	V	NNP	O	V	appos	2	SENT_405	[p25l474t2195r515b2244],
6	,	,	O	,	_	0	SENT_405	[p25l474t2195r515b2244],
7	Zakowski	NNP	O	Zakowski	nn	8	SENT_405	[p25l545t2191r779b2235],
8	M	NNP	O	M	appos	2	SENT_405	[p25l805t2195r865b2244],
9	,	,	O	,	_	0	SENT_405	[p25l805t2195r865b2244],
10	et	FW	O	et	nn	11	SENT_405	[p25l897t2200r940b2234],
11	al.	FW	O	al.	appos	2	SENT_405	[p25l965t2191r1019b2234],
12	.	.	O	.	_	0	SENT_405	[p25l965t2191r1019b2234],

1	EGF	NN	ORGANIZATION	egf	nn	4	SENT_406	[p25l8t2264r108b2305],
2	receptor	NN	O	receptor	nn	4	SENT_406	[p25l139t2270r344b2316],
3	gene	NN	O	gene	nn	4	SENT_406	[p25l373t2275r486b2317],
4	mutations	NNS	O	mutation	nsubjpass	17	SENT_406	[p25l516t2262r765b2305],
5	are	VBP	O	be	cop	6	SENT_406	[p25l796t2275r870b2304],
6	common	JJ	O	common	_	0	SENT_406	[p25l901t2275r1022b2304, p25l8t2345r117b2375],
7	in	IN	O	in	_	0	SENT_406	[p25l141t2332r188b2374],
8	lung	NN	O	lung	nn	9	SENT_406	[p25l211t2331r321b2387],
9	cancers	NNS	O	cancer	prep_in	6	SENT_406	[p25l343t2345r527b2374],
10	from	IN	O	from	_	0	SENT_406	[p25l552t2331r672b2375],
11	“	CD	NUMBER	“	prep_from	9	SENT_406	[p25l697t2334r853b2375],
12	never	RB	O	never	advmod	9	SENT_406	[p25l697t2334r853b2375],
13	smokers	NNS	O	smoker	dep	9	SENT_406	[p25l876t2331r1022b2375, p25l9t2404r102b2444],
14	”	CD	NUMBER	”	tmod	6	SENT_406	[p25l876t2331r1022b2375, p25l9t2404r102b2444],
15	and	CC	O	and	_	0	SENT_406	[p25l133t2401r223b2444],
16	are	VBP	O	be	auxpass	17	SENT_406	[p25l251t2415r324b2444],
17	associated	VBN	O	associate	conj_and	6	SENT_406	[p25l352t2401r608b2445],
18	with	IN	O	with	_	0	SENT_406	[p25l634t2401r745b2445],
19	sensitivity	NN	O	sensitivity	prep_with	17	SENT_406	[p25l775t2402r1025b2456],
20	of	IN	O	of	_	0	SENT_406	[p25l9t2471r65b2514],
21	tumors	NNS	O	tumor	prep_of	19	SENT_406	[p25l72t2480r248b2515],
22	to	TO	O	to	_	0	SENT_406	[p25l267t2480r313b2514],
23	gefitinib	NN	O	gefitinib	prep_to	17	SENT_406	[p25l331t2471r545b2527],
24	and	CC	O	and	_	0	SENT_406	[p25l562t2471r652b2514],
25	erlotinib	NN	O	erlotinib	conj_and	23	SENT_406	[p25l670t2471r895b2515],
26	.	.	O	.	_	0	SENT_406	[p25l670t2471r895b2515],

1	Proc	NNP	ORGANIZATION	Proc	nn	7	SENT_407	[p25l915t2475r1023b2515],
2	Natl	NNP	ORGANIZATION	Natl	nn	7	SENT_407	[p25l7t2541r109b2585],
3	Acad	NNP	ORGANIZATION	Acad	nn	7	SENT_407	[p25l126t2541r245b2584],
4	Sci	NNP	ORGANIZATION	Sci	nn	7	SENT_407	[p25l265t2542r332b2585],
5	U	NNP	ORGANIZATION	U	nn	7	SENT_407	[p25l350t2545r388b2584],
6	S	NNP	ORGANIZATION	S	nn	7	SENT_407	[p25l407t2544r430b2584],
7	A	NNP	O	A	_	0	SENT_407	[p25l449t2545r485b2584],
8	2004	CD	DATE	2004	num	7	SENT_407	[p25l503t2544r970b2593],
9	;	:	O	;	_	0	SENT_407	[p25l503t2544r970b2593],
10	101:13306	CD	NUMBER	101:13306	number	11	SENT_407	[p25l503t2544r970b2593],
11	-11	CD	NUMBER	-11	dep	7	SENT_407	[p25l503t2544r970b2593],
12	.	.	O	.	_	0	SENT_407	[p25l503t2544r970b2593],

1	4	LS	NUMBER	4	_	0	SENT_408	[p25l7t2617r46b2654],
2	.	.	O	.	_	0	SENT_408	[p25l7t2617r46b2654],

1	Kutok	NNP	PERSON	Kutok	nn	2	SENT_409	[p25l103t2611r249b2656],
2	IL	NN	PERSON	il	_	0	SENT_409	[p25l262t2615r326b2664],
3	,	,	O	,	_	0	SENT_409	[p25l262t2615r326b2664],
4	Aster	NNP	O	Aster	nn	5	SENT_409	[p25l349t2615r477b2654],
5	JC	NNP	O	JC	appos	2	SENT_409	[p25l490t2614r559b2661],
6	.	.	O	.	_	0	SENT_409	[p25l490t2614r559b2661],

1	Molecular	JJ	O	molecular	amod	2	SENT_410	[p25l581t2611r826b2655],
2	biology	NN	O	biology	_	0	SENT_410	[p25l846t2611r1025b2667],
3	of	IN	O	of	_	0	SENT_410	[p25l9t2681r65b2724],
4	anaplastic	JJ	O	anaplastic	amod	5	SENT_410	[p25l83t2681r334b2736],
5	lymphoma	NN	O	lymphoma	prep_of	2	SENT_410	[p25l361t2681r623b2736],
6	kinase-positive	JJ	O	kinase-positive	amod	9	SENT_410	[p25l650t2681r1023b2736],
7	anaplastic	JJ	O	anaplastic	amod	9	SENT_410	[p25l8t2751r259b2806],
8	large-cell	JJ	O	large-cell	amod	9	SENT_410	[p25l293t2751r525b2807],
9	lymphoma	NN	O	lymphoma	dep	5	SENT_410	[p25l559t2751r834b2806],
10	.	.	O	.	_	0	SENT_410	[p25l559t2751r834b2806],

1	J	NNP	O	J	nn	3	SENT_411	[p25l867t2755r888b2801],
2	Clin	NNP	O	Clin	nn	3	SENT_411	[p25l922t2751r1023b2794],
3	Oncol	NNP	O	Oncol	_	0	SENT_411	[p25l8t2821r151b2865],
4	2002	CD	DATE	2002	num	3	SENT_411	[p25l170t2824r602b2873],
5	;	:	O	;	_	0	SENT_411	[p25l170t2824r602b2873],
6	20:3691	CD	NUMBER	20:3691	num	7	SENT_411	[p25l170t2824r602b2873],
7	—	NN	O	—	dep	3	SENT_411	[p25l170t2824r602b2873],
8	702	CD	NUMBER	702	dep	7	SENT_411	[p25l170t2824r602b2873],
9	.	.	O	.	_	0	SENT_411	[p25l170t2824r602b2873],

1	5	CD	NUMBER	5	_	0	SENT_412	[p25l9t2896r45b2934],
2	.	.	O	.	_	0	SENT_412	[p25l9t2896r45b2934],

1	George	NNP	PERSON	George	nn	2	SENT_413	[p25l103t2894r277b2947],
2	RE	NNP	PERSON	RE	_	0	SENT_413	[p25l298t2895r379b2944],
3	,	,	O	,	_	0	SENT_413	[p25l298t2895r379b2944],
4	Sanda	NNP	ORGANIZATION	Sanda	nn	5	SENT_413	[p25l405t2891r550b2934],
5	T	NN	ORGANIZATION	t	appos	2	SENT_413	[p25l569t2894r612b2944],
6	,	,	O	,	_	0	SENT_413	[p25l569t2894r612b2944],
7	Hanna	NNP	PERSON	Hanna	nn	8	SENT_413	[p25l636t2895r799b2934],
8	M	NNP	PERSON	M	appos	2	SENT_413	[p25l818t2895r878b2944],
9	,	,	O	,	_	0	SENT_413	[p25l818t2895r878b2944],
10	et	FW	O	et	nn	11	SENT_413	[p25l903t2900r947b2934],
11	al.	FW	O	al.	appos	2	SENT_413	[p25l965t2891r1020b2934],
12	.	.	O	.	_	0	SENT_413	[p25l965t2891r1020b2934],

1	Activating	VBG	O	activate	amod	2	SENT_414	[p25l6t2962r255b3017],
2	mutations	NNS	O	mutation	nsubj	5	SENT_414	[p25l288t2962r532b3005],
3	in	IN	O	in	_	0	SENT_414	[p25l567t2962r614b3004],
4	ALK	NNP	O	ALK	prep_in	2	SENT_414	[p25l647t2965r753b3006],
5	provide	VBP	O	provide	_	0	SENT_414	[p25l785t2961r964b3016],
6	a	DT	O	a	det	8	SENT_414	[p25l999t2975r1024b3004],
7	therapeutic	JJ	O	therapeutic	amod	8	SENT_414	[p25l9t3031r282b3086],
8	target	NN	O	target	dobj	5	SENT_414	[p25l304t3040r448b3087],
9	in	IN	O	in	_	0	SENT_414	[p25l467t3032r514b3074],
10	neuroblastoma	NN	O	neuroblastoma	prep_in	8	SENT_414	[p25l537t3031r914b3075],
11	.	.	O	.	_	0	SENT_414	[p25l537t3031r914b3075],

1	Nature	NNP	O	Nature	_	0	SENT_415	[p25l938t3035r1022b3075, p25l9t3110r104b3145],
2	2008	CD	DATE	2008	num	1	SENT_415	[p25l123t3104r503b3153],
3	;	:	O	;	_	0	SENT_415	[p25l123t3104r503b3153],
4	455:975	CD	NUMBER	455:975	number	5	SENT_415	[p25l123t3104r503b3153],
5	-8	CD	NUMBER	-8	dep	1	SENT_415	[p25l123t3104r503b3153],
6	.	.	O	.	_	0	SENT_415	[p25l123t3104r503b3153],

1	6	CD	NUMBER	6	_	0	SENT_416	[p25l8t3176r47b3215],
2	.	.	O	.	_	0	SENT_416	[p25l8t3176r47b3215],

1	Mossé	NNP	O	Mossé	nn	2	SENT_417	[p25l101t3170r254b3215],
2	YP	NNP	O	YP	_	0	SENT_417	[p25l277t3175r346b3224],
3	,	,	O	,	_	0	SENT_417	[p25l277t3175r346b3224],
4	Laudenslager	NNP	O	Laudenslager	nn	5	SENT_417	[p25l372t3171r695b3227],
5	M	NNP	O	M	appos	2	SENT_417	[p25l716t3175r776b3224],
6	,	,	O	,	_	0	SENT_417	[p25l716t3175r776b3224],
7	Longo	NNP	PERSON	Longo	nn	8	SENT_417	[p25l803t3175r954b3227],
8	L	NNP	PERSON	L	appos	2	SENT_417	[p25l978t3175r1020b3224],
9	,	,	O	,	_	0	SENT_417	[p25l978t3175r1020b3224],
10	et	FW	O	et	nn	11	SENT_417	[p25l9t3250r52b3284],
11	al.	FW	O	al.	appos	2	SENT_417	[p25l69t3241r124b3284],
12	.	.	O	.	_	0	SENT_417	[p25l69t3241r124b3284],

1	Identification	NN	O	identification	_	0	SENT_418	[p25l147t3241r479b3285],
2	of	IN	O	of	_	0	SENT_418	[p25l500t3241r555b3284],
3	ALK	NNP	O	ALK	prep_of	1	SENT_418	[p25l564t3245r671b3286],
4	as	IN	O	as	_	0	SENT_418	[p25l689t3255r736b3284],
5	a	DT	O	a	det	10	SENT_418	[p25l758t3255r782b3284],
6	major	JJ	O	major	amod	10	SENT_418	[p25l802t3242r942b3296],
7	familial	JJ	O	familial	amod	10	SENT_418	[p25l961t3241r1022b3284, p25l8t3311r148b3354],
8	neuroblastoma	NN	O	neuroblastoma	nn	10	SENT_418	[p25l165t3311r522b3355],
9	predisposition	NN	O	predisposition	nn	10	SENT_418	[p25l537t3311r880b3366],
10	gene	NN	O	gene	prep_as	1	SENT_418	[p25l897t3325r1020b3367],
11	.	.	O	.	_	0	SENT_418	[p25l897t3325r1020b3367],

1	Nature	NNP	O	Nature	_	0	SENT_419	[p25l7t3385r172b3425],
2	2008	CD	DATE	2008	num	1	SENT_419	[p25l191t3384r570b3433],
3	;	:	O	;	_	0	SENT_419	[p25l191t3384r570b3433],
4	455:930	CD	NUMBER	455:930	number	5	SENT_419	[p25l191t3384r570b3433],
5	-5	CD	NUMBER	-5	dep	1	SENT_419	[p25l191t3384r570b3433],
6	.	.	O	.	_	0	SENT_419	[p25l191t3384r570b3433],

1	7	CD	NUMBER	7	_	0	SENT_420	[p25l10t3456r42b3494],
2	.	.	O	.	_	0	SENT_420	[p25l10t3456r42b3494],

1	Pulford	NNP	PERSON	Pulford	nn	2	SENT_421	[p25l102t3451r283b3495],
2	K	NNP	PERSON	K	_	0	SENT_421	[p25l300t3455r349b3504],
3	,	,	O	,	_	0	SENT_421	[p25l300t3455r349b3504],
4	Lamant	NNP	O	Lamant	nn	5	SENT_421	[p25l369t3455r556b3494],
5	L	NNP	O	L	appos	2	SENT_421	[p25l571t3455r613b3504],
6	,	,	O	,	_	0	SENT_421	[p25l571t3455r613b3504],
7	Espinos	NNP	O	Espinos	nn	8	SENT_421	[p25l634t3452r822b3506],
8	E	NNP	O	E	appos	2	SENT_421	[p25l841t3455r884b3503],
9	,	,	O	,	_	0	SENT_421	[p25l841t3455r884b3503],
10	et	FW	O	et	nn	11	SENT_421	[p25l906t3460r950b3494],
11	al.	FW	O	al.	appos	2	SENT_421	[p25l965t3451r1020b3494],
12	.	.	O	.	_	0	SENT_421	[p25l965t3451r1020b3494],

1	The	DT	O	the	_	0	SENT_422	[p25l7t3521r96b3564],
2	emerging	VBG	O	emerge	amod	1	SENT_422	[p25l115t3522r346b3577],
3	normal	JJ	O	normal	amod	6	SENT_422	[p25l362t3521r538b3564],
4	and	CC	O	and	_	0	SENT_422	[p25l555t3521r644b3564],
5	disease-related	JJ	O	disease-related	amod	6	SENT_422	[p25l662t3521r1023b3564],
6	roles	NNS	O	role	npadvmod	1	SENT_422	[p25l8t3591r122b3635],
7	of	IN	O	of	_	0	SENT_422	[p25l141t3591r197b3634],
8	anaplastic	JJ	O	anaplastic	amod	10	SENT_422	[p25l204t3591r449b3646],
9	lymphoma	NN	O	lymphoma	nn	10	SENT_422	[p25l466t3591r724b3646],
10	kinase	NN	O	kinase	prep_of	1	SENT_422	[p25l740t3591r910b3635],
11	.	.	O	.	_	0	SENT_422	[p25l740t3591r910b3635],

1	Cell	NN	O	cell	_	0	SENT_423	[p25l930t3591r1023b3635],
2	Mol	NNP	O	Mol	nn	4	SENT_423	[p25l7t3661r100b3704],
3	Life	NNP	O	Life	nn	4	SENT_423	[p25l118t3661r208b3704],
4	Sci	NNP	O	Sci	dep	1	SENT_423	[p25l228t3662r295b3704],
5	2004	CD	DATE	2004	num	4	SENT_423	[p25l314t3664r723b3713],
6	;	:	O	;	_	0	SENT_423	[p25l314t3664r723b3713],
7	61:2939	CD	NUMBER	61:2939	num	8	SENT_423	[p25l314t3664r723b3713],
8	-53	CD	NUMBER	-53	dep	1	SENT_423	[p25l314t3664r723b3713],
9	.	.	O	.	_	0	SENT_423	[p25l314t3664r723b3713],

1	8	CD	NUMBER	8	_	0	SENT_424	[p25l8t3735r47b3775],
2	.	.	O	.	_	0	SENT_424	[p25l8t3735r47b3775],

1	Soda	NNP	O	Soda	nn	2	SENT_425	[p25l104t3731r220b3774],
2	M	NNP	O	M	_	0	SENT_425	[p25l242t3735r303b3784],
3	,	,	O	,	_	0	SENT_425	[p25l242t3735r303b3784],
4	Choi	NNP	PERSON	Choi	nn	5	SENT_425	[p25l331t3731r442b3774],
5	YL	NNP	PERSON	YL	appos	2	SENT_425	[p25l465t3735r539b3784],
6	,	,	O	,	_	0	SENT_425	[p25l465t3735r539b3784],
7	Enomoto	NNP	PERSON	Enomoto	nn	8	SENT_425	[p25l567t3735r786b3774],
8	M	NNP	O	M	appos	2	SENT_425	[p25l811t3735r871b3784],
9	,	,	O	,	_	0	SENT_425	[p25l811t3735r871b3784],
10	et	FW	O	et	nn	11	SENT_425	[p25l899t3740r943b3774],
11	al.	FW	O	al.	appos	2	SENT_425	[p25l965t3731r1020b3774],
12	13	CD	NUMBER	13	dep	11	SENT_425	[p25l1099t2196r1162b2234],
13	.	.	O	.	_	0	SENT_425	[p25l1099t2196r1162b2234],

1	Perner	NNP	PERSON	Perner	nn	2	SENT_426	[p25l1191t2195r1351b2234],
2	S	NNP	O	S	_	0	SENT_426	[p25l1379t2194r1417b2244],
3	,	,	O	,	_	0	SENT_426	[p25l1379t2194r1417b2244],
4	Wagner	NNP	PERSON	Wagner	nn	5	SENT_426	[p25l1447t2195r1637b2247],
5	PL	NNP	O	PL	appos	2	SENT_426	[p25l1663t2195r1735b2244],
6	,	,	O	,	_	0	SENT_426	[p25l1663t2195r1735b2244],
7	Demichelis	NNP	O	Demichelis	nn	8	SENT_426	[p25l1765t2191r2042b2234],
8	F	NN	O	f	appos	2	SENT_426	[p25l2070t2195r2109b2244],
9	,	,	O	,	_	0	SENT_426	[p25l2070t2195r2109b2244],
10	et	FW	O	et	nn	11	SENT_426	[p25l1097t2270r1141b2304],
11	al.	FW	O	al.	appos	2	SENT_426	[p25l1157t2261r1211b2304],
12	.	.	O	.	_	0	SENT_426	[p25l1157t2261r1211b2304],

1	EML4-ALK	CD	NUMBER	eml4-alk	num	4	SENT_427	[p25l1230t2264r1492b2306],
2	fusion	NN	O	fusion	nn	4	SENT_427	[p25l1507t2261r1655b2305],
3	lung	NN	O	lung	nn	4	SENT_427	[p25l1672t2261r1778b2317],
4	cancer	NN	O	cancer	_	0	SENT_427	[p25l1794t2275r1960b2304],
5	:	:	O	:	_	0	SENT_427	[p25l1794t2275r1960b2304],
6	a	DT	O	a	det	9	SENT_427	[p25l1979t2275r2003b2304],
7	rare	JJ	O	rare	amod	9	SENT_427	[p25l2019t2275r2111b2304],
8	acquired	VBN	O	acquire	amod	9	SENT_427	[p25l1097t2331r1309b2386],
9	event	NN	O	event	dep	4	SENT_427	[p25l1342t2340r1483b2375],
10	.	.	O	.	_	0	SENT_427	[p25l1342t2340r1483b2375],

1	Neoplasia	NN	O	neoplasium	_	0	SENT_428	[p25l1517t2331r1761b2386],
2	2008	CD	DATE	2008	num	1	SENT_428	[p25l1793t2334r2111b2383, p25l1097t2404r1196b2445],
3	;	:	O	;	_	0	SENT_428	[p25l1793t2334r2111b2383, p25l1097t2404r1196b2445],
4	10:298302	CD	NUMBER	10:298302	dep	1	SENT_428	[p25l1793t2334r2111b2383, p25l1097t2404r1196b2445],
5	.	.	O	.	_	0	SENT_428	[p25l1793t2334r2111b2383, p25l1097t2404r1196b2445],

1	14	CD	NUMBER	14	_	0	SENT_429	[p25l1099t2476r1161b2514],
2	.	.	O	.	_	0	SENT_429	[p25l1099t2476r1161b2514],

1	Wong	NNP	PERSON	Wong	nn	2	SENT_430	[p25l1190t2475r1332b2527],
2	DW	NNP	O	DW	_	0	SENT_430	[p25l1345t2475r1442b2524],
3	,	,	O	,	_	0	SENT_430	[p25l1345t2475r1442b2524],
4	Leung	NNP	PERSON	Leung	nn	5	SENT_430	[p25l1460t2475r1611b2527],
5	EL	NNP	O	EL	appos	2	SENT_430	[p25l1624t2475r1697b2524],
6	,	,	O	,	_	0	SENT_430	[p25l1624t2475r1697b2524],
7	So	RB	O	so	advmod	8	SENT_430	[p25l1717t2474r1772b2515],
8	KK	NNP	O	KK	appos	2	SENT_430	[p25l1788t2475r1876b2524],
9	,	,	O	,	_	0	SENT_430	[p25l1788t2475r1876b2524],
10	et	FW	O	et	nn	11	SENT_430	[p25l1895t2480r1938b2514],
11	al.	FW	O	al.	appos	8	SENT_430	[p25l1950t2471r2005b2514],
12	.	.	O	.	_	0	SENT_430	[p25l1950t2471r2005b2514],

1	The	DT	O	the	det	4	SENT_431	[p25l2021t2471r2111b2514],
2	EML4-ALK	NN	O	eml4-alk	nn	4	SENT_431	[p25l1096t2544r1363b2586],
3	fusion	NN	O	fusion	nn	4	SENT_431	[p25l1377t2541r1529b2585],
4	gene	NN	O	gene	nsubjpass	6	SENT_431	[p25l1545t2555r1657b2597],
5	is	VBZ	O	be	auxpass	6	SENT_431	[p25l1674t2542r1710b2584],
6	involved	VBN	O	involve	_	0	SENT_431	[p25l1728t2541r1926b2585],
7	in	IN	O	in	_	0	SENT_431	[p25l1942t2542r1989b2584],
8	various	JJ	O	various	amod	10	SENT_431	[p25l2003t2542r2111b2585, p25l1097t2625r1179b2655],
9	histologic	JJ	O	histologic	amod	10	SENT_431	[p25l1199t2611r1439b2667],
10	types	NNS	O	type	prep_in	6	SENT_431	[p25l1457t2620r1583b2666],
11	of	IN	O	of	_	0	SENT_431	[p25l1604t2611r1659b2655],
12	lung	NN	O	lung	nn	13	SENT_431	[p25l1667t2611r1776b2667],
13	cancers	NNS	O	cancer	prep_of	10	SENT_431	[p25l1793t2625r1973b2654],
14	from	IN	O	from	_	0	SENT_431	[p25l1994t2611r2111b2655],
15	nonsmokers	NNS	O	nonsmoker	prep_from	6	SENT_431	[p25l1097t2681r1393b2725],
16	with	IN	O	with	_	0	SENT_431	[p25l1432t2681r1541b2725],
17	wild-type	JJ	O	wild-type	amod	18	SENT_431	[p25l1579t2681r1807b2736],
18	EGFR	NN	ORGANIZATION	egfr	prep_with	15	SENT_431	[p25l1846t2684r1989b2727],
19	and	CC	O	and	_	0	SENT_431	[p25l2023t2681r2112b2724],
20	KRAS	NNP	ORGANIZATION	KRAS	conj_and	18	SENT_431	[p25l1097t2754r1251b2797],
21	.	.	O	.	_	0	SENT_431	[p25l1097t2754r1251b2797],

1	Cancer	NN	O	cancer	_	0	SENT_432	[p25l1273t2754r1440b2795],
2	2009	CD	DATE	2009	num	1	SENT_432	[p25l1458t2754r1896b2803],
3	;	:	O	;	_	0	SENT_432	[p25l1458t2754r1896b2803],
4	115:1723	CD	NUMBER	115:1723	number	5	SENT_432	[p25l1458t2754r1896b2803],
5	-33	CD	NUMBER	-33	dep	1	SENT_432	[p25l1458t2754r1896b2803],
6	.	.	O	.	_	0	SENT_432	[p25l1458t2754r1896b2803],

1	15	CD	NUMBER	15	_	0	SENT_433	[p25l1099t2826r1160b2864],
2	.	.	O	.	_	0	SENT_433	[p25l1099t2826r1160b2864],

1	Takeuchi	NNP	PERSON	Takeuchi	nn	2	SENT_434	[p25l1190t2821r1410b2865],
2	K	NNP	PERSON	K	_	0	SENT_434	[p25l1429t2825r1477b2874],
3	,	,	O	,	_	0	SENT_434	[p25l1429t2825r1477b2874],
4	Choi	NNP	PERSON	Choi	nn	5	SENT_434	[p25l1500t2821r1611b2865],
5	YL	NNP	PERSON	YL	appos	2	SENT_434	[p25l1628t2825r1702b2874],
6	,	,	O	,	_	0	SENT_434	[p25l1628t2825r1702b2874],
7	Togashi	NNP	PERSON	Togashi	nn	8	SENT_434	[p25l1723t2821r1915b2877],
8	Y	NN	PERSON	y	appos	2	SENT_434	[p25l1931t2825r1971b2874],
9	,	,	O	,	_	0	SENT_434	[p25l1931t2825r1971b2874],
10	et	FW	O	et	nn	11	SENT_434	[p25l1994t2830r2038b2864],
11	al.	FW	O	al.	appos	2	SENT_434	[p25l2054t2821r2108b2864],
12	.	.	O	.	_	0	SENT_434	[p25l2054t2821r2108b2864],

1	KIFSB-ALK	NN	O	kifsb-alk	_	0	SENT_435	[p25l1097t2895r1382b2944],
2	,	,	O	,	_	0	SENT_435	[p25l1097t2895r1382b2944],
3	a	DT	O	a	det	6	SENT_435	[p25l1422t2905r1447b2934],
4	novel	JJ	O	novel	amod	6	SENT_435	[p25l1484t2891r1610b2935],
5	fusion	NN	O	fusion	nn	6	SENT_435	[p25l1647t2891r1799b2935],
6	oncokinase	NN	O	oncokinase	appos	1	SENT_435	[p25l1837t2891r2111b2935],
7	identified	VBN	O	identify	partmod	6	SENT_435	[p25l1096t2961r1332b3005],
8	by	IN	O	by	_	0	SENT_435	[p25l1359t2961r1413b3016],
9	an	DT	O	a	det	12	SENT_435	[p25l1437t2975r1494b3004],
10	immunohistochemistrybased	JJ	O	immunohistochemistrybased	amod	12	SENT_435	[p25l1520t2961r2111b3016, p25l1097t3031r1235b3075],
11	diagnostic	JJ	O	diagnostic	amod	12	SENT_435	[p25l1256t3031r1509b3087],
12	system	NN	O	system	agent	7	SENT_435	[p25l1532t3040r1695b3086],
13	for	IN	O	for	_	0	SENT_435	[p25l1717t3031r1786b3074],
14	ALK-positive	JJ	O	alk-positive	amod	16	SENT_435	[p25l1804t3032r2111b3086],
15	lung	NN	O	lung	nn	16	SENT_435	[p25l1096t3101r1205b3157],
16	cancer	NN	O	cancer	prep_for	12	SENT_435	[p25l1239t3115r1408b3144],
17	.	.	O	.	_	0	SENT_435	[p25l1239t3115r1408b3144],

1	Clin	NNP	O	Clin	nn	3	SENT_436	[p25l1447t3101r1546b3144],
2	Cancer	NNP	O	Cancer	nn	3	SENT_436	[p25l1583t3104r1751b3145],
3	Res	NNP	O	Res	_	0	SENT_436	[p25l1784t3105r1868b3147],
4	2009	CD	DATE	2009	num	3	SENT_436	[p25l1906t3104r2109b3154],
5	;	:	O	;	_	0	SENT_436	[p25l1906t3104r2109b3154],
6	15	CD	NUMBER	15	num	8	SENT_436	[p25l1906t3104r2109b3154],
7	:	:	O	:	_	0	SENT_436	[p25l1906t3104r2109b3154],
8	3143-9	CD	NUMBER	3143-9	dep	3	SENT_436	[p25l1097t3174r1266b3215],
9	.	.	O	.	_	0	SENT_436	[p25l1097t3174r1266b3215],

1	16	CD	NUMBER	16	_	0	SENT_437	[p25l1099t3246r1162b3284],
2	.	.	O	.	_	0	SENT_437	[p25l1099t3246r1162b3284],

1	McDermott	NNP	PERSON	McDermott	nn	2	SENT_438	[p25l1190t3245r1475b3284],
2	U	NNP	PERSON	U	_	0	SENT_438	[p25l1492t3245r1542b3294],
3	,	,	O	,	_	0	SENT_438	[p25l1492t3245r1542b3294],
4	Iafrate	NNP	PERSON	Iafrate	nn	6	SENT_438	[p25l1564t3241r1726b3284],
5	A	NNP	O	A	nn	6	SENT_438	[p25l1744t3245r1810b3294],
6	]	NN	O	]	appos	2	SENT_438	[p25l1744t3245r1810b3294],
7	,	,	O	,	_	0	SENT_438	[p25l1744t3245r1810b3294],
8	Gray	NNP	PERSON	Gray	nn	9	SENT_438	[p25l1833t3244r1948b3296],
9	NS	NNP	O	NS	appos	2	SENT_438	[p25l1964t3244r2047b3294],
10	,	,	O	,	_	0	SENT_438	[p25l1964t3244r2047b3294],
11	et	FW	O	et	nn	12	SENT_438	[p25l2070t3250r2114b3284],
12	al.	FW	O	al.	appos	2	SENT_438	[p25l1097t3311r1153b3354],
13	.	.	O	.	_	0	SENT_438	[p25l1097t3311r1153b3354],

1	Genomic	JJ	MISC	genomic	amod	2	SENT_439	[p25l1173t3312r1392b3355],
2	alterations	NNS	O	alteration	nsubj	8	SENT_439	[p25l1408t3311r1664b3355],
3	of	IN	O	of	_	0	SENT_439	[p25l1682t3311r1738b3355],
4	anaplastic	JJ	O	anaplastic	amod	6	SENT_439	[p25l1744t3311r1989b3366],
5	lymphoma	NN	O	lymphoma	nn	6	SENT_439	[p25l2005t3311r2111b3366, p25l1096t3381r1264b3436],
6	kinase	NN	O	kinase	prep_of	2	SENT_439	[p25l1295t3381r1452b3425],
7	may	MD	O	may	aux	8	SENT_439	[p25l1485t3395r1585b3436],
8	sensitize	VB	O	sensitize	_	0	SENT_439	[p25l1616t3382r1826b3424],
9	tumors	NNS	O	tumor	dobj	8	SENT_439	[p25l1859t3390r2031b3425],
10	to	TO	O	to	_	0	SENT_439	[p25l2065t3390r2111b3424],
11	anaplastic	JJ	O	anaplastic	amod	14	SENT_439	[p25l1097t3451r1342b3506],
12	lymphoma	NN	O	lymphoma	nn	14	SENT_439	[p25l1375t3451r1633b3506],
13	kinase	NN	O	kinase	nn	14	SENT_439	[p25l1666t3451r1823b3495],
14	inhibitors	NNS	O	inhibitor	prep_to	8	SENT_439	[p25l1856t3451r2108b3494],
15	.	.	O	.	_	0	SENT_439	[p25l1856t3451r2108b3494],

1	Cancer	NN	O	cancer	_	0	SENT_440	[p25l1097t3524r1265b3565],
2	Res	NNP	O	Res	dep	1	SENT_440	[p25l1281t3525r1365b3567],
3	2008	CD	DATE	2008	num	2	SENT_440	[p25l1385t3524r1798b3573],
4	;	:	O	;	_	0	SENT_440	[p25l1385t3524r1798b3573],
5	68:3389	CD	NUMBER	68:3389	num	6	SENT_440	[p25l1385t3524r1798b3573],
6	-95	CD	NUMBER	-95	dep	1	SENT_440	[p25l1385t3524r1798b3573],
7	.	.	O	.	_	0	SENT_440	[p25l1385t3524r1798b3573],

1	17	CD	NUMBER	17	_	0	SENT_441	[p25l1099t3596r1156b3634],
2	.	.	O	.	_	0	SENT_441	[p25l1099t3596r1156b3634],

1	Christensen	NNP	PERSON	Christensen	nn	2	SENT_442	[p25l1192t3591r1481b3634],
2	JG	NNP	O	JG	_	0	SENT_442	[p25l1498t3594r1571b3644],
3	,	,	O	,	_	0	SENT_442	[p25l1498t3594r1571b3644],
4	Zou	NNP	PERSON	Zou	nn	5	SENT_442	[p25l1595t3595r1687b3635],
5	HY	NNP	PERSON	HY	appos	2	SENT_442	[p25l1709t3595r1792b3644],
6	,	,	O	,	_	0	SENT_442	[p25l1709t3595r1792b3644],
7	Arango	NNP	PERSON	Arango	nn	8	SENT_442	[p25l1815t3595r1994b3647],
8	ME	NNP	O	ME	appos	2	SENT_442	[p25l2015t3595r2108b3644],
9	,	,	O	,	_	0	SENT_442	[p25l2015t3595r2108b3644],
10	et	FW	O	et	nn	11	SENT_442	[p25l1097t3670r1141b3704],
11	al.	FW	O	al.	appos	2	SENT_442	[p25l1162t3661r1217b3704],
12	.	.	O	.	_	0	SENT_442	[p25l1162t3661r1217b3704],

1	Cytoreductive	JJ	MISC	cytoreductive	amod	3	SENT_443	[p25l1245t3661r1575b3716],
2	antitumor	NN	O	antitumor	nn	3	SENT_443	[p25l1600t3662r1846b3705],
3	activity	NN	O	activity	_	0	SENT_443	[p25l1868t3662r2043b3716],
4	of	IN	O	of	_	0	SENT_443	[p25l2066t3661r2122b3704],
5	PF-2341066	NN	O	pf-2341066	prep_of	3	SENT_443	[p25l1096t3734r1385b3783],
6	,	,	O	,	_	0	SENT_443	[p25l1096t3734r1385b3783],
7	a	DT	O	a	det	9	SENT_443	[p25l1410t3745r1435b3774],
8	novel	JJ	O	novel	amod	9	SENT_443	[p25l1456t3731r1582b3775],
9	inhibitor	NN	O	inhibitor	appos	5	SENT_443	[p25l1604t3731r1819b3774],
10	of	IN	O	of	_	0	SENT_443	[p25l1840t3731r1896b3774],
11	anaplasIdentification	NN	O	anaplasidentification	prep_of	9	SENT_443	[p25l1908t3731r2111b3786, p26l8t14r340b58],

1	of	IN	O	of	_	0	SENT_444	[p26l360t14r415b57],
2	the	DT	O	the	det	6	SENT_444	[p26l425t14r499b57],
3	transforming	VBG	O	transform	amod	6	SENT_444	[p26l519t14r845b70],
4	EML4ALK	NN	O	eml4alk	nn	6	SENT_444	[p26l862t17r1022b57, p26l6t88r113b129],
5	fusion	NN	O	fusion	nn	6	SENT_444	[p26l140t84r292b128],
6	gene	NN	O	gene	pobj	1	SENT_444	[p26l321t98r433b140],
7	in	IN	O	in	_	0	SENT_444	[p26l462t85r509b127],
8	non-small-cell	JJ	O	non-small-cell	amod	10	SENT_444	[p26l538t84r888b127],
9	lung	NN	O	lung	nn	10	SENT_444	[p26l916t84r1025b140],
10	cancer	NN	O	cancer	prep_in	6	SENT_444	[p26l9t168r177b197],
11	.	.	O	.	_	0	SENT_444	[p26l9t168r177b197],

1	Nature	NNP	O	Nature	_	0	SENT_445	[p26l198t158r363b198],
2	2007	CD	DATE	2007	num	1	SENT_445	[p26l382t157r760b206],
3	;	:	O	;	_	0	SENT_445	[p26l382t157r760b206],
4	448:561	CD	NUMBER	448:561	number	5	SENT_445	[p26l382t157r760b206],
5	—	CD	NUMBER	—	dep	1	SENT_445	[p26l382t157r760b206],
6	6	CD	NUMBER	6	dep	5	SENT_445	[p26l382t157r760b206],
7	.	.	O	.	_	0	SENT_445	[p26l382t157r760b206],

1	9	CD	NUMBER	9	_	0	SENT_446	[p26l8t229r45b267],
2	.	.	O	.	_	0	SENT_446	[p26l8t229r45b267],

1	Choi	NNP	PERSON	Choi	nn	2	SENT_447	[p26l103t224r214b267],
2	YL	NNP	PERSON	YL	_	0	SENT_447	[p26l239t228r313b277],
3	,	,	O	,	_	0	SENT_447	[p26l239t228r313b277],
4	Takeuchi	NNP	PERSON	Takeuchi	nn	5	SENT_447	[p26l341t224r562b268],
5	K	NNP	O	K	appos	2	SENT_447	[p26l588t228r636b276],
6	,	,	O	,	_	0	SENT_447	[p26l588t228r636b276],
7	Soda	NNP	O	Soda	nn	8	SENT_447	[p26l668t224r783b267],
8	M	NNP	O	M	appos	2	SENT_447	[p26l807t228r868b277],
9	,	,	O	,	_	0	SENT_447	[p26l807t228r868b277],
10	et	FW	O	et	nn	11	SENT_447	[p26l898t233r941b267],
11	al.	FW	O	al.	appos	2	SENT_447	[p26l965t224r1020b267],
12	.	.	O	.	_	0	SENT_447	[p26l965t224r1020b267],

1	Identification	NN	O	identification	_	0	SENT_448	[p26l8t294r340b338],
2	of	IN	O	of	_	0	SENT_448	[p26l375t294r431b337],
3	novel	JJ	O	novel	amod	4	SENT_448	[p26l456t294r583b338],
4	isoforms	NNS	O	isoform	prep_of	1	SENT_448	[p26l617t294r830b337],
5	of	IN	O	of	_	0	SENT_448	[p26l867t294r923b337],
6	the	DT	O	the	det	7	SENT_448	[p26l948t294r1023b337],
7	EML4-ALK	NN	O	eml4-alk	prep_of	4	SENT_448	[p26l8t368r278b409],
8	transforming	VBG	O	transform	partmod	1	SENT_448	[p26l312t364r645b420],
9	gene	NN	O	gene	dobj	8	SENT_448	[p26l679t378r792b420],
10	in	IN	O	in	_	0	SENT_448	[p26l828t365r875b407],
11	nonsmall	JJ	O	nonsmall	amod	14	SENT_448	[p26l911t378r1022b407, p26l9t434r143b477],
12	cell	NN	O	cell	nn	14	SENT_448	[p26l167t434r249b477],
13	lung	NN	O	lung	nn	14	SENT_448	[p26l271t434r380b490],
14	cancer	NN	O	cancer	prep_in	9	SENT_448	[p26l401t448r569b477],
15	.	.	O	.	_	0	SENT_448	[p26l401t448r569b477],

1	Cancer	NN	O	cancer	_	0	SENT_449	[p26l595t437r763b477],
2	Res	NNP	O	Res	dep	1	SENT_449	[p26l783t438r867b480],
3	2008	CD	DATE	2008	num	2	SENT_449	[p26l891t437r1020b486],
4	;	:	O	;	_	0	SENT_449	[p26l891t437r1020b486],
5	68:4971	CD	NUMBER	68:4971	number	6	SENT_449	[p26l9t507r255b547],
6	—	CD	NUMBER	—	dep	1	SENT_449	[p26l9t507r255b547],
7	6	CD	NUMBER	6	dep	6	SENT_449	[p26l9t507r255b547],
8	.	.	O	.	_	0	SENT_449	[p26l9t507r255b547],

1	10	CD	NUMBER	10	_	0	SENT_450	[p26l10t578r72b617],
2	.	.	O	.	_	0	SENT_450	[p26l10t578r72b617],

1	Takeuchi	NNP	PERSON	Takeuchi	nn	2	SENT_451	[p26l101t574r322b618],
2	K	NNP	PERSON	K	_	0	SENT_451	[p26l348t578r396b627],
3	,	,	O	,	_	0	SENT_451	[p26l348t578r396b627],
4	Choi	NNP	PERSON	Choi	nn	5	SENT_451	[p26l426t574r537b617],
5	YL	NNP	PERSON	YL	appos	2	SENT_451	[p26l562t578r636b627],
6	,	,	O	,	_	0	SENT_451	[p26l562t578r636b627],
7	Soda	NNP	O	Soda	nn	8	SENT_451	[p26l668t574r783b617],
8	M	NNP	O	M	appos	2	SENT_451	[p26l807t578r868b627],
9	,	,	O	,	_	0	SENT_451	[p26l807t578r868b627],
10	et	FW	O	et	nn	11	SENT_451	[p26l898t583r941b617],
11	al.	FW	O	al.	appos	2	SENT_451	[p26l965t574r1020b617],
12	.	.	O	.	_	0	SENT_451	[p26l965t574r1020b617],

1	Multiplex	JJ	O	multiplex	amod	3	SENT_452	[p26l7t644r228b699],
2	reverse	JJ	O	reverse	amod	3	SENT_452	[p26l243t658r404b688],
3	transcription	NN	O	transcription	_	0	SENT_452	[p26l422t645r846b699],
4	.	.	O	.	_	0	SENT_452	[p26l422t645r846b699],

1	—	NN	O	—	_	0	SENT_453	[p26l422t645r846b699],
2	.	.	O	.	_	0	SENT_453	[p26l422t645r846b699],

1	PCR	NN	O	pcr	nn	2	SENT_454	[p26l422t645r846b699],
2	screening	NN	O	screening	_	0	SENT_454	[p26l859t658r1022b687, p26l8t715r86b770],
3	for	IN	O	for	_	0	SENT_454	[p26l100t714r169b757],
4	EML4-ALK	NN	O	eml4-alk	nn	6	SENT_454	[p26l182t717r448b759],
5	fusion	NN	O	fusion	nn	6	SENT_454	[p26l462t714r614b758],
6	transcripts	NNS	O	transcript	prep_for	2	SENT_454	[p26l629t715r905b769],
7	.	.	O	.	_	0	SENT_454	[p26l629t715r905b769],

1	Clin	NNP	O	Clin	nn	3	SENT_455	[p26l923t714r1023b758],
2	Cancer	NNP	O	Cancer	nn	3	SENT_455	[p26l8t787r176b828],
3	Res	NNP	O	Res	_	0	SENT_455	[p26l192t788r277b830],
4	2008	CD	DATE	2008	num	3	SENT_455	[p26l297t787r701b836],
5	;	:	O	;	_	0	SENT_455	[p26l297t787r701b836],
6	14:6618	CD	NUMBER	14:6618	number	7	SENT_455	[p26l297t787r701b836],
7	-24	CD	NUMBER	-24	dep	3	SENT_455	[p26l297t787r701b836],
8	.	.	O	.	_	0	SENT_455	[p26l297t787r701b836],

1	11	CD	NUMBER	11	_	0	SENT_456	[p26l10t859r72b897],
2	.	.	O	.	_	0	SENT_456	[p26l10t859r72b897],

1	Koivunen	NNP	PERSON	Koivunen	nn	2	SENT_457	[p26l102t855r332b899],
2	JP	NNP	O	JP	_	0	SENT_457	[p26l345t858r404b907],
3	,	,	O	,	_	0	SENT_457	[p26l345t858r404b907],
4	Mermel	NNP	PERSON	Mermel	nn	5	SENT_457	[p26l424t854r610b897],
5	C	NNP	O	C	appos	2	SENT_457	[p26l628t857r674b906],
6	,	,	O	,	_	0	SENT_457	[p26l628t857r674b906],
7	Zejnullahu	NNP	PERSON	Zejnullahu	nn	8	SENT_457	[p26l694t854r954b909],
8	K	NNP	PERSON	K	appos	2	SENT_457	[p26l971t858r1019b906],
9	,	,	O	,	_	0	SENT_457	[p26l971t858r1019b906],
10	et	FW	O	et	nn	11	SENT_457	[p26l9t933r52b967],
11	al.	FW	O	al.	appos	2	SENT_457	[p26l68t924r123b967],
12	.	.	O	.	_	0	SENT_457	[p26l68t924r123b967],

1	EML4-ALK	CD	NUMBER	eml4-alk	num	2	SENT_458	[p26l144t927r410b969],
2	fusion	NN	O	fusion	_	0	SENT_458	[p26l427t924r579b968],
3	gene	NN	O	gene	dep	2	SENT_458	[p26l598t938r710b980],
4	and	CC	O	and	_	0	SENT_458	[p26l728t924r817b967],
5	efficacy	NN	O	efficacy	dep	2	SENT_458	[p26l836t924r1025b979],
6	of	IN	O	of	_	0	SENT_458	[p26l9t994r64b1038],
7	an	DT	O	a	det	10	SENT_458	[p26l70t1008r128b1037],
8	ALK	NN	O	alk	nn	10	SENT_458	[p26l142t998r249b1039],
9	kinase	NN	O	kinase	nn	10	SENT_458	[p26l263t994r420b1038],
10	inhibitor	NN	O	inhibitor	prep_of	3	SENT_458	[p26l436t994r651b1037],
11	in	IN	O	in	_	0	SENT_458	[p26l666t995r712b1037],
12	lung	NN	O	lung	nn	13	SENT_458	[p26l728t994r836b1050],
13	cancer	NN	O	cancer	prep_in	10	SENT_458	[p26l851t1008r1019b1037],
14	.	.	O	.	_	0	SENT_458	[p26l851t1008r1019b1037],

1	Clin	NNP	O	Clin	nn	3	SENT_459	[p26l8t1064r107b1108],
2	Cancer	NNP	O	Cancer	nn	3	SENT_459	[p26l126t1067r294b1108],
3	Res	NNP	O	Res	_	0	SENT_459	[p26l311t1068r395b1110],
4	2008	CD	DATE	2008	num	3	SENT_459	[p26l415t1067r823b1117],
5	;	:	O	;	_	0	SENT_459	[p26l415t1067r823b1117],
6	14:4275	CD	NUMBER	14:4275	number	7	SENT_459	[p26l415t1067r823b1117],
7	—	CD	NUMBER	—	dep	3	SENT_459	[p26l415t1067r823b1117],
8	83	CD	NUMBER	83	dep	7	SENT_459	[p26l415t1067r823b1117],
9	.	.	O	.	_	0	SENT_459	[p26l415t1067r823b1117],

1	12	CD	NUMBER	12	_	0	SENT_460	[p26l10t1139r73b1177],
2	.	.	O	.	_	0	SENT_460	[p26l10t1139r73b1177],

1	Mano	NNP	O	Mano	nn	6	SENT_461	[p26l101t1138r237b1178],
2	H.	NNP	O	H.	nn	6	SENT_461	[p26l255t1138r307b1177],
3	Non	NNP	O	Non	nn	6	SENT_461	[p26l327t1134r561b1178],
4	—	CD	NUMBER	—	num	6	SENT_461	[p26l327t1134r561b1178],
5	solid	JJ	O	solid	amod	6	SENT_461	[p26l327t1134r561b1178],
6	oncogenes	NNS	O	oncogene	_	0	SENT_461	[p26l579t1148r828b1190],
7	in	IN	O	in	_	0	SENT_461	[p26l846t1135r892b1177],
8	solid	JJ	O	solid	amod	9	SENT_461	[p26l910t1134r1023b1178],
9	tumors	NNS	O	tumor	prep_in	6	SENT_461	[p26l9t1213r195b1248],
10	:	:	O	:	_	0	SENT_461	[p26l9t1213r195b1248],
11	EML4-ALK	NN	O	eml4-alk	nn	13	SENT_461	[p26l221t1208r487b1249],
12	fusion	NN	O	fusion	nn	13	SENT_461	[p26l509t1204r661b1248],
13	genes	NNS	O	gene	dep	6	SENT_461	[p26l685t1218r821b1260],
14	in	IN	O	in	_	0	SENT_461	[p26l846t1205r892b1247],
15	lung	NN	O	lung	nn	16	SENT_461	[p26l916t1204r1025b1260],
16	cancer	NN	O	cancer	prep_in	13	SENT_461	[p26l9t1288r177b1317],
17	.	.	O	.	_	0	SENT_461	[p26l9t1288r177b1317],

1	Cancer	NN	O	cancer	_	0	SENT_462	[p26l199t1277r367b1317],
2	Sci	NNP	O	Sci	dep	1	SENT_462	[p26l385t1275r452b1317],
3	2008	CD	DATE	2008	num	2	SENT_462	[p26l471t1277r882b1326],
4	;	:	O	;	_	0	SENT_462	[p26l471t1277r882b1326],
5	99:2349	CD	NUMBER	99:2349	number	6	SENT_462	[p26l471t1277r882b1326],
6	—	CD	NUMBER	—	dep	1	SENT_462	[p26l471t1277r882b1326],
7	55	CD	NUMBER	55	dep	6	SENT_462	[p26l471t1277r882b1326],
8	.	.	O	.	_	0	SENT_462	[p26l471t1277r882b1326],

1	tic	JJ	O	tic	amod	2	SENT_463	[p26l1097t15r1154b57],
2	lymphoma	NN	O	lymphoma	_	0	SENT_463	[p26l1171t14r1425b69],
3	kinase	NN	O	kinase	dep	2	SENT_463	[p26l1442t14r1596b58],
4	and	CC	O	and	_	0	SENT_463	[p26l1614t14r1701b57],
5	c	NN	O	c	dep	2	SENT_463	[p26l1719t18r1863b67],
6	.	.	O	.	_	0	SENT_463	[p26l1719t18r1863b67],

1	—	NN	O	—	_	0	SENT_464	[p26l1719t18r1863b67],
2	.	.	O	.	_	0	SENT_464	[p26l1719t18r1863b67],

1	Met	NNP	O	Met	_	0	SENT_465	[p26l1719t18r1863b67],
2	,	,	O	,	_	0	SENT_465	[p26l1719t18r1863b67],
3	in	IN	O	in	dep	1	SENT_465	[p26l1884t15r1930b57],
4	experimental	JJ	O	experimental	amod	5	SENT_465	[p26l1949t15r2111b69, p26l1097t84r1265b127],
5	models	NNS	O	model	pobj	3	SENT_465	[p26l1303t84r1477b127],
6	of	IN	O	of	_	0	SENT_465	[p26l1517t84r1573b127],
7	anaplastic	JJ	O	anaplastic	amod	11	SENT_465	[p26l1602t84r1847b139],
8	large	JJ	O	large	amod	11	SENT_465	[p26l1885t84r2112b140],
9	—	NN	O	—	nn	11	SENT_465	[p26l1885t84r2112b140],
10	cell	NN	O	cell	nn	11	SENT_465	[p26l1885t84r2112b140],
11	lymphoma	NN	O	lymphoma	prep_of	5	SENT_465	[p26l1096t154r1367b209],
12	.	.	O	.	_	0	SENT_465	[p26l1096t154r1367b209],

1	Mol	NNP	O	Mol	nn	3	SENT_466	[p26l1386t154r1479b197],
2	Cancer	NNP	O	Cancer	nn	3	SENT_466	[p26l1496t157r1664b197],
3	Ther	NNP	O	Ther	_	0	SENT_466	[p26l1678t154r1790b197],
4	2007	CD	DATE	2007	num	3	SENT_466	[p26l1806t157r2111b206],
5	;	:	O	;	_	0	SENT_466	[p26l1806t157r2111b206],
6	6:3314	CD	NUMBER	6:3314	number	7	SENT_466	[p26l1806t157r2111b206],
7	—	CD	NUMBER	—	dep	3	SENT_466	[p26l1806t157r2111b206],
8	22	CD	NUMBER	22	dep	7	SENT_466	[p26l1097t227r1167b267],
9	.	.	O	.	_	0	SENT_466	[p26l1097t227r1167b267],

1	18	CD	NUMBER	18	_	0	SENT_467	[p26l1099t298r1162b338],
2	.	.	O	.	_	0	SENT_467	[p26l1099t298r1162b338],

1	Kwak	NNP	PERSON	Kwak	nn	2	SENT_468	[p26l1191t294r1326b339],
2	EL	NNP	O	EL	_	0	SENT_468	[p26l1344t298r1418b347],
3	,	,	O	,	_	0	SENT_468	[p26l1344t298r1418b347],
4	Camidge	NNP	O	Camidge	nn	5	SENT_468	[p26l1443t294r1656b350],
5	DR	NN	O	dr	appos	2	SENT_468	[p26l1677t298r1765b347],
6	,	,	O	,	_	0	SENT_468	[p26l1677t298r1765b347],
7	Clark	NNP	PERSON	Clark	nn	8	SENT_468	[p26l1790t294r1921b338],
8	J	NNP	PERSON	J	appos	2	SENT_468	[p26l1935t298r1967b347],
9	,	,	O	,	_	0	SENT_468	[p26l1935t298r1967b347],
10	et	FW	O	et	nn	11	SENT_468	[p26l1992t303r2035b337],
11	al.	FW	O	al.	appos	2	SENT_468	[p26l2053t294r2108b337],
12	.	.	O	.	_	0	SENT_468	[p26l2053t294r2108b337],

1	Clinical	JJ	O	clinical	amod	2	SENT_469	[p26l1097t364r1284b408],
2	activity	NN	O	activity	nsubj	3	SENT_469	[p26l1299t365r1474b419],
3	observed	VBN	O	observe	_	0	SENT_469	[p26l1487t364r1701b408],
4	in	IN	O	in	_	0	SENT_469	[p26l1716t365r1763b407],
5	a	DT	O	a	det	6	SENT_469	[p26l1778t378r1802b407],
6	phase	NN	O	phase	prep_in	3	SENT_469	[p26l1816t364r1955b419],
7	I	PRP	O	I	dep	6	SENT_469	[p26l1970t368r1987b407],
8	dose	NN	O	dose	nn	10	SENT_469	[p26l2002t364r2111b407],
9	escalation	NN	O	escalation	nn	10	SENT_469	[p26l1097t434r1342b477],
10	trial	NN	O	trial	dobj	3	SENT_469	[p26l1360t434r1460b477],
11	of	IN	O	of	_	0	SENT_469	[p26l1479t434r1535b478],
12	an	DT	O	a	det	14	SENT_469	[p26l1542t448r1600b477],
13	oral	JJ	O	oral	amod	14	SENT_469	[p26l1618t434r1711b477],
14	c-MET	NN	O	c-met	prep_of	10	SENT_469	[p26l1730t437r1886b477],
15	and	CC	O	and	_	0	SENT_469	[p26l1902t434r1991b477],
16	ALK	NN	O	alk	nn	17	SENT_469	[p26l2007t438r2113b479],
17	inhibitor	NN	O	inhibitor	prep_of	10	SENT_469	[p26l1096t504r1317b556],
18	,	,	O	,	_	0	SENT_469	[p26l1096t504r1317b556],
19	PF-02341066	NN	O	pf-02341066	appos	14	SENT_469	[p26l1338t507r1654b548],
20	.	.	O	.	_	0	SENT_469	[p26l1338t507r1654b548],

1	J	NNP	O	J	nn	3	SENT_470	[p26l1670t508r1690b554],
2	Clin	NNP	O	Clin	nn	3	SENT_470	[p26l1708t504r1805b547],
3	Oncol	NNP	O	Oncol	_	0	SENT_470	[p26l1823t504r1964b547],
4	2009	CD	DATE	2009	num	6	SENT_470	[p26l1981t507r2109b556],
5	;	:	O	;	_	0	SENT_470	[p26l1981t507r2109b556],
6	27	CD	NUMBER	27	dep	3	SENT_470	[p26l1097t574r1439b629],
7	:	:	O	:	_	0	SENT_470	[p26l1097t574r1439b629],
8	Suppl	NNP	O	Suppl	dep	3	SENT_470	[p26l1097t574r1439b629],
9	:148	CD	NUMBER	:148	num	8	SENT_470	[p26l1097t574r1439b629],
10	s.	NN	O	s.	dep	8	SENT_470	[p26l1097t574r1439b629],
11	19	CD	NUMBER	19	num	10	SENT_470	[p26l1099t649r1160b687],
12	.	.	O	.	_	0	SENT_470	[p26l1099t649r1160b687],

1	Oken	NNP	O	Oken	nn	2	SENT_471	[p26l1192t644r1318b688],
2	MM	NN	O	mm	_	0	SENT_471	[p26l1335t648r1445b697],
3	,	,	O	,	_	0	SENT_471	[p26l1335t648r1445b697],
4	Creech	NNP	PERSON	Creech	nn	5	SENT_471	[p26l1467t644r1631b687],
5	RH	NNP	O	RH	appos	2	SENT_471	[p26l1649t648r1741b697],
6	,	,	O	,	_	0	SENT_471	[p26l1649t648r1741b697],
7	Tormey	NNP	ORGANIZATION	Tormey	nn	8	SENT_471	[p26l1761t647r1945b699],
8	DC	NNP	ORGANIZATION	DC	appos	2	SENT_471	[p26l1961t647r2048b697],
9	,	,	O	,	_	0	SENT_471	[p26l1961t647r2048b697],
10	et	FW	O	et	nn	11	SENT_471	[p26l2071t653r2114b687],
11	al.	FW	O	al.	appos	2	SENT_471	[p26l1096t714r1151b757],
12	.	.	O	.	_	0	SENT_471	[p26l1096t714r1151b757],

1	Toxicity	NN	O	toxicity	nn	4	SENT_472	[p26l1182t715r1374b769],
2	and	CC	O	and	_	0	SENT_472	[p26l1400t714r1489b757],
3	response	NN	O	response	nn	4	SENT_472	[p26l1518t728r1732b769],
4	criteria	NNS	O	criterion	_	0	SENT_472	[p26l1762t715r1933b757],
5	of	IN	O	of	_	0	SENT_472	[p26l1962t714r2018b757],
6	the	DT	O	the	det	10	SENT_472	[p26l2037t714r2111b757],
7	Eastern	NNP	ORGANIZATION	Eastern	nn	10	SENT_472	[p26l1096t788r1278b827],
8	Cooperative	NNP	ORGANIZATION	Cooperative	nn	10	SENT_472	[p26l1294t785r1581b839],
9	Oncology	NNP	ORGANIZATION	Oncology	nn	10	SENT_472	[p26l1598t784r1830b840],
10	Group	NNP	ORGANIZATION	Group	prep_of	4	SENT_472	[p26l1845t787r2009b839],
11	.	.	O	.	_	0	SENT_472	[p26l1845t787r2009b839],

1	Am	NNP	O	Am	nn	4	SENT_473	[p26l2027t788r2112b827],
2	J	NNP	O	J	nn	4	SENT_473	[p26l1092t858r1112b904],
3	Clin	NNP	O	Clin	nn	4	SENT_473	[p26l1130t854r1229b897],
4	Oncol	NNP	O	Oncol	_	0	SENT_473	[p26l1248t854r1390b897],
5	1982	CD	DATE	1982	num	4	SENT_473	[p26l1411t857r1760b906],
6	;	:	O	;	_	0	SENT_473	[p26l1411t857r1760b906],
7	5:649	CD	NUMBER	5:649	number	8	SENT_473	[p26l1411t857r1760b906],
8	—	CD	NUMBER	—	dep	4	SENT_473	[p26l1411t857r1760b906],
9	55	CD	NUMBER	55	dep	8	SENT_473	[p26l1411t857r1760b906],
10	.	.	O	.	_	0	SENT_473	[p26l1411t857r1760b906],

1	20	CD	NUMBER	20	_	0	SENT_474	[p26l1096t928r1163b967],
2	.	.	O	.	_	0	SENT_474	[p26l1096t928r1163b967],

1	Rodig	NNP	O	Rodig	nn	2	SENT_475	[p26l1191t924r1336b980],
2	SJ	NNP	O	SJ	_	0	SENT_475	[p26l1355t927r1409b977],
3	,	,	O	,	_	0	SENT_475	[p26l1355t927r1409b977],
4	Mino-Kenudson	NNP	O	Mino-Kenudson	nn	5	SENT_475	[p26l1430t924r1820b969],
5	M	NNP	O	M	appos	2	SENT_475	[p26l1837t928r1897b977],
6	,	,	O	,	_	0	SENT_475	[p26l1837t928r1897b977],
7	Dacic	NNP	PERSON	Dacic	nn	8	SENT_475	[p26l1919t925r2050b967],
8	S	NNP	O	S	appos	2	SENT_475	[p26l2070t927r2108b977],
9	,	,	O	,	_	0	SENT_475	[p26l2070t927r2108b977],
10	et	FW	O	et	nn	11	SENT_475	[p26l1097t1003r1141b1037],
11	al.	FW	O	al.	appos	2	SENT_475	[p26l1169t994r1224b1037],
12	.	.	O	.	_	0	SENT_475	[p26l1169t994r1224b1037],

1	Unique	JJ	O	unique	amod	3	SENT_476	[p26l1259t995r1432b1049],
2	clinicopathologic	JJ	O	clinicopathologic	amod	3	SENT_476	[p26l1464t994r1886b1050],
3	features	NNS	O	feature	nsubj	4	SENT_476	[p26l1917t994r2110b1038],
4	characterize	VBP	O	characterize	_	0	SENT_476	[p26l1097t1064r1393b1107],
5	ALK-rearranged	JJ	MISC	alk-rearranged	amod	7	SENT_476	[p26l1412t1064r1799b1120],
6	lung	NN	O	lung	nn	7	SENT_476	[p26l1820t1064r1929b1120],
7	adenocarcinoma	NN	O	adenocarcinoma	dobj	4	SENT_476	[p26l1948t1064r2111b1107, p26l1097t1135r1352b1177],
8	in	IN	O	in	_	0	SENT_476	[p26l1393t1135r1440b1177],
9	the	DT	O	the	det	11	SENT_476	[p26l1483t1134r1557b1177],
10	western	JJ	O	western	amod	11	SENT_476	[p26l1598t1143r1788b1178],
11	population	NN	O	population	prep_in	7	SENT_476	[p26l1830t1134r2109b1189],
12	.	.	O	.	_	0	SENT_476	[p26l1830t1134r2109b1189],

1	Clin	NNP	O	Clin	nn	3	SENT_477	[p26l1097t1204r1196b1248],
2	Cancer	NNP	O	Cancer	nn	3	SENT_477	[p26l1215t1207r1383b1248],
3	Res	NNP	O	Res	_	0	SENT_477	[p26l1399t1208r1484b1250],
4	2009	CD	DATE	2009	num	3	SENT_477	[p26l1504t1207r1911b1256],
5	;	:	O	;	_	0	SENT_477	[p26l1504t1207r1911b1256],
6	15:5216	CD	NUMBER	15:5216	number	7	SENT_477	[p26l1504t1207r1911b1256],
7	—	CD	NUMBER	—	dep	3	SENT_477	[p26l1504t1207r1911b1256],
8	23	CD	NUMBER	23	dep	7	SENT_477	[p26l1504t1207r1911b1256],
9	.	.	O	.	_	0	SENT_477	[p26l1504t1207r1911b1256],

1	21	CD	NUMBER	21	_	0	SENT_478	[p26l1096t1279r1162b1317],
2	.	.	O	.	_	0	SENT_478	[p26l1096t1279r1162b1317],

1	Mino-Kenudson	NNP	O	Mino-Kenudson	nn	2	SENT_479	[p26l1190t1274r1580b1319],
2	M	NNP	O	M	_	0	SENT_479	[p26l1602t1278r1662b1327],
3	,	,	O	,	_	0	SENT_479	[p26l1602t1278r1662b1327],
4	Chirieac	NNP	O	Chirieac	nn	7	SENT_479	[p26l1688t1274r1889b1317],
5	LR	NNP	O	LR	nn	7	SENT_479	[p26l1911t1278r1989b1326],
6	,	,	O	,	_	0	SENT_479	[p26l1911t1278r1989b1326],
7	Law	NNP	O	Law	appos	2	SENT_479	[p26l2015t1278r2114b1318],

1	K	NNP	O	K	_	0	SENT_480	[p26l11t1776r112b1879],
2	,	,	O	,	_	0	SENT_480	[p26l11t1776r112b1879],
3	et	FW	O	et	nn	4	SENT_480	[p26l155t1788r246b1859],
4	al.	FW	O	al.	appos	1	SENT_480	[p26l276t1768r391b1859],
5	.	.	O	.	_	0	SENT_480	[p26l276t1768r391b1859],

1	A	DT	O	a	det	6	SENT_481	[p26l428t1776r505b1857],
2	novel	JJ	O	novel	amod	5	SENT_481	[p26l539t1768r828b1879],
3	,	,	O	,	_	0	SENT_481	[p26l539t1768r828b1879],
4	highly	RB	O	highly	advmod	5	SENT_481	[p26l871t1768r1192b1885],
5	sensitive	JJ	O	sensitive	amod	6	SENT_481	[p26l1225t1770r1655b1859],
6	antibody	NN	O	antibody	nsubj	7	SENT_481	[p26l1690t1768r2137b1883],
7	allows	VBZ	O	allow	_	0	SENT_481	[p26l11t1916r333b2007],
8	for	IN	O	for	_	0	SENT_481	[p26l389t1916r535b2007],
9	the	DT	O	the	det	11	SENT_481	[p26l585t1916r741b2007],
10	routine	JJ	O	routine	amod	11	SENT_481	[p26l796t1918r1160b2007],
11	detection	NN	O	detection	prep_for	7	SENT_481	[p26l1215t1916r1682b2007],
12	of	IN	O	of	_	0	SENT_481	[p26l1736t1914r1853b2007],
13	ALKrearranged	NNP	O	ALKrearranged	prep_of	11	SENT_481	[p26l1882t1924r2129b2009, p26l13t2065r555b2182],

1	lung	NN	O	lung	nn	2	SENT_482	[p26l587t2065r810b2182],
2	adenocarcinomas	NNS	O	adenocarcinoma	_	0	SENT_482	[p26l839t2065r1708b2156],
3	by	IN	O	by	_	0	SENT_482	[p26l1745t2065r1857b2180],
4	standard	JJ	O	standard	amod	5	SENT_482	[p26l1888t2085r2129b2155, p26l13t2214r236b2305],
5	immunohistochemistry	NN	O	immunohistochemistry	prep_by	2	SENT_482	[p26l286t2214r1478b2329],
6	.	.	O	.	_	0	SENT_482	[p26l286t2214r1478b2329],

1	Clin	NNP	O	Clin	nn	2	SENT_483	[p26l1534t2214r1738b2305],
2	Cancer	NNP	O	Cancer	_	0	SENT_483	[p26l1787t2220r2135b2305],

1	Res	NNP	O	Res	_	0	SENT_484	[p26l11t2371r185b2460],
2	2010	CD	DATE	2010	num	1	SENT_484	[p26l228t2369r1061b2472],
3	;	:	O	;	_	0	SENT_484	[p26l228t2369r1061b2472],
4	16:1561	CD	NUMBER	16:1561	number	5	SENT_484	[p26l228t2369r1061b2472],
5	—	CD	NUMBER	—	dep	1	SENT_484	[p26l228t2369r1061b2472],
6	71	CD	NUMBER	71	dep	5	SENT_484	[p26l228t2369r1061b2472],
7	.	.	O	.	_	0	SENT_484	[p26l228t2369r1061b2472],

1	22	CD	NUMBER	22	_	0	SENT_485	[p26l11t2524r151b2603],
2	.	.	O	.	_	0	SENT_485	[p26l11t2524r151b2603],

1	Gridelli	NN	PERSON	gridellus	nn	2	SENT_486	[p26l210t2512r595b2603],
2	C	NN	PERSON	c	_	0	SENT_486	[p26l644t2518r741b2621],
3	,	,	O	,	_	0	SENT_486	[p26l644t2518r741b2621],
4	Ardizzoni	NNP	MISC	Ardizzoni	nn	5	SENT_486	[p26l794t2512r1299b2603],
5	A	NNP	MISC	A	dep	2	SENT_486	[p26l1344t2520r1447b2621],
6	,	,	O	,	_	0	SENT_486	[p26l1344t2520r1447b2621],
7	Ciardiello	NNP	O	Ciardiello	nn	8	SENT_486	[p26l1504t2512r1997b2603],
8	F	NN	O	f	appos	5	SENT_486	[p26l2046t2520r2125b2621],
9	,	,	O	,	_	0	SENT_486	[p26l2046t2520r2125b2621],

1	et	FW	O	et	_	0	SENT_487	[p26l13t2679r104b2749],
2	al.	FW	O	al.	dep	1	SENT_487	[p26l151t2660r264b2751],
3	.	.	O	.	_	0	SENT_487	[p26l151t2660r264b2751],

1	Second-line	JJ	O	second-line	amod	2	SENT_488	[p26l329t2660r915b2751],
2	treatment	NN	O	treatment	_	0	SENT_488	[p26l970t2679r1469b2751],
3	of	IN	O	of	_	0	SENT_488	[p26l1518t2660r1635b2751],
4	advanced	JJ	O	advanced	amod	8	SENT_488	[p26l1667t2660r2131b2751],
5	non-small	JJ	O	non-small	amod	8	SENT_488	[p26l13t2809r524b2900],
6	cell	NN	O	cell	nn	8	SENT_488	[p26l573t2809r745b2899],
7	lung	NN	O	lung	nn	8	SENT_488	[p26l792t2809r1018b2926],
8	cancer	NN	O	cancer	prep_of	2	SENT_488	[p26l1065t2839r1415b2900],
9	.	.	O	.	_	0	SENT_488	[p26l1065t2839r1415b2900],

1	J	NNP	O	J	nn	3	SENT_489	[p26l1460t2817r1503b2914],
2	Thorac	NNP	O	Thorac	nn	3	SENT_489	[p26l1546t2809r1898b2900],
3	Oncol	NNP	O	Oncol	_	0	SENT_489	[p26l1945t2815r2129b2900, p26l13t2958r156b3049],
4	2008	CD	DATE	2008	num	3	SENT_489	[p26l195t2964r941b3067],
5	;	:	O	;	_	0	SENT_489	[p26l195t2964r941b3067],
6	3:430	CD	NUMBER	3:430	number	7	SENT_489	[p26l195t2964r941b3067],
7	-40	CD	NUMBER	-40	dep	3	SENT_489	[p26l195t2964r941b3067],
8	.	.	O	.	_	0	SENT_489	[p26l195t2964r941b3067],

1	23	CD	NUMBER	23	_	0	SENT_490	[p26l11t3119r147b3198],
2	.	.	O	.	_	0	SENT_490	[p26l11t3119r147b3198],

1	Asahina	NNP	PERSON	Asahina	nn	2	SENT_491	[p26l205t3107r622b3197],
2	H	NNP	PERSON	H	_	0	SENT_491	[p26l667t3115r779b3218],
3	,	,	O	,	_	0	SENT_491	[p26l667t3115r779b3218],
4	Yamazaki	NNP	PERSON	Yamazaki	nn	5	SENT_491	[p26l828t3107r1324b3198],
5	K	NNP	PERSON	K	appos	2	SENT_491	[p26l1370t3115r1471b3216],
6	,	,	O	,	_	0	SENT_491	[p26l1370t3115r1471b3216],
7	Kinoshita	NNP	PERSON	Kinoshita	appos	2	SENT_491	[p26l1524t3107r2019b3200],
8	I	PRP	O	I	dep	7	SENT_491	[p26l2064t3115r2125b3216],
9	,	,	O	,	_	0	SENT_491	[p26l2064t3115r2125b3216],

1	et	FW	O	et	_	0	SENT_492	[p26l13t3276r102b3347],
2	al.	FW	O	al.	dep	1	SENT_492	[p26l139t3256r254b3347],
3	.	.	O	.	_	0	SENT_492	[p26l139t3256r254b3347],

1	A	DT	O	a	det	4	SENT_493	[p26l300t3264r375b3345],
2	phase	NN	O	phase	nn	4	SENT_493	[p26l414t3256r705b3371],
3	II	CD	NUMBER	ii	num	4	SENT_493	[p26l747t3264r824b3345],
4	trial	NN	O	trial	_	0	SENT_493	[p26l867t3256r1075b3346],
5	of	IN	O	of	_	0	SENT_493	[p26l1119t3256r1235b3347],
6	gefitinib	NN	O	gefitinib	prep_of	4	SENT_493	[p26l1257t3256r1694b3373],
7	as	IN	O	as	_	0	SENT_493	[p26l1739t3286r1839b3346],
8	firstline	NN	O	firstline	nn	9	SENT_493	[p26l1884t3256r2129b3346, p26l11t3405r197b3496],
9	therapy	NN	O	therapy	prep_as	4	SENT_493	[p26l252t3405r630b3520],
10	for	IN	O	for	_	0	SENT_493	[p26l679t3405r824b3496],
11	advanced	JJ	O	advanced	amod	15	SENT_493	[p26l875t3405r1340b3496],
12	non-small	JJ	O	non-small	amod	15	SENT_493	[p26l1393t3405r1906b3496],
13	cell	NN	O	cell	nn	15	SENT_493	[p26l1961t3405r2132b3496],
14	lung	NN	O	lung	nn	15	SENT_493	[p26l11t3554r237b3671],
15	cancer	NN	O	cancer	prep_for	9	SENT_493	[p26l270t3584r600b3644],
16	with	IN	O	with	_	0	SENT_493	[p26l628t3554r856b3645],
17	epidermal	JJ	O	epidermal	amod	21	SENT_493	[p26l893t3554r1400b3669],
18	growth	NN	O	growth	nn	21	SENT_493	[p26l1435t3554r1803b3671],
19	factor	NN	O	factor	nn	21	SENT_493	[p26l1840t3554r2135b3645],
20	receptor	NN	O	receptor	nn	21	SENT_493	[p27l13t42r430b137],
21	mutations	NNS	O	mutation	prep_with	4	SENT_493	[p27l476t24r1016b113],
22	.	.	O	.	_	0	SENT_493	[p27l476t24r1016b113],

1	Br	NN	O	br	_	0	SENT_494	[p27l1069t30r1259b127],
2	]	CD	NUMBER	]	num	1	SENT_494	[p27l1069t30r1259b127],
3	Cancer	NN	O	cancer	dep	1	SENT_494	[p27l1306t28r1657b113],
4	2006	CD	DATE	2006	num	3	SENT_494	[p27l1702t30r2127b131],
5	;	:	O	;	_	0	SENT_494	[p27l1702t30r2127b131],
6	95	CD	NUMBER	95	num	8	SENT_494	[p27l1702t30r2127b131],
7	:	:	O	:	_	0	SENT_494	[p27l1702t30r2127b131],
8	998-1004	CD	NUMBER	998-1004	dep	1	SENT_494	[p27l13t176r498b261],
9	.	.	O	.	_	0	SENT_494	[p27l13t176r498b261],

1	24	CD	NUMBER	24	_	0	SENT_495	[p27l11t331r149b410],
2	.	.	O	.	_	0	SENT_495	[p27l11t331r149b410],

1	Inoue	NNP	PERSON	Inoue	nn	2	SENT_496	[p27l209t327r492b410],
2	A	NNP	O	A	_	0	SENT_496	[p27l535t327r636b428],
3	,	,	O	,	_	0	SENT_496	[p27l535t327r636b428],
4	Suzuki	NNP	ORGANIZATION	Suzuki	nn	5	SENT_496	[p27l691t319r1034b410],
5	T	NN	ORGANIZATION	t	appos	2	SENT_496	[p27l1073t327r1162b430],
6	,	,	O	,	_	0	SENT_496	[p27l1073t327r1162b430],
7	Fukuhara	NNP	ORGANIZATION	Fukuhara	nn	8	SENT_496	[p27l1213t319r1700b410],
8	T	NN	ORGANIZATION	t	appos	2	SENT_496	[p27l1740t327r1829b428],
9	,	,	O	,	_	0	SENT_496	[p27l1740t327r1829b428],
10	et	FW	O	et	nn	11	SENT_496	[p27l1882t339r1973b410],
11	al.	FW	O	al.	appos	2	SENT_496	[p27l2011t319r2125b410],
12	.	.	O	.	_	0	SENT_496	[p27l2011t319r2125b410],

1	Prospective	JJ	O	prospective	amod	2	SENT_497	[p27l11t470r585b583],
2	phase	NN	O	phase	_	0	SENT_497	[p27l624t468r915b583],
3	II	CD	NUMBER	ii	num	4	SENT_497	[p27l954t476r1031b557],
4	study	NN	O	study	dep	2	SENT_497	[p27l1071t468r1340b583],
5	of	IN	O	of	_	0	SENT_497	[p27l1376t468r1493b559],
6	gefitinib	NN	O	gefitinib	prep_of	4	SENT_497	[p27l1512t468r1949b585],
7	for	IN	O	for	_	0	SENT_497	[p27l1991t468r2135b559],
8	chemotherapy	NN	O	chemotherapy	nn	9	SENT_497	[p27l13t617r1049b732],
9	—	NN	O	—	prep_for	6	SENT_497	[p27l13t617r1049b732],
10	naive	JJ	O	naive	amod	11	SENT_497	[p27l13t617r1049b732],
11	patients	NNS	O	patient	dep	2	SENT_497	[p27l1144t619r1554b732],
12	with	IN	O	with	_	0	SENT_497	[p27l1648t617r1880b708],
13	advanced	JJ	O	advanced	amod	15	SENT_497	[p27l1977t617r2129b708, p27l7t766r361b857],
14	non	JJ	O	non	amod	15	SENT_497	[p27l420t766r1166b857],
15	—	NN	O	—	prep_with	11	SENT_497	[p27l420t766r1166b857],
16	small	JJ	O	small	amod	20	SENT_497	[p27l420t766r1166b857],
17	—	NN	O	—	nn	20	SENT_497	[p27l420t766r1166b857],
18	cell	NN	O	cell	nn	20	SENT_497	[p27l420t766r1166b857],
19	lung	NN	O	lung	nn	20	SENT_497	[p27l1225t766r1455b883],
20	cancer	NN	O	cancer	dep	2	SENT_497	[p27l1512t796r1848b856],
21	with	IN	O	with	_	0	SENT_497	[p27l1900t766r2131b857],
22	epidermal	JJ	O	epidermal	amod	27	SENT_497	[p27l13t915r529b1030],
23	growth	NN	O	growth	nn	27	SENT_497	[p27l596t915r970b1032],
24	factor	NN	O	factor	nn	27	SENT_497	[p27l1039t915r1340b1006],
25	receptor	NN	O	receptor	nn	27	SENT_497	[p27l1403t935r1831b1030],
26	gene	NN	O	gene	nn	27	SENT_497	[p27l1894t945r2131b1032],
27	mutations	NNS	O	mutation	prep_with	20	SENT_497	[p27l13t1066r551b1155],
28	.	.	O	.	_	0	SENT_497	[p27l13t1066r551b1155],

1	J	NNP	O	J	nn	3	SENT_498	[p27l586t1072r628b1169],
2	Clin	NNP	O	Clin	nn	3	SENT_498	[p27l667t1064r874b1155],
3	Oncol	NNP	O	Oncol	_	0	SENT_498	[p27l913t1064r1210b1155],
4	2006	CD	DATE	2006	num	3	SENT_498	[p27l1249t1070r2060b1173],
5	;	:	O	;	_	0	SENT_498	[p27l1249t1070r2060b1173],
6	24:3340	CD	NUMBER	24:3340	number	7	SENT_498	[p27l1249t1070r2060b1173],
7	—	CD	NUMBER	—	dep	3	SENT_498	[p27l1249t1070r2060b1173],
8	6	CD	NUMBER	6	dep	7	SENT_498	[p27l1249t1070r2060b1173],
9	.	.	O	.	_	0	SENT_498	[p27l1249t1070r2060b1173],

1	25	CD	NUMBER	25	_	0	SENT_499	[p27l11t1225r147b1304],
2	.	.	O	.	_	0	SENT_499	[p27l11t1225r147b1304],

1	Mok	NN	O	mok	nn	2	SENT_500	[p27l207t1213r434b1304],
2	TS	NN	O	t	_	0	SENT_500	[p27l460t1219r616b1324],
3	,	,	O	,	_	0	SENT_500	[p27l460t1219r616b1324],
4	Wu	NNP	O	Wu	nn	5	SENT_500	[p27l654t1221r822b1304],
5	YL	NNP	O	YL	appos	2	SENT_500	[p27l851t1221r1008b1324],
6	,	,	O	,	_	0	SENT_500	[p27l851t1221r1008b1324],
7	-	:	O	-	_	0	SENT_500	[p27l1086t1231r1087b1282],
8	+	CC	O	+	cc	9	SENT_500	[p27l1086t1231r1087b1282],
9	hongprasert	NN	O	hongprasert	dep	2	SENT_500	[p27l1118t1213r1740b1330],
10	S	NN	O	s	dep	9	SENT_500	[p27l1771t1219r1850b1324],
11	,	,	O	,	_	0	SENT_500	[p27l1771t1219r1850b1324],
12	et	FW	O	et	nn	13	SENT_500	[p27l1892t1233r1983b1304],
13	al.	FW	O	al.	appos	10	SENT_500	[p27l2011t1213r2125b1304],
14	.	.	O	.	_	0	SENT_500	[p27l2011t1213r2125b1304],

1	Gefitinib	NN	O	gefitinib	_	0	SENT_501	[p27l11t1362r464b1453],
2	or	CC	O	or	_	0	SENT_501	[p27l509t1392r612b1453],
3	carboplatin	NN	O	carboplatin	conj_or	1	SENT_501	[p27l652t1362r1757b1477],
4	—	CD	NUMBER	—	num	5	SENT_501	[p27l652t1362r1757b1477],
5	paclitaxel	NN	O	paclitaxel	dep	1	SENT_501	[p27l652t1362r1757b1477],
6	in	IN	O	in	_	0	SENT_501	[p27l1799t1364r1894b1451],
7	pulmonary	JJ	O	pulmonary	amod	8	SENT_501	[p27l1935t1362r2129b1477, p27l13t1541r403b1626],
8	adenocarcinoma	NN	O	adenocarcinoma	prep_in	5	SENT_501	[p27l460t1511r1325b1602],
9	.	.	O	.	_	0	SENT_501	[p27l460t1511r1325b1602],

1	N	NN	O	n	nn	3	SENT_502	[p27l1392t1519r1479b1602],
2	Engl	NNP	O	Engl	nn	3	SENT_502	[p27l1538t1511r1764b1628],
3	J	NNP	O	J	nsubj	4	SENT_502	[p27l1815t1519r1858b1616],
4	Med	VBD	O	med	_	0	SENT_502	[p27l1914t1511r2131b1602],
5	2009	CD	DATE	2009	dobj	4	SENT_502	[p27l13t1668r848b1769],
6	;	:	O	;	_	0	SENT_502	[p27l13t1668r848b1769],
7	361:947	CD	NUMBER	361:947	number	8	SENT_502	[p27l13t1668r848b1769],
8	—	CD	NUMBER	—	dep	5	SENT_502	[p27l13t1668r848b1769],
9	57	CD	NUMBER	57	dep	8	SENT_502	[p27l13t1668r848b1769],
10	.	.	O	.	_	0	SENT_502	[p27l13t1668r848b1769],

1	26	CD	NUMBER	26	_	0	SENT_503	[p27l11t1819r148b1900],
2	.	.	O	.	_	0	SENT_503	[p27l11t1819r148b1900],

1	Sequist	NNP	O	Sequist	nn	2	SENT_504	[p27l213t1811r571b1924],
2	LV	NNP	O	LV	_	0	SENT_504	[p27l598t1817r735b1918],
3	,	,	O	,	_	0	SENT_504	[p27l598t1817r735b1918],
4	Martins	NNP	PERSON	Martins	nn	5	SENT_504	[p27l772t1811r1164b1899],
5	RG	NNP	O	RG	appos	2	SENT_504	[p27l1200t1815r1380b1920],
6	,	,	O	,	_	0	SENT_504	[p27l1200t1815r1380b1920],
7	Spigel	NNP	PERSON	Spigel	nn	8	SENT_504	[p27l1425t1809r1718b1926],
8	D	NNP	O	D	appos	2	SENT_504	[p27l1751t1817r1853b1918],
9	,	,	O	,	_	0	SENT_504	[p27l1751t1817r1853b1918],
10	et	FW	O	et	nn	11	SENT_504	[p27l1896t1829r1985b1899],
11	al.	FW	O	al.	appos	2	SENT_504	[p27l2013t1809r2125b1900],
12	.	.	O	.	_	0	SENT_504	[p27l2013t1809r2125b1900],

1	First-line	JJ	O	first-line	amod	2	SENT_505	[p27l11t1958r472b2048],
2	gefitinib	NN	O	gefitinib	_	0	SENT_505	[p27l535t1958r984b2075],
3	in	IN	O	in	_	0	SENT_505	[p27l1049t1960r1146b2047],
4	patients	NNS	O	patient	prep_in	2	SENT_505	[p27l1209t1960r1619b2073],
5	with	IN	O	with	_	0	SENT_505	[p27l1680t1958r1912b2049],
6	advanced	JJ	O	advanced	amod	8	SENT_505	[p27l1977t1958r2129b2049, p27l7t2107r361b2198],
7	non	JJ	O	non	amod	8	SENT_505	[p27l434t2107r1164b2198],
8	—	NN	O	—	prep_with	4	SENT_505	[p27l434t2107r1164b2198],
9	small	JJ	O	small	amod	13	SENT_505	[p27l434t2107r1164b2198],
10	—	NN	O	—	nn	13	SENT_505	[p27l434t2107r1164b2198],
11	cell	NN	O	cell	nn	13	SENT_505	[p27l434t2107r1164b2198],
12	lung	NN	O	lung	nn	13	SENT_505	[p27l1235t2107r1461b2224],
13	cancer	NN	O	cancer	dep	2	SENT_505	[p27l1530t2137r1858b2197],
14	harboring	VBG	O	harbor	partmod	2	SENT_505	[p27l1927t2107r2129b2197, p27l13t2256r349b2373],
15	somatic	JJ	O	somatic	amod	17	SENT_505	[p27l412t2258r806b2347],
16	EGFR	NN	ORGANIZATION	egfr	nn	17	SENT_505	[p27l869t2262r1166b2353],
17	mutations	NNS	O	mutation	dobj	14	SENT_505	[p27l1219t2258r1760b2347],
18	.	.	O	.	_	0	SENT_505	[p27l1219t2258r1760b2347],

1	J	NNP	O	J	nn	3	SENT_506	[p27l1819t2264r1862b2361],
2	Clin	NNP	O	Clin	nn	3	SENT_506	[p27l1925t2256r2131b2347],
3	Oncol	NNP	O	Oncol	_	0	SENT_506	[p27l11t2405r310b2496],
4	2008	CD	DATE	2008	num	3	SENT_506	[p27l349t2411r1142b2514],
5	;	:	O	;	_	0	SENT_506	[p27l349t2411r1142b2514],
6	26:2442	CD	NUMBER	26:2442	number	7	SENT_506	[p27l349t2411r1142b2514],
7	—	CD	NUMBER	—	dep	3	SENT_506	[p27l349t2411r1142b2514],
8	9	CD	NUMBER	9	dep	7	SENT_506	[p27l349t2411r1142b2514],
9	.	.	O	.	_	0	SENT_506	[p27l349t2411r1142b2514],

1	27	CD	NUMBER	27	_	0	SENT_507	[p27l11t2566r138b2645],
2	.	.	O	.	_	0	SENT_507	[p27l11t2566r138b2645],

1	Di	NNP	ORGANIZATION	Di	nn	3	SENT_508	[p27l209t2556r322b2643],
2	Maio	NNP	ORGANIZATION	Maio	nn	3	SENT_508	[p27l351t2556r604b2645],
3	M	NN	ORGANIZATION	m	_	0	SENT_508	[p27l634t2562r761b2665],
4	,	,	O	,	_	0	SENT_508	[p27l634t2562r761b2665],
5	Chiodini	NNP	PERSON	Chiodini	nn	6	SENT_508	[p27l800t2554r1243b2645],
6	P	NN	PERSON	p	appos	3	SENT_508	[p27l1273t2562r1350b2665],
7	,	,	O	,	_	0	SENT_508	[p27l1273t2562r1350b2665],
8	Georgoulias	NNP	O	Georgoulias	nn	9	SENT_508	[p27l1391t2554r2009b2671],
9	V	NNP	O	V	appos	3	SENT_508	[p27l2040t2562r2125b2665],
10	,	,	O	,	_	0	SENT_508	[p27l2040t2562r2125b2665],
11	et	FW	O	et	nn	12	SENT_508	[p27l13t2723r102b2793],
12	al.	FW	O	al.	appos	3	SENT_508	[p27l130t2703r241b2794],
13	.	.	O	.	_	0	SENT_508	[p27l130t2703r241b2794],

1	Meta-analysis	NN	O	meta-analysis	_	0	SENT_509	[p27l280t2703r958b2818],
2	of	IN	O	of	_	0	SENT_509	[p27l996t2703r1111b2794],
3	single	JJ	O	single	amod	6	SENT_509	[p27l1126t2703r1734b2820],
4	—	JJ	O	—	amod	6	SENT_509	[p27l1126t2703r1734b2820],
5	agent	NN	O	agent	nn	6	SENT_509	[p27l1126t2703r1734b2820],
6	chemotherapy	NN	O	chemotherapy	prep_of	1	SENT_509	[p27l1763t2703r2129b2794, p27l13t2852r391b2967],
7	compared	VBN	O	compare	_	0	SENT_509	[p27l428t2852r929b2967],
8	With	IN	O	with	prepc_compared_with	6	SENT_509	[p27l966t2852r1194b2943],
9	combination	NN	O	combination	nn	10	SENT_509	[p27l1239t2852r1878b2943],
10	chemotherapy	NN	O	chemotherapy	pobj	6	SENT_509	[p27l1923t2852r2129b2942, p27l13t3001r555b3116],
11	as	IN	O	as	_	0	SENT_509	[p27l628t3031r727b3091],
12	second-line	JJ	O	second-line	amod	13	SENT_509	[p27l810t3001r1386b3092],
13	treatment	NN	O	treatment	prep_as	10	SENT_509	[p27l1466t3021r1963b3092],
14	of	IN	O	of	_	0	SENT_509	[p27l2036t3001r2153b3092],
15	advanced	JJ	O	advanced	amod	17	SENT_509	[p27l11t3150r464b3241],
16	non	JJ	O	non	amod	17	SENT_509	[p27l497t3150r1204b3241],
17	—	NN	O	—	prep_of	13	SENT_509	[p27l497t3150r1204b3241],
18	small	JJ	O	small	amod	22	SENT_509	[p27l497t3150r1204b3241],
19	—	NN	O	—	nn	22	SENT_509	[p27l497t3150r1204b3241],
20	cell	NN	O	cell	nn	22	SENT_509	[p27l497t3150r1204b3241],
21	lung	NN	O	lung	nn	22	SENT_509	[p27l1235t3150r1457b3267],
22	cancer	NN	O	cancer	dep	17	SENT_509	[p27l1486t3180r1827b3241],
23	.	.	O	.	_	0	SENT_509	[p27l1486t3180r1827b3241],

1	J	NNP	O	J	nn	3	SENT_510	[p27l1856t3158r1898b3255],
2	Clin	NNP	O	Clin	nn	3	SENT_510	[p27l1929t3150r2131b3241],
3	Oncol	NNP	O	Oncol	_	0	SENT_510	[p27l11t3299r310b3390],
4	2009	CD	DATE	2009	num	3	SENT_510	[p27l349t3305r1204b3408],
5	;	:	O	;	_	0	SENT_510	[p27l349t3305r1204b3408],
6	27:1836	CD	NUMBER	27:1836	number	7	SENT_510	[p27l349t3305r1204b3408],
7	—	CD	NUMBER	—	dep	3	SENT_510	[p27l349t3305r1204b3408],
8	43	CD	NUMBER	43	dep	7	SENT_510	[p27l349t3305r1204b3408],
9	.	.	O	.	_	0	SENT_510	[p27l349t3305r1204b3408],

1	28	CD	NUMBER	28	_	0	SENT_511	[p27l11t3458r150b3539],
2	.	.	O	.	_	0	SENT_511	[p27l11t3458r150b3539],

1	Shaw	NNP	ORGANIZATION	Shaw	nn	2	SENT_512	[p27l213t3448r478b3539],
2	AT	NNP	O	AT	_	0	SENT_512	[p27l503t3456r666b3557],
3	,	,	O	,	_	0	SENT_512	[p27l503t3456r666b3557],
4	Yeap	NNP	PERSON	Yeap	nn	5	SENT_512	[p27l703t3456r933b3563],
5	BY	NNP	O	BY	appos	2	SENT_512	[p27l966t3456r1115b3557],
6	,	,	O	,	_	0	SENT_512	[p27l966t3456r1115b3557],
7	Mino	NNP	PERSON	Mino	appos	5	SENT_512	[p27l1154t3448r1969b3541],
8	.	.	O	.	_	0	SENT_512	[p27l1154t3448r1969b3541],

1	—	NN	O	—	_	0	SENT_513	[p27l1154t3448r1969b3541],
2	.	.	O	.	_	0	SENT_513	[p27l1154t3448r1969b3541],

1	Kenudson	NN	O	kenudson	nn	2	SENT_514	[p27l1154t3448r1969b3541],
2	M	NN	O	m	_	0	SENT_514	[p27l1999t3456r2125b3557],
3	,	,	O	,	_	0	SENT_514	[p27l1999t3456r2125b3557],
4	et	FW	O	et	nn	5	SENT_514	[p27l13t3617r104b3687],
5	al.	FW	O	al.	appos	2	SENT_514	[p27l133t3597r246b3688],
6	.	.	O	.	_	0	SENT_514	[p27l133t3597r246b3688],

1	Clinical	JJ	O	clinical	amod	2	SENT_515	[p27l290t3597r680b3688],
2	features	NNS	O	feature	_	0	SENT_515	[p27l717t3595r1119b3688],
3	and	CC	O	and	_	0	SENT_515	[p27l1156t3597r1340b3688],
4	outcome	NN	O	outcome	conj_and	2	SENT_515	[p27l1377t3617r1809b3688],
5	of	IN	O	of	_	0	SENT_515	[p27l1846t3597r1963b3688],
6	patients	NNS	O	patient	prep_of	2	SENT_515	[p27l1975t3627r2129b3712, p28l13t26r296b114],

1	with	IN	O	with	_	0	SENT_516	[p28l369t24r601b115],
2	non-small	JJ	O	non-small	amod	6	SENT_516	[p28l677t24r1423b115],
3	—	NN	O	—	nn	6	SENT_516	[p28l677t24r1423b115],
4	cell	NN	O	cell	nn	6	SENT_516	[p28l677t24r1423b115],
5	lung	NN	O	lung	nn	6	SENT_516	[p28l1496t24r1726b141],
6	cancer	NN	O	cancer	pobj	1	SENT_516	[p28l1799t54r2135b115],
7	who	WP	O	who	nsubj	8	SENT_516	[p28l7t173r223b264],
8	harbor	VBP	O	harbor	rcmod	6	SENT_516	[p28l262t173r598b264],
9	EM	NN	O	em	nn	11	SENT_516	[p28l626t181r1198b266],
10	]	CD	NUMBER	]	num	11	SENT_516	[p28l626t181r1198b266],
11	L4	NN	O	l4	dobj	8	SENT_516	[p28l626t181r1198b266],
12	.	.	O	.	_	0	SENT_516	[p28l626t181r1198b266],

1	—	NN	O	—	_	0	SENT_517	[p28l626t181r1198b266],
2	.	.	O	.	_	0	SENT_517	[p28l626t181r1198b266],

1	ALK	NNP	O	ALK	_	0	SENT_518	[p28l626t181r1198b266],
2	.	.	O	.	_	0	SENT_518	[p28l626t181r1198b266],

1	J	NNP	O	J	nn	3	SENT_519	[p28l1225t181r1269b278],
2	Clin	NNP	O	Clin	nn	3	SENT_519	[p28l1298t173r1502b264],
3	Oncol	NNP	O	Oncol	_	0	SENT_519	[p28l1536t173r1827b264],
4	2009	CD	DATE	2009	num	3	SENT_519	[p28l1860t179r2127b282],
5	;	:	O	;	_	0	SENT_519	[p28l1860t179r2127b282],
6	27:4247	CD	NUMBER	27:4247	number	7	SENT_519	[p28l13t327r565b412],
7	—	CD	NUMBER	—	dep	3	SENT_519	[p28l13t327r565b412],
8	53	CD	NUMBER	53	dep	7	SENT_519	[p28l13t327r565b412],
9	.	.	O	.	_	0	SENT_519	[p28l13t327r565b412],

1	Copyright	NN	O	copyright	_	0	SENT_520	[p28l15t485r383b582],
2	©	CD	NUMBER	©	num	6	SENT_520	[p28l420t493r502b574],
3	2010	CD	DATE	2010	num	6	SENT_520	[p28l543t489r741b560],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_520	[p28l772t485r1326b559],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_520	[p28l1362t485r1667b560],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_520	[p28l1696t487r1983b582],
7	.	.	O	.	_	0	SENT_520	[p28l1696t487r1983b582],

1	RECEIVE	VB	O	receive	_	0	SENT_521	[p28l645t693r733b709],
2	IMMEDIATE	JJ	O	immediate	amod	3	SENT_521	[p28l746t693r872b709],
3	NOTIFICATION	NN	O	notification	dobj	1	SENT_521	[p28l885t693r1046b709],
4	WHEN	WRB	O	when	advmod	8	SENT_521	[p28l1058t693r1126b709],
5	AJOURNAL	NNP	O	AJOURNAL	nn	6	SENT_521	[p28l658t731r784b752],
6	ARTICLE	NN	O	article	nsubjpass	8	SENT_521	[p28l795t731r884b747],
7	IS	VBZ	O	be	auxpass	8	SENT_521	[p28l897t731r914b747],
8	RELEASED	VBN	O	release	advcl	1	SENT_521	[p28l928t731r1036b747],
9	EARLY	NN	O	early	dobj	8	SENT_521	[p28l1049t731r1114b746],

1	To	TO	O	to	aux	3	SENT_522	[p28l594t780r627b801],
2	be	VB	O	be	auxpass	3	SENT_522	[p28l636t778r664b801],
3	notiﬁed	VBN	O	notiﬁed	_	0	SENT_522	[p28l673t778r771b801],
4	when	WRB	O	when	advmod	8	SENT_522	[p28l778t778r847b801],
5	an	DT	O	a	det	6	SENT_522	[p28l856t786r885b801],
6	article	NN	O	article	nsubjpass	8	SENT_522	[p28l894t778r971b801],
7	is	VBZ	O	be	auxpass	8	SENT_522	[p28l979t778r999b801],
8	released	VBN	O	release	advcl	3	SENT_522	[p28l1008t778r1110b801],
9	early	RB	O	early	advmod	8	SENT_522	[p28l1119t778r1178b807],
10	on	IN	O	on	_	0	SENT_522	[p28l591t823r623b839],
11	the	DT	O	the	det	12	SENT_522	[p28l632t816r670b839],
12	Web	NN	MISC	web	prep_on	8	SENT_522	[p28l677t816r734b839],
13	and	CC	O	and	dep	3	SENT_522	[p28l743t816r789b839],
14	to	TO	O	to	dep	3	SENT_522	[p28l798t820r821b839],
15	receive	VB	O	receive	dep	14	SENT_522	[p28l830t816r916b839],
16	the	DT	O	the	det	17	SENT_522	[p28l924t816r963b839],
17	table	NN	O	table	dobj	15	SENT_522	[p28l972t816r1032b839],
18	of	IN	O	of	_	0	SENT_522	[p28l1041t815r1070b839],
19	contents	NNS	O	contents	prep_of	17	SENT_522	[p28l1074t821r1180b839],
20	of	IN	O	of	_	0	SENT_522	[p28l575t853r605b876],
21	thejaumal	JJ	O	thejaumal	amod	26	SENT_522	[p28l609t853r736b882],
22	by	IN	O	by	_	0	SENT_522	[p28l745t853r774b882],
23	e-mail	JJ	O	e-mail	amod	24	SENT_522	[p28l781t853r860b876],
24	every	DT	SET	every	prep_by	21	SENT_522	[p28l869t861r932b882],
25	Wednesday	NNP	DATE	Wednesday	tmod	24	SENT_522	[p28l939t853r1084b882],
26	evening	NN	TIME	evening	prep_of	19	SENT_522	[p28l1091t853r1195b883],
27	,	,	O	,	_	0	SENT_522	[p28l1091t853r1195b883],

1	sign	NN	O	sign	_	0	SENT_523	[p28l686t891r739b920],
2	up	IN	O	up	advmod	1	SENT_523	[p28l747t898r778b920],
3	through	IN	O	through	_	0	SENT_523	[p28l788t891r889b920],
4	our	PRP$	O	we	poss	6	SENT_523	[p28l898t898r940b914],
5	Web	NN	O	web	nn	6	SENT_523	[p28l947t891r1004b914],
6	site	NN	O	site	prep_through	2	SENT_523	[p28l1013t891r1056b914],
7	at	IN	O	at	dep	1	SENT_523	[p28l1064t895r1088b914],

1	NEJM.org	NN	O	nejm.org	_	0	SENT_524	[p28l818t930r953b958],
2	.	.	O	.	_	0	SENT_524	[p28l818t930r953b958],

1	N	NN	O	n	nn	3	SENT_525	[p28l546t1092r559b1107],
2	ENGLJ	NN	O	englj	nn	3	SENT_525	[p28l574t1092r652b1114],
3	MED	NN	O	med	_	0	SENT_525	[p28l667t1092r719b1107],
4	363	CD	NUMBER	363	dep	3	SENT_525	[p28l729t1086r805b1114],
5	;	:	O	;	_	0	SENT_525	[p28l729t1086r805b1114],
6	18	CD	NUMBER	18	num	8	SENT_525	[p28l729t1086r805b1114],
7	NEJM.ORG	NN	O	nejm.org	nn	8	SENT_525	[p28l841t1092r965b1114],
8	OCTOBER	NN	DATE	october	dep	4	SENT_525	[p28l1000t1092r1112b1107],
9	28	CD	DATE	28	dep	8	SENT_525	[p28l1122t1086r1157b1112],
10	,	,	DATE	,	_	0	SENT_525	[p28l1122t1086r1157b1112],
11	2010	CD	DATE	2010	num	12	SENT_525	[p28l1169t1092r1229b1108],
12	1703	CD	DATE	1703	appos	9	SENT_525	[p28l1940t1082r2015b1105],

1	The	DT	O	the	det	4	SENT_526	[p28l702t1125r753b1149],
2	New	NNP	O	New	nn	4	SENT_526	[p28l762t1126r824b1149],
3	England	NNP	O	England	nn	4	SENT_526	[p28l833t1125r944b1156],
4	Journal	NNP	O	Journal	_	0	SENT_526	[p28l952t1125r1050b1149],
5	of	IN	O	of	_	0	SENT_526	[p28l1059t1125r1088b1149],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_526	[p28l1095t1125r1220b1149],

